data_1bct_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bct _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.634 0.254 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.9 t -47.03 -60.46 2.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.7 t -59.3 -40.44 86.19 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.473 -0.767 . . . . 0.0 112.462 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -56.56 -53.91 52.11 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.628 -0.67 . . . . 0.0 111.523 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -59.46 -44.0 93.09 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.809 -0.557 . . . . 0.0 112.287 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -54.19 -48.59 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.763 -0.586 . . . . 0.0 111.559 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.4 tt -52.4 -56.1 17.25 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.831 -0.543 . . . . 0.0 110.816 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.28 -47.82 71.91 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -50.76 -58.19 6.53 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.735 -0.603 . . . . 0.0 111.492 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.59 -50.75 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 122.047 -0.408 . . . . 0.0 111.945 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 47.0 p -58.64 -49.04 78.98 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.8 -48.25 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.512 -0.743 . . . . 0.0 111.846 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.26 -53.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.723 -0.611 . . . . 0.0 110.96 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.2 tt -51.78 -51.74 54.09 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.817 -0.552 . . . . 0.0 110.499 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -50.4 -56.22 12.37 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -61.02 -42.77 99.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.717 0.77 . . . . 0.0 111.728 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.97 68.12 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -57.4 -54.85 50.62 Favored Pre-proline 0 N--CA 1.475 0.819 0 O-C-N 121.289 -0.882 . . . . 0.0 112.889 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -60.51 -36.86 84.45 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.943 2.429 . . . . 0.0 112.606 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.58 -55.27 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.813 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 82.1 t -56.03 -45.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.972 0.509 . . . . 0.0 111.283 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -51.51 -58.98 4.8 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.935 -0.478 . . . . 0.0 111.252 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.63 -47.17 49.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.226 0.611 . . . . 0.0 111.63 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.91 -55.64 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.834 -0.541 . . . . 0.0 110.239 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 O-C-N 121.671 -0.643 . . . . 0.0 113.546 177.14 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.956 0.408 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.65 -54.82 39.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.031 -0.418 . . . . 0.0 110.85 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.29 -53.53 27.87 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.223 0.535 . . . . 0.0 111.252 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.74 -52.82 54.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.127 0.571 . . . . 0.0 111.254 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.34 -48.14 68.76 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.772 -0.58 . . . . 0.0 112.351 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -53.42 -49.7 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.544 -0.723 . . . . 0.0 111.239 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.94 -51.09 64.92 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.986 -0.446 . . . . 0.0 111.237 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -50.38 -53.09 31.72 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.907 -0.496 . . . . 0.0 111.612 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.24 -54.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 122.04 -0.412 . . . . 0.0 111.895 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 70.4 p -57.37 -45.37 84.5 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.666 -0.646 . . . . 0.0 111.752 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.93 73.98 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.002 -0.436 . . . . 0.0 111.975 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -54.52 -48.62 71.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.16 -51.92 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.855 -0.528 . . . . 0.0 111.165 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.51 -50.95 46.05 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 121.964 -0.46 . . . . 0.0 112.039 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -52.52 -49.73 64.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.165 -0.609 . . . . 0.0 111.385 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.78 -52.86 32.26 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 121.93 -0.481 . . . . 0.0 111.964 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.9 mt -53.67 -50.56 65.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 122.084 -0.656 . . . . 0.0 111.93 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.24 -51.46 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 122.064 -0.397 . . . . 0.0 111.384 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.3 tp . . . . . 0 N--CA 1.476 0.827 0 O-C-N 121.936 -0.478 . . . . 0.0 112.281 179.344 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 120.698 0.285 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -66.74 -46.98 73.7 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.844 -0.535 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 89.4 m -51.99 -50.17 61.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.674 0.39 . . . . 0.0 111.356 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.6 -53.24 59.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.896 -0.503 . . . . 0.0 111.129 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.82 -48.39 59.81 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.16 -50.68 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.984 -0.448 . . . . 0.0 111.549 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tt -52.57 -54.26 35.29 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.099 0.476 . . . . 0.0 111.092 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -52.67 -48.61 66.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.176 0.59 . . . . 0.0 111.761 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -53.32 -57.9 8.95 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.97 -0.456 . . . . 0.0 111.472 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 69.5 t -52.25 -49.61 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.959 -0.463 . . . . 0.0 112.192 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 45.6 p -58.46 -53.79 54.3 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.775 -0.578 . . . . 0.0 111.921 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.44 -46.18 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.421 -0.8 . . . . 0.0 111.991 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.53 -53.31 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.65 -0.656 . . . . 0.0 110.913 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 tt -51.74 -50.08 61.3 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.699 -0.626 . . . . 0.0 110.547 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.83 -54.62 31.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 111.851 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -61.89 -41.91 98.45 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.582 0.706 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.54 66.81 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -58.58 -56.92 30.68 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.197 -0.939 . . . . 0.0 111.859 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -60.38 -35.84 89.46 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.898 2.399 . . . . 0.0 112.65 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.83 -56.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.563 -0.711 . . . . 0.0 111.041 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 77.1 t -56.99 -45.62 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.831 -0.543 . . . . 0.0 111.229 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -53.12 -52.03 60.02 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 0.0 111.287 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.33 -49.29 64.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.14 0.576 . . . . 0.0 111.185 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 86.4 mt -51.92 -49.79 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.302 -0.874 . . . . 0.0 110.842 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.625 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 177.541 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.427 HD11 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -61.79 -44.25 97.25 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.451 -0.781 . . . . 0.0 112.024 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.427 ' N ' HD11 ' A' ' 206' ' ' LEU . 91.6 mt -57.62 -50.97 71.39 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.511 -0.743 . . . . 0.0 111.398 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.62 -53.3 48.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 59.8 ttp -52.36 -50.67 61.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.209 0.604 . . . . 0.0 112.385 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -52.27 -49.62 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.466 -0.771 . . . . 0.0 111.592 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.63 -49.02 73.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.136 0.493 . . . . 0.0 111.811 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -54.11 -51.96 62.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.14 0.495 . . . . 0.0 111.853 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.1 -54.66 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.117 -0.364 . . . . 0.0 111.688 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.4 p -56.0 -46.42 78.72 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.713 -0.617 . . . . 0.0 112.014 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.13 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.917 -0.489 . . . . 0.0 111.975 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.59 -48.49 74.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.956 -0.465 . . . . 0.0 112.087 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.8 t -55.04 -52.14 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.948 -0.47 . . . . 0.0 111.137 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.93 -51.65 33.69 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.83 -48.72 66.8 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 122.23 -0.57 . . . . 0.0 111.224 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.99 -56.41 16.63 Favored Glycine 0 N--CA 1.475 1.252 0 O-C-N 121.874 -0.516 . . . . 0.0 112.205 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.4 -45.66 69.41 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.734 -0.862 . . . . 0.0 112.265 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.7 mt -55.73 -49.95 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.741 -0.6 . . . . 0.0 111.661 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.3 tp . . . . . 0 N--CA 1.475 0.818 0 C-N-CA 122.944 0.498 . . . . 0.0 111.766 177.427 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 80.3 p -59.79 -48.47 81.54 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.62 -0.675 . . . . 0.0 112.085 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 25.5 p -56.42 -43.21 79.16 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.931 -0.481 . . . . 0.0 112.204 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -55.08 -48.04 74.08 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.715 -0.616 . . . . 0.0 111.501 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -52.89 -53.24 51.99 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.974 -0.454 . . . . 0.0 111.287 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.14 -46.48 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 122.426 0.29 . . . . 0.0 111.589 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 tt -51.32 -59.83 3.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.915 0.486 . . . . 0.0 110.889 177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -58.26 -44.06 88.17 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -51.23 -59.79 3.82 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.797 -0.564 . . . . 0.0 111.571 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.3 t -55.57 -49.29 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 122.073 -0.392 . . . . 0.0 111.774 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.4 p -56.84 -49.59 74.99 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.5 t -56.89 -48.83 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.503 -0.748 . . . . 0.0 111.667 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.2 t -56.67 -57.79 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.664 -0.648 . . . . 0.0 111.494 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 97.4 mt -56.07 -42.83 77.28 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.466 -0.771 . . . . 0.0 112.002 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -52.11 -59.54 4.25 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.999 -0.438 . . . . 0.0 111.924 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.6 p -60.85 -37.52 82.36 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.457 0.646 . . . . 0.0 111.928 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.33 63.81 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -54.89 -58.61 13.72 Favored Pre-proline 0 N--CA 1.478 0.945 0 CA-C-N 119.223 0.919 . . . . 0.0 113.213 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -57.9 -37.55 95.77 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.897 2.398 . . . . 0.0 112.678 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.05 -54.89 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.765 -0.584 . . . . 0.0 111.03 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 78.3 t -56.0 -46.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.891 -0.506 . . . . 0.0 111.386 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.8 t90 -50.71 -55.32 17.13 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.966 -0.459 . . . . 0.0 111.391 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tt -52.56 -50.8 62.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.781 0.433 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 97.9 mt -52.15 -52.74 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.683 -0.635 . . . . 0.0 111.296 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.542 0 O-C-N 121.833 -0.542 . . . . 0.0 114.258 179.145 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.812 0.339 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -52.95 -54.31 36.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.027 -0.421 . . . . 0.0 111.235 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.1 tp -51.23 -51.59 52.59 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.947 -0.47 . . . . 0.0 111.979 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -53.65 -50.54 65.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.871 0.367 . . . . 0.0 111.356 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 57.3 ttp -54.01 -51.09 65.06 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 122.07 -0.393 . . . . 0.0 111.977 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.09 -50.26 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.787 -0.571 . . . . 0.0 111.507 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 95.4 mt -53.78 -52.39 60.39 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.062 -0.399 . . . . 0.0 111.73 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.45 -56.13 14.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.82 -0.55 . . . . 0.0 111.227 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.3 t -50.6 -52.88 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.3 p -58.13 -44.08 87.59 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.696 -0.627 . . . . 0.0 111.586 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.07 -48.49 75.99 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.897 -0.502 . . . . 0.0 111.961 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -58.18 -45.09 88.13 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.872 -0.518 . . . . 0.0 112.227 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.8 t -55.41 -50.42 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.44 -0.787 . . . . 0.0 111.405 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.99 -51.18 47.63 Favored Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.77 -52.44 31.85 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.087 0.555 . . . . 0.0 111.268 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.11 -52.42 35.81 Favored Glycine 0 N--CA 1.477 1.398 0 O-C-N 121.803 -0.56 . . . . 0.0 112.585 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 66.7 tp -54.58 -52.65 61.47 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.04 -0.682 . . . . 0.0 111.64 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.73 -49.96 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.67 0.388 . . . . 0.0 111.421 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.0 tp . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 122.938 0.495 . . . . 0.0 111.85 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 120.356 0.122 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.3 m -52.32 -57.54 9.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 23.9 p -58.38 -46.81 85.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.74 -48.73 72.21 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.699 -0.626 . . . . 0.0 111.662 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.25 -49.95 74.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.614 -0.679 . . . . 0.0 112.284 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.6 t -54.29 -47.3 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 121.819 -0.551 . . . . 0.0 111.738 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.8 tt -52.85 -56.65 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.001 -0.437 . . . . 0.0 110.788 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -52.05 -49.24 63.85 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -49.73 -59.41 3.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.981 -0.449 . . . . 0.0 111.7 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.76 -52.28 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 122.057 -0.402 . . . . 0.0 111.94 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -58.03 -49.7 75.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.5 t -59.53 -50.46 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.598 -0.688 . . . . 0.0 111.59 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.83 -48.82 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.826 -0.546 . . . . 0.0 111.319 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.29 -56.13 21.53 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.795 -0.565 . . . . 0.0 110.876 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -54.09 -51.43 64.19 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -59.32 -44.8 92.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.602 -0.686 . . . . 0.0 112.0 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.84 -20.2 64.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -58.91 -55.71 43.55 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 120.99 -1.069 . . . . 0.0 112.134 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -60.43 -31.84 93.09 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.0 2.466 . . . . 0.0 112.769 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.11 -52.31 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.463 -0.773 . . . . 0.0 110.672 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.07 -46.38 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.848 -0.533 . . . . 0.0 111.024 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -51.83 -55.95 16.89 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.995 -0.441 . . . . 0.0 111.157 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.915 0.886 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 73.4 mt -51.59 -60.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 CA-C-O 121.283 0.38 . . . . 0.0 113.067 179.669 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.7 mt -54.31 -54.76 35.88 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -48.34 75.07 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.666 -0.647 . . . . 0.0 111.778 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -53.5 -53.36 52.58 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.029 -0.419 . . . . 0.0 111.463 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 58.1 ttp -49.38 -48.79 46.68 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.324 0.65 . . . . 0.0 112.45 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.1 t -51.29 -51.0 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.725 -0.609 . . . . 0.0 111.201 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.8 mt -54.92 -51.46 65.99 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 122.203 -0.311 . . . . 0.0 111.605 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -51.08 -50.83 57.96 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.875 -0.516 . . . . 0.0 111.969 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.5 -51.2 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.5 p -58.55 -46.05 87.66 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.433 -0.792 . . . . 0.0 111.681 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.1 77.03 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.925 -0.484 . . . . 0.0 111.845 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -50.01 -54.25 21.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.899 0.48 . . . . 0.0 111.648 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.3 t -55.26 -50.56 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 122.212 -0.305 . . . . 0.0 111.555 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.95 -51.49 34.42 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 121.897 -0.502 . . . . 0.0 112.134 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.34 -52.58 63.03 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.972 -0.722 . . . . 0.0 111.289 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.82 -48.45 44.47 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 94.8 mt -56.02 -56.31 22.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.205 -0.585 . . . . 0.0 111.921 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.1 mt -49.66 -43.81 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.542 0.687 . . . . 0.0 111.736 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 N--CA 1.47 0.527 0 O-C-N 121.818 -0.551 . . . . 0.0 110.513 175.168 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.5 p -73.66 -44.02 57.85 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.387 -0.821 . . . . 0.0 111.116 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.0 t -57.38 -43.25 83.45 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.418 -0.802 . . . . 0.0 110.735 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.76 -50.45 73.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.689 -0.632 . . . . 0.0 110.926 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -50.32 -50.56 50.47 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.42 -53.04 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.629 0.372 . . . . 0.0 111.712 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tt -51.16 -53.54 33.68 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.382 0.611 . . . . 0.0 110.59 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.9 ttm105 -52.33 -51.78 56.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.609 0.764 . . . . 0.0 112.401 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -53.03 -54.08 40.61 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.566 -0.708 . . . . 0.0 111.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.76 -52.79 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.02 -0.425 . . . . 0.0 111.648 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 56.5 p -55.05 -44.8 75.05 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.647 -0.658 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 68.9 t -56.11 -48.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.561 -0.712 . . . . 0.0 111.83 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.82 -55.12 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.526 -0.734 . . . . 0.0 111.473 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.4 -45.06 72.85 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.438 -0.789 . . . . 0.0 112.116 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -55.44 23.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.011 -0.431 . . . . 0.0 111.367 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.7 p -61.47 -38.85 88.74 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.562 -0.711 . . . . 0.0 112.533 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.89 -56.66 17.99 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.738 -0.601 . . . . 0.0 112.309 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -37.62 -56.99 1.63 Allowed Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -59.61 -44.58 30.91 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.001 2.467 . . . . 0.0 112.379 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.4 -46.87 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.751 -0.593 . . . . 0.0 110.682 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.1 t -51.25 -53.14 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -57.05 -52.47 65.13 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.932 -0.48 . . . . 0.0 111.768 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 59.7 tp -46.18 -50.81 15.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.59 -43.72 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.799 -0.563 . . . . 0.0 111.448 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 CA-C-O 121.753 0.64 . . . . 0.0 112.836 173.874 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.445 HD13 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -61.74 -38.93 89.78 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.579 -0.701 . . . . 0.0 112.28 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 206' ' ' LEU . 64.6 tp -54.84 -54.39 43.0 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.51 -0.744 . . . . 0.0 110.937 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.11 -50.35 61.84 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.258 0.623 . . . . 0.0 111.187 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 63.5 mtt -52.23 -52.3 53.21 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.654 -0.654 . . . . 0.0 112.395 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.68 -47.76 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.639 -0.663 . . . . 0.0 111.674 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -54.72 -47.98 73.08 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -54.23 -56.11 21.5 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.873 -0.517 . . . . 0.0 110.713 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.8 t -51.68 -54.97 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.97 -0.456 . . . . 0.0 111.918 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 61.8 p -58.08 -50.48 73.32 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.665 -0.647 . . . . 0.0 112.451 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.7 85.56 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.857 -0.527 . . . . 0.0 111.907 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -55.71 -50.48 70.21 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.572 0.749 . . . . 0.0 111.343 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.95 -51.39 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.998 -0.439 . . . . 0.0 111.11 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -49.52 -51.29 27.94 Favored Glycine 0 N--CA 1.476 1.307 0 O-C-N 121.935 -0.478 . . . . 0.0 111.926 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -53.96 -47.64 71.14 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.142 -0.622 . . . . 0.0 111.182 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.46 -51.16 22.55 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.975 -0.453 . . . . 0.0 112.446 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 9.2 mp -58.37 -52.27 66.31 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.933 -0.745 . . . . 0.0 112.07 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.2 mt -49.87 -46.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.818 -0.551 . . . . 0.0 111.376 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 N--CA 1.47 0.565 0 O-C-N 121.823 -0.548 . . . . 0.0 110.443 173.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 121.37 0.605 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.1 m -54.19 -63.38 1.17 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.067 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 86.8 m -61.96 -48.68 79.3 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.893 -0.505 . . . . 0.0 111.302 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.9 -52.71 47.97 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 110.795 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.513 ' HZ2' ' HB3' ' A' ' 172' ' ' LYS . 6.9 ttpm? -59.24 -51.68 68.92 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 63.9 t -55.71 -53.41 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.846 -0.533 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.15 -47.23 86.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.699 -0.625 . . . . 0.0 112.242 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -56.25 -48.19 77.03 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.726 -0.609 . . . . 0.0 111.551 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -53.03 -55.42 23.86 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.688 -0.632 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.5 t -52.34 -50.38 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 67.6 p -58.74 -47.18 85.52 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.546 -0.721 . . . . 0.0 112.282 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 75.3 t -56.55 -51.45 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.528 -0.732 . . . . 0.0 111.775 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -53.78 -46.01 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.918 -0.489 . . . . 0.0 111.357 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.74 -56.42 20.68 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.686 -0.634 . . . . 0.0 110.931 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -55.53 -48.55 74.52 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.739 -0.601 . . . . 0.0 112.422 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.4 p -60.77 -44.01 97.32 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.644 -0.66 . . . . 0.0 112.11 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.81 -22.01 66.32 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.41 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 1.2 t80 -59.49 -54.92 51.22 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 120.97 -1.081 . . . . 0.0 111.431 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 56.1 Cg_endo -61.21 -34.73 88.04 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.58 2.187 . . . . 0.0 112.365 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.4 -51.78 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.12 0.873 . . . . 0.0 111.556 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.83 -50.21 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.686 -0.634 . . . . 0.0 111.304 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -60.7 -46.31 90.87 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.871 -0.518 . . . . 0.0 111.969 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 26.6 tp -46.35 -50.28 16.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.131 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.5 mt -57.7 -59.82 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.981 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 CA-C-O 121.403 0.446 . . . . 0.0 112.362 179.141 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.907 0.384 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -47.96 83.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.005 -0.434 . . . . 0.0 112.164 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -54.87 24.23 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.545 -0.722 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -54.71 -49.93 69.54 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.454 0.302 . . . . 0.0 111.379 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 47.8 ttm -51.08 -49.5 60.53 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 72.6 t -54.14 -48.86 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.456 -0.777 . . . . 0.0 111.306 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.41 -51.32 65.25 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.948 -0.47 . . . . 0.0 111.284 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -51.11 -50.35 58.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.151 0.58 . . . . 0.0 111.617 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.97 -54.07 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 64.4 p -57.18 -45.34 83.79 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.351 -0.843 . . . . 0.0 111.539 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.27 76.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.707 0.403 . . . . 0.0 111.504 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -52.48 -50.78 62.02 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.949 -0.469 . . . . 0.0 111.952 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.41 -53.21 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 122.087 -0.383 . . . . 0.0 111.297 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.82 -50.55 49.59 Favored Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -54.31 -51.49 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.247 -0.561 . . . . 0.0 111.262 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.2 51.28 Favored Glycine 0 N--CA 1.475 1.281 0 O-C-N 121.923 -0.486 . . . . 0.0 112.216 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 87.1 mt -56.05 -51.22 68.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.966 -0.726 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.2 mt -55.8 -48.28 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.856 -0.527 . . . . 0.0 111.905 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.2 tp . . . . . 0 N--CA 1.474 0.75 0 O-C-N 121.874 -0.516 . . . . 0.0 111.562 177.563 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 t -66.08 -49.75 66.49 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.596 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 84.5 m -53.52 -52.88 58.2 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 122.341 -0.225 . . . . 0.0 111.43 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -56.34 -49.31 74.72 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.622 -0.674 . . . . 0.0 111.708 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.52 -50.62 69.5 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.603 -0.686 . . . . 0.0 111.771 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.23 -58.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.967 -0.458 . . . . 0.0 111.668 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.18 -41.32 83.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 175' ' ' ARG . 15.2 mmm-85 -60.96 -47.71 85.19 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.066 -1.021 . . . . 0.0 112.542 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -52.89 -51.48 61.03 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.816 -0.553 . . . . 0.0 110.645 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.06 -54.21 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 p -55.61 -46.46 77.35 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.49 -0.756 . . . . 0.0 112.666 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.55 -53.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.628 -0.67 . . . . 0.0 111.799 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.55 -45.91 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.777 -0.577 . . . . 0.0 111.837 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.79 -53.1 61.67 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.674 -0.641 . . . . 0.0 110.498 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -54.35 -51.63 64.16 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.032 -0.418 . . . . 0.0 112.03 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.5 p -61.68 -40.64 95.68 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -58.76 -47.66 83.89 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.444 -0.785 . . . . 0.0 112.571 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -41.3 -58.05 3.18 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -61.05 -38.16 70.21 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.157 2.571 . . . . 0.0 112.572 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.58 -53.17 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.574 -0.704 . . . . 0.0 110.768 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 72.4 t -53.59 -50.37 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.318 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -54.37 -54.77 36.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.871 0.367 . . . . 0.0 111.211 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.4 tp -49.11 -51.41 31.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.542 0.737 . . . . 0.0 111.479 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.02 -57.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.982 -0.448 . . . . 0.0 110.005 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.334 0 O-C-N 122.079 -0.388 . . . . 0.0 112.401 177.251 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.583 0.23 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.63 -50.2 72.72 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.927 -0.483 . . . . 0.0 112.064 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -53.43 -53.71 47.42 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.765 -0.584 . . . . 0.0 110.511 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.97 -48.41 73.27 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.104 -0.373 . . . . 0.0 110.852 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.6 ttt -52.62 -49.97 64.04 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.688 -0.633 . . . . 0.0 111.872 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.0 t -52.98 -50.61 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.54 -0.725 . . . . 0.0 111.28 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.3 mt -54.52 -50.23 68.33 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.888 -0.507 . . . . 0.0 112.194 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.22 -54.1 44.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.966 0.507 . . . . 0.0 111.426 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.04 -55.07 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.987 -0.445 . . . . 0.0 111.517 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -55.79 -47.63 76.75 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.596 -0.69 . . . . 0.0 112.284 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.96 -49.7 72.83 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.902 -0.499 . . . . 0.0 111.875 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 216' ' ' LYS . 0.1 OUTLIER -58.53 -43.1 89.07 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.804 0.442 . . . . 0.0 112.164 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 69.3 t -55.01 -54.01 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.495 -0.753 . . . . 0.0 110.645 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.87 -50.54 37.62 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -50.4 -50.63 51.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.159 0.583 . . . . 0.0 110.987 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.91 -51.65 33.59 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 122.004 -0.435 . . . . 0.0 112.549 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.33 -52.52 63.23 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 122.081 -0.658 . . . . 0.0 111.858 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 94.6 mt -54.7 -47.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.162 0.506 . . . . 0.0 111.894 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 29.2 tp . . . . . 0 N--CA 1.472 0.66 0 O-C-N 121.784 -0.572 . . . . 0.0 109.743 175.769 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 61.1 p -51.89 -63.31 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 m -74.89 -43.38 54.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 -174.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.03 -44.56 91.76 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.027 -0.42 . . . . 0.0 111.951 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.56 -50.26 72.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.232 -0.917 . . . . 0.0 110.997 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 83.7 t -54.6 -53.67 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.587 0.232 . . . . 0.0 110.497 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.42 -57.35 8.21 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.166 0.586 . . . . 0.0 111.237 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.439 ' HE ' ' HA ' ' A' ' 176' ' ' ASN . 2.4 tmm_? -50.24 -57.95 6.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.336 0.654 . . . . 0.0 110.581 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.439 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 7.7 t30 -58.41 -49.7 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.169 -0.332 . . . . 0.0 111.181 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -54.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 23.9 p -55.47 -50.62 69.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.74 -0.6 . . . . 0.0 111.81 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.77 -50.87 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.701 -0.624 . . . . 0.0 111.606 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.1 t -55.86 -51.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.888 -0.508 . . . . 0.0 111.837 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -53.13 -48.13 68.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.252 -0.905 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -55.72 -52.83 62.56 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.4 p -60.7 -41.98 96.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.771 0.796 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -17.17 61.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.439 ' HB3' ' CD ' ' A' ' 186' ' ' PRO . 1.5 t80 -59.25 -59.9 12.32 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 119.972 1.26 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.439 ' CD ' ' HB3' ' A' ' 185' ' ' TYR . 52.5 Cg_endo -61.86 -30.99 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.88 2.387 . . . . 0.0 113.187 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.45 -56.56 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.408 -0.808 . . . . 0.0 110.675 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.92 -43.58 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.939 -0.476 . . . . 0.0 111.313 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -51.18 -59.46 4.17 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.038 -0.414 . . . . 0.0 111.086 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -50.99 45.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.388 0.675 . . . . 0.0 110.432 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.58 -61.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 122.127 -0.358 . . . . 0.0 110.612 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 O-C-N 122.025 -0.422 . . . . 0.0 112.129 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.5 -50.74 70.91 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.676 -0.64 . . . . 0.0 112.3 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.9 tp -51.42 -51.05 58.2 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.443 0.64 . . . . 0.0 111.479 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.27 -52.9 61.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.118 0.485 . . . . 0.0 111.068 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 42.1 ttm -50.42 -49.64 54.22 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 112.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.34 -51.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.614 -0.678 . . . . 0.0 111.464 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.41 -48.95 71.01 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.2 0.524 . . . . 0.0 111.624 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 216' ' ' LYS . 70.7 m-20 -53.75 -54.37 39.06 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.006 -0.434 . . . . 0.0 111.908 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.35 -54.83 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.899 -0.501 . . . . 0.0 111.911 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -56.17 -45.22 79.8 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.42 -48.86 68.36 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.848 -0.532 . . . . 0.0 112.255 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 212' ' ' ASP . 9.5 mmtp -57.29 -46.48 83.1 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 122.003 -0.436 . . . . 0.0 111.598 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.42 -52.23 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.716 -0.615 . . . . 0.0 110.711 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.44 -51.17 33.03 Favored Glycine 0 N--CA 1.478 1.435 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -51.76 -48.51 63.68 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 122.364 -0.492 . . . . 0.0 111.584 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -49.65 -52.59 24.3 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 122.035 -0.415 . . . . 0.0 112.348 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.23 -50.79 72.31 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.05 -0.677 . . . . 0.0 112.331 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 38.6 mt -49.27 -49.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 121.299 0.571 . . . . 0.0 111.67 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 40.2 tp . . . . . 0 N--CA 1.475 0.788 0 O-C-N 121.847 -0.533 . . . . 0.0 111.125 174.622 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.787 0.327 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m -59.04 -52.95 63.55 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 0.0 111.696 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.2 p -56.59 -48.07 78.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.33 -46.63 83.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.735 -0.603 . . . . 0.0 111.303 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.559 ' HZ2' ' HB3' ' A' ' 172' ' ' LYS . 8.3 mtpm? -51.92 -51.32 57.77 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.484 -0.76 . . . . 0.0 112.102 174.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.59 -53.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.43 -52.01 63.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.215 0.531 . . . . 0.0 111.97 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 -52.32 -52.63 52.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.409 0.683 . . . . 0.0 111.47 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -51.35 -57.93 7.6 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.925 -0.484 . . . . 0.0 111.614 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.0 t -54.41 -49.8 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.963 -0.46 . . . . 0.0 112.17 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.7 p -58.84 -49.34 78.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.62 -0.675 . . . . 0.0 112.718 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.9 t -57.21 -49.93 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.463 -0.773 . . . . 0.0 111.742 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.76 -51.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.742 -0.599 . . . . 0.0 110.929 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.9 tt -51.51 -50.07 60.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.57 -0.706 . . . . 0.0 111.395 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 42.7 t90 -51.81 -57.4 9.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.5 p -61.54 -37.48 83.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.52 0.676 . . . . 0.0 112.214 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.57 65.7 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -57.32 -56.1 37.41 Favored Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 121.137 -0.977 . . . . 0.0 111.97 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -59.9 -33.41 95.85 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.793 2.329 . . . . 0.0 113.145 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.1 t -59.3 -53.17 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.397 -0.814 . . . . 0.0 111.116 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.7 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.805 -0.559 . . . . 0.0 110.95 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -52.54 -56.4 15.52 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.139 -0.35 . . . . 0.0 111.428 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.09 -56.04 2.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.871 0.869 . . . . 0.0 110.128 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.1 mt -54.94 -59.67 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 122.04 -0.413 . . . . 0.0 110.655 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -175.767 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -62.56 -42.71 99.72 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.614 -0.678 . . . . 0.0 112.417 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.425 ' N ' HD11 ' A' ' 206' ' ' LEU . 5.0 tt -56.26 -53.8 52.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.538 -0.726 . . . . 0.0 110.027 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -52.87 -50.57 63.54 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.659 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 54.5 ttm -51.29 -49.72 60.71 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -52.65 -52.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.694 -0.629 . . . . 0.0 111.289 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.54 -51.46 66.97 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.33 0.586 . . . . 0.0 111.827 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -48.78 -53.95 17.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.605 0.762 . . . . 0.0 111.327 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.84 -51.01 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 58.5 p -57.27 -39.13 75.04 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.281 -0.887 . . . . 0.0 111.486 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.89 73.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -52.76 -51.27 61.3 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 110.98 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.14 -52.42 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.067 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.12 -50.83 50.03 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.62 -50.87 67.07 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.093 -0.651 . . . . 0.0 111.235 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.39 -50.23 41.94 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.753 -0.592 . . . . 0.0 112.134 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.54 -53.56 54.86 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.153 -0.616 . . . . 0.0 112.15 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 79.0 mt -52.55 -51.95 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.108 0.48 . . . . 0.0 111.082 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 43.7 tp . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 123.406 0.682 . . . . 0.0 112.128 -178.02 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.034 0.445 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.3 m -49.3 -52.92 24.6 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.3 m -57.14 -49.72 75.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.805 -0.559 . . . . 0.0 111.586 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.18 -48.02 71.39 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.112 0.482 . . . . 0.0 111.709 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -55.65 -49.21 73.5 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.783 -0.573 . . . . 0.0 112.061 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.5 -49.16 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.94 -0.475 . . . . 0.0 111.667 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.4 tt -52.18 -55.0 23.9 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.184 0.516 . . . . 0.0 110.497 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -52.72 -50.5 63.29 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -52.82 -56.87 12.58 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.581 -0.699 . . . . 0.0 111.995 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.7 t -54.17 -49.74 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.971 -0.456 . . . . 0.0 111.935 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.2 p -56.16 -46.04 79.44 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.625 -0.672 . . . . 0.0 112.6 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.51 -48.4 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.373 -0.83 . . . . 0.0 111.879 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -54.16 -48.52 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.629 -0.669 . . . . 0.0 111.668 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.7 mt -55.61 -50.01 71.28 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.509 -0.744 . . . . 0.0 111.887 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -53.22 -53.3 52.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.868 -0.52 . . . . 0.0 112.353 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.5 p -61.5 -38.38 87.13 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.09 95.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.207 -0.933 . . . . 0.0 112.463 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -40.79 -51.83 6.84 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -58.47 -40.4 74.94 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.905 2.404 . . . . 0.0 112.516 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.5 t -60.63 -45.08 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.795 -0.565 . . . . 0.0 110.375 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.54 -50.05 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.823 -0.548 . . . . 0.0 110.723 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -53.1 -51.19 62.67 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 48.0 tp -47.04 -53.38 12.7 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.985 -0.447 . . . . 0.0 111.511 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -52.39 -55.71 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 O-C-N 121.89 -0.506 . . . . 0.0 112.192 177.043 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -60.78 -39.86 90.42 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.626 -0.671 . . . . 0.0 112.279 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.416 ' N ' HD13 ' A' ' 206' ' ' LEU . 3.1 tm? -54.09 -56.19 20.43 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.544 -0.723 . . . . 0.0 110.603 174.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.43 -53.48 29.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.556 0.342 . . . . 0.0 111.385 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 92.6 mtp -49.1 -49.64 40.9 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 76.6 t -52.87 -51.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.601 -0.687 . . . . 0.0 111.372 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.83 -47.84 73.6 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -54.22 -52.59 60.82 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.703 -0.623 . . . . 0.0 111.889 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.8 t -56.38 -54.94 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.925 -0.484 . . . . 0.0 111.899 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.1 p -56.24 -47.68 77.99 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.781 -0.574 . . . . 0.0 112.3 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.03 -48.72 75.45 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.905 -0.497 . . . . 0.0 111.972 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -53.32 50.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.589 0.356 . . . . 0.0 111.273 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.26 -51.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.077 -0.39 . . . . 0.0 111.281 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.59 31.87 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -53.97 -47.56 71.23 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.239 -0.565 . . . . 0.0 111.583 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.21 -54.37 12.72 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.57 -53.35 58.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.134 -0.627 . . . . 0.0 112.226 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.8 mt -52.2 -54.05 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.6 tp . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 123.279 0.632 . . . . 0.0 111.698 -179.882 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -51.07 -65.19 0.6 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.235 -0.291 . . . . 0.0 111.751 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.2 p -67.91 -39.52 83.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.424 -0.798 . . . . 0.0 111.83 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -53.69 -54.57 36.01 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.053 -0.404 . . . . 0.0 111.597 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.51 -47.21 84.93 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.747 -0.595 . . . . 0.0 112.128 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -50.17 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.873 -0.517 . . . . 0.0 111.569 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.8 tp -57.27 -48.57 78.54 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.775 -0.578 . . . . 0.0 111.541 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 20.8 mmm-85 -57.68 -44.79 86.02 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.453 -0.779 . . . . 0.0 112.919 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -51.31 -56.61 12.11 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.78 -0.575 . . . . 0.0 111.073 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.79 -51.08 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.2 p -56.84 -47.82 79.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.56 -47.04 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.463 -0.773 . . . . 0.0 111.979 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.94 -49.53 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.684 -0.635 . . . . 0.0 111.491 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.03 -48.34 76.14 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.628 -0.67 . . . . 0.0 111.994 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -52.37 -54.42 32.06 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.0 p -59.64 -47.49 85.39 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.477 -0.764 . . . . 0.0 111.554 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.6 -14.13 61.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.415 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 4.3 t80 -62.99 -56.29 29.9 Favored Pre-proline 0 N--CA 1.476 0.832 0 O-C-N 120.84 -1.162 . . . . 0.0 111.153 -173.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 58.2 Cg_endo -62.22 -35.96 71.39 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.994 2.463 . . . . 0.0 112.243 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.28 -57.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.812 -0.555 . . . . 0.0 111.057 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.88 -40.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.806 -0.559 . . . . 0.0 111.493 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.57 -50.22 68.48 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.62 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 54.9 tp -53.2 -43.42 67.17 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.958 -0.463 . . . . 0.0 111.181 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.49 -53.95 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.359 -0.838 . . . . 0.0 109.716 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.58 0 O-C-N 121.62 -0.675 . . . . 0.0 113.738 177.788 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 96.3 m . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.36 -57.1 13.22 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.718 -0.613 . . . . 0.0 111.89 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.22 -51.28 69.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.247 0.546 . . . . 0.0 111.773 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.79 -53.07 57.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.493 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 26.9 ttt -52.04 -45.57 64.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.638 0.375 . . . . 0.0 112.003 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.8 t -51.5 -53.24 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.513 -0.742 . . . . 0.0 111.202 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.97 -50.76 68.13 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.965 -0.459 . . . . 0.0 112.173 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -52.71 -54.91 27.09 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.051 -0.406 . . . . 0.0 111.752 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.3 t -57.16 -54.71 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 122.122 -0.361 . . . . 0.0 111.741 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.4 p -55.18 -49.96 70.54 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.519 -0.738 . . . . 0.0 112.306 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.65 76.86 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.908 -0.495 . . . . 0.0 112.037 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -57.2 -48.72 78.07 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.085 -0.385 . . . . 0.0 110.826 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.8 t -53.98 -53.27 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.481 -0.762 . . . . 0.0 111.235 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.83 -50.78 36.5 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 121.797 -0.564 . . . . 0.0 111.762 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.01 -49.51 68.72 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.267 -0.549 . . . . 0.0 111.186 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.62 -49.72 51.81 Favored Glycine 0 N--CA 1.475 1.274 0 O-C-N 121.962 -0.461 . . . . 0.0 112.754 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.92 -50.67 68.25 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.942 -0.74 . . . . 0.0 111.933 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.39 -50.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.293 0.568 . . . . 0.0 111.326 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 123.482 0.713 . . . . 0.0 111.94 178.304 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 121.012 0.434 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -59.37 -54.92 41.26 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.956 -0.465 . . . . 0.0 111.808 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.7 t -58.78 -41.37 86.52 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.957 -0.465 . . . . 0.0 111.643 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -56.19 -51.9 66.36 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.476 -0.765 . . . . 0.0 111.322 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -55.05 -46.74 75.36 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.847 -0.533 . . . . 0.0 112.224 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 70.9 t -55.4 -52.09 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 122.024 -0.423 . . . . 0.0 111.521 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.7 tp -52.81 -50.51 63.51 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.711 -0.618 . . . . 0.0 111.624 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.498 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.09 -50.39 66.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -53.67 -56.08 20.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.233 -0.292 . . . . 0.0 111.013 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.77 -52.78 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.659 0.383 . . . . 0.0 111.844 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.5 p -56.71 -52.24 65.73 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 80.4 t -58.33 -48.96 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.729 -0.607 . . . . 0.0 112.001 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 77.1 t -57.25 -54.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.703 -0.623 . . . . 0.0 111.215 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.3 mt -53.23 -46.83 69.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.492 -0.755 . . . . 0.0 111.857 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.8 t90 -53.5 -56.96 12.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.1 p -61.0 -42.91 99.35 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.695 0.759 . . . . 0.0 112.151 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.1 67.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.08 -56.19 36.21 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 121.345 -0.847 . . . . 0.0 112.652 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.15 -36.05 90.07 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.971 2.447 . . . . 0.0 112.802 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.99 -55.7 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.596 -0.69 . . . . 0.0 110.925 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.24 -45.65 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.98 -0.45 . . . . 0.0 111.234 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -50.32 -58.5 5.53 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.207 -0.308 . . . . 0.0 111.015 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -47.72 -49.63 27.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.799 0.84 . . . . 0.0 110.546 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.3 mt -52.32 -59.18 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.687 -0.633 . . . . 0.0 110.486 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 CA-C-O 121.409 0.45 . . . . 0.0 112.985 179.268 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 121.147 0.498 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.73 -52.12 65.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.914 0.387 . . . . 0.0 111.792 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.5 tt -51.11 -56.59 11.93 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.469 0.708 . . . . 0.0 110.772 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.76 -48.43 72.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.242 0.617 . . . . 0.0 111.366 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 56.5 ttp -53.73 -50.72 65.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.597 -0.689 . . . . 0.0 111.913 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.4 t -54.3 -48.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.786 -0.571 . . . . 0.0 111.401 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.0 mt -53.31 -53.79 45.88 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.864 -0.522 . . . . 0.0 111.67 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -47.67 -54.24 12.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.888 -0.508 . . . . 0.0 111.659 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.66 -57.23 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 122.002 -0.436 . . . . 0.0 111.706 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 86.5 p -58.71 -48.7 80.22 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.695 -0.628 . . . . 0.0 112.621 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.19 94.6 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.88 -0.513 . . . . 0.0 111.319 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.437 ' HB2' ' HZ3' ' A' ' 216' ' ' LYS . 3.6 ttmp? -55.06 -49.91 70.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.77 0.428 . . . . 0.0 111.547 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.22 -52.57 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 122.041 -0.412 . . . . 0.0 111.005 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.54 -50.4 36.24 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 121.885 -0.509 . . . . 0.0 112.391 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -53.12 -49.96 65.45 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.056 -0.673 . . . . 0.0 111.102 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.43 -48.53 64.31 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 121.888 -0.508 . . . . 0.0 112.714 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.82 -45.27 82.41 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.783 -0.834 . . . . 0.0 112.463 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.13 -47.5 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.653 -0.654 . . . . 0.0 111.902 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 65.5 tp . . . . . 0 N--CA 1.476 0.827 0 O-C-N 121.794 -0.566 . . . . 0.0 110.601 175.634 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.5 m -60.32 -64.94 0.77 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.522 -0.737 . . . . 0.0 111.433 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.2 m -63.5 -36.76 84.85 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.635 -0.665 . . . . 0.0 111.758 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -52.49 -52.38 54.71 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.558 -0.714 . . . . 0.0 111.306 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -58.98 -47.27 85.74 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.939 -0.476 . . . . 0.0 111.464 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 68.8 t -51.59 -53.26 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 122.06 -0.4 . . . . 0.0 111.48 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.8 tt -54.15 -52.37 61.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.112 0.565 . . . . 0.0 110.869 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -52.35 45.57 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.948 0.404 . . . . 0.0 110.632 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -53.52 -55.11 28.3 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.701 -0.625 . . . . 0.0 111.776 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.1 t -52.95 -48.66 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 71.8 p -61.46 -45.58 93.67 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.518 -0.738 . . . . 0.0 112.252 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.51 -49.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.346 -0.846 . . . . 0.0 111.638 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.7 t -52.99 -51.03 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 122.047 -0.408 . . . . 0.0 110.722 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.67 -54.46 22.86 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.742 -0.599 . . . . 0.0 111.106 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -57.52 -47.39 82.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.4 p -61.15 -42.87 99.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.242 -0.912 . . . . 0.0 111.08 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.24 -13.0 61.56 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -62.48 -56.42 30.32 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.464 -1.398 . . . . 0.0 111.197 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -61.41 -39.17 58.47 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.801 2.334 . . . . 0.0 111.862 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.8 t -46.87 -52.6 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 122.004 -0.435 . . . . 0.0 111.753 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.49 -57.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 122.059 -0.401 . . . . 0.0 111.086 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -47.94 -45.07 30.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.7 tp -50.7 -35.22 30.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.8 tt -68.95 -44.39 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.095 -1.003 . . . . 0.0 109.658 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.55 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.05 -50.8 71.62 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.805 -0.56 . . . . 0.0 111.604 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.35 -54.03 42.42 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.441 0.639 . . . . 0.0 110.349 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -52.0 -51.65 55.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.093 0.557 . . . . 0.0 111.477 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.2 ttt -49.4 -48.07 47.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 90.7 t -52.3 -52.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.76 -0.588 . . . . 0.0 111.29 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.8 mp -54.05 -50.65 66.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -50.09 -57.45 7.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.772 -0.58 . . . . 0.0 111.306 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.07 -53.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 122.21 -0.306 . . . . 0.0 111.504 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.6 p -57.03 -44.84 83.29 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.944 -0.472 . . . . 0.0 111.604 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.42 65.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.958 -0.464 . . . . 0.0 112.202 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -46.11 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.04 -50.7 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.659 -0.65 . . . . 0.0 111.524 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.16 -51.39 54.35 Favored Glycine 0 N--CA 1.475 1.238 0 O-C-N 121.806 -0.559 . . . . 0.0 112.018 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.82 -51.59 63.05 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 122.109 -0.642 . . . . 0.0 110.989 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.0 -48.16 63.83 Favored Glycine 0 N--CA 1.473 1.163 0 O-C-N 122.07 -0.394 . . . . 0.0 112.218 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.28 -51.17 65.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.912 -0.758 . . . . 0.0 112.399 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.72 -50.74 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.717 -0.614 . . . . 0.0 111.083 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.5 tp . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 123.136 0.574 . . . . 0.0 111.263 179.341 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 121.173 0.511 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 m -53.97 -59.07 5.12 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.801 0.44 . . . . 0.0 111.475 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 41.5 p -59.83 -44.59 93.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.724 -0.61 . . . . 0.0 112.131 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.95 -55.35 14.87 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.851 -0.531 . . . . 0.0 111.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -55.09 -52.1 64.31 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.038 -0.414 . . . . 0.0 111.953 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 79.3 t -53.93 -51.93 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 122.141 -0.35 . . . . 0.0 111.876 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.81 -57.2 13.5 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.786 0.434 . . . . 0.0 110.902 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -53.17 -49.54 66.45 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.054 0.454 . . . . 0.0 110.515 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -52.05 -62.07 1.86 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.991 -0.443 . . . . 0.0 111.946 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.9 t -55.65 -46.82 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.8 p -58.86 -50.43 74.04 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.708 -0.62 . . . . 0.0 112.426 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.88 -45.4 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.596 -0.69 . . . . 0.0 111.854 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.53 -55.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.748 -0.595 . . . . 0.0 110.918 175.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.07 -49.71 60.1 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.813 -0.555 . . . . 0.0 111.114 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -49.75 -58.04 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 82.4 p -61.12 -41.09 96.06 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.765 0.793 . . . . 0.0 111.833 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.17 -29.49 68.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' TYR . . . . . 0.408 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 51.6 t80 -54.81 -53.94 55.17 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 39.3 Cg_endo -59.17 -36.93 94.57 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.994 2.462 . . . . 0.0 112.762 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.49 -52.68 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.613 -0.68 . . . . 0.0 110.459 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.52 -46.12 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.04 0.536 . . . . 0.0 111.365 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -52.04 -58.85 5.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.012 -0.43 . . . . 0.0 111.24 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 53.7 tp -50.44 -42.92 54.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.604 0.362 . . . . 0.0 111.93 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 91.0 mt -56.08 -61.16 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 122.072 -0.393 . . . . 0.0 110.192 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.418 0 CA-C-O 121.781 0.656 . . . . 0.0 112.506 179.588 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -53.93 -58.24 8.0 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.934 -0.479 . . . . 0.0 111.821 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -54.77 -48.24 72.93 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.771 -0.581 . . . . 0.0 111.987 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.59 -55.49 21.92 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.106 0.479 . . . . 0.0 110.958 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 28.0 ttt -54.28 -47.11 72.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 69.8 t -51.17 -52.05 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.499 -0.751 . . . . 0.0 111.255 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.9 mt -56.64 -48.51 77.4 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.097 0.475 . . . . 0.0 111.9 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -53.91 -53.61 50.31 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.381 0.61 . . . . 0.0 112.253 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -58.02 -53.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.947 -0.471 . . . . 0.0 111.632 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 63.6 p -55.7 -45.8 77.77 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.739 -0.601 . . . . 0.0 111.923 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.68 -49.44 72.93 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.882 -0.511 . . . . 0.0 112.057 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.416 ' HA ' ' HE2' ' A' ' 216' ' ' LYS . 5.5 mmpt? -57.11 -45.8 83.15 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 95.8 t -54.57 -51.99 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.618 -0.676 . . . . 0.0 110.549 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.24 -51.66 30.28 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -49.79 -49.25 49.33 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.241 -0.564 . . . . 0.0 112.123 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.19 -52.58 31.19 Favored Glycine 0 N--CA 1.476 1.365 0 O-C-N 122.094 -0.379 . . . . 0.0 112.396 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.93 -51.88 67.39 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.966 -0.726 . . . . 0.0 112.147 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.7 mt -49.75 -49.37 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.041 0.536 . . . . 0.0 111.294 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 60.5 tp . . . . . 0 N--CA 1.473 0.683 0 O-C-N 122.038 -0.414 . . . . 0.0 110.755 174.186 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 120.836 0.351 . . . . 0.0 111.53 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.29 118.86 4.28 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.39 57.89 6.7 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.871 3.048 . . . . 0.0 111.626 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -68.96 165.83 19.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.229 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.55 -50.1 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.71 -53.28 58.5 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.691 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.9 t -47.03 -60.46 2.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.7 t -59.3 -40.44 86.19 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.473 -0.767 . . . . 0.0 112.462 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -56.56 -53.91 52.11 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.628 -0.67 . . . . 0.0 111.523 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -59.46 -44.0 93.09 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.809 -0.557 . . . . 0.0 112.287 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -54.19 -48.59 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.763 -0.586 . . . . 0.0 111.559 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.4 tt -52.4 -56.1 17.25 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.831 -0.543 . . . . 0.0 110.816 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.28 -47.82 71.91 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -50.76 -58.19 6.53 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.735 -0.603 . . . . 0.0 111.492 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.59 -50.75 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 122.047 -0.408 . . . . 0.0 111.945 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 47.0 p -58.64 -49.04 78.98 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.8 -48.25 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.512 -0.743 . . . . 0.0 111.846 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.26 -53.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.723 -0.611 . . . . 0.0 110.96 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.2 tt -51.78 -51.74 54.09 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.817 -0.552 . . . . 0.0 110.499 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -50.4 -56.22 12.37 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -61.02 -42.77 99.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.717 0.77 . . . . 0.0 111.728 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.97 68.12 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -57.4 -54.85 50.62 Favored Pre-proline 0 N--CA 1.475 0.819 0 O-C-N 121.289 -0.882 . . . . 0.0 112.889 -171.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -60.51 -36.86 84.45 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.943 2.429 . . . . 0.0 112.606 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.58 -55.27 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.813 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 82.1 t -56.03 -45.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.972 0.509 . . . . 0.0 111.283 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -51.51 -58.98 4.8 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.935 -0.478 . . . . 0.0 111.252 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.63 -47.17 49.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.226 0.611 . . . . 0.0 111.63 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.91 -55.64 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.834 -0.541 . . . . 0.0 110.239 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.07 29.68 2.44 Favored Glycine 0 CA--C 1.537 1.434 0 O-C-N 121.671 -0.643 . . . . 0.0 113.546 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 90.2 p -163.09 40.14 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.464 1.132 . . . . 0.0 110.114 169.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -48.24 -65.39 0.57 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 171.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.542 ' H ' ' CD ' ' A' ' 194' ' ' GLU . . . -77.37 -39.88 25.15 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -55.89 -63.47 1.17 Allowed 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.789 -0.83 . . . . 0.0 111.913 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -90.37 34.49 4.14 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 9.3 tt -67.57 -36.38 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.581 -0.953 . . . . 0.0 109.94 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 98.5 t -44.85 -57.8 6.41 Favored Pre-proline 0 N--CA 1.479 1.007 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -60.94 -41.39 45.07 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.0 2.467 . . . . 0.0 112.696 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -53.67 -52.55 59.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 122.012 -0.43 . . . . 0.0 110.416 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -52.56 -50.61 62.59 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.86 0.464 . . . . 0.0 111.699 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 99.8 mt -51.65 -52.59 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 122.159 -0.338 . . . . 0.0 111.701 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -58.98 -49.69 76.93 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.938 -0.476 . . . . 0.0 111.935 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 91.1 m -52.63 -47.83 66.79 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.604 -0.685 . . . . 0.0 111.499 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.65 -54.82 39.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.031 -0.418 . . . . 0.0 110.85 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.29 -53.53 27.87 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.223 0.535 . . . . 0.0 111.252 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.74 -52.82 54.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.127 0.571 . . . . 0.0 111.254 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.34 -48.14 68.76 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.772 -0.58 . . . . 0.0 112.351 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -53.42 -49.7 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.544 -0.723 . . . . 0.0 111.239 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.94 -51.09 64.92 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.986 -0.446 . . . . 0.0 111.237 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -50.38 -53.09 31.72 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.907 -0.496 . . . . 0.0 111.612 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.24 -54.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 122.04 -0.412 . . . . 0.0 111.895 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 70.4 p -57.37 -45.37 84.5 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.666 -0.646 . . . . 0.0 111.752 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.93 73.98 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.002 -0.436 . . . . 0.0 111.975 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -54.52 -48.62 71.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.16 -51.92 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.855 -0.528 . . . . 0.0 111.165 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.51 -50.95 46.05 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 121.964 -0.46 . . . . 0.0 112.039 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -52.52 -49.73 64.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.165 -0.609 . . . . 0.0 111.385 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.78 -52.86 32.26 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 121.93 -0.481 . . . . 0.0 111.964 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.9 mt -53.67 -50.56 65.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 122.084 -0.656 . . . . 0.0 111.93 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.24 -51.46 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 122.064 -0.397 . . . . 0.0 111.384 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.2 -50.04 68.0 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.936 -0.478 . . . . 0.0 112.281 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 90.2 mt -53.31 -51.3 62.82 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.303 0.573 . . . . 0.0 111.772 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -55.13 -51.52 66.2 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.068 0.461 . . . . 0.0 111.89 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 53.2 m -53.67 -53.95 44.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.475 ' HD2' ' N ' ' A' ' 228' ' ' ALA . 0.1 OUTLIER -61.67 -37.25 83.39 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.698 -0.626 . . . . 0.0 112.458 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.475 ' N ' ' HD2' ' A' ' 227' ' ' ARG . . . -59.98 -50.59 73.13 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.668 -0.645 . . . . 0.0 111.817 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 98.3 mt -57.16 -46.59 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 120.9 0.381 . . . . 0.0 111.621 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -56.3 -53.78 53.19 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.627 0 N-CA-C 114.199 0.44 . . . . 0.0 114.199 179.062 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.2 ptm . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.1 ttp-105 -163.19 86.32 1.33 Allowed Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 121.452 -0.78 . . . . 0.0 111.437 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.02 105.47 0.68 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.004 2.469 . . . . 0.0 110.459 169.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -54.18 135.47 43.85 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -169.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.85 -42.48 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.39 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.37 81.42 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.089 -0.382 . . . . 0.0 111.709 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -66.74 -46.98 73.7 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.844 -0.535 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 89.4 m -51.99 -50.17 61.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.674 0.39 . . . . 0.0 111.356 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.6 -53.24 59.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.896 -0.503 . . . . 0.0 111.129 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.82 -48.39 59.81 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.16 -50.68 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.984 -0.448 . . . . 0.0 111.549 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tt -52.57 -54.26 35.29 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.099 0.476 . . . . 0.0 111.092 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -52.67 -48.61 66.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.176 0.59 . . . . 0.0 111.761 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -53.32 -57.9 8.95 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.97 -0.456 . . . . 0.0 111.472 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 69.5 t -52.25 -49.61 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.959 -0.463 . . . . 0.0 112.192 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 45.6 p -58.46 -53.79 54.3 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.775 -0.578 . . . . 0.0 111.921 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.44 -46.18 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.421 -0.8 . . . . 0.0 111.991 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.53 -53.31 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.65 -0.656 . . . . 0.0 110.913 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 tt -51.74 -50.08 61.3 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.699 -0.626 . . . . 0.0 110.547 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.83 -54.62 31.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 111.851 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -61.89 -41.91 98.45 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.582 0.706 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.54 66.81 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -58.58 -56.92 30.68 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.197 -0.939 . . . . 0.0 111.859 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -60.38 -35.84 89.46 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.898 2.399 . . . . 0.0 112.65 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.83 -56.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.563 -0.711 . . . . 0.0 111.041 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 77.1 t -56.99 -45.62 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.831 -0.543 . . . . 0.0 111.229 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -53.12 -52.03 60.02 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 0.0 111.287 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.33 -49.29 64.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.14 0.576 . . . . 0.0 111.185 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 86.4 mt -51.92 -49.79 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.302 -0.874 . . . . 0.0 110.842 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.21 -19.48 75.82 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 64.4 p -174.47 69.72 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.987 1.375 . . . . 0.0 110.276 -167.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.498 ' H ' ' CD ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -66.45 -48.74 68.97 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.905 -176.306 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.89 -158.89 53.39 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.29 56.41 2.08 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.27 1.033 . . . . 0.0 110.701 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 61.75 54.19 37.42 Favored Glycine 0 N--CA 1.474 1.181 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 79.7 mt -64.32 -52.5 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.796 -0.826 . . . . 0.0 111.013 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 96.7 t -51.71 -58.71 10.05 Favored Pre-proline 0 N--CA 1.478 0.933 0 O-C-N 121.727 -0.608 . . . . 0.0 112.4 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.38 -39.89 62.82 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.605 2.203 . . . . 0.0 113.028 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 58.6 tp -54.74 -52.53 62.24 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.563 -0.71 . . . . 0.0 111.546 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -55.83 -46.23 78.16 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.669 -0.644 . . . . 0.0 112.732 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 96.4 mt -52.65 -51.69 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.73 -0.606 . . . . 0.0 111.258 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.33 -56.2 18.56 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.777 -0.577 . . . . 0.0 111.252 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.3 m -54.7 -49.87 69.68 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.427 HD11 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -61.79 -44.25 97.25 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.451 -0.781 . . . . 0.0 112.024 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.427 ' N ' HD11 ' A' ' 206' ' ' LEU . 91.6 mt -57.62 -50.97 71.39 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.511 -0.743 . . . . 0.0 111.398 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.62 -53.3 48.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 59.8 ttp -52.36 -50.67 61.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.209 0.604 . . . . 0.0 112.385 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -52.27 -49.62 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.466 -0.771 . . . . 0.0 111.592 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.63 -49.02 73.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.136 0.493 . . . . 0.0 111.811 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -54.11 -51.96 62.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.14 0.495 . . . . 0.0 111.853 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.1 -54.66 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.117 -0.364 . . . . 0.0 111.688 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.4 p -56.0 -46.42 78.72 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.713 -0.617 . . . . 0.0 112.014 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.13 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.917 -0.489 . . . . 0.0 111.975 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.59 -48.49 74.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.956 -0.465 . . . . 0.0 112.087 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.8 t -55.04 -52.14 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.948 -0.47 . . . . 0.0 111.137 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.93 -51.65 33.69 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.83 -48.72 66.8 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 122.23 -0.57 . . . . 0.0 111.224 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.99 -56.41 16.63 Favored Glycine 0 N--CA 1.475 1.252 0 O-C-N 121.874 -0.516 . . . . 0.0 112.205 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.4 -45.66 69.41 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.734 -0.862 . . . . 0.0 112.265 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.462 HG22 HH12 ' A' ' 225' ' ' ARG . 96.7 mt -55.73 -49.95 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.741 -0.6 . . . . 0.0 111.661 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.3 tp -54.16 -48.12 71.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.944 0.498 . . . . 0.0 111.766 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.1 mp -56.51 -51.15 69.59 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.759 -0.588 . . . . 0.0 112.135 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.462 HH12 HG22 ' A' ' 222' ' ' ILE . 21.7 ttp-105 -47.5 -53.74 13.48 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.405 -0.809 . . . . 0.0 111.001 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 61.6 m -62.97 -58.55 6.95 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.472 HH22 ' C ' ' A' ' 231' ' ' GLY . 5.1 tpm_? -91.22 -59.85 2.05 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.48 -0.762 . . . . 0.0 112.431 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.2 -48.66 73.52 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.471 -0.768 . . . . 0.0 112.378 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.18 -66.71 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 122.095 -0.378 . . . . 0.0 111.355 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 231' ' ' GLY . 53.9 t80 -82.4 176.13 9.68 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.472 ' C ' HH22 ' A' ' 227' ' ' ARG . . . . . . . . 0 CA--C 1.54 1.61 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 121.194 0.521 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -130.5 73.23 81.42 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.9 -0.5 . . . . 0.0 110.14 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.15 82.24 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.193 3.262 . . . . 0.0 112.895 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -174.66 0.78 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.892 0.853 . . . . 0.0 112.487 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.9 t -46.51 -42.6 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.429 0.692 . . . . 0.0 112.7 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.52 -57.78 11.43 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.459 -0.775 . . . . 0.0 111.795 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 80.3 p -59.79 -48.47 81.54 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.62 -0.675 . . . . 0.0 112.085 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 25.5 p -56.42 -43.21 79.16 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.931 -0.481 . . . . 0.0 112.204 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -55.08 -48.04 74.08 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.715 -0.616 . . . . 0.0 111.501 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -52.89 -53.24 51.99 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.974 -0.454 . . . . 0.0 111.287 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.14 -46.48 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 122.426 0.29 . . . . 0.0 111.589 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 tt -51.32 -59.83 3.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.915 0.486 . . . . 0.0 110.889 177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -58.26 -44.06 88.17 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -51.23 -59.79 3.82 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.797 -0.564 . . . . 0.0 111.571 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.3 t -55.57 -49.29 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 122.073 -0.392 . . . . 0.0 111.774 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.4 p -56.84 -49.59 74.99 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.5 t -56.89 -48.83 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.503 -0.748 . . . . 0.0 111.667 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.2 t -56.67 -57.79 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.664 -0.648 . . . . 0.0 111.494 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 97.4 mt -56.07 -42.83 77.28 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.466 -0.771 . . . . 0.0 112.002 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -52.11 -59.54 4.25 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.999 -0.438 . . . . 0.0 111.924 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.6 p -60.85 -37.52 82.36 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.457 0.646 . . . . 0.0 111.928 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.33 63.81 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -54.89 -58.61 13.72 Favored Pre-proline 0 N--CA 1.478 0.945 0 CA-C-N 119.223 0.919 . . . . 0.0 113.213 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -57.9 -37.55 95.77 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.897 2.398 . . . . 0.0 112.678 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.05 -54.89 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.765 -0.584 . . . . 0.0 111.03 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 78.3 t -56.0 -46.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.891 -0.506 . . . . 0.0 111.386 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.8 t90 -50.71 -55.32 17.13 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.966 -0.459 . . . . 0.0 111.391 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tt -52.56 -50.8 62.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.781 0.433 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 97.9 mt -52.15 -52.74 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.683 -0.635 . . . . 0.0 111.296 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -69.15 -20.21 74.71 Favored Glycine 0 CA--C 1.539 1.542 0 O-C-N 121.833 -0.542 . . . . 0.0 114.258 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 57.1 p -174.1 76.72 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.39 -1.065 . . . . 0.0 109.698 -167.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.94 -71.04 0.2 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -171.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 170.06 104.97 0.18 Allowed Glycine 0 N--CA 1.475 1.283 0 O-C-N 121.134 -0.979 . . . . 0.0 112.59 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -51.44 -44.26 62.3 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.67 -0.9 . . . . 0.0 112.72 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -53.35 -21.99 14.16 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 123.316 0.484 . . . . 0.0 114.283 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.02 -38.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.342 -1.093 . . . . 0.0 111.195 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 88.4 t -58.42 -60.19 11.07 Favored Pre-proline 0 N--CA 1.476 0.828 0 O-C-N 121.601 -0.687 . . . . 0.0 111.301 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -60.97 -37.44 76.77 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.519 2.146 . . . . 0.0 112.767 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 52.1 tp -54.63 -53.6 52.56 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.6 -0.688 . . . . 0.0 111.846 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -59.54 -43.04 93.62 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.547 -0.721 . . . . 0.0 112.722 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.6 mt -54.09 -48.81 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 121.382 -0.824 . . . . 0.0 111.574 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.65 -48.88 74.26 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.671 -0.643 . . . . 0.0 111.603 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.4 m -51.68 -50.33 60.64 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.923 -0.485 . . . . 0.0 111.54 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -52.95 -54.31 36.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.027 -0.421 . . . . 0.0 111.235 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.1 tp -51.23 -51.59 52.59 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.947 -0.47 . . . . 0.0 111.979 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -53.65 -50.54 65.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.871 0.367 . . . . 0.0 111.356 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 57.3 ttp -54.01 -51.09 65.06 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 122.07 -0.393 . . . . 0.0 111.977 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.09 -50.26 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.787 -0.571 . . . . 0.0 111.507 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 95.4 mt -53.78 -52.39 60.39 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.062 -0.399 . . . . 0.0 111.73 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.45 -56.13 14.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.82 -0.55 . . . . 0.0 111.227 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.3 t -50.6 -52.88 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.3 p -58.13 -44.08 87.59 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.696 -0.627 . . . . 0.0 111.586 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.07 -48.49 75.99 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.897 -0.502 . . . . 0.0 111.961 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -58.18 -45.09 88.13 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.872 -0.518 . . . . 0.0 112.227 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.8 t -55.41 -50.42 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.44 -0.787 . . . . 0.0 111.405 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.99 -51.18 47.63 Favored Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.77 -52.44 31.85 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.087 0.555 . . . . 0.0 111.268 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.11 -52.42 35.81 Favored Glycine 0 N--CA 1.477 1.398 0 O-C-N 121.803 -0.56 . . . . 0.0 112.585 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 66.7 tp -54.58 -52.65 61.47 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.04 -0.682 . . . . 0.0 111.64 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.73 -49.96 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.67 0.388 . . . . 0.0 111.421 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.0 tp -52.84 -50.6 63.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.938 0.495 . . . . 0.0 111.85 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.82 -49.54 76.31 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.889 -0.507 . . . . 0.0 110.992 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.525 HH21 ' C ' ' A' ' 231' ' ' GLY . 51.8 ttt85 -55.54 -44.06 76.39 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.713 -0.617 . . . . 0.0 112.409 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 230' ' ' PHE . 77.9 p -62.93 -57.03 12.16 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.713 -1.242 . . . . 0.0 113.769 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 100.11 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 53.95 33.32 17.12 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.73 0.812 . . . . 0.0 112.772 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 77.2 mt -145.98 -19.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.964 -0.46 . . . . 0.0 110.892 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.476 ' HB2' ' HA ' ' A' ' 226' ' ' SER . 46.9 t80 -50.17 155.06 1.03 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -174.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.525 ' C ' HH21 ' A' ' 225' ' ' ARG . . . . . . . . 0 CA--C 1.537 1.458 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.227 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.296 0.57 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.447 ' CZ ' ' HG3' ' A' ' 166' ' ' GLU . 23.4 mtp-105 -60.44 160.62 17.25 Favored Pre-proline 0 N--CA 1.477 0.915 0 O-C-N 121.824 -0.548 . . . . 0.0 111.55 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.37 52.45 3.89 Favored 'Trans proline' 0 N--CA 1.482 0.804 0 C-N-CA 124.972 3.781 . . . . 0.0 111.81 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' A' ' 164' ' ' ARG . 5.1 mm-40 -144.92 -26.32 0.49 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 113.932 -1.486 . . . . 0.0 110.315 -167.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.9 p -55.38 -45.69 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.597 0.713 . . . . 0.0 109.176 170.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.48 89.0 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.057 -0.402 . . . . 0.0 111.302 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.3 m -52.32 -57.54 9.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 23.9 p -58.38 -46.81 85.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.74 -48.73 72.21 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.699 -0.626 . . . . 0.0 111.662 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.25 -49.95 74.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.614 -0.679 . . . . 0.0 112.284 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.6 t -54.29 -47.3 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 121.819 -0.551 . . . . 0.0 111.738 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.8 tt -52.85 -56.65 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.001 -0.437 . . . . 0.0 110.788 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -52.05 -49.24 63.85 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -49.73 -59.41 3.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.981 -0.449 . . . . 0.0 111.7 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.76 -52.28 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 122.057 -0.402 . . . . 0.0 111.94 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -58.03 -49.7 75.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.5 t -59.53 -50.46 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.598 -0.688 . . . . 0.0 111.59 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.83 -48.82 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.826 -0.546 . . . . 0.0 111.319 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.9 tt -54.29 -56.13 21.53 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.795 -0.565 . . . . 0.0 110.876 177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -54.09 -51.43 64.19 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -59.32 -44.8 92.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.602 -0.686 . . . . 0.0 112.0 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.84 -20.2 64.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -58.91 -55.71 43.55 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 120.99 -1.069 . . . . 0.0 112.134 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -60.43 -31.84 93.09 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.0 2.466 . . . . 0.0 112.769 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.11 -52.31 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.463 -0.773 . . . . 0.0 110.672 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.07 -46.38 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.848 -0.533 . . . . 0.0 111.024 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -51.83 -55.95 16.89 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.995 -0.441 . . . . 0.0 111.157 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.915 0.886 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.407 HG12 HG23 ' A' ' 199' ' ' VAL . 73.4 mt -51.59 -60.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 173.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.84 51.21 4.27 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 121.283 0.38 . . . . 0.0 113.067 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 44.5 p -162.07 -57.48 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.477 0.711 . . . . 0.0 109.82 173.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -150.43 46.01 0.88 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.11 0.481 . . . . 0.0 110.807 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -166.74 29.12 0.18 Allowed Glycine 0 N--CA 1.475 1.275 0 O-C-N 120.289 -1.507 . . . . 0.0 113.376 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -81.36 55.29 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 123.352 1.549 . . . . 0.0 109.672 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.95 -46.71 0.09 OUTLIER Glycine 0 N--CA 1.469 0.864 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 67.1 mt -57.93 -57.27 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 122.44 -0.447 . . . . 0.0 110.001 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 200' ' ' PRO . 86.6 t -57.58 -54.6 53.43 Favored Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 121.754 -0.591 . . . . 0.0 112.484 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 199' ' ' VAL . 41.1 Cg_endo -58.97 -40.43 71.5 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.49 2.127 . . . . 0.0 113.127 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -56.03 -53.51 56.13 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.507 -0.746 . . . . 0.0 110.96 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -53.02 -47.77 68.07 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.684 -0.635 . . . . 0.0 112.427 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.2 mt -52.09 -54.59 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.734 -0.604 . . . . 0.0 111.179 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -50.32 -51.92 41.24 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.341 0.591 . . . . 0.0 111.494 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 46.0 m -53.15 -48.89 67.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.899 0.48 . . . . 0.0 111.826 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.7 mt -54.31 -54.76 35.88 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -48.34 75.07 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.666 -0.647 . . . . 0.0 111.778 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -53.5 -53.36 52.58 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.029 -0.419 . . . . 0.0 111.463 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 58.1 ttp -49.38 -48.79 46.68 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.324 0.65 . . . . 0.0 112.45 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.1 t -51.29 -51.0 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.725 -0.609 . . . . 0.0 111.201 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.8 mt -54.92 -51.46 65.99 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 122.203 -0.311 . . . . 0.0 111.605 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -51.08 -50.83 57.96 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.875 -0.516 . . . . 0.0 111.969 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.5 -51.2 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.5 p -58.55 -46.05 87.66 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.433 -0.792 . . . . 0.0 111.681 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.1 77.03 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.925 -0.484 . . . . 0.0 111.845 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -50.01 -54.25 21.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.899 0.48 . . . . 0.0 111.648 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.3 t -55.26 -50.56 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 122.212 -0.305 . . . . 0.0 111.555 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.95 -51.49 34.42 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 121.897 -0.502 . . . . 0.0 112.134 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.34 -52.58 63.03 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.972 -0.722 . . . . 0.0 111.289 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.82 -48.45 44.47 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 94.8 mt -56.02 -56.31 22.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.205 -0.585 . . . . 0.0 111.921 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.1 mt -49.66 -43.81 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.542 0.687 . . . . 0.0 111.736 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.502 ' N ' HH21 ' A' ' 227' ' ' ARG . 36.9 tp -58.59 -59.17 5.81 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.818 -0.551 . . . . 0.0 110.513 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.04 56.56 3.53 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 122.712 1.244 . . . . 0.0 109.841 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.6 -57.51 0.07 Allowed 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.544 -0.722 . . . . 0.0 109.918 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 74.0 p -157.83 53.3 0.46 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.153 0.978 . . . . 0.0 111.64 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.502 HH21 ' N ' ' A' ' 223' ' ' LEU . 17.0 ttp180 -154.4 -57.93 0.11 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.43 -0.794 . . . . 0.0 109.937 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -73.19 -46.1 52.58 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 167.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 33.1 mt -58.13 -39.03 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.678 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -61.31 -53.94 50.27 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.022 -0.424 . . . . 0.0 110.678 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.705 0 N-CA-C 114.081 0.392 . . . . 0.0 114.081 176.47 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 20.3 ptp . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 120.665 0.269 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.417 ' HB2' ' CD ' ' A' ' 165' ' ' PRO . 51.3 mtp85 -163.2 -64.45 0.01 OUTLIER Pre-proline 0 N--CA 1.48 1.034 0 O-C-N 122.113 -0.367 . . . . 0.0 110.847 -172.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 164' ' ' ARG . 40.9 Cg_endo -79.44 -179.62 5.54 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.075 2.517 . . . . 0.0 111.155 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -81.45 -75.49 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.025 -1.047 . . . . 0.0 110.194 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 58.1 t -55.16 -52.56 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -170.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.18 -43.06 87.32 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.626 -0.671 . . . . 0.0 112.368 -176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.5 p -73.66 -44.02 57.85 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.387 -0.821 . . . . 0.0 111.116 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.0 t -57.38 -43.25 83.45 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.418 -0.802 . . . . 0.0 110.735 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.76 -50.45 73.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.689 -0.632 . . . . 0.0 110.926 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -50.32 -50.56 50.47 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.42 -53.04 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.629 0.372 . . . . 0.0 111.712 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tt -51.16 -53.54 33.68 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.382 0.611 . . . . 0.0 110.59 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.9 ttm105 -52.33 -51.78 56.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.609 0.764 . . . . 0.0 112.401 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -53.03 -54.08 40.61 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.566 -0.708 . . . . 0.0 111.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.76 -52.79 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.02 -0.425 . . . . 0.0 111.648 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 56.5 p -55.05 -44.8 75.05 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.647 -0.658 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 68.9 t -56.11 -48.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.561 -0.712 . . . . 0.0 111.83 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.82 -55.12 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.526 -0.734 . . . . 0.0 111.473 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.4 -45.06 72.85 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.438 -0.789 . . . . 0.0 112.116 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -55.44 23.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.011 -0.431 . . . . 0.0 111.367 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.7 p -61.47 -38.85 88.74 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.562 -0.711 . . . . 0.0 112.533 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.89 -56.66 17.99 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.738 -0.601 . . . . 0.0 112.309 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -37.62 -56.99 1.63 Allowed Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -59.61 -44.58 30.91 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.001 2.467 . . . . 0.0 112.379 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.4 -46.87 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.751 -0.593 . . . . 0.0 110.682 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.481 ' HA ' HD13 ' A' ' 198' ' ' ILE . 96.1 t -51.25 -53.14 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -57.05 -52.47 65.13 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.932 -0.48 . . . . 0.0 111.768 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 59.7 tp -46.18 -50.81 15.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.402 HG22 ' H ' ' A' ' 198' ' ' ILE . 1.9 mp -66.59 -43.72 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.799 -0.563 . . . . 0.0 111.448 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.62 53.57 2.84 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 121.753 0.64 . . . . 0.0 112.836 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 33.4 p -172.23 -49.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.864 1.266 . . . . 0.0 109.318 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -132.73 -45.48 0.88 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.55 -168.27 11.52 Favored Glycine 0 CA--C 1.537 1.459 0 O-C-N 121.457 -0.777 . . . . 0.0 113.956 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.56 -7.29 0.17 Allowed 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.569 -0.959 . . . . 0.0 113.267 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -51.42 -37.34 39.85 Favored Glycine 0 N--CA 1.481 1.681 0 O-C-N 121.308 -0.87 . . . . 0.0 114.14 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 188' ' ' VAL . 86.0 mt -52.82 -38.18 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.5 t -41.83 -59.7 2.39 Favored Pre-proline 0 N--CA 1.483 1.19 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -166.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.19 -47.92 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.037 2.491 . . . . 0.0 112.951 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.46 -49.7 73.86 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.957 -0.464 . . . . 0.0 112.145 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -57.47 -47.51 81.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.436 0.694 . . . . 0.0 111.812 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.1 mt -52.55 -51.0 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.868 -0.52 . . . . 0.0 111.134 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -59.0 -45.77 89.83 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.62 -0.675 . . . . 0.0 111.802 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 62.4 m -52.59 -54.59 30.91 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.363 -0.836 . . . . 0.0 111.805 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.445 HD13 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -61.74 -38.93 89.78 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.579 -0.701 . . . . 0.0 112.28 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 206' ' ' LEU . 64.6 tp -54.84 -54.39 43.0 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.51 -0.744 . . . . 0.0 110.937 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.11 -50.35 61.84 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.258 0.623 . . . . 0.0 111.187 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 63.5 mtt -52.23 -52.3 53.21 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.654 -0.654 . . . . 0.0 112.395 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.68 -47.76 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.639 -0.663 . . . . 0.0 111.674 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -54.72 -47.98 73.08 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -54.23 -56.11 21.5 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.873 -0.517 . . . . 0.0 110.713 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.8 t -51.68 -54.97 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.97 -0.456 . . . . 0.0 111.918 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 61.8 p -58.08 -50.48 73.32 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.665 -0.647 . . . . 0.0 112.451 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.7 85.56 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.857 -0.527 . . . . 0.0 111.907 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -55.71 -50.48 70.21 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.572 0.749 . . . . 0.0 111.343 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.95 -51.39 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.998 -0.439 . . . . 0.0 111.11 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -49.52 -51.29 27.94 Favored Glycine 0 N--CA 1.476 1.307 0 O-C-N 121.935 -0.478 . . . . 0.0 111.926 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -53.96 -47.64 71.14 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.142 -0.622 . . . . 0.0 111.182 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.46 -51.16 22.55 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.975 -0.453 . . . . 0.0 112.446 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 9.2 mp -58.37 -52.27 66.31 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.933 -0.745 . . . . 0.0 112.07 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.2 mt -49.87 -46.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.818 -0.551 . . . . 0.0 111.376 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 63.4 tp -57.64 -62.32 1.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.823 -0.548 . . . . 0.0 110.443 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 26.0 tp -85.43 54.42 3.11 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.692 1.234 . . . . 0.0 111.366 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.64 -66.66 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.2 t -71.78 -58.66 3.28 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.493 HH22 ' C ' ' A' ' 231' ' ' GLY . 0.0 OUTLIER -85.18 58.75 5.21 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 123.704 1.716 . . . . 0.0 109.057 175.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -159.38 -64.36 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.632 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.69 -42.29 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 122.96 0.504 . . . . 0.0 110.631 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.66 -36.48 67.13 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.493 ' C ' HH22 ' A' ' 227' ' ' ARG . . . . . . . . 0 CA--C 1.543 1.807 0 O-C-N 121.451 -0.78 . . . . 0.0 113.045 -164.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.439 ' SD ' HG21 ' A' ' 167' ' ' VAL . 25.1 ptt? . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.669 0.271 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -174.64 -58.54 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.4 -81.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.38 2.053 . . . . 0.0 112.138 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -78.27 44.3 0.49 Allowed 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.329 -0.857 . . . . 0.0 112.144 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 168' ' ' ALA . 7.3 p -65.99 -65.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.974 -1.079 . . . . 0.0 110.46 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.462 ' H ' HG12 ' A' ' 167' ' ' VAL . . . -69.05 -35.64 76.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.37 0.605 . . . . 0.0 110.198 175.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.1 m -54.19 -63.38 1.17 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.067 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 86.8 m -61.96 -48.68 79.3 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.893 -0.505 . . . . 0.0 111.302 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.9 -52.71 47.97 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 110.795 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.513 ' HZ2' ' HB3' ' A' ' 172' ' ' LYS . 6.9 ttpm? -59.24 -51.68 68.92 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 63.9 t -55.71 -53.41 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.846 -0.533 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.15 -47.23 86.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.699 -0.625 . . . . 0.0 112.242 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -56.25 -48.19 77.03 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.726 -0.609 . . . . 0.0 111.551 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -53.03 -55.42 23.86 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.688 -0.632 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.5 t -52.34 -50.38 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 67.6 p -58.74 -47.18 85.52 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.546 -0.721 . . . . 0.0 112.282 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 75.3 t -56.55 -51.45 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.528 -0.732 . . . . 0.0 111.775 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -53.78 -46.01 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.918 -0.489 . . . . 0.0 111.357 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.74 -56.42 20.68 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.686 -0.634 . . . . 0.0 110.931 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -55.53 -48.55 74.52 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.739 -0.601 . . . . 0.0 112.422 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.4 p -60.77 -44.01 97.32 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.644 -0.66 . . . . 0.0 112.11 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.81 -22.01 66.32 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.41 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 1.2 t80 -59.49 -54.92 51.22 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 120.97 -1.081 . . . . 0.0 111.431 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 56.1 Cg_endo -61.21 -34.73 88.04 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.58 2.187 . . . . 0.0 112.365 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.4 -51.78 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.12 0.873 . . . . 0.0 111.556 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.83 -50.21 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.686 -0.634 . . . . 0.0 111.304 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -60.7 -46.31 90.87 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.871 -0.518 . . . . 0.0 111.969 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 26.6 tp -46.35 -50.28 16.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.131 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.5 mt -57.7 -59.82 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.981 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.89 53.12 4.7 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-O 121.403 0.446 . . . . 0.0 112.362 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 83.1 p -153.57 -55.49 0.11 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.102 -0.646 . . . . 0.0 109.406 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -150.33 -66.98 0.2 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 122.062 -0.399 . . . . 0.0 110.03 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 146.86 65.44 0.01 OUTLIER Glycine 0 N--CA 1.475 1.245 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.199 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 52.77 67.99 0.9 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 169.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.74 -72.36 0.07 OUTLIER Glycine 0 N--CA 1.474 1.21 0 O-C-N 121.037 -1.039 . . . . 0.0 111.506 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.0 mt -67.04 -41.92 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.91 -0.759 . . . . 0.0 110.393 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.42 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 26.0 t -43.28 -56.76 6.19 Favored Pre-proline 0 N--CA 1.48 1.043 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.42 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 74.1 Cg_endo -66.28 -40.19 15.61 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.907 2.405 . . . . 0.0 112.684 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 45.8 tp -51.96 -45.91 64.57 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.86 -0.525 . . . . 0.0 111.801 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -51.58 -55.37 19.6 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.973 -0.455 . . . . 0.0 110.419 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 67.4 mt -49.41 -51.0 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 120.731 0.3 . . . . 0.0 111.158 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -57.81 -52.83 63.84 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 88.1 m -52.2 -51.07 60.39 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.641 -0.662 . . . . 0.0 111.859 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -47.96 83.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.005 -0.434 . . . . 0.0 112.164 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -54.87 24.23 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.545 -0.722 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -54.71 -49.93 69.54 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.454 0.302 . . . . 0.0 111.379 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 47.8 ttm -51.08 -49.5 60.53 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 72.6 t -54.14 -48.86 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.456 -0.777 . . . . 0.0 111.306 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.41 -51.32 65.25 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.948 -0.47 . . . . 0.0 111.284 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -51.11 -50.35 58.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.151 0.58 . . . . 0.0 111.617 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.97 -54.07 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 64.4 p -57.18 -45.34 83.79 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.351 -0.843 . . . . 0.0 111.539 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.27 76.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.707 0.403 . . . . 0.0 111.504 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -52.48 -50.78 62.02 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.949 -0.469 . . . . 0.0 111.952 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.41 -53.21 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 122.087 -0.383 . . . . 0.0 111.297 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.82 -50.55 49.59 Favored Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -54.31 -51.49 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.247 -0.561 . . . . 0.0 111.262 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.2 51.28 Favored Glycine 0 N--CA 1.475 1.281 0 O-C-N 121.923 -0.486 . . . . 0.0 112.216 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 87.1 mt -56.05 -51.22 68.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.966 -0.726 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.2 mt -55.8 -48.28 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.856 -0.527 . . . . 0.0 111.905 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.19 -50.64 72.21 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.874 -0.516 . . . . 0.0 111.562 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 39.2 tp -50.98 -55.49 17.09 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.609 -0.682 . . . . 0.0 110.313 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -53.36 -65.57 0.54 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 95.0 p -91.15 22.07 3.98 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.34 -57.8 0.18 Allowed 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.085 -1.009 . . . . 0.0 110.445 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -67.85 -54.37 19.48 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.629 0.728 . . . . 0.0 110.629 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.89 -56.63 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.69 73.0 5.25 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.403 1.097 . . . . 0.0 109.864 173.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.556 0 CA-C-N 115.476 -0.783 . . . . 0.0 113.076 174.529 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.199 0.523 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.443 ' HD3' ' HD2' ' A' ' 165' ' ' PRO . 24.3 tpp180 -69.88 132.04 88.94 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.652 -0.655 . . . . 0.0 109.613 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.443 ' HD2' ' HD3' ' A' ' 164' ' ' ARG . 66.9 Cg_endo -77.16 63.63 7.74 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.9 3.067 . . . . 0.0 112.772 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 169' ' ' SER . 2.3 mp0 62.83 -166.39 0.22 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.198 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.0 t 69.95 -76.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.644 1.178 . . . . 0.0 111.307 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.03 87.59 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 165.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.424 ' HB3' ' HA ' ' A' ' 166' ' ' GLU . 47.5 t -66.08 -49.75 66.49 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.596 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 84.5 m -53.52 -52.88 58.2 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 122.341 -0.225 . . . . 0.0 111.43 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -56.34 -49.31 74.72 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.622 -0.674 . . . . 0.0 111.708 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.52 -50.62 69.5 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.603 -0.686 . . . . 0.0 111.771 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.23 -58.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.967 -0.458 . . . . 0.0 111.668 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.18 -41.32 83.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.427 ' HA ' ' NE ' ' A' ' 175' ' ' ARG . 15.2 mmm-85 -60.96 -47.71 85.19 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.066 -1.021 . . . . 0.0 112.542 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -52.89 -51.48 61.03 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.816 -0.553 . . . . 0.0 110.645 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.06 -54.21 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 p -55.61 -46.46 77.35 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.49 -0.756 . . . . 0.0 112.666 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.55 -53.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.628 -0.67 . . . . 0.0 111.799 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.55 -45.91 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.777 -0.577 . . . . 0.0 111.837 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.79 -53.1 61.67 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.674 -0.641 . . . . 0.0 110.498 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -54.35 -51.63 64.16 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.032 -0.418 . . . . 0.0 112.03 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.5 p -61.68 -40.64 95.68 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -58.76 -47.66 83.89 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.444 -0.785 . . . . 0.0 112.571 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -41.3 -58.05 3.18 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -61.05 -38.16 70.21 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.157 2.571 . . . . 0.0 112.572 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.58 -53.17 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.574 -0.704 . . . . 0.0 110.768 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 72.4 t -53.59 -50.37 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.318 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -54.37 -54.77 36.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.871 0.367 . . . . 0.0 111.211 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.4 tp -49.11 -51.41 31.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.542 0.737 . . . . 0.0 111.479 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.02 -57.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.982 -0.448 . . . . 0.0 110.005 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.85 51.38 4.3 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 122.079 -0.388 . . . . 0.0 112.401 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.0 p -155.74 -34.05 0.09 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.672 -0.899 . . . . 0.0 111.862 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.36 68.95 0.79 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.967 0.889 . . . . 0.0 111.846 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -45.01 -45.32 9.31 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 123.785 0.707 . . . . 0.0 112.126 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.51 57.27 1.53 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 122.853 1.311 . . . . 0.0 111.508 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.65 -57.42 0.07 OUTLIER Glycine 0 CA--C 1.527 0.844 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.5 tt -64.62 -48.8 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.966 -0.726 . . . . 0.0 110.95 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' A' ' 200' ' ' PRO . 80.9 t -59.97 -55.69 43.04 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 121.577 -0.702 . . . . 0.0 111.619 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 199' ' ' VAL . 36.7 Cg_endo -57.04 -44.77 41.16 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.569 2.179 . . . . 0.0 112.956 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.58 -48.33 82.07 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.437 -0.789 . . . . 0.0 112.823 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -56.81 -44.49 82.02 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.044 -1.035 . . . . 0.0 112.789 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.6 mt -55.2 -51.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.497 -0.752 . . . . 0.0 111.169 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -53.57 -51.02 64.3 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.942 -0.473 . . . . 0.0 111.653 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 87.8 m -52.45 -51.3 59.97 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.133 0.573 . . . . 0.0 111.466 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.63 -50.2 72.72 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.927 -0.483 . . . . 0.0 112.064 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -53.43 -53.71 47.42 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.765 -0.584 . . . . 0.0 110.511 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.97 -48.41 73.27 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.104 -0.373 . . . . 0.0 110.852 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.6 ttt -52.62 -49.97 64.04 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.688 -0.633 . . . . 0.0 111.872 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.0 t -52.98 -50.61 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.54 -0.725 . . . . 0.0 111.28 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.3 mt -54.52 -50.23 68.33 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.888 -0.507 . . . . 0.0 112.194 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.22 -54.1 44.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.966 0.507 . . . . 0.0 111.426 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.04 -55.07 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.987 -0.445 . . . . 0.0 111.517 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -55.79 -47.63 76.75 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.596 -0.69 . . . . 0.0 112.284 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.96 -49.7 72.83 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.902 -0.499 . . . . 0.0 111.875 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 216' ' ' LYS . 0.1 OUTLIER -58.53 -43.1 89.07 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.804 0.442 . . . . 0.0 112.164 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 69.3 t -55.01 -54.01 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.495 -0.753 . . . . 0.0 110.645 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.87 -50.54 37.62 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -50.4 -50.63 51.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.159 0.583 . . . . 0.0 110.987 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.91 -51.65 33.59 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 122.004 -0.435 . . . . 0.0 112.549 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.33 -52.52 63.23 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 122.081 -0.658 . . . . 0.0 111.858 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 94.6 mt -54.7 -47.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.162 0.506 . . . . 0.0 111.894 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 29.2 tp -54.66 -54.91 35.45 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.784 -0.572 . . . . 0.0 109.743 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.444 ' HA ' ' HB2' ' A' ' 228' ' ' ALA . 39.2 tp -80.67 59.43 3.61 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.615 1.197 . . . . 0.0 110.417 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -161.14 -60.7 0.05 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.378 1.471 . . . . 0.0 108.043 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 76.8 p -89.43 -47.37 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.368 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -83.61 -57.99 3.0 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.758 -0.589 . . . . 0.0 112.445 -175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 224' ' ' LEU . . . -77.35 -53.65 7.42 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.03 -66.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.813 -0.554 . . . . 0.0 111.016 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -71.69 169.93 14.6 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.628 -0.67 . . . . 0.0 111.267 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 O-C-N 121.578 -0.701 . . . . 0.0 113.226 -178.641 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.454 ' SD ' ' HD2' ' A' ' 164' ' ' ARG . 4.7 ppp? . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.454 ' HD2' ' SD ' ' A' ' 163' ' ' MET . 0.9 OUTLIER -54.52 -50.12 87.16 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 178.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -80.52 62.79 8.65 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 124.057 3.172 . . . . 0.0 114.869 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 78.22 -45.07 0.41 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.739 1.615 . . . . 0.0 113.224 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.484 HG21 ' H ' ' A' ' 168' ' ' ALA . 1.4 p 55.65 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.426 1.49 . . . . 0.0 112.532 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.484 ' H ' HG21 ' A' ' 167' ' ' VAL . . . -49.56 -43.56 46.06 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.39 -0.819 . . . . 0.0 112.77 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 61.1 p -51.89 -63.31 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 m -74.89 -43.38 54.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 -174.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.03 -44.56 91.76 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.027 -0.42 . . . . 0.0 111.951 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.56 -50.26 72.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.232 -0.917 . . . . 0.0 110.997 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 83.7 t -54.6 -53.67 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.587 0.232 . . . . 0.0 110.497 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.42 -57.35 8.21 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.166 0.586 . . . . 0.0 111.237 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.439 ' HE ' ' HA ' ' A' ' 176' ' ' ASN . 2.4 tmm_? -50.24 -57.95 6.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.336 0.654 . . . . 0.0 110.581 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.439 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 7.7 t30 -58.41 -49.7 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.169 -0.332 . . . . 0.0 111.181 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -54.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 23.9 p -55.47 -50.62 69.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.74 -0.6 . . . . 0.0 111.81 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.77 -50.87 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.701 -0.624 . . . . 0.0 111.606 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.1 t -55.86 -51.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.888 -0.508 . . . . 0.0 111.837 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -53.13 -48.13 68.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.252 -0.905 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -55.72 -52.83 62.56 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.4 p -60.7 -41.98 96.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.771 0.796 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -17.17 61.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.439 ' HB3' ' CD ' ' A' ' 186' ' ' PRO . 1.5 t80 -59.25 -59.9 12.32 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 119.972 1.26 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.439 ' CD ' ' HB3' ' A' ' 185' ' ' TYR . 52.5 Cg_endo -61.86 -30.99 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.88 2.387 . . . . 0.0 113.187 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.45 -56.56 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.408 -0.808 . . . . 0.0 110.675 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.92 -43.58 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.939 -0.476 . . . . 0.0 111.313 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -51.18 -59.46 4.17 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.038 -0.414 . . . . 0.0 111.086 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -50.99 45.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.388 0.675 . . . . 0.0 110.432 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.58 -61.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 122.127 -0.358 . . . . 0.0 110.612 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.12 51.31 3.74 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 122.025 -0.422 . . . . 0.0 112.129 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.2 p -159.25 -40.81 0.06 Allowed 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.623 -0.927 . . . . 0.0 112.495 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 64.5 77.91 0.3 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.199 1.0 . . . . 0.0 109.369 -167.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -37.44 -45.65 1.37 Allowed Glycine 0 N--CA 1.477 1.384 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.785 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -83.21 53.7 2.55 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.802 1.287 . . . . 0.0 110.666 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.3 -55.33 0.07 OUTLIER Glycine 0 N--CA 1.47 0.901 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 16.2 tt -61.1 -44.62 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 122.086 -0.655 . . . . 0.0 111.348 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.84 -59.74 11.56 Favored Pre-proline 0 N--CA 1.475 0.776 0 O-C-N 121.515 -0.741 . . . . 0.0 112.074 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -59.23 -43.46 41.23 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.44 2.093 . . . . 0.0 112.114 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.85 -56.3 18.89 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.113 -0.367 . . . . 0.0 111.927 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -55.28 -45.26 76.18 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 90.3 mt -50.44 -52.16 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.533 -0.729 . . . . 0.0 111.006 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -56.88 -49.32 75.88 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.224 0.535 . . . . 0.0 111.778 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 80.9 m -50.95 -49.98 58.88 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.573 0.749 . . . . 0.0 112.441 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.5 -50.74 70.91 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.676 -0.64 . . . . 0.0 112.3 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.9 tp -51.42 -51.05 58.2 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.443 0.64 . . . . 0.0 111.479 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.27 -52.9 61.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.118 0.485 . . . . 0.0 111.068 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 42.1 ttm -50.42 -49.64 54.22 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 112.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.34 -51.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.614 -0.678 . . . . 0.0 111.464 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.41 -48.95 71.01 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.2 0.524 . . . . 0.0 111.624 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.418 ' O ' ' HG2' ' A' ' 216' ' ' LYS . 70.7 m-20 -53.75 -54.37 39.06 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.006 -0.434 . . . . 0.0 111.908 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.35 -54.83 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.899 -0.501 . . . . 0.0 111.911 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -56.17 -45.22 79.8 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.42 -48.86 68.36 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.848 -0.532 . . . . 0.0 112.255 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 212' ' ' ASP . 9.5 mmtp -57.29 -46.48 83.1 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 122.003 -0.436 . . . . 0.0 111.598 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.42 -52.23 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.716 -0.615 . . . . 0.0 110.711 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.44 -51.17 33.03 Favored Glycine 0 N--CA 1.478 1.435 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -51.76 -48.51 63.68 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 122.364 -0.492 . . . . 0.0 111.584 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -49.65 -52.59 24.3 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 122.035 -0.415 . . . . 0.0 112.348 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.23 -50.79 72.31 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.05 -0.677 . . . . 0.0 112.331 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 38.6 mt -49.27 -49.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 121.299 0.571 . . . . 0.0 111.67 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 227' ' ' ARG . 40.2 tp -57.04 -56.8 17.09 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.847 -0.533 . . . . 0.0 111.125 174.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.55 56.81 2.7 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 123.018 1.389 . . . . 0.0 110.792 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -158.02 -56.53 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.508 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.407 ' HA ' ' HB3' ' A' ' 230' ' ' PHE . 74.3 m -148.23 43.8 1.04 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -137.2 -47.22 0.58 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.083 -1.011 . . . . 0.0 110.156 166.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.65 -47.06 14.62 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 165.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.6 mt -77.11 -78.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.407 ' HB3' ' HA ' ' A' ' 226' ' ' SER . 53.3 t80 -60.3 -51.56 69.0 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.016 1.28 . . . . 0.0 112.196 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.544 0 O-C-N 121.788 -0.57 . . . . 0.0 113.346 178.825 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 71.9 mtm . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 64.08 161.04 0.12 Allowed Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.533 1.133 . . . . 0.0 112.739 -173.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.25 -164.02 0.18 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.602 2.868 . . . . 0.0 113.5 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 58.3 59.93 2.83 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.224 1.012 . . . . 0.0 110.763 -171.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.0 p -53.28 -44.71 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.789 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.25 -51.99 67.12 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.75 -0.594 . . . . 0.0 111.557 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m -59.04 -52.95 63.55 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 0.0 111.696 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.2 p -56.59 -48.07 78.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.33 -46.63 83.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.735 -0.603 . . . . 0.0 111.303 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.559 ' HZ2' ' HB3' ' A' ' 172' ' ' LYS . 8.3 mtpm? -51.92 -51.32 57.77 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.484 -0.76 . . . . 0.0 112.102 174.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.59 -53.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.43 -52.01 63.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.215 0.531 . . . . 0.0 111.97 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 -52.32 -52.63 52.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.409 0.683 . . . . 0.0 111.47 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -51.35 -57.93 7.6 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.925 -0.484 . . . . 0.0 111.614 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.0 t -54.41 -49.8 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.963 -0.46 . . . . 0.0 112.17 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.7 p -58.84 -49.34 78.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.62 -0.675 . . . . 0.0 112.718 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.9 t -57.21 -49.93 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.463 -0.773 . . . . 0.0 111.742 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.76 -51.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.742 -0.599 . . . . 0.0 110.929 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.9 tt -51.51 -50.07 60.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.57 -0.706 . . . . 0.0 111.395 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 42.7 t90 -51.81 -57.4 9.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.5 p -61.54 -37.48 83.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.52 0.676 . . . . 0.0 112.214 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.57 65.7 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -57.32 -56.1 37.41 Favored Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 121.137 -0.977 . . . . 0.0 111.97 -174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -59.9 -33.41 95.85 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.793 2.329 . . . . 0.0 113.145 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.1 t -59.3 -53.17 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.397 -0.814 . . . . 0.0 111.116 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.7 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.805 -0.559 . . . . 0.0 110.95 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -52.54 -56.4 15.52 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.139 -0.35 . . . . 0.0 111.428 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.416 HD21 ' HA2' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -42.09 -56.04 2.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.871 0.869 . . . . 0.0 110.128 178.205 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.1 mt -54.94 -59.67 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 122.04 -0.413 . . . . 0.0 110.655 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.54 30.79 3.05 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 90.6 p -167.84 24.97 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.11 1.455 . . . . 0.0 111.029 168.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.41 ' HG2' ' HA3' ' A' ' 197' ' ' GLY . 1.7 pm0 36.19 55.37 1.03 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.862 1.315 . . . . 0.0 112.698 -175.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.416 ' HA2' HD21 ' A' ' 190' ' ' LEU . . . 65.24 -140.75 41.97 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.993 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -80.81 51.33 1.5 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.666 -0.902 . . . . 0.0 110.245 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.41 ' HA3' ' HG2' ' A' ' 194' ' ' GLU . . . -89.86 -51.26 2.88 Favored Glycine 0 N--CA 1.473 1.105 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.7 mt -53.4 -41.13 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.154 -0.615 . . . . 0.0 111.519 173.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.401 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 71.7 t -49.93 -57.39 12.63 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.401 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 67.7 Cg_endo -67.68 -35.55 21.74 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.114 2.543 . . . . 0.0 113.053 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.85 -46.9 51.84 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.757 -0.59 . . . . 0.0 111.567 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -48.55 -54.15 15.53 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.678 -0.638 . . . . 0.0 111.406 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.7 mt -54.61 -49.07 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.041 0.536 . . . . 0.0 111.137 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -53.86 -56.07 20.94 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.877 0.37 . . . . 0.0 111.145 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 52.6 m -53.77 -51.7 62.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.116 0.566 . . . . 0.0 112.086 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.425 HD11 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -62.56 -42.71 99.72 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.614 -0.678 . . . . 0.0 112.417 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.425 ' N ' HD11 ' A' ' 206' ' ' LEU . 5.0 tt -56.26 -53.8 52.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.538 -0.726 . . . . 0.0 110.027 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -52.87 -50.57 63.54 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.659 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 54.5 ttm -51.29 -49.72 60.71 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -52.65 -52.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.694 -0.629 . . . . 0.0 111.289 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.54 -51.46 66.97 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.33 0.586 . . . . 0.0 111.827 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -48.78 -53.95 17.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.605 0.762 . . . . 0.0 111.327 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.84 -51.01 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 58.5 p -57.27 -39.13 75.04 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.281 -0.887 . . . . 0.0 111.486 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.89 73.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -52.76 -51.27 61.3 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 110.98 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.14 -52.42 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.067 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.12 -50.83 50.03 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.62 -50.87 67.07 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.093 -0.651 . . . . 0.0 111.235 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.39 -50.23 41.94 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.753 -0.592 . . . . 0.0 112.134 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.54 -53.56 54.86 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.153 -0.616 . . . . 0.0 112.15 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.425 ' HA ' HH21 ' A' ' 225' ' ' ARG . 79.0 mt -52.55 -51.95 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.108 0.48 . . . . 0.0 111.082 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 43.7 tp -55.17 -55.16 34.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.406 0.682 . . . . 0.0 112.128 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.11 -50.89 71.9 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.127 0.489 . . . . 0.0 111.38 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 222' ' ' ILE . 35.7 ttp180 -49.55 -41.08 40.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.398 0.679 . . . . 0.0 112.75 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 75.3 m -64.19 -60.89 2.66 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.45 -0.781 . . . . 0.0 111.741 170.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 51.3 mmt-85 -58.04 104.71 0.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 56.14 34.25 23.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.744 0.818 . . . . 0.0 112.743 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 69.1 mt -140.61 -40.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 121.866 -0.521 . . . . 0.0 110.316 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -79.73 177.17 9.09 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.591 -0.693 . . . . 0.0 110.382 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.659 0 O-C-N 121.346 -0.847 . . . . 0.0 113.455 -177.384 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.572 ' H2 ' ' HB3' ' A' ' 169' ' ' SER . 48.2 ttp . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.028 0.442 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.457 ' H ' ' HG2' ' A' ' 163' ' ' MET . 0.9 OUTLIER -58.43 -51.26 83.06 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 178.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -59.62 -63.46 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.983 2.455 . . . . 0.0 115.776 -162.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.57 162.41 27.11 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.198 -0.939 . . . . 0.0 111.953 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.01 -50.68 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 121.64 -0.663 . . . . 0.0 110.334 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.29 82.98 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.034 0.445 . . . . 0.0 110.645 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.572 ' HB3' ' H2 ' ' A' ' 163' ' ' MET . 39.3 m -49.3 -52.92 24.6 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 176.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.3 m -57.14 -49.72 75.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.805 -0.559 . . . . 0.0 111.586 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.18 -48.02 71.39 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.112 0.482 . . . . 0.0 111.709 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -55.65 -49.21 73.5 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.783 -0.573 . . . . 0.0 112.061 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.5 -49.16 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.94 -0.475 . . . . 0.0 111.667 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.4 tt -52.18 -55.0 23.9 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.184 0.516 . . . . 0.0 110.497 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -52.72 -50.5 63.29 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -52.82 -56.87 12.58 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.581 -0.699 . . . . 0.0 111.995 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.7 t -54.17 -49.74 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.971 -0.456 . . . . 0.0 111.935 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.2 p -56.16 -46.04 79.44 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.625 -0.672 . . . . 0.0 112.6 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.51 -48.4 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.373 -0.83 . . . . 0.0 111.879 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -54.16 -48.52 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.629 -0.669 . . . . 0.0 111.668 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.7 mt -55.61 -50.01 71.28 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.509 -0.744 . . . . 0.0 111.887 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -53.22 -53.3 52.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.868 -0.52 . . . . 0.0 112.353 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.5 p -61.5 -38.38 87.13 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.09 95.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.207 -0.933 . . . . 0.0 112.463 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -40.79 -51.83 6.84 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -58.47 -40.4 74.94 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.905 2.404 . . . . 0.0 112.516 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.5 t -60.63 -45.08 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.795 -0.565 . . . . 0.0 110.375 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.54 -50.05 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.823 -0.548 . . . . 0.0 110.723 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -53.1 -51.19 62.67 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.442 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 48.0 tp -47.04 -53.38 12.7 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.985 -0.447 . . . . 0.0 111.511 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -52.39 -55.71 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.04 52.55 4.55 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.89 -0.506 . . . . 0.0 112.192 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 58.6 p -164.16 -42.34 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.485 1.143 . . . . 0.0 112.522 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 53.21 30.6 10.17 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.824 0.821 . . . . 0.0 110.971 -171.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 143.08 -47.48 0.8 Allowed Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.37 58.7 2.67 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 122.471 1.129 . . . . 0.0 113.049 -172.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -172.84 -62.4 0.05 OUTLIER Glycine 0 N--CA 1.471 0.987 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.442 ' CD1' ' HB2' ' A' ' 190' ' ' LEU . 6.0 mt -61.95 -47.81 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 O-C-N 121.959 -0.73 . . . . 0.0 112.161 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 71.1 t -46.28 -55.22 14.35 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -66.69 -43.16 7.81 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.729 2.286 . . . . 0.0 112.821 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 10.4 tt -51.48 -43.45 62.16 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -45.36 -46.11 12.89 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 61.2 mt -60.41 -48.9 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 121.457 0.646 . . . . 0.0 110.134 -175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -59.75 -47.92 83.73 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.413 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 83.5 m -53.69 -55.27 27.55 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.662 -0.649 . . . . 0.0 111.732 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -60.78 -39.86 90.42 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.626 -0.671 . . . . 0.0 112.279 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.416 ' N ' HD13 ' A' ' 206' ' ' LEU . 3.1 tm? -54.09 -56.19 20.43 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.544 -0.723 . . . . 0.0 110.603 174.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.43 -53.48 29.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.556 0.342 . . . . 0.0 111.385 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 92.6 mtp -49.1 -49.64 40.9 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 76.6 t -52.87 -51.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.601 -0.687 . . . . 0.0 111.372 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.83 -47.84 73.6 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -54.22 -52.59 60.82 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.703 -0.623 . . . . 0.0 111.889 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.8 t -56.38 -54.94 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.925 -0.484 . . . . 0.0 111.899 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.1 p -56.24 -47.68 77.99 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.781 -0.574 . . . . 0.0 112.3 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.03 -48.72 75.45 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.905 -0.497 . . . . 0.0 111.972 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -53.32 50.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.589 0.356 . . . . 0.0 111.273 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.26 -51.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.077 -0.39 . . . . 0.0 111.281 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.59 31.87 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -53.97 -47.56 71.23 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.239 -0.565 . . . . 0.0 111.583 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.21 -54.37 12.72 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.57 -53.35 58.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.134 -0.627 . . . . 0.0 112.226 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.8 mt -52.2 -54.05 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.6 tp -56.23 -51.81 66.76 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.279 0.632 . . . . 0.0 111.698 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -51.6 -53.57 36.93 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -58.76 -56.94 15.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 25.1 p -56.51 -46.18 80.68 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.825 -0.547 . . . . 0.0 112.052 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.44 -51.63 64.36 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.055 0.542 . . . . 0.0 111.575 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.49 76.86 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.02 -49.0 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 120.977 0.417 . . . . 0.0 111.464 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 231' ' ' GLY . 19.5 t80 -61.52 155.07 22.94 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.651 0.738 . . . . 0.0 112.229 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . 0.404 ' N ' ' CD1' ' A' ' 230' ' ' PHE . . . . . . . . 0 CA--C 1.54 1.645 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.68 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.488 ' HG2' ' H ' ' A' ' 164' ' ' ARG . 10.4 ttt . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.488 ' H ' ' HG2' ' A' ' 163' ' ' MET . 50.3 mmm-85 61.84 69.42 0.99 Allowed Pre-proline 0 N--CA 1.479 0.999 0 O-C-N 121.444 -0.785 . . . . 0.0 111.548 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.04 61.11 7.59 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.211 3.274 . . . . 0.0 111.034 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -157.86 -161.08 0.98 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.879 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m 52.16 -170.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.96 21.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.978 0.511 . . . . 0.0 112.365 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -51.07 -65.19 0.6 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.235 -0.291 . . . . 0.0 111.751 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.2 p -67.91 -39.52 83.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.424 -0.798 . . . . 0.0 111.83 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -53.69 -54.57 36.01 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.053 -0.404 . . . . 0.0 111.597 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.51 -47.21 84.93 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.747 -0.595 . . . . 0.0 112.128 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -50.17 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.873 -0.517 . . . . 0.0 111.569 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.8 tp -57.27 -48.57 78.54 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.775 -0.578 . . . . 0.0 111.541 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 20.8 mmm-85 -57.68 -44.79 86.02 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.453 -0.779 . . . . 0.0 112.919 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -51.31 -56.61 12.11 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.78 -0.575 . . . . 0.0 111.073 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.79 -51.08 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.2 p -56.84 -47.82 79.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.56 -47.04 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.463 -0.773 . . . . 0.0 111.979 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.94 -49.53 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.684 -0.635 . . . . 0.0 111.491 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.03 -48.34 76.14 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.628 -0.67 . . . . 0.0 111.994 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -52.37 -54.42 32.06 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.0 p -59.64 -47.49 85.39 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.477 -0.764 . . . . 0.0 111.554 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.6 -14.13 61.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.415 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 4.3 t80 -62.99 -56.29 29.9 Favored Pre-proline 0 N--CA 1.476 0.832 0 O-C-N 120.84 -1.162 . . . . 0.0 111.153 -173.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 58.2 Cg_endo -62.22 -35.96 71.39 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.994 2.463 . . . . 0.0 112.243 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.28 -57.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.812 -0.555 . . . . 0.0 111.057 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.88 -40.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.806 -0.559 . . . . 0.0 111.493 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.57 -50.22 68.48 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.62 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 54.9 tp -53.2 -43.42 67.17 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.958 -0.463 . . . . 0.0 111.181 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.49 -53.95 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.359 -0.838 . . . . 0.0 109.716 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -71.75 29.64 0.62 Allowed Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.62 -0.675 . . . . 0.0 113.738 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.0 p -151.07 -10.68 0.23 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.642 -0.916 . . . . 0.0 110.74 168.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -158.48 55.69 0.45 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.394 1.078 . . . . 0.0 108.562 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 176.94 -57.31 0.1 Allowed Glycine 0 N--CA 1.476 1.31 0 O-C-N 120.908 -1.12 . . . . 0.0 111.811 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 47.82 50.41 15.54 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.027 0.931 . . . . 0.0 112.485 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 157.46 -33.75 0.54 Allowed Glycine 0 N--CA 1.475 1.257 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 9.5 mt -73.92 25.95 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-O 121.258 0.551 . . . . 0.0 112.216 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.486 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 67.1 t -79.03 -59.43 0.63 Allowed Pre-proline 0 N--CA 1.478 0.933 0 O-C-N 119.893 -1.754 . . . . 0.0 108.79 175.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.486 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 37.8 Cg_endo -58.86 -41.07 66.2 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.623 2.215 . . . . 0.0 111.126 170.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 83.9 mt -56.46 -51.21 69.29 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 122.091 -0.381 . . . . 0.0 111.845 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -52.28 -57.19 10.49 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.58 -0.7 . . . . 0.0 111.868 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 80.0 mt -56.08 -51.66 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.217 0.532 . . . . 0.0 111.186 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.19 -56.45 14.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.378 0.671 . . . . 0.0 111.429 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 96.3 m -54.57 -47.53 73.16 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.128 -0.357 . . . . 0.0 111.683 -177.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.36 -57.1 13.22 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.718 -0.613 . . . . 0.0 111.89 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.22 -51.28 69.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.247 0.546 . . . . 0.0 111.773 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.79 -53.07 57.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.493 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 26.9 ttt -52.04 -45.57 64.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.638 0.375 . . . . 0.0 112.003 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.8 t -51.5 -53.24 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.513 -0.742 . . . . 0.0 111.202 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.97 -50.76 68.13 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.965 -0.459 . . . . 0.0 112.173 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -52.71 -54.91 27.09 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.051 -0.406 . . . . 0.0 111.752 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.3 t -57.16 -54.71 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 122.122 -0.361 . . . . 0.0 111.741 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.4 p -55.18 -49.96 70.54 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.519 -0.738 . . . . 0.0 112.306 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.65 76.86 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.908 -0.495 . . . . 0.0 112.037 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -57.2 -48.72 78.07 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.085 -0.385 . . . . 0.0 110.826 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.8 t -53.98 -53.27 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.481 -0.762 . . . . 0.0 111.235 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.83 -50.78 36.5 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 121.797 -0.564 . . . . 0.0 111.762 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.01 -49.51 68.72 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.267 -0.549 . . . . 0.0 111.186 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.62 -49.72 51.81 Favored Glycine 0 N--CA 1.475 1.274 0 O-C-N 121.962 -0.461 . . . . 0.0 112.754 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.92 -50.67 68.25 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.942 -0.74 . . . . 0.0 111.933 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.39 -50.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.293 0.568 . . . . 0.0 111.326 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 61.2 tp -53.13 -48.39 67.94 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.482 0.713 . . . . 0.0 111.94 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 tt -55.22 -56.22 22.43 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.798 -0.564 . . . . 0.0 109.848 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -59.51 -13.84 10.54 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.7 t -90.19 -60.05 2.03 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.36 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -59.96 103.84 0.25 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.913 0.885 . . . . 0.0 112.605 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 64.27 34.03 11.08 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 122.077 0.941 . . . . 0.0 111.968 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 51.3 mt -141.8 -48.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -84.6 -47.81 10.15 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.69 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.394 176.225 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.824 0.345 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -161.85 82.59 1.8 Allowed Pre-proline 0 N--CA 1.473 0.677 0 O-C-N 121.813 -0.554 . . . . 0.0 110.326 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.61 61.22 7.41 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.991 3.127 . . . . 0.0 111.572 172.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 61.69 85.69 0.12 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.271 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 53.2 t -44.79 -51.41 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.77 -49.49 75.12 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.914 -0.491 . . . . 0.0 111.773 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -59.37 -54.92 41.26 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.956 -0.465 . . . . 0.0 111.808 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.7 t -58.78 -41.37 86.52 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.957 -0.465 . . . . 0.0 111.643 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -56.19 -51.9 66.36 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.476 -0.765 . . . . 0.0 111.322 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -55.05 -46.74 75.36 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.847 -0.533 . . . . 0.0 112.224 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 70.9 t -55.4 -52.09 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 122.024 -0.423 . . . . 0.0 111.521 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.7 tp -52.81 -50.51 63.51 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.711 -0.618 . . . . 0.0 111.624 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.498 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.09 -50.39 66.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -53.67 -56.08 20.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.233 -0.292 . . . . 0.0 111.013 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.77 -52.78 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.659 0.383 . . . . 0.0 111.844 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.5 p -56.71 -52.24 65.73 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 80.4 t -58.33 -48.96 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.729 -0.607 . . . . 0.0 112.001 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 77.1 t -57.25 -54.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.703 -0.623 . . . . 0.0 111.215 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.3 mt -53.23 -46.83 69.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.492 -0.755 . . . . 0.0 111.857 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.8 t90 -53.5 -56.96 12.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.1 p -61.0 -42.91 99.35 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.695 0.759 . . . . 0.0 112.151 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.1 67.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.08 -56.19 36.21 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 121.345 -0.847 . . . . 0.0 112.652 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.15 -36.05 90.07 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.971 2.447 . . . . 0.0 112.802 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.99 -55.7 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.596 -0.69 . . . . 0.0 110.925 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.24 -45.65 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.98 -0.45 . . . . 0.0 111.234 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -50.32 -58.5 5.53 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.207 -0.308 . . . . 0.0 111.015 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -47.72 -49.63 27.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.799 0.84 . . . . 0.0 110.546 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.3 mt -52.32 -59.18 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.687 -0.633 . . . . 0.0 110.486 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.72 52.04 4.52 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 121.409 0.45 . . . . 0.0 112.985 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 14.3 p -163.21 -49.67 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.962 -0.728 . . . . 0.0 110.529 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.15 42.91 0.11 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.748 0.785 . . . . 0.0 111.521 176.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -159.57 38.62 0.48 Allowed Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.982 -1.074 . . . . 0.0 111.858 173.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -80.9 -42.37 21.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.777 -0.837 . . . . 0.0 110.926 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -58.44 -44.88 95.06 Favored Glycine 0 N--CA 1.475 1.274 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.952 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 28.1 pt 8.72 73.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 99.1 t -41.66 -58.03 3.45 Favored Pre-proline 0 N--CA 1.475 0.808 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -172.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -56.36 -38.38 95.29 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.038 2.492 . . . . 0.0 113.785 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.25 -51.74 22.88 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -51.99 -47.79 64.72 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.012 0.434 . . . . 0.0 111.941 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 81.0 mt -55.06 -53.47 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.982 -0.448 . . . . 0.0 111.517 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -56.42 -44.65 80.57 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.728 -0.607 . . . . 0.0 112.052 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 m -51.97 -52.6 49.26 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.448 -0.783 . . . . 0.0 110.889 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.73 -52.12 65.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.914 0.387 . . . . 0.0 111.792 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.5 tt -51.11 -56.59 11.93 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.469 0.708 . . . . 0.0 110.772 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.76 -48.43 72.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.242 0.617 . . . . 0.0 111.366 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 56.5 ttp -53.73 -50.72 65.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.597 -0.689 . . . . 0.0 111.913 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.4 t -54.3 -48.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.786 -0.571 . . . . 0.0 111.401 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.0 mt -53.31 -53.79 45.88 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.864 -0.522 . . . . 0.0 111.67 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -47.67 -54.24 12.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.888 -0.508 . . . . 0.0 111.659 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.66 -57.23 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 122.002 -0.436 . . . . 0.0 111.706 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 86.5 p -58.71 -48.7 80.22 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.695 -0.628 . . . . 0.0 112.621 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.19 94.6 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.88 -0.513 . . . . 0.0 111.319 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.437 ' HB2' ' HZ3' ' A' ' 216' ' ' LYS . 3.6 ttmp? -55.06 -49.91 70.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.77 0.428 . . . . 0.0 111.547 177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.22 -52.57 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 122.041 -0.412 . . . . 0.0 111.005 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.54 -50.4 36.24 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 121.885 -0.509 . . . . 0.0 112.391 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -53.12 -49.96 65.45 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.056 -0.673 . . . . 0.0 111.102 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.43 -48.53 64.31 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 121.888 -0.508 . . . . 0.0 112.714 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.82 -45.27 82.41 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.783 -0.834 . . . . 0.0 112.463 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.13 -47.5 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.653 -0.654 . . . . 0.0 111.902 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.39 -55.53 15.32 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.794 -0.566 . . . . 0.0 110.601 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 32.6 tp -80.94 62.06 4.79 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.761 1.267 . . . . 0.0 110.16 174.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -164.02 -54.54 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.6 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 55.2 p -147.03 54.16 1.09 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.155 0.979 . . . . 0.0 111.858 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.89 -66.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.521 -0.737 . . . . 0.0 109.396 176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -70.81 -46.14 63.36 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.704 0.764 . . . . 0.0 109.68 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.9 mt -57.16 -29.35 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.144 173.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -83.94 64.65 8.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.486 1.136 . . . . 0.0 110.412 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.653 0 CA-C-N 115.672 -0.694 . . . . 0.0 113.184 177.535 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 20.5 ptt? . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -153.82 62.76 4.07 Favored Pre-proline 0 N--CA 1.475 0.813 0 O-C-N 121.589 -0.695 . . . . 0.0 111.225 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.3 -62.99 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.141 2.561 . . . . 0.0 111.883 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 167' ' ' VAL . 0.7 OUTLIER -81.94 -114.92 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 170.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 168' ' ' ALA . 2.7 t 63.19 -169.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.005 -1.059 . . . . 0.0 110.004 168.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.556 ' H ' HG13 ' A' ' 167' ' ' VAL . . . -45.7 -31.1 1.81 Allowed 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.716 -1.24 . . . . 0.0 113.562 174.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.5 m -60.32 -64.94 0.77 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.522 -0.737 . . . . 0.0 111.433 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.2 m -63.5 -36.76 84.85 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.635 -0.665 . . . . 0.0 111.758 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -52.49 -52.38 54.71 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.558 -0.714 . . . . 0.0 111.306 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -58.98 -47.27 85.74 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.939 -0.476 . . . . 0.0 111.464 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 68.8 t -51.59 -53.26 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 122.06 -0.4 . . . . 0.0 111.48 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.8 tt -54.15 -52.37 61.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.112 0.565 . . . . 0.0 110.869 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -52.35 45.57 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.948 0.404 . . . . 0.0 110.632 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -53.52 -55.11 28.3 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.701 -0.625 . . . . 0.0 111.776 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.1 t -52.95 -48.66 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 71.8 p -61.46 -45.58 93.67 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.518 -0.738 . . . . 0.0 112.252 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.51 -49.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.346 -0.846 . . . . 0.0 111.638 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.7 t -52.99 -51.03 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 122.047 -0.408 . . . . 0.0 110.722 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.67 -54.46 22.86 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.742 -0.599 . . . . 0.0 111.106 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -57.52 -47.39 82.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.4 p -61.15 -42.87 99.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.242 -0.912 . . . . 0.0 111.08 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.24 -13.0 61.56 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -62.48 -56.42 30.32 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.464 -1.398 . . . . 0.0 111.197 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -61.41 -39.17 58.47 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.801 2.334 . . . . 0.0 111.862 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.446 HG11 ' HB3' ' A' ' 202' ' ' ASN . 35.8 t -46.87 -52.6 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 122.004 -0.435 . . . . 0.0 111.753 173.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.49 -57.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 122.059 -0.401 . . . . 0.0 111.086 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -47.94 -45.07 30.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.7 tp -50.7 -35.22 30.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.485 ' HB ' HD13 ' A' ' 198' ' ' ILE . 9.8 tt -68.95 -44.39 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.095 -1.003 . . . . 0.0 109.658 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.26 52.13 4.26 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 18.8 p -169.47 -67.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.308 0.643 . . . . 0.0 110.557 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -95.17 47.79 1.15 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.281 1.038 . . . . 0.0 111.18 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 57.25 -166.15 5.47 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 121.6 -0.687 . . . . 0.0 112.231 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.425 ' HA ' HG13 ' A' ' 191' ' ' ILE . . . -81.59 37.83 0.48 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.471 -1.017 . . . . 0.0 112.443 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -85.73 45.22 3.45 Favored Glycine 0 N--CA 1.476 1.322 0 O-C-N 121.459 -0.776 . . . . 0.0 112.19 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.485 HD13 ' HB ' ' A' ' 191' ' ' ILE . 7.3 pt -151.83 -175.03 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 122.063 -0.669 . . . . 0.0 111.308 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . 0.275 94.6 t 113.63 -64.68 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 126.89 2.076 . . . . 0.0 112.777 171.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.01 -54.4 1.15 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.934 1.756 . . . . 0.0 111.369 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.98 -45.37 74.99 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.944 0.402 . . . . 0.0 110.809 173.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.446 ' HB3' HG11 ' A' ' 187' ' ' VAL . 4.4 m120 -57.28 -53.08 62.22 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 95.9 mt -57.67 -46.86 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.109 -0.369 . . . . 0.0 110.704 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -50.95 -55.08 18.98 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.196 -0.315 . . . . 0.0 111.313 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.3 m -53.31 -50.7 64.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.916 0.487 . . . . 0.0 111.899 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.05 -50.8 71.62 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.805 -0.56 . . . . 0.0 111.604 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.35 -54.03 42.42 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.441 0.639 . . . . 0.0 110.349 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -52.0 -51.65 55.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.093 0.557 . . . . 0.0 111.477 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.2 ttt -49.4 -48.07 47.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 90.7 t -52.3 -52.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.76 -0.588 . . . . 0.0 111.29 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.8 mp -54.05 -50.65 66.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -50.09 -57.45 7.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.772 -0.58 . . . . 0.0 111.306 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.07 -53.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 122.21 -0.306 . . . . 0.0 111.504 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.6 p -57.03 -44.84 83.29 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.944 -0.472 . . . . 0.0 111.604 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.42 65.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.958 -0.464 . . . . 0.0 112.202 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -46.11 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.04 -50.7 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.659 -0.65 . . . . 0.0 111.524 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.16 -51.39 54.35 Favored Glycine 0 N--CA 1.475 1.238 0 O-C-N 121.806 -0.559 . . . . 0.0 112.018 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.82 -51.59 63.05 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 122.109 -0.642 . . . . 0.0 110.989 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.0 -48.16 63.83 Favored Glycine 0 N--CA 1.473 1.163 0 O-C-N 122.07 -0.394 . . . . 0.0 112.218 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.28 -51.17 65.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.912 -0.758 . . . . 0.0 112.399 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.72 -50.74 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.717 -0.614 . . . . 0.0 111.083 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.5 tp -53.68 -58.28 7.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.136 0.574 . . . . 0.0 111.263 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.32 60.89 4.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.357 1.075 . . . . 0.0 110.59 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -172.73 -53.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.346 -178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 75.1 m -139.2 65.52 1.44 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.501 1.143 . . . . 0.0 111.041 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -174.55 -60.23 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -85.35 -51.57 6.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.6 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 18.4 mt -70.03 -75.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.98 -0.45 . . . . 0.0 110.567 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.94 -174.25 2.82 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.516 0 O-C-N 121.053 -1.03 . . . . 0.0 112.336 172.685 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.501 ' CG ' ' HD2' ' A' ' 165' ' ' PRO . 48.0 ttt85 69.58 158.19 0.15 Allowed Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -149.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.501 ' HD2' ' CG ' ' A' ' 164' ' ' ARG . 80.4 Cg_endo -74.22 42.42 0.75 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.134 1.889 . . . . 0.0 114.121 173.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 36.01 41.15 0.12 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 176.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.35 -55.77 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.73 91.75 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.173 0.511 . . . . 0.0 110.442 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 m -53.97 -59.07 5.12 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.801 0.44 . . . . 0.0 111.475 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 41.5 p -59.83 -44.59 93.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.724 -0.61 . . . . 0.0 112.131 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.95 -55.35 14.87 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.851 -0.531 . . . . 0.0 111.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -55.09 -52.1 64.31 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.038 -0.414 . . . . 0.0 111.953 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 79.3 t -53.93 -51.93 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 122.141 -0.35 . . . . 0.0 111.876 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.2 tt -56.81 -57.2 13.5 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.786 0.434 . . . . 0.0 110.902 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -53.17 -49.54 66.45 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.054 0.454 . . . . 0.0 110.515 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -52.05 -62.07 1.86 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.991 -0.443 . . . . 0.0 111.946 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.9 t -55.65 -46.82 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.8 p -58.86 -50.43 74.04 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.708 -0.62 . . . . 0.0 112.426 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.88 -45.4 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.596 -0.69 . . . . 0.0 111.854 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.53 -55.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.748 -0.595 . . . . 0.0 110.918 175.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.07 -49.71 60.1 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.813 -0.555 . . . . 0.0 111.114 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -49.75 -58.04 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 82.4 p -61.12 -41.09 96.06 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.765 0.793 . . . . 0.0 111.833 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.17 -29.49 68.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . 0.408 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 51.6 t80 -54.81 -53.94 55.17 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 39.3 Cg_endo -59.17 -36.93 94.57 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.994 2.462 . . . . 0.0 112.762 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.49 -52.68 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.613 -0.68 . . . . 0.0 110.459 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.52 -46.12 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.04 0.536 . . . . 0.0 111.365 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -52.04 -58.85 5.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.012 -0.43 . . . . 0.0 111.24 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 53.7 tp -50.44 -42.92 54.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.604 0.362 . . . . 0.0 111.93 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 91.0 mt -56.08 -61.16 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 122.072 -0.393 . . . . 0.0 110.192 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.35 53.14 4.63 Favored Glycine 0 N--CA 1.477 1.418 0 CA-C-O 121.781 0.656 . . . . 0.0 112.506 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' SER . . . . . 0.447 ' HG ' ' H ' ' A' ' 195' ' ' GLY . 88.1 p -171.34 -26.39 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.144 0.978 . . . . 0.0 110.333 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 38.48 40.16 0.36 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.433 1.093 . . . . 0.0 113.44 -166.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.447 ' H ' ' HG ' ' A' ' 193' ' ' SER . . . -79.12 51.15 3.83 Favored Glycine 0 N--CA 1.478 1.481 0 O-C-N 122.054 -0.404 . . . . 0.0 113.281 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.64 82.84 0.43 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.909 0.861 . . . . 0.0 111.532 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 63.91 26.72 70.36 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 16.6 mt -72.17 -34.79 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.684 -0.892 . . . . 0.0 110.925 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 90.7 t -52.26 -60.88 5.32 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.517 -0.739 . . . . 0.0 111.836 177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.72 -38.95 56.79 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.763 2.309 . . . . 0.0 112.749 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 6.0 tt -50.11 -59.06 4.28 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.038 -0.414 . . . . 0.0 110.872 174.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -59.02 -40.75 85.92 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 88.5 mt -50.96 -55.7 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.547 -0.721 . . . . 0.0 110.706 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -55.23 -51.07 67.79 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.919 -0.488 . . . . 0.0 111.619 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.0 m -49.33 -46.98 47.48 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.695 0.398 . . . . 0.0 111.946 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -53.93 -58.24 8.0 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.934 -0.479 . . . . 0.0 111.821 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -54.77 -48.24 72.93 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.771 -0.581 . . . . 0.0 111.987 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.59 -55.49 21.92 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.106 0.479 . . . . 0.0 110.958 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 28.0 ttt -54.28 -47.11 72.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 69.8 t -51.17 -52.05 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.499 -0.751 . . . . 0.0 111.255 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.9 mt -56.64 -48.51 77.4 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.097 0.475 . . . . 0.0 111.9 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -53.91 -53.61 50.31 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.381 0.61 . . . . 0.0 112.253 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -58.02 -53.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.947 -0.471 . . . . 0.0 111.632 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 63.6 p -55.7 -45.8 77.77 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.739 -0.601 . . . . 0.0 111.923 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.68 -49.44 72.93 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.882 -0.511 . . . . 0.0 112.057 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.416 ' HA ' ' HE2' ' A' ' 216' ' ' LYS . 5.5 mmpt? -57.11 -45.8 83.15 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 95.8 t -54.57 -51.99 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.618 -0.676 . . . . 0.0 110.549 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.24 -51.66 30.28 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -49.79 -49.25 49.33 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.241 -0.564 . . . . 0.0 112.123 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.19 -52.58 31.19 Favored Glycine 0 N--CA 1.476 1.365 0 O-C-N 122.094 -0.379 . . . . 0.0 112.396 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.93 -51.88 67.39 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.966 -0.726 . . . . 0.0 112.147 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.7 mt -49.75 -49.37 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.041 0.536 . . . . 0.0 111.294 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 60.5 tp -54.45 -58.54 7.05 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.038 -0.414 . . . . 0.0 110.755 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.29 52.91 2.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.19 0.995 . . . . 0.0 111.116 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.25 -47.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.281 -0.887 . . . . 0.0 111.04 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 58.8 m -144.92 58.81 1.3 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.008 0.909 . . . . 0.0 111.324 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -166.98 -62.63 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.49 -0.756 . . . . 0.0 109.839 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -95.45 -48.49 5.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 4.1 mt 56.15 61.69 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.39 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -77.21 173.59 11.69 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.851 -1.155 . . . . 0.0 110.631 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.648 0 O-C-N 121.409 -0.807 . . . . 0.0 112.715 177.841 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.634 0.254 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.9 t -47.03 -60.46 2.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.7 t -59.3 -40.44 86.19 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.473 -0.767 . . . . 0.0 112.462 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -56.56 -53.91 52.11 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.628 -0.67 . . . . 0.0 111.523 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -59.46 -44.0 93.09 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.809 -0.557 . . . . 0.0 112.287 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -54.19 -48.59 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.763 -0.586 . . . . 0.0 111.559 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.4 tt -52.4 -56.1 17.25 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.831 -0.543 . . . . 0.0 110.816 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.28 -47.82 71.91 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -50.76 -58.19 6.53 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.735 -0.603 . . . . 0.0 111.492 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.59 -50.75 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 122.047 -0.408 . . . . 0.0 111.945 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 47.0 p -58.64 -49.04 78.98 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.8 -48.25 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.512 -0.743 . . . . 0.0 111.846 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.26 -53.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.723 -0.611 . . . . 0.0 110.96 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.2 tt -51.78 -51.74 54.09 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.817 -0.552 . . . . 0.0 110.499 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -50.4 -56.22 12.37 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -61.02 -42.77 99.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.717 0.77 . . . . 0.0 111.728 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.97 68.12 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.408 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 60.2 t80 -57.4 -54.85 50.62 Favored Pre-proline 0 N--CA 1.475 0.819 0 O-C-N 121.289 -0.882 . . . . 0.0 112.889 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 48.0 Cg_endo -60.51 -36.86 84.45 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.943 2.429 . . . . 0.0 112.606 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.58 -55.27 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.813 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 82.1 t -56.03 -45.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.972 0.509 . . . . 0.0 111.283 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -51.51 -58.98 4.8 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.935 -0.478 . . . . 0.0 111.252 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.63 -47.17 49.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.226 0.611 . . . . 0.0 111.63 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.91 -55.64 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.834 -0.541 . . . . 0.0 110.239 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 O-C-N 121.671 -0.643 . . . . 0.0 113.546 177.14 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.956 0.408 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.65 -54.82 39.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.031 -0.418 . . . . 0.0 110.85 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.29 -53.53 27.87 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.223 0.535 . . . . 0.0 111.252 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.74 -52.82 54.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.127 0.571 . . . . 0.0 111.254 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.34 -48.14 68.76 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.772 -0.58 . . . . 0.0 112.351 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -53.42 -49.7 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.544 -0.723 . . . . 0.0 111.239 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.94 -51.09 64.92 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.986 -0.446 . . . . 0.0 111.237 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -50.38 -53.09 31.72 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.907 -0.496 . . . . 0.0 111.612 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.24 -54.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 122.04 -0.412 . . . . 0.0 111.895 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 70.4 p -57.37 -45.37 84.5 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.666 -0.646 . . . . 0.0 111.752 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.93 73.98 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.002 -0.436 . . . . 0.0 111.975 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -54.52 -48.62 71.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.16 -51.92 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.855 -0.528 . . . . 0.0 111.165 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.51 -50.95 46.05 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 121.964 -0.46 . . . . 0.0 112.039 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -52.52 -49.73 64.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.165 -0.609 . . . . 0.0 111.385 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.78 -52.86 32.26 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 121.93 -0.481 . . . . 0.0 111.964 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.9 mt -53.67 -50.56 65.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 122.084 -0.656 . . . . 0.0 111.93 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.24 -51.46 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 122.064 -0.397 . . . . 0.0 111.384 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.3 tp . . . . . 0 N--CA 1.476 0.827 0 O-C-N 121.936 -0.478 . . . . 0.0 112.281 179.344 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 120.698 0.285 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -66.74 -46.98 73.7 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.844 -0.535 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 89.4 m -51.99 -50.17 61.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.674 0.39 . . . . 0.0 111.356 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.6 -53.24 59.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.896 -0.503 . . . . 0.0 111.129 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.82 -48.39 59.81 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.16 -50.68 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.984 -0.448 . . . . 0.0 111.549 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 174' ' ' LEU . 6.6 tt -52.57 -54.26 35.29 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.099 0.476 . . . . 0.0 111.092 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -52.67 -48.61 66.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.176 0.59 . . . . 0.0 111.761 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -53.32 -57.9 8.95 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.97 -0.456 . . . . 0.0 111.472 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 69.5 t -52.25 -49.61 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.959 -0.463 . . . . 0.0 112.192 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 45.6 p -58.46 -53.79 54.3 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.775 -0.578 . . . . 0.0 111.921 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.44 -46.18 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.421 -0.8 . . . . 0.0 111.991 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.53 -53.31 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.65 -0.656 . . . . 0.0 110.913 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 tt -51.74 -50.08 61.3 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.699 -0.626 . . . . 0.0 110.547 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.83 -54.62 31.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 111.851 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -61.89 -41.91 98.45 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.582 0.706 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.54 66.81 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -58.58 -56.92 30.68 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.197 -0.939 . . . . 0.0 111.859 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -60.38 -35.84 89.46 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.898 2.399 . . . . 0.0 112.65 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.83 -56.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.563 -0.711 . . . . 0.0 111.041 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 77.1 t -56.99 -45.62 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.831 -0.543 . . . . 0.0 111.229 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -53.12 -52.03 60.02 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 0.0 111.287 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.33 -49.29 64.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.14 0.576 . . . . 0.0 111.185 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 86.4 mt -51.92 -49.79 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.302 -0.874 . . . . 0.0 110.842 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.625 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 177.541 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -61.79 -44.25 97.25 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.451 -0.781 . . . . 0.0 112.024 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 206' ' ' LEU . 91.6 mt -57.62 -50.97 71.39 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.511 -0.743 . . . . 0.0 111.398 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.62 -53.3 48.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 59.8 ttp -52.36 -50.67 61.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.209 0.604 . . . . 0.0 112.385 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -52.27 -49.62 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.466 -0.771 . . . . 0.0 111.592 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.63 -49.02 73.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.136 0.493 . . . . 0.0 111.811 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -54.11 -51.96 62.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.14 0.495 . . . . 0.0 111.853 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.1 -54.66 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.117 -0.364 . . . . 0.0 111.688 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.4 p -56.0 -46.42 78.72 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.713 -0.617 . . . . 0.0 112.014 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.13 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.917 -0.489 . . . . 0.0 111.975 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.59 -48.49 74.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.956 -0.465 . . . . 0.0 112.087 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.8 t -55.04 -52.14 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.948 -0.47 . . . . 0.0 111.137 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.93 -51.65 33.69 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.83 -48.72 66.8 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 122.23 -0.57 . . . . 0.0 111.224 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.99 -56.41 16.63 Favored Glycine 0 N--CA 1.475 1.252 0 O-C-N 121.874 -0.516 . . . . 0.0 112.205 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.4 -45.66 69.41 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.734 -0.862 . . . . 0.0 112.265 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.7 mt -55.73 -49.95 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.741 -0.6 . . . . 0.0 111.661 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.3 tp . . . . . 0 N--CA 1.475 0.818 0 C-N-CA 122.944 0.498 . . . . 0.0 111.766 177.427 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 80.3 p -59.79 -48.47 81.54 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.62 -0.675 . . . . 0.0 112.085 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 25.5 p -56.42 -43.21 79.16 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.931 -0.481 . . . . 0.0 112.204 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -55.08 -48.04 74.08 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.715 -0.616 . . . . 0.0 111.501 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -52.89 -53.24 51.99 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.974 -0.454 . . . . 0.0 111.287 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.14 -46.48 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 122.426 0.29 . . . . 0.0 111.589 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 tt -51.32 -59.83 3.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.915 0.486 . . . . 0.0 110.889 177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -58.26 -44.06 88.17 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -51.23 -59.79 3.82 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.797 -0.564 . . . . 0.0 111.571 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.3 t -55.57 -49.29 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 122.073 -0.392 . . . . 0.0 111.774 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.4 p -56.84 -49.59 74.99 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.5 t -56.89 -48.83 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.503 -0.748 . . . . 0.0 111.667 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.2 t -56.67 -57.79 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.664 -0.648 . . . . 0.0 111.494 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 97.4 mt -56.07 -42.83 77.28 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.466 -0.771 . . . . 0.0 112.002 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -52.11 -59.54 4.25 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.999 -0.438 . . . . 0.0 111.924 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.6 p -60.85 -37.52 82.36 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.457 0.646 . . . . 0.0 111.928 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.33 63.81 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -54.89 -58.61 13.72 Favored Pre-proline 0 N--CA 1.478 0.945 0 CA-C-N 119.223 0.919 . . . . 0.0 113.213 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -57.9 -37.55 95.77 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.897 2.398 . . . . 0.0 112.678 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.05 -54.89 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.765 -0.584 . . . . 0.0 111.03 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 78.3 t -56.0 -46.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.891 -0.506 . . . . 0.0 111.386 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.8 t90 -50.71 -55.32 17.13 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.966 -0.459 . . . . 0.0 111.391 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tt -52.56 -50.8 62.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.781 0.433 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 97.9 mt -52.15 -52.74 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.683 -0.635 . . . . 0.0 111.296 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.542 0 O-C-N 121.833 -0.542 . . . . 0.0 114.258 179.145 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.812 0.339 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.411 ' C ' HD13 ' A' ' 206' ' ' LEU . 3.0 tm? -52.95 -54.31 36.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.027 -0.421 . . . . 0.0 111.235 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.1 tp -51.23 -51.59 52.59 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.947 -0.47 . . . . 0.0 111.979 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -53.65 -50.54 65.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.871 0.367 . . . . 0.0 111.356 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 57.3 ttp -54.01 -51.09 65.06 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 122.07 -0.393 . . . . 0.0 111.977 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.09 -50.26 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.787 -0.571 . . . . 0.0 111.507 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 95.4 mt -53.78 -52.39 60.39 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.062 -0.399 . . . . 0.0 111.73 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.45 -56.13 14.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.82 -0.55 . . . . 0.0 111.227 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.3 t -50.6 -52.88 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.3 p -58.13 -44.08 87.59 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.696 -0.627 . . . . 0.0 111.586 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.07 -48.49 75.99 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.897 -0.502 . . . . 0.0 111.961 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -58.18 -45.09 88.13 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.872 -0.518 . . . . 0.0 112.227 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.8 t -55.41 -50.42 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.44 -0.787 . . . . 0.0 111.405 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.99 -51.18 47.63 Favored Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.77 -52.44 31.85 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.087 0.555 . . . . 0.0 111.268 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.11 -52.42 35.81 Favored Glycine 0 N--CA 1.477 1.398 0 O-C-N 121.803 -0.56 . . . . 0.0 112.585 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 66.7 tp -54.58 -52.65 61.47 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.04 -0.682 . . . . 0.0 111.64 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.73 -49.96 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.67 0.388 . . . . 0.0 111.421 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.0 tp . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 122.938 0.495 . . . . 0.0 111.85 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 120.356 0.122 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.3 m -52.32 -57.54 9.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 23.9 p -58.38 -46.81 85.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.74 -48.73 72.21 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.699 -0.626 . . . . 0.0 111.662 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.25 -49.95 74.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.614 -0.679 . . . . 0.0 112.284 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.6 t -54.29 -47.3 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 121.819 -0.551 . . . . 0.0 111.738 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 174' ' ' LEU . 6.8 tt -52.85 -56.65 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.001 -0.437 . . . . 0.0 110.788 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -52.05 -49.24 63.85 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -49.73 -59.41 3.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.981 -0.449 . . . . 0.0 111.7 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.76 -52.28 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 122.057 -0.402 . . . . 0.0 111.94 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -58.03 -49.7 75.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.5 t -59.53 -50.46 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.598 -0.688 . . . . 0.0 111.59 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.83 -48.82 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.826 -0.546 . . . . 0.0 111.319 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 181' ' ' LEU . 5.9 tt -54.29 -56.13 21.53 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.795 -0.565 . . . . 0.0 110.876 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -54.09 -51.43 64.19 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -59.32 -44.8 92.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.602 -0.686 . . . . 0.0 112.0 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.84 -20.2 64.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -58.91 -55.71 43.55 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 120.99 -1.069 . . . . 0.0 112.134 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -60.43 -31.84 93.09 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.0 2.466 . . . . 0.0 112.769 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.11 -52.31 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.463 -0.773 . . . . 0.0 110.672 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.07 -46.38 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.848 -0.533 . . . . 0.0 111.024 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -51.83 -55.95 16.89 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.995 -0.441 . . . . 0.0 111.157 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.915 0.886 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 73.4 mt -51.59 -60.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 CA-C-O 121.283 0.38 . . . . 0.0 113.067 179.669 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.7 mt -54.31 -54.76 35.88 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -48.34 75.07 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.666 -0.647 . . . . 0.0 111.778 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -53.5 -53.36 52.58 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.029 -0.419 . . . . 0.0 111.463 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 58.1 ttp -49.38 -48.79 46.68 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.324 0.65 . . . . 0.0 112.45 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.1 t -51.29 -51.0 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.725 -0.609 . . . . 0.0 111.201 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.8 mt -54.92 -51.46 65.99 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 122.203 -0.311 . . . . 0.0 111.605 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -51.08 -50.83 57.96 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.875 -0.516 . . . . 0.0 111.969 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.5 -51.2 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.5 p -58.55 -46.05 87.66 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.433 -0.792 . . . . 0.0 111.681 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.1 77.03 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.925 -0.484 . . . . 0.0 111.845 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -50.01 -54.25 21.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.899 0.48 . . . . 0.0 111.648 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.3 t -55.26 -50.56 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 122.212 -0.305 . . . . 0.0 111.555 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.95 -51.49 34.42 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 121.897 -0.502 . . . . 0.0 112.134 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.34 -52.58 63.03 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.972 -0.722 . . . . 0.0 111.289 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.82 -48.45 44.47 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 94.8 mt -56.02 -56.31 22.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.205 -0.585 . . . . 0.0 111.921 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.1 mt -49.66 -43.81 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.542 0.687 . . . . 0.0 111.736 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 N--CA 1.47 0.527 0 O-C-N 121.818 -0.551 . . . . 0.0 110.513 175.168 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.5 p -73.66 -44.02 57.85 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.387 -0.821 . . . . 0.0 111.116 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.0 t -57.38 -43.25 83.45 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.418 -0.802 . . . . 0.0 110.735 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.76 -50.45 73.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.689 -0.632 . . . . 0.0 110.926 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -50.32 -50.56 50.47 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.42 -53.04 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.629 0.372 . . . . 0.0 111.712 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tt -51.16 -53.54 33.68 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.382 0.611 . . . . 0.0 110.59 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.9 ttm105 -52.33 -51.78 56.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.609 0.764 . . . . 0.0 112.401 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -53.03 -54.08 40.61 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.566 -0.708 . . . . 0.0 111.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.76 -52.79 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.02 -0.425 . . . . 0.0 111.648 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 56.5 p -55.05 -44.8 75.05 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.647 -0.658 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 68.9 t -56.11 -48.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.561 -0.712 . . . . 0.0 111.83 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.82 -55.12 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.526 -0.734 . . . . 0.0 111.473 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.4 -45.06 72.85 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.438 -0.789 . . . . 0.0 112.116 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -55.44 23.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.011 -0.431 . . . . 0.0 111.367 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.7 p -61.47 -38.85 88.74 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.562 -0.711 . . . . 0.0 112.533 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.89 -56.66 17.99 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.738 -0.601 . . . . 0.0 112.309 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -37.62 -56.99 1.63 Allowed Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -59.61 -44.58 30.91 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.001 2.467 . . . . 0.0 112.379 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.4 -46.87 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.751 -0.593 . . . . 0.0 110.682 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.1 t -51.25 -53.14 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -57.05 -52.47 65.13 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.932 -0.48 . . . . 0.0 111.768 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 59.7 tp -46.18 -50.81 15.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.59 -43.72 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.799 -0.563 . . . . 0.0 111.448 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 CA-C-O 121.753 0.64 . . . . 0.0 112.836 173.874 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -61.74 -38.93 89.78 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.579 -0.701 . . . . 0.0 112.28 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 206' ' ' LEU . 64.6 tp -54.84 -54.39 43.0 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.51 -0.744 . . . . 0.0 110.937 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.11 -50.35 61.84 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.258 0.623 . . . . 0.0 111.187 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 63.5 mtt -52.23 -52.3 53.21 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.654 -0.654 . . . . 0.0 112.395 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.68 -47.76 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.639 -0.663 . . . . 0.0 111.674 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -54.72 -47.98 73.08 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -54.23 -56.11 21.5 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.873 -0.517 . . . . 0.0 110.713 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.8 t -51.68 -54.97 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.97 -0.456 . . . . 0.0 111.918 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 61.8 p -58.08 -50.48 73.32 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.665 -0.647 . . . . 0.0 112.451 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.7 85.56 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.857 -0.527 . . . . 0.0 111.907 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -55.71 -50.48 70.21 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.572 0.749 . . . . 0.0 111.343 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.95 -51.39 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.998 -0.439 . . . . 0.0 111.11 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -49.52 -51.29 27.94 Favored Glycine 0 N--CA 1.476 1.307 0 O-C-N 121.935 -0.478 . . . . 0.0 111.926 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -53.96 -47.64 71.14 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.142 -0.622 . . . . 0.0 111.182 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.46 -51.16 22.55 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.975 -0.453 . . . . 0.0 112.446 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 9.2 mp -58.37 -52.27 66.31 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.933 -0.745 . . . . 0.0 112.07 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.2 mt -49.87 -46.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.818 -0.551 . . . . 0.0 111.376 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 N--CA 1.47 0.565 0 O-C-N 121.823 -0.548 . . . . 0.0 110.443 173.992 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 121.37 0.605 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.1 m -54.19 -63.38 1.17 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.067 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 86.8 m -61.96 -48.68 79.3 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.893 -0.505 . . . . 0.0 111.302 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.9 -52.71 47.97 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 110.795 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.24 -51.68 68.92 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 63.9 t -55.71 -53.41 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.846 -0.533 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.15 -47.23 86.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.699 -0.625 . . . . 0.0 112.242 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -56.25 -48.19 77.03 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.726 -0.609 . . . . 0.0 111.551 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -53.03 -55.42 23.86 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.688 -0.632 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.5 t -52.34 -50.38 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 67.6 p -58.74 -47.18 85.52 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.546 -0.721 . . . . 0.0 112.282 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 75.3 t -56.55 -51.45 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.528 -0.732 . . . . 0.0 111.775 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -53.78 -46.01 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.918 -0.489 . . . . 0.0 111.357 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.74 -56.42 20.68 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.686 -0.634 . . . . 0.0 110.931 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -55.53 -48.55 74.52 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.739 -0.601 . . . . 0.0 112.422 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.4 p -60.77 -44.01 97.32 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.644 -0.66 . . . . 0.0 112.11 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.81 -22.01 66.32 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.415 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 1.2 t80 -59.49 -54.92 51.22 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 120.97 -1.081 . . . . 0.0 111.431 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 56.1 Cg_endo -61.21 -34.73 88.04 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.58 2.187 . . . . 0.0 112.365 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.4 -51.78 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.12 0.873 . . . . 0.0 111.556 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.83 -50.21 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.686 -0.634 . . . . 0.0 111.304 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -60.7 -46.31 90.87 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.871 -0.518 . . . . 0.0 111.969 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 26.6 tp -46.35 -50.28 16.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.131 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.5 mt -57.7 -59.82 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.981 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 CA-C-O 121.403 0.446 . . . . 0.0 112.362 179.141 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.907 0.384 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -47.96 83.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.005 -0.434 . . . . 0.0 112.164 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -54.87 24.23 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.545 -0.722 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -54.71 -49.93 69.54 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.454 0.302 . . . . 0.0 111.379 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 47.8 ttm -51.08 -49.5 60.53 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 72.6 t -54.14 -48.86 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.456 -0.777 . . . . 0.0 111.306 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.41 -51.32 65.25 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.948 -0.47 . . . . 0.0 111.284 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -51.11 -50.35 58.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.151 0.58 . . . . 0.0 111.617 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.97 -54.07 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 64.4 p -57.18 -45.34 83.79 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.351 -0.843 . . . . 0.0 111.539 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.27 76.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.707 0.403 . . . . 0.0 111.504 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -52.48 -50.78 62.02 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.949 -0.469 . . . . 0.0 111.952 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.41 -53.21 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 122.087 -0.383 . . . . 0.0 111.297 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.82 -50.55 49.59 Favored Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -54.31 -51.49 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.247 -0.561 . . . . 0.0 111.262 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.2 51.28 Favored Glycine 0 N--CA 1.475 1.281 0 O-C-N 121.923 -0.486 . . . . 0.0 112.216 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 87.1 mt -56.05 -51.22 68.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.966 -0.726 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.2 mt -55.8 -48.28 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.856 -0.527 . . . . 0.0 111.905 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.2 tp . . . . . 0 N--CA 1.474 0.75 0 O-C-N 121.874 -0.516 . . . . 0.0 111.562 177.563 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 t -66.08 -49.75 66.49 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.596 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 84.5 m -53.52 -52.88 58.2 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 122.341 -0.225 . . . . 0.0 111.43 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -56.34 -49.31 74.72 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.622 -0.674 . . . . 0.0 111.708 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.52 -50.62 69.5 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.603 -0.686 . . . . 0.0 111.771 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.23 -58.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.967 -0.458 . . . . 0.0 111.668 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.18 -41.32 83.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.432 ' HA ' ' NE ' ' A' ' 175' ' ' ARG . 15.2 mmm-85 -60.96 -47.71 85.19 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.066 -1.021 . . . . 0.0 112.542 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -52.89 -51.48 61.03 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.816 -0.553 . . . . 0.0 110.645 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.06 -54.21 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 p -55.61 -46.46 77.35 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.49 -0.756 . . . . 0.0 112.666 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.55 -53.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.628 -0.67 . . . . 0.0 111.799 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.55 -45.91 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.777 -0.577 . . . . 0.0 111.837 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.79 -53.1 61.67 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.674 -0.641 . . . . 0.0 110.498 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -54.35 -51.63 64.16 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.032 -0.418 . . . . 0.0 112.03 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.5 p -61.68 -40.64 95.68 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -58.76 -47.66 83.89 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.444 -0.785 . . . . 0.0 112.571 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -41.3 -58.05 3.18 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -61.05 -38.16 70.21 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.157 2.571 . . . . 0.0 112.572 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.58 -53.17 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.574 -0.704 . . . . 0.0 110.768 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 72.4 t -53.59 -50.37 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.318 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -54.37 -54.77 36.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.871 0.367 . . . . 0.0 111.211 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.4 tp -49.11 -51.41 31.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.542 0.737 . . . . 0.0 111.479 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.02 -57.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.982 -0.448 . . . . 0.0 110.005 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.334 0 O-C-N 122.079 -0.388 . . . . 0.0 112.401 177.251 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.583 0.23 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.63 -50.2 72.72 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.927 -0.483 . . . . 0.0 112.064 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -53.43 -53.71 47.42 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.765 -0.584 . . . . 0.0 110.511 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.97 -48.41 73.27 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.104 -0.373 . . . . 0.0 110.852 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.6 ttt -52.62 -49.97 64.04 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.688 -0.633 . . . . 0.0 111.872 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.0 t -52.98 -50.61 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.54 -0.725 . . . . 0.0 111.28 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.3 mt -54.52 -50.23 68.33 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.888 -0.507 . . . . 0.0 112.194 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.22 -54.1 44.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.966 0.507 . . . . 0.0 111.426 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.04 -55.07 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.987 -0.445 . . . . 0.0 111.517 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -55.79 -47.63 76.75 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.596 -0.69 . . . . 0.0 112.284 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.96 -49.7 72.83 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.902 -0.499 . . . . 0.0 111.875 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 216' ' ' LYS . 0.1 OUTLIER -58.53 -43.1 89.07 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.804 0.442 . . . . 0.0 112.164 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 69.3 t -55.01 -54.01 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.495 -0.753 . . . . 0.0 110.645 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.87 -50.54 37.62 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -50.4 -50.63 51.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.159 0.583 . . . . 0.0 110.987 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.91 -51.65 33.59 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 122.004 -0.435 . . . . 0.0 112.549 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.33 -52.52 63.23 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 122.081 -0.658 . . . . 0.0 111.858 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 94.6 mt -54.7 -47.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.162 0.506 . . . . 0.0 111.894 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 29.2 tp . . . . . 0 N--CA 1.472 0.66 0 O-C-N 121.784 -0.572 . . . . 0.0 109.743 175.769 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 61.1 p -51.89 -63.31 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 m -74.89 -43.38 54.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 -174.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.03 -44.56 91.76 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.027 -0.42 . . . . 0.0 111.951 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.56 -50.26 72.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.232 -0.917 . . . . 0.0 110.997 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 83.7 t -54.6 -53.67 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.587 0.232 . . . . 0.0 110.497 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.42 -57.35 8.21 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.166 0.586 . . . . 0.0 111.237 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HE ' ' HA ' ' A' ' 176' ' ' ASN . 2.4 tmm_? -50.24 -57.95 6.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.336 0.654 . . . . 0.0 110.581 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.475 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 7.7 t30 -58.41 -49.7 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.169 -0.332 . . . . 0.0 111.181 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -54.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 23.9 p -55.47 -50.62 69.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.74 -0.6 . . . . 0.0 111.81 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.77 -50.87 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.701 -0.624 . . . . 0.0 111.606 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.1 t -55.86 -51.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.888 -0.508 . . . . 0.0 111.837 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -53.13 -48.13 68.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.252 -0.905 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -55.72 -52.83 62.56 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.4 p -60.7 -41.98 96.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.771 0.796 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -17.17 61.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.457 ' HB3' ' CD ' ' A' ' 186' ' ' PRO . 1.5 t80 -59.25 -59.9 12.32 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 119.972 1.26 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.457 ' CD ' ' HB3' ' A' ' 185' ' ' TYR . 52.5 Cg_endo -61.86 -30.99 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.88 2.387 . . . . 0.0 113.187 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.45 -56.56 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.408 -0.808 . . . . 0.0 110.675 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.92 -43.58 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.939 -0.476 . . . . 0.0 111.313 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -51.18 -59.46 4.17 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.038 -0.414 . . . . 0.0 111.086 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -50.99 45.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.388 0.675 . . . . 0.0 110.432 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.58 -61.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 122.127 -0.358 . . . . 0.0 110.612 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 O-C-N 122.025 -0.422 . . . . 0.0 112.129 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.5 -50.74 70.91 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.676 -0.64 . . . . 0.0 112.3 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.9 tp -51.42 -51.05 58.2 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.443 0.64 . . . . 0.0 111.479 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.27 -52.9 61.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.118 0.485 . . . . 0.0 111.068 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 42.1 ttm -50.42 -49.64 54.22 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 112.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.34 -51.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.614 -0.678 . . . . 0.0 111.464 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.41 -48.95 71.01 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.2 0.524 . . . . 0.0 111.624 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 216' ' ' LYS . 70.7 m-20 -53.75 -54.37 39.06 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.006 -0.434 . . . . 0.0 111.908 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.35 -54.83 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.899 -0.501 . . . . 0.0 111.911 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -56.17 -45.22 79.8 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.42 -48.86 68.36 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.848 -0.532 . . . . 0.0 112.255 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 212' ' ' ASP . 9.5 mmtp -57.29 -46.48 83.1 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 122.003 -0.436 . . . . 0.0 111.598 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.42 -52.23 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.716 -0.615 . . . . 0.0 110.711 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.44 -51.17 33.03 Favored Glycine 0 N--CA 1.478 1.435 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -51.76 -48.51 63.68 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 122.364 -0.492 . . . . 0.0 111.584 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -49.65 -52.59 24.3 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 122.035 -0.415 . . . . 0.0 112.348 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.23 -50.79 72.31 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.05 -0.677 . . . . 0.0 112.331 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 38.6 mt -49.27 -49.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 121.299 0.571 . . . . 0.0 111.67 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 40.2 tp . . . . . 0 N--CA 1.475 0.788 0 O-C-N 121.847 -0.533 . . . . 0.0 111.125 174.622 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.787 0.327 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m -59.04 -52.95 63.55 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 0.0 111.696 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.2 p -56.59 -48.07 78.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.33 -46.63 83.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.735 -0.603 . . . . 0.0 111.303 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -51.92 -51.32 57.77 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.484 -0.76 . . . . 0.0 112.102 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.59 -53.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.43 -52.01 63.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.215 0.531 . . . . 0.0 111.97 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 -52.32 -52.63 52.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.409 0.683 . . . . 0.0 111.47 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -51.35 -57.93 7.6 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.925 -0.484 . . . . 0.0 111.614 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.0 t -54.41 -49.8 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.963 -0.46 . . . . 0.0 112.17 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.7 p -58.84 -49.34 78.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.62 -0.675 . . . . 0.0 112.718 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.9 t -57.21 -49.93 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.463 -0.773 . . . . 0.0 111.742 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.76 -51.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.742 -0.599 . . . . 0.0 110.929 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.9 tt -51.51 -50.07 60.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.57 -0.706 . . . . 0.0 111.395 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 42.7 t90 -51.81 -57.4 9.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.5 p -61.54 -37.48 83.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.52 0.676 . . . . 0.0 112.214 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.57 65.7 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.4 ' HB3' ' CD ' ' A' ' 186' ' ' PRO . 1.4 t80 -57.32 -56.1 37.41 Favored Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 121.137 -0.977 . . . . 0.0 111.97 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 185' ' ' TYR . 43.1 Cg_endo -59.9 -33.41 95.85 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.793 2.329 . . . . 0.0 113.145 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.1 t -59.3 -53.17 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.397 -0.814 . . . . 0.0 111.116 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.7 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.805 -0.559 . . . . 0.0 110.95 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -52.54 -56.4 15.52 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.139 -0.35 . . . . 0.0 111.428 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.09 -56.04 2.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.871 0.869 . . . . 0.0 110.128 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.1 mt -54.94 -59.67 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 122.04 -0.413 . . . . 0.0 110.655 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -175.767 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -62.56 -42.71 99.72 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.614 -0.678 . . . . 0.0 112.417 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 206' ' ' LEU . 5.0 tt -56.26 -53.8 52.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.538 -0.726 . . . . 0.0 110.027 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -52.87 -50.57 63.54 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.659 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 54.5 ttm -51.29 -49.72 60.71 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -52.65 -52.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.694 -0.629 . . . . 0.0 111.289 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.54 -51.46 66.97 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.33 0.586 . . . . 0.0 111.827 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -48.78 -53.95 17.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.605 0.762 . . . . 0.0 111.327 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.84 -51.01 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 58.5 p -57.27 -39.13 75.04 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.281 -0.887 . . . . 0.0 111.486 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.89 73.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -52.76 -51.27 61.3 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 110.98 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.14 -52.42 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.067 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.12 -50.83 50.03 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.62 -50.87 67.07 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.093 -0.651 . . . . 0.0 111.235 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.39 -50.23 41.94 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.753 -0.592 . . . . 0.0 112.134 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.54 -53.56 54.86 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.153 -0.616 . . . . 0.0 112.15 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 79.0 mt -52.55 -51.95 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.108 0.48 . . . . 0.0 111.082 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 43.7 tp . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 123.406 0.682 . . . . 0.0 112.128 -178.02 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.034 0.445 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.3 m -49.3 -52.92 24.6 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.3 m -57.14 -49.72 75.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.805 -0.559 . . . . 0.0 111.586 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.18 -48.02 71.39 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.112 0.482 . . . . 0.0 111.709 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -55.65 -49.21 73.5 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.783 -0.573 . . . . 0.0 112.061 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.5 -49.16 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.94 -0.475 . . . . 0.0 111.667 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.4 tt -52.18 -55.0 23.9 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.184 0.516 . . . . 0.0 110.497 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -52.72 -50.5 63.29 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -52.82 -56.87 12.58 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.581 -0.699 . . . . 0.0 111.995 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.7 t -54.17 -49.74 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.971 -0.456 . . . . 0.0 111.935 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.2 p -56.16 -46.04 79.44 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.625 -0.672 . . . . 0.0 112.6 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.51 -48.4 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.373 -0.83 . . . . 0.0 111.879 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -54.16 -48.52 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.629 -0.669 . . . . 0.0 111.668 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.7 mt -55.61 -50.01 71.28 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.509 -0.744 . . . . 0.0 111.887 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -53.22 -53.3 52.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.868 -0.52 . . . . 0.0 112.353 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.5 p -61.5 -38.38 87.13 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.09 95.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.207 -0.933 . . . . 0.0 112.463 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -40.79 -51.83 6.84 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -58.47 -40.4 74.94 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.905 2.404 . . . . 0.0 112.516 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.5 t -60.63 -45.08 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.795 -0.565 . . . . 0.0 110.375 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.54 -50.05 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.823 -0.548 . . . . 0.0 110.723 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -53.1 -51.19 62.67 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 48.0 tp -47.04 -53.38 12.7 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.985 -0.447 . . . . 0.0 111.511 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -52.39 -55.71 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 O-C-N 121.89 -0.506 . . . . 0.0 112.192 177.043 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -60.78 -39.86 90.42 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.626 -0.671 . . . . 0.0 112.279 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 206' ' ' LEU . 3.1 tm? -54.09 -56.19 20.43 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.544 -0.723 . . . . 0.0 110.603 174.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.43 -53.48 29.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.556 0.342 . . . . 0.0 111.385 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 92.6 mtp -49.1 -49.64 40.9 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 76.6 t -52.87 -51.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.601 -0.687 . . . . 0.0 111.372 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.83 -47.84 73.6 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -54.22 -52.59 60.82 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.703 -0.623 . . . . 0.0 111.889 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.8 t -56.38 -54.94 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.925 -0.484 . . . . 0.0 111.899 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.1 p -56.24 -47.68 77.99 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.781 -0.574 . . . . 0.0 112.3 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.03 -48.72 75.45 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.905 -0.497 . . . . 0.0 111.972 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -53.32 50.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.589 0.356 . . . . 0.0 111.273 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.26 -51.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.077 -0.39 . . . . 0.0 111.281 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.59 31.87 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -53.97 -47.56 71.23 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.239 -0.565 . . . . 0.0 111.583 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.21 -54.37 12.72 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.57 -53.35 58.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.134 -0.627 . . . . 0.0 112.226 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.8 mt -52.2 -54.05 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.6 tp . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 123.279 0.632 . . . . 0.0 111.698 -179.882 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -51.07 -65.19 0.6 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.235 -0.291 . . . . 0.0 111.751 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.2 p -67.91 -39.52 83.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.424 -0.798 . . . . 0.0 111.83 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -53.69 -54.57 36.01 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.053 -0.404 . . . . 0.0 111.597 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.51 -47.21 84.93 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.747 -0.595 . . . . 0.0 112.128 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -50.17 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.873 -0.517 . . . . 0.0 111.569 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.8 tp -57.27 -48.57 78.54 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.775 -0.578 . . . . 0.0 111.541 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 20.8 mmm-85 -57.68 -44.79 86.02 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.453 -0.779 . . . . 0.0 112.919 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -51.31 -56.61 12.11 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.78 -0.575 . . . . 0.0 111.073 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.79 -51.08 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.2 p -56.84 -47.82 79.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.56 -47.04 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.463 -0.773 . . . . 0.0 111.979 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.94 -49.53 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.684 -0.635 . . . . 0.0 111.491 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.03 -48.34 76.14 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.628 -0.67 . . . . 0.0 111.994 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -52.37 -54.42 32.06 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.0 p -59.64 -47.49 85.39 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.477 -0.764 . . . . 0.0 111.554 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.6 -14.13 61.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.421 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 4.3 t80 -62.99 -56.29 29.9 Favored Pre-proline 0 N--CA 1.476 0.832 0 O-C-N 120.84 -1.162 . . . . 0.0 111.153 -173.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 58.2 Cg_endo -62.22 -35.96 71.39 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.994 2.463 . . . . 0.0 112.243 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.28 -57.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.812 -0.555 . . . . 0.0 111.057 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.88 -40.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.806 -0.559 . . . . 0.0 111.493 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.57 -50.22 68.48 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.62 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 54.9 tp -53.2 -43.42 67.17 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.958 -0.463 . . . . 0.0 111.181 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.49 -53.95 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.359 -0.838 . . . . 0.0 109.716 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.58 0 O-C-N 121.62 -0.675 . . . . 0.0 113.738 177.788 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 96.3 m . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.36 -57.1 13.22 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.718 -0.613 . . . . 0.0 111.89 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.22 -51.28 69.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.247 0.546 . . . . 0.0 111.773 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.79 -53.07 57.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.493 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 26.9 ttt -52.04 -45.57 64.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.638 0.375 . . . . 0.0 112.003 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.8 t -51.5 -53.24 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.513 -0.742 . . . . 0.0 111.202 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.97 -50.76 68.13 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.965 -0.459 . . . . 0.0 112.173 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -52.71 -54.91 27.09 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.051 -0.406 . . . . 0.0 111.752 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.3 t -57.16 -54.71 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 122.122 -0.361 . . . . 0.0 111.741 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.4 p -55.18 -49.96 70.54 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.519 -0.738 . . . . 0.0 112.306 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.65 76.86 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.908 -0.495 . . . . 0.0 112.037 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -57.2 -48.72 78.07 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.085 -0.385 . . . . 0.0 110.826 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.8 t -53.98 -53.27 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.481 -0.762 . . . . 0.0 111.235 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.83 -50.78 36.5 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 121.797 -0.564 . . . . 0.0 111.762 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.01 -49.51 68.72 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.267 -0.549 . . . . 0.0 111.186 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.62 -49.72 51.81 Favored Glycine 0 N--CA 1.475 1.274 0 O-C-N 121.962 -0.461 . . . . 0.0 112.754 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.92 -50.67 68.25 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.942 -0.74 . . . . 0.0 111.933 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.39 -50.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.293 0.568 . . . . 0.0 111.326 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 123.482 0.713 . . . . 0.0 111.94 178.304 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 121.012 0.434 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -59.37 -54.92 41.26 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.956 -0.465 . . . . 0.0 111.808 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.7 t -58.78 -41.37 86.52 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.957 -0.465 . . . . 0.0 111.643 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -56.19 -51.9 66.36 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.476 -0.765 . . . . 0.0 111.322 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -55.05 -46.74 75.36 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.847 -0.533 . . . . 0.0 112.224 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 70.9 t -55.4 -52.09 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 122.024 -0.423 . . . . 0.0 111.521 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.7 tp -52.81 -50.51 63.51 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.711 -0.618 . . . . 0.0 111.624 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.629 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.09 -50.39 66.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -53.67 -56.08 20.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.233 -0.292 . . . . 0.0 111.013 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.77 -52.78 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.659 0.383 . . . . 0.0 111.844 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.5 p -56.71 -52.24 65.73 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 80.4 t -58.33 -48.96 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.729 -0.607 . . . . 0.0 112.001 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 77.1 t -57.25 -54.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.703 -0.623 . . . . 0.0 111.215 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.3 mt -53.23 -46.83 69.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.492 -0.755 . . . . 0.0 111.857 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.8 t90 -53.5 -56.96 12.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.1 p -61.0 -42.91 99.35 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.695 0.759 . . . . 0.0 112.151 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.1 67.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.08 -56.19 36.21 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 121.345 -0.847 . . . . 0.0 112.652 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.15 -36.05 90.07 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.971 2.447 . . . . 0.0 112.802 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.99 -55.7 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.596 -0.69 . . . . 0.0 110.925 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.24 -45.65 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.98 -0.45 . . . . 0.0 111.234 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -50.32 -58.5 5.53 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.207 -0.308 . . . . 0.0 111.015 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -47.72 -49.63 27.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.799 0.84 . . . . 0.0 110.546 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.3 mt -52.32 -59.18 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.687 -0.633 . . . . 0.0 110.486 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 CA-C-O 121.409 0.45 . . . . 0.0 112.985 179.268 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 121.147 0.498 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.73 -52.12 65.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.914 0.387 . . . . 0.0 111.792 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.5 tt -51.11 -56.59 11.93 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.469 0.708 . . . . 0.0 110.772 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.76 -48.43 72.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.242 0.617 . . . . 0.0 111.366 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 56.5 ttp -53.73 -50.72 65.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.597 -0.689 . . . . 0.0 111.913 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.4 t -54.3 -48.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.786 -0.571 . . . . 0.0 111.401 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.0 mt -53.31 -53.79 45.88 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.864 -0.522 . . . . 0.0 111.67 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -47.67 -54.24 12.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.888 -0.508 . . . . 0.0 111.659 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.66 -57.23 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 122.002 -0.436 . . . . 0.0 111.706 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 86.5 p -58.71 -48.7 80.22 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.695 -0.628 . . . . 0.0 112.621 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.19 94.6 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.88 -0.513 . . . . 0.0 111.319 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -55.06 -49.91 70.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.77 0.428 . . . . 0.0 111.547 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.22 -52.57 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 122.041 -0.412 . . . . 0.0 111.005 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.54 -50.4 36.24 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 121.885 -0.509 . . . . 0.0 112.391 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -53.12 -49.96 65.45 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.056 -0.673 . . . . 0.0 111.102 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.43 -48.53 64.31 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 121.888 -0.508 . . . . 0.0 112.714 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.82 -45.27 82.41 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.783 -0.834 . . . . 0.0 112.463 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.13 -47.5 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.653 -0.654 . . . . 0.0 111.902 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 65.5 tp . . . . . 0 N--CA 1.476 0.827 0 O-C-N 121.794 -0.566 . . . . 0.0 110.601 175.634 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.5 m -60.32 -64.94 0.77 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.522 -0.737 . . . . 0.0 111.433 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.2 m -63.5 -36.76 84.85 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.635 -0.665 . . . . 0.0 111.758 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -52.49 -52.38 54.71 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.558 -0.714 . . . . 0.0 111.306 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -58.98 -47.27 85.74 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.939 -0.476 . . . . 0.0 111.464 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 68.8 t -51.59 -53.26 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 122.06 -0.4 . . . . 0.0 111.48 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.8 tt -54.15 -52.37 61.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.112 0.565 . . . . 0.0 110.869 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -52.35 45.57 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.948 0.404 . . . . 0.0 110.632 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -53.52 -55.11 28.3 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.701 -0.625 . . . . 0.0 111.776 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.1 t -52.95 -48.66 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 71.8 p -61.46 -45.58 93.67 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.518 -0.738 . . . . 0.0 112.252 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.51 -49.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.346 -0.846 . . . . 0.0 111.638 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.7 t -52.99 -51.03 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 122.047 -0.408 . . . . 0.0 110.722 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.67 -54.46 22.86 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.742 -0.599 . . . . 0.0 111.106 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -57.52 -47.39 82.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.4 p -61.15 -42.87 99.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.242 -0.912 . . . . 0.0 111.08 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.24 -13.0 61.56 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -62.48 -56.42 30.32 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.464 -1.398 . . . . 0.0 111.197 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -61.41 -39.17 58.47 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.801 2.334 . . . . 0.0 111.862 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.8 t -46.87 -52.6 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 122.004 -0.435 . . . . 0.0 111.753 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.49 -57.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 122.059 -0.401 . . . . 0.0 111.086 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -47.94 -45.07 30.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.7 tp -50.7 -35.22 30.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.8 tt -68.95 -44.39 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.095 -1.003 . . . . 0.0 109.658 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.55 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.05 -50.8 71.62 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.805 -0.56 . . . . 0.0 111.604 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.35 -54.03 42.42 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.441 0.639 . . . . 0.0 110.349 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -52.0 -51.65 55.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.093 0.557 . . . . 0.0 111.477 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.2 ttt -49.4 -48.07 47.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 90.7 t -52.3 -52.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.76 -0.588 . . . . 0.0 111.29 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.8 mp -54.05 -50.65 66.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -50.09 -57.45 7.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.772 -0.58 . . . . 0.0 111.306 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.07 -53.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 122.21 -0.306 . . . . 0.0 111.504 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.6 p -57.03 -44.84 83.29 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.944 -0.472 . . . . 0.0 111.604 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.42 65.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.958 -0.464 . . . . 0.0 112.202 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -46.11 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.04 -50.7 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.659 -0.65 . . . . 0.0 111.524 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.16 -51.39 54.35 Favored Glycine 0 N--CA 1.475 1.238 0 O-C-N 121.806 -0.559 . . . . 0.0 112.018 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.82 -51.59 63.05 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 122.109 -0.642 . . . . 0.0 110.989 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.0 -48.16 63.83 Favored Glycine 0 N--CA 1.473 1.163 0 O-C-N 122.07 -0.394 . . . . 0.0 112.218 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.28 -51.17 65.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.912 -0.758 . . . . 0.0 112.399 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.72 -50.74 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.717 -0.614 . . . . 0.0 111.083 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.5 tp . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 123.136 0.574 . . . . 0.0 111.263 179.341 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 121.173 0.511 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 m -53.97 -59.07 5.12 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.801 0.44 . . . . 0.0 111.475 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 41.5 p -59.83 -44.59 93.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.724 -0.61 . . . . 0.0 112.131 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.95 -55.35 14.87 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.851 -0.531 . . . . 0.0 111.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -55.09 -52.1 64.31 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.038 -0.414 . . . . 0.0 111.953 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 79.3 t -53.93 -51.93 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 122.141 -0.35 . . . . 0.0 111.876 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 174' ' ' LEU . 6.2 tt -56.81 -57.2 13.5 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.786 0.434 . . . . 0.0 110.902 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -53.17 -49.54 66.45 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.054 0.454 . . . . 0.0 110.515 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -52.05 -62.07 1.86 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.991 -0.443 . . . . 0.0 111.946 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.9 t -55.65 -46.82 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.8 p -58.86 -50.43 74.04 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.708 -0.62 . . . . 0.0 112.426 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.88 -45.4 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.596 -0.69 . . . . 0.0 111.854 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.53 -55.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.748 -0.595 . . . . 0.0 110.918 175.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.07 -49.71 60.1 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.813 -0.555 . . . . 0.0 111.114 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -49.75 -58.04 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 82.4 p -61.12 -41.09 96.06 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.765 0.793 . . . . 0.0 111.833 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.17 -29.49 68.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' TYR . . . . . 0.416 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 51.6 t80 -54.81 -53.94 55.17 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 39.3 Cg_endo -59.17 -36.93 94.57 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.994 2.462 . . . . 0.0 112.762 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.49 -52.68 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.613 -0.68 . . . . 0.0 110.459 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.52 -46.12 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.04 0.536 . . . . 0.0 111.365 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -52.04 -58.85 5.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.012 -0.43 . . . . 0.0 111.24 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 53.7 tp -50.44 -42.92 54.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.604 0.362 . . . . 0.0 111.93 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 91.0 mt -56.08 -61.16 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 122.072 -0.393 . . . . 0.0 110.192 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.418 0 CA-C-O 121.781 0.656 . . . . 0.0 112.506 179.588 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -53.93 -58.24 8.0 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.934 -0.479 . . . . 0.0 111.821 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -54.77 -48.24 72.93 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.771 -0.581 . . . . 0.0 111.987 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.59 -55.49 21.92 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.106 0.479 . . . . 0.0 110.958 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 28.0 ttt -54.28 -47.11 72.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 69.8 t -51.17 -52.05 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.499 -0.751 . . . . 0.0 111.255 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.9 mt -56.64 -48.51 77.4 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.097 0.475 . . . . 0.0 111.9 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -53.91 -53.61 50.31 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.381 0.61 . . . . 0.0 112.253 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -58.02 -53.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.947 -0.471 . . . . 0.0 111.632 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 63.6 p -55.7 -45.8 77.77 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.739 -0.601 . . . . 0.0 111.923 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.68 -49.44 72.93 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.882 -0.511 . . . . 0.0 112.057 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 216' ' ' LYS . 5.5 mmpt? -57.11 -45.8 83.15 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 95.8 t -54.57 -51.99 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.618 -0.676 . . . . 0.0 110.549 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.24 -51.66 30.28 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -49.79 -49.25 49.33 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.241 -0.564 . . . . 0.0 112.123 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.19 -52.58 31.19 Favored Glycine 0 N--CA 1.476 1.365 0 O-C-N 122.094 -0.379 . . . . 0.0 112.396 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.93 -51.88 67.39 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.966 -0.726 . . . . 0.0 112.147 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.7 mt -49.75 -49.37 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.041 0.536 . . . . 0.0 111.294 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 60.5 tp . . . . . 0 N--CA 1.473 0.683 0 O-C-N 122.038 -0.414 . . . . 0.0 110.755 174.186 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 120.836 0.351 . . . . 0.0 111.53 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.29 118.86 4.28 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.39 57.89 6.7 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.871 3.048 . . . . 0.0 111.626 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -68.96 165.83 19.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.229 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.55 -50.1 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.71 -53.28 58.5 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.691 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.9 t -47.03 -60.46 2.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.7 t -59.3 -40.44 86.19 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.473 -0.767 . . . . 0.0 112.462 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -56.56 -53.91 52.11 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.628 -0.67 . . . . 0.0 111.523 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -59.46 -44.0 93.09 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.809 -0.557 . . . . 0.0 112.287 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -54.19 -48.59 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.763 -0.586 . . . . 0.0 111.559 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.4 tt -52.4 -56.1 17.25 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.831 -0.543 . . . . 0.0 110.816 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.28 -47.82 71.91 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -50.76 -58.19 6.53 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.735 -0.603 . . . . 0.0 111.492 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.59 -50.75 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 122.047 -0.408 . . . . 0.0 111.945 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 47.0 p -58.64 -49.04 78.98 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.8 -48.25 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.512 -0.743 . . . . 0.0 111.846 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.26 -53.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.723 -0.611 . . . . 0.0 110.96 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.2 tt -51.78 -51.74 54.09 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.817 -0.552 . . . . 0.0 110.499 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -50.4 -56.22 12.37 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -61.02 -42.77 99.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.717 0.77 . . . . 0.0 111.728 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.97 68.12 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.408 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 60.2 t80 -57.4 -54.85 50.62 Favored Pre-proline 0 N--CA 1.475 0.819 0 O-C-N 121.289 -0.882 . . . . 0.0 112.889 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 48.0 Cg_endo -60.51 -36.86 84.45 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.943 2.429 . . . . 0.0 112.606 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.58 -55.27 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.813 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 82.1 t -56.03 -45.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.972 0.509 . . . . 0.0 111.283 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -51.51 -58.98 4.8 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.935 -0.478 . . . . 0.0 111.252 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.63 -47.17 49.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.226 0.611 . . . . 0.0 111.63 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.91 -55.64 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.834 -0.541 . . . . 0.0 110.239 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.07 29.68 2.44 Favored Glycine 0 CA--C 1.537 1.434 0 O-C-N 121.671 -0.643 . . . . 0.0 113.546 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 90.2 p -163.09 40.14 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.464 1.132 . . . . 0.0 110.114 169.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -48.24 -65.39 0.57 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 171.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.554 ' H ' ' CD ' ' A' ' 194' ' ' GLU . . . -77.37 -39.88 25.15 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -55.89 -63.47 1.17 Allowed 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.789 -0.83 . . . . 0.0 111.913 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -90.37 34.49 4.14 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 9.3 tt -67.57 -36.38 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.581 -0.953 . . . . 0.0 109.94 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 98.5 t -44.85 -57.8 6.41 Favored Pre-proline 0 N--CA 1.479 1.007 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -60.94 -41.39 45.07 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.0 2.467 . . . . 0.0 112.696 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -53.67 -52.55 59.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 122.012 -0.43 . . . . 0.0 110.416 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -52.56 -50.61 62.59 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.86 0.464 . . . . 0.0 111.699 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 99.8 mt -51.65 -52.59 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 122.159 -0.338 . . . . 0.0 111.701 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -58.98 -49.69 76.93 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.938 -0.476 . . . . 0.0 111.935 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 91.1 m -52.63 -47.83 66.79 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.604 -0.685 . . . . 0.0 111.499 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.65 -54.82 39.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.031 -0.418 . . . . 0.0 110.85 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.29 -53.53 27.87 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.223 0.535 . . . . 0.0 111.252 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.74 -52.82 54.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.127 0.571 . . . . 0.0 111.254 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.34 -48.14 68.76 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.772 -0.58 . . . . 0.0 112.351 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -53.42 -49.7 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.544 -0.723 . . . . 0.0 111.239 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.94 -51.09 64.92 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.986 -0.446 . . . . 0.0 111.237 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -50.38 -53.09 31.72 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.907 -0.496 . . . . 0.0 111.612 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.24 -54.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 122.04 -0.412 . . . . 0.0 111.895 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 70.4 p -57.37 -45.37 84.5 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.666 -0.646 . . . . 0.0 111.752 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.93 73.98 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.002 -0.436 . . . . 0.0 111.975 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -54.52 -48.62 71.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.16 -51.92 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.855 -0.528 . . . . 0.0 111.165 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.51 -50.95 46.05 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 121.964 -0.46 . . . . 0.0 112.039 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -52.52 -49.73 64.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.165 -0.609 . . . . 0.0 111.385 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.78 -52.86 32.26 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 121.93 -0.481 . . . . 0.0 111.964 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.9 mt -53.67 -50.56 65.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 122.084 -0.656 . . . . 0.0 111.93 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.24 -51.46 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 122.064 -0.397 . . . . 0.0 111.384 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.2 -50.04 68.0 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.936 -0.478 . . . . 0.0 112.281 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 90.2 mt -53.31 -51.3 62.82 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.303 0.573 . . . . 0.0 111.772 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -55.13 -51.52 66.2 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.068 0.461 . . . . 0.0 111.89 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 53.2 m -53.67 -53.95 44.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.499 ' HD2' ' N ' ' A' ' 228' ' ' ALA . 0.1 OUTLIER -61.67 -37.25 83.39 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.698 -0.626 . . . . 0.0 112.458 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.499 ' N ' ' HD2' ' A' ' 227' ' ' ARG . . . -59.98 -50.59 73.13 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.668 -0.645 . . . . 0.0 111.817 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 98.3 mt -57.16 -46.59 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 120.9 0.381 . . . . 0.0 111.621 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -56.3 -53.78 53.19 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.627 0 N-CA-C 114.199 0.44 . . . . 0.0 114.199 179.062 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.2 ptm . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.1 ttp-105 -163.19 86.32 1.33 Allowed Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 121.452 -0.78 . . . . 0.0 111.437 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.02 105.47 0.68 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.004 2.469 . . . . 0.0 110.459 169.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -54.18 135.47 43.85 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -169.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.85 -42.48 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.39 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.37 81.42 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.089 -0.382 . . . . 0.0 111.709 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -66.74 -46.98 73.7 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.844 -0.535 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 89.4 m -51.99 -50.17 61.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.674 0.39 . . . . 0.0 111.356 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.6 -53.24 59.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.896 -0.503 . . . . 0.0 111.129 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.82 -48.39 59.81 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.16 -50.68 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.984 -0.448 . . . . 0.0 111.549 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 174' ' ' LEU . 6.6 tt -52.57 -54.26 35.29 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.099 0.476 . . . . 0.0 111.092 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -52.67 -48.61 66.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.176 0.59 . . . . 0.0 111.761 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -53.32 -57.9 8.95 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.97 -0.456 . . . . 0.0 111.472 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 69.5 t -52.25 -49.61 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.959 -0.463 . . . . 0.0 112.192 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 45.6 p -58.46 -53.79 54.3 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.775 -0.578 . . . . 0.0 111.921 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.44 -46.18 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.421 -0.8 . . . . 0.0 111.991 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.53 -53.31 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.65 -0.656 . . . . 0.0 110.913 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 tt -51.74 -50.08 61.3 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.699 -0.626 . . . . 0.0 110.547 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.83 -54.62 31.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 111.851 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -61.89 -41.91 98.45 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.582 0.706 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.54 66.81 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -58.58 -56.92 30.68 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.197 -0.939 . . . . 0.0 111.859 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -60.38 -35.84 89.46 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.898 2.399 . . . . 0.0 112.65 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.83 -56.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.563 -0.711 . . . . 0.0 111.041 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 77.1 t -56.99 -45.62 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.831 -0.543 . . . . 0.0 111.229 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -53.12 -52.03 60.02 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 0.0 111.287 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.33 -49.29 64.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.14 0.576 . . . . 0.0 111.185 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 86.4 mt -51.92 -49.79 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.302 -0.874 . . . . 0.0 110.842 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.21 -19.48 75.82 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 64.4 p -174.47 69.72 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.987 1.375 . . . . 0.0 110.276 -167.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -66.45 -48.74 68.97 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.905 -176.306 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.89 -158.89 53.39 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.29 56.41 2.08 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.27 1.033 . . . . 0.0 110.701 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 61.75 54.19 37.42 Favored Glycine 0 N--CA 1.474 1.181 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 79.7 mt -64.32 -52.5 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.796 -0.826 . . . . 0.0 111.013 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 96.7 t -51.71 -58.71 10.05 Favored Pre-proline 0 N--CA 1.478 0.933 0 O-C-N 121.727 -0.608 . . . . 0.0 112.4 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.38 -39.89 62.82 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.605 2.203 . . . . 0.0 113.028 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 58.6 tp -54.74 -52.53 62.24 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.563 -0.71 . . . . 0.0 111.546 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -55.83 -46.23 78.16 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.669 -0.644 . . . . 0.0 112.732 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 96.4 mt -52.65 -51.69 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.73 -0.606 . . . . 0.0 111.258 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.33 -56.2 18.56 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.777 -0.577 . . . . 0.0 111.252 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.3 m -54.7 -49.87 69.68 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -61.79 -44.25 97.25 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.451 -0.781 . . . . 0.0 112.024 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 206' ' ' LEU . 91.6 mt -57.62 -50.97 71.39 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.511 -0.743 . . . . 0.0 111.398 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.62 -53.3 48.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 59.8 ttp -52.36 -50.67 61.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.209 0.604 . . . . 0.0 112.385 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -52.27 -49.62 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.466 -0.771 . . . . 0.0 111.592 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.63 -49.02 73.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.136 0.493 . . . . 0.0 111.811 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -54.11 -51.96 62.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.14 0.495 . . . . 0.0 111.853 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.1 -54.66 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.117 -0.364 . . . . 0.0 111.688 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.4 p -56.0 -46.42 78.72 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.713 -0.617 . . . . 0.0 112.014 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.13 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.917 -0.489 . . . . 0.0 111.975 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.59 -48.49 74.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.956 -0.465 . . . . 0.0 112.087 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.8 t -55.04 -52.14 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.948 -0.47 . . . . 0.0 111.137 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.93 -51.65 33.69 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.83 -48.72 66.8 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 122.23 -0.57 . . . . 0.0 111.224 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.99 -56.41 16.63 Favored Glycine 0 N--CA 1.475 1.252 0 O-C-N 121.874 -0.516 . . . . 0.0 112.205 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.4 -45.66 69.41 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.734 -0.862 . . . . 0.0 112.265 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.495 HG23 HH12 ' A' ' 225' ' ' ARG . 96.7 mt -55.73 -49.95 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.741 -0.6 . . . . 0.0 111.661 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.3 tp -54.16 -48.12 71.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.944 0.498 . . . . 0.0 111.766 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.1 mp -56.51 -51.15 69.59 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.759 -0.588 . . . . 0.0 112.135 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.495 HH12 HG23 ' A' ' 222' ' ' ILE . 21.7 ttp-105 -47.5 -53.74 13.48 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.405 -0.809 . . . . 0.0 111.001 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 61.6 m -62.97 -58.55 6.95 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.444 HH22 ' C ' ' A' ' 231' ' ' GLY . 5.1 tpm_? -91.22 -59.85 2.05 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.48 -0.762 . . . . 0.0 112.431 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.2 -48.66 73.52 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.471 -0.768 . . . . 0.0 112.378 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.18 -66.71 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 122.095 -0.378 . . . . 0.0 111.355 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 231' ' ' GLY . 53.9 t80 -82.4 176.13 9.68 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.444 ' C ' HH22 ' A' ' 227' ' ' ARG . . . . . . . . 0 CA--C 1.54 1.61 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 121.194 0.521 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -130.5 73.23 81.42 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.9 -0.5 . . . . 0.0 110.14 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.15 82.24 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.193 3.262 . . . . 0.0 112.895 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -69.87 -174.66 0.78 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.892 0.853 . . . . 0.0 112.487 -178.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.9 t -46.51 -42.6 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.429 0.692 . . . . 0.0 112.7 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.52 -57.78 11.43 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.459 -0.775 . . . . 0.0 111.795 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 80.3 p -59.79 -48.47 81.54 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.62 -0.675 . . . . 0.0 112.085 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 25.5 p -56.42 -43.21 79.16 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.931 -0.481 . . . . 0.0 112.204 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -55.08 -48.04 74.08 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.715 -0.616 . . . . 0.0 111.501 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -52.89 -53.24 51.99 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.974 -0.454 . . . . 0.0 111.287 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.14 -46.48 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 122.426 0.29 . . . . 0.0 111.589 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 tt -51.32 -59.83 3.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.915 0.486 . . . . 0.0 110.889 177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -58.26 -44.06 88.17 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -51.23 -59.79 3.82 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.797 -0.564 . . . . 0.0 111.571 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.3 t -55.57 -49.29 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 122.073 -0.392 . . . . 0.0 111.774 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.4 p -56.84 -49.59 74.99 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.5 t -56.89 -48.83 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.503 -0.748 . . . . 0.0 111.667 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.2 t -56.67 -57.79 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.664 -0.648 . . . . 0.0 111.494 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 97.4 mt -56.07 -42.83 77.28 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.466 -0.771 . . . . 0.0 112.002 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -52.11 -59.54 4.25 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.999 -0.438 . . . . 0.0 111.924 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.6 p -60.85 -37.52 82.36 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.457 0.646 . . . . 0.0 111.928 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.33 63.81 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -54.89 -58.61 13.72 Favored Pre-proline 0 N--CA 1.478 0.945 0 CA-C-N 119.223 0.919 . . . . 0.0 113.213 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -57.9 -37.55 95.77 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.897 2.398 . . . . 0.0 112.678 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.05 -54.89 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.765 -0.584 . . . . 0.0 111.03 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 78.3 t -56.0 -46.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.891 -0.506 . . . . 0.0 111.386 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.8 t90 -50.71 -55.32 17.13 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.966 -0.459 . . . . 0.0 111.391 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tt -52.56 -50.8 62.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.781 0.433 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 97.9 mt -52.15 -52.74 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.683 -0.635 . . . . 0.0 111.296 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -69.15 -20.21 74.71 Favored Glycine 0 CA--C 1.539 1.542 0 O-C-N 121.833 -0.542 . . . . 0.0 114.258 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 57.1 p -174.1 76.72 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.39 -1.065 . . . . 0.0 109.698 -167.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.94 -71.04 0.2 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -171.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 170.06 104.97 0.18 Allowed Glycine 0 N--CA 1.475 1.283 0 O-C-N 121.134 -0.979 . . . . 0.0 112.59 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -51.44 -44.26 62.3 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.67 -0.9 . . . . 0.0 112.72 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -53.35 -21.99 14.16 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 123.316 0.484 . . . . 0.0 114.283 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.02 -38.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.342 -1.093 . . . . 0.0 111.195 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.428 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 88.4 t -58.42 -60.19 11.07 Favored Pre-proline 0 N--CA 1.476 0.828 0 O-C-N 121.601 -0.687 . . . . 0.0 111.301 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.428 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 50.5 Cg_endo -60.97 -37.44 76.77 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.519 2.146 . . . . 0.0 112.767 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 52.1 tp -54.63 -53.6 52.56 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.6 -0.688 . . . . 0.0 111.846 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -59.54 -43.04 93.62 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.547 -0.721 . . . . 0.0 112.722 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.6 mt -54.09 -48.81 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 121.382 -0.824 . . . . 0.0 111.574 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.65 -48.88 74.26 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.671 -0.643 . . . . 0.0 111.603 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.4 m -51.68 -50.33 60.64 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.923 -0.485 . . . . 0.0 111.54 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.411 ' C ' HD13 ' A' ' 206' ' ' LEU . 3.0 tm? -52.95 -54.31 36.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.027 -0.421 . . . . 0.0 111.235 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.1 tp -51.23 -51.59 52.59 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.947 -0.47 . . . . 0.0 111.979 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -53.65 -50.54 65.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.871 0.367 . . . . 0.0 111.356 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 57.3 ttp -54.01 -51.09 65.06 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 122.07 -0.393 . . . . 0.0 111.977 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.09 -50.26 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.787 -0.571 . . . . 0.0 111.507 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 95.4 mt -53.78 -52.39 60.39 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.062 -0.399 . . . . 0.0 111.73 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.45 -56.13 14.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.82 -0.55 . . . . 0.0 111.227 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.3 t -50.6 -52.88 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.3 p -58.13 -44.08 87.59 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.696 -0.627 . . . . 0.0 111.586 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.07 -48.49 75.99 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.897 -0.502 . . . . 0.0 111.961 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -58.18 -45.09 88.13 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.872 -0.518 . . . . 0.0 112.227 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.8 t -55.41 -50.42 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.44 -0.787 . . . . 0.0 111.405 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.99 -51.18 47.63 Favored Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.77 -52.44 31.85 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.087 0.555 . . . . 0.0 111.268 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.11 -52.42 35.81 Favored Glycine 0 N--CA 1.477 1.398 0 O-C-N 121.803 -0.56 . . . . 0.0 112.585 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 66.7 tp -54.58 -52.65 61.47 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.04 -0.682 . . . . 0.0 111.64 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.73 -49.96 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.67 0.388 . . . . 0.0 111.421 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.0 tp -52.84 -50.6 63.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.938 0.495 . . . . 0.0 111.85 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.82 -49.54 76.31 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.889 -0.507 . . . . 0.0 110.992 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.539 HH21 ' C ' ' A' ' 231' ' ' GLY . 51.8 ttt85 -55.54 -44.06 76.39 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.713 -0.617 . . . . 0.0 112.409 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 230' ' ' PHE . 77.9 p -62.93 -57.03 12.16 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.713 -1.242 . . . . 0.0 113.769 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 100.11 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 53.95 33.32 17.12 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.73 0.812 . . . . 0.0 112.772 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 225' ' ' ARG . 77.2 mt -145.98 -19.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.964 -0.46 . . . . 0.0 110.892 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 226' ' ' SER . 46.9 t80 -50.17 155.06 1.03 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -174.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.539 ' C ' HH21 ' A' ' 225' ' ' ARG . . . . . . . . 0 CA--C 1.537 1.458 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.227 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.296 0.57 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.459 ' CZ ' ' HG3' ' A' ' 166' ' ' GLU . 23.4 mtp-105 -60.44 160.62 17.25 Favored Pre-proline 0 N--CA 1.477 0.915 0 O-C-N 121.824 -0.548 . . . . 0.0 111.55 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.37 52.45 3.89 Favored 'Trans proline' 0 N--CA 1.482 0.804 0 C-N-CA 124.972 3.781 . . . . 0.0 111.81 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.459 ' HG3' ' CZ ' ' A' ' 164' ' ' ARG . 5.1 mm-40 -144.92 -26.32 0.49 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 113.932 -1.486 . . . . 0.0 110.315 -167.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.9 p -55.38 -45.69 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.597 0.713 . . . . 0.0 109.176 170.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.48 89.0 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.057 -0.402 . . . . 0.0 111.302 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.3 m -52.32 -57.54 9.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 23.9 p -58.38 -46.81 85.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.74 -48.73 72.21 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.699 -0.626 . . . . 0.0 111.662 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.25 -49.95 74.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.614 -0.679 . . . . 0.0 112.284 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.6 t -54.29 -47.3 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 121.819 -0.551 . . . . 0.0 111.738 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 174' ' ' LEU . 6.8 tt -52.85 -56.65 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.001 -0.437 . . . . 0.0 110.788 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -52.05 -49.24 63.85 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -49.73 -59.41 3.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.981 -0.449 . . . . 0.0 111.7 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.76 -52.28 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 122.057 -0.402 . . . . 0.0 111.94 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -58.03 -49.7 75.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.5 t -59.53 -50.46 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.598 -0.688 . . . . 0.0 111.59 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.83 -48.82 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.826 -0.546 . . . . 0.0 111.319 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 181' ' ' LEU . 5.9 tt -54.29 -56.13 21.53 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.795 -0.565 . . . . 0.0 110.876 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -54.09 -51.43 64.19 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -59.32 -44.8 92.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.602 -0.686 . . . . 0.0 112.0 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.84 -20.2 64.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -58.91 -55.71 43.55 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 120.99 -1.069 . . . . 0.0 112.134 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -60.43 -31.84 93.09 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.0 2.466 . . . . 0.0 112.769 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.11 -52.31 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.463 -0.773 . . . . 0.0 110.672 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.07 -46.38 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.848 -0.533 . . . . 0.0 111.024 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -51.83 -55.95 16.89 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.995 -0.441 . . . . 0.0 111.157 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.915 0.886 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.457 HG12 HG21 ' A' ' 199' ' ' VAL . 73.4 mt -51.59 -60.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 173.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.84 51.21 4.27 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 121.283 0.38 . . . . 0.0 113.067 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 44.5 p -162.07 -57.48 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.477 0.711 . . . . 0.0 109.82 173.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -150.43 46.01 0.88 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.11 0.481 . . . . 0.0 110.807 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -166.74 29.12 0.18 Allowed Glycine 0 N--CA 1.475 1.275 0 O-C-N 120.289 -1.507 . . . . 0.0 113.376 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -81.36 55.29 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 123.352 1.549 . . . . 0.0 109.672 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.95 -46.71 0.09 OUTLIER Glycine 0 N--CA 1.469 0.864 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 67.1 mt -57.93 -57.27 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 122.44 -0.447 . . . . 0.0 110.001 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.457 HG21 HG12 ' A' ' 191' ' ' ILE . 86.6 t -57.58 -54.6 53.43 Favored Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 121.754 -0.591 . . . . 0.0 112.484 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 199' ' ' VAL . 41.1 Cg_endo -58.97 -40.43 71.5 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.49 2.127 . . . . 0.0 113.127 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.413 ' C ' HD13 ' A' ' 201' ' ' LEU . 3.3 tm? -56.03 -53.51 56.13 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.507 -0.746 . . . . 0.0 110.96 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -53.02 -47.77 68.07 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.684 -0.635 . . . . 0.0 112.427 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.2 mt -52.09 -54.59 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.734 -0.604 . . . . 0.0 111.179 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -50.32 -51.92 41.24 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.341 0.591 . . . . 0.0 111.494 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 46.0 m -53.15 -48.89 67.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.899 0.48 . . . . 0.0 111.826 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.7 mt -54.31 -54.76 35.88 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -48.34 75.07 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.666 -0.647 . . . . 0.0 111.778 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -53.5 -53.36 52.58 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.029 -0.419 . . . . 0.0 111.463 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 58.1 ttp -49.38 -48.79 46.68 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.324 0.65 . . . . 0.0 112.45 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.1 t -51.29 -51.0 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.725 -0.609 . . . . 0.0 111.201 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.8 mt -54.92 -51.46 65.99 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 122.203 -0.311 . . . . 0.0 111.605 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -51.08 -50.83 57.96 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.875 -0.516 . . . . 0.0 111.969 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.5 -51.2 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.5 p -58.55 -46.05 87.66 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.433 -0.792 . . . . 0.0 111.681 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.1 77.03 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.925 -0.484 . . . . 0.0 111.845 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -50.01 -54.25 21.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.899 0.48 . . . . 0.0 111.648 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.3 t -55.26 -50.56 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 122.212 -0.305 . . . . 0.0 111.555 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.95 -51.49 34.42 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 121.897 -0.502 . . . . 0.0 112.134 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.34 -52.58 63.03 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.972 -0.722 . . . . 0.0 111.289 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.82 -48.45 44.47 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 94.8 mt -56.02 -56.31 22.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.205 -0.585 . . . . 0.0 111.921 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.1 mt -49.66 -43.81 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.542 0.687 . . . . 0.0 111.736 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.524 ' N ' HH21 ' A' ' 227' ' ' ARG . 36.9 tp -58.59 -59.17 5.81 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.818 -0.551 . . . . 0.0 110.513 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.04 56.56 3.53 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 122.712 1.244 . . . . 0.0 109.841 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.6 -57.51 0.07 Allowed 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.544 -0.722 . . . . 0.0 109.918 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 74.0 p -157.83 53.3 0.46 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.153 0.978 . . . . 0.0 111.64 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.524 HH21 ' N ' ' A' ' 223' ' ' LEU . 17.0 ttp180 -154.4 -57.93 0.11 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.43 -0.794 . . . . 0.0 109.937 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -73.19 -46.1 52.58 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 167.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 33.1 mt -58.13 -39.03 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.678 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -61.31 -53.94 50.27 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.022 -0.424 . . . . 0.0 110.678 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.705 0 N-CA-C 114.081 0.392 . . . . 0.0 114.081 176.47 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 20.3 ptp . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 120.665 0.269 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.445 ' HB2' ' CD ' ' A' ' 165' ' ' PRO . 51.3 mtp85 -163.2 -64.45 0.01 OUTLIER Pre-proline 0 N--CA 1.48 1.034 0 O-C-N 122.113 -0.367 . . . . 0.0 110.847 -172.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.445 ' CD ' ' HB2' ' A' ' 164' ' ' ARG . 40.9 Cg_endo -79.44 -179.62 5.54 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.075 2.517 . . . . 0.0 111.155 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -81.45 -75.49 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.025 -1.047 . . . . 0.0 110.194 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 58.1 t -55.16 -52.56 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -170.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.406 ' HB3' ' CG ' ' A' ' 165' ' ' PRO . . . -58.18 -43.06 87.32 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.626 -0.671 . . . . 0.0 112.368 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.5 p -73.66 -44.02 57.85 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.387 -0.821 . . . . 0.0 111.116 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.0 t -57.38 -43.25 83.45 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.418 -0.802 . . . . 0.0 110.735 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.76 -50.45 73.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.689 -0.632 . . . . 0.0 110.926 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -50.32 -50.56 50.47 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.42 -53.04 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.629 0.372 . . . . 0.0 111.712 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tt -51.16 -53.54 33.68 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.382 0.611 . . . . 0.0 110.59 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.9 ttm105 -52.33 -51.78 56.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.609 0.764 . . . . 0.0 112.401 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -53.03 -54.08 40.61 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.566 -0.708 . . . . 0.0 111.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.76 -52.79 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.02 -0.425 . . . . 0.0 111.648 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 56.5 p -55.05 -44.8 75.05 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.647 -0.658 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 68.9 t -56.11 -48.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.561 -0.712 . . . . 0.0 111.83 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.82 -55.12 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.526 -0.734 . . . . 0.0 111.473 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.4 -45.06 72.85 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.438 -0.789 . . . . 0.0 112.116 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -55.44 23.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.011 -0.431 . . . . 0.0 111.367 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.7 p -61.47 -38.85 88.74 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.562 -0.711 . . . . 0.0 112.533 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.89 -56.66 17.99 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.738 -0.601 . . . . 0.0 112.309 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -37.62 -56.99 1.63 Allowed Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -59.61 -44.58 30.91 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.001 2.467 . . . . 0.0 112.379 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.4 -46.87 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.751 -0.593 . . . . 0.0 110.682 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.559 ' HA ' HD11 ' A' ' 198' ' ' ILE . 96.1 t -51.25 -53.14 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -57.05 -52.47 65.13 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.932 -0.48 . . . . 0.0 111.768 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 59.7 tp -46.18 -50.81 15.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.459 HG21 ' H ' ' A' ' 198' ' ' ILE . 1.9 mp -66.59 -43.72 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.799 -0.563 . . . . 0.0 111.448 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.62 53.57 2.84 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 121.753 0.64 . . . . 0.0 112.836 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 33.4 p -172.23 -49.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.864 1.266 . . . . 0.0 109.318 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -132.73 -45.48 0.88 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.55 -168.27 11.52 Favored Glycine 0 CA--C 1.537 1.459 0 O-C-N 121.457 -0.777 . . . . 0.0 113.956 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.56 -7.29 0.17 Allowed 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.569 -0.959 . . . . 0.0 113.267 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -51.42 -37.34 39.85 Favored Glycine 0 N--CA 1.481 1.681 0 O-C-N 121.308 -0.87 . . . . 0.0 114.14 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 188' ' ' VAL . 86.0 mt -52.82 -38.18 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.5 t -41.83 -59.7 2.39 Favored Pre-proline 0 N--CA 1.483 1.19 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -166.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.19 -47.92 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.037 2.491 . . . . 0.0 112.951 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.46 -49.7 73.86 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.957 -0.464 . . . . 0.0 112.145 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -57.47 -47.51 81.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.436 0.694 . . . . 0.0 111.812 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.1 mt -52.55 -51.0 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.868 -0.52 . . . . 0.0 111.134 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -59.0 -45.77 89.83 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.62 -0.675 . . . . 0.0 111.802 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 62.4 m -52.59 -54.59 30.91 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.363 -0.836 . . . . 0.0 111.805 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -61.74 -38.93 89.78 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.579 -0.701 . . . . 0.0 112.28 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 206' ' ' LEU . 64.6 tp -54.84 -54.39 43.0 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.51 -0.744 . . . . 0.0 110.937 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.11 -50.35 61.84 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.258 0.623 . . . . 0.0 111.187 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 63.5 mtt -52.23 -52.3 53.21 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.654 -0.654 . . . . 0.0 112.395 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.68 -47.76 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.639 -0.663 . . . . 0.0 111.674 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -54.72 -47.98 73.08 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -54.23 -56.11 21.5 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.873 -0.517 . . . . 0.0 110.713 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.8 t -51.68 -54.97 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.97 -0.456 . . . . 0.0 111.918 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 61.8 p -58.08 -50.48 73.32 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.665 -0.647 . . . . 0.0 112.451 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.7 85.56 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.857 -0.527 . . . . 0.0 111.907 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -55.71 -50.48 70.21 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.572 0.749 . . . . 0.0 111.343 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.95 -51.39 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.998 -0.439 . . . . 0.0 111.11 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -49.52 -51.29 27.94 Favored Glycine 0 N--CA 1.476 1.307 0 O-C-N 121.935 -0.478 . . . . 0.0 111.926 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -53.96 -47.64 71.14 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.142 -0.622 . . . . 0.0 111.182 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.46 -51.16 22.55 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.975 -0.453 . . . . 0.0 112.446 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 9.2 mp -58.37 -52.27 66.31 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.933 -0.745 . . . . 0.0 112.07 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.2 mt -49.87 -46.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.818 -0.551 . . . . 0.0 111.376 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 63.4 tp -57.64 -62.32 1.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.823 -0.548 . . . . 0.0 110.443 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 26.0 tp -85.43 54.42 3.11 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.692 1.234 . . . . 0.0 111.366 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.64 -66.66 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.2 t -71.78 -58.66 3.28 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.486 HH22 ' C ' ' A' ' 231' ' ' GLY . 0.0 OUTLIER -85.18 58.75 5.21 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 123.704 1.716 . . . . 0.0 109.057 175.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -159.38 -64.36 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.632 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.69 -42.29 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 122.96 0.504 . . . . 0.0 110.631 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.66 -36.48 67.13 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.486 ' C ' HH22 ' A' ' 227' ' ' ARG . . . . . . . . 0 CA--C 1.543 1.807 0 O-C-N 121.451 -0.78 . . . . 0.0 113.045 -164.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 167' ' ' VAL . 25.1 ptt? . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.669 0.271 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -174.64 -58.54 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.4 -81.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.38 2.053 . . . . 0.0 112.138 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -78.27 44.3 0.49 Allowed 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.329 -0.857 . . . . 0.0 112.144 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.594 HG13 ' H ' ' A' ' 168' ' ' ALA . 7.3 p -65.99 -65.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.974 -1.079 . . . . 0.0 110.46 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.594 ' H ' HG13 ' A' ' 167' ' ' VAL . . . -69.05 -35.64 76.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.37 0.605 . . . . 0.0 110.198 175.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.1 m -54.19 -63.38 1.17 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.067 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 86.8 m -61.96 -48.68 79.3 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.893 -0.505 . . . . 0.0 111.302 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.9 -52.71 47.97 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 110.795 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.24 -51.68 68.92 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 63.9 t -55.71 -53.41 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.846 -0.533 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.15 -47.23 86.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.699 -0.625 . . . . 0.0 112.242 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -56.25 -48.19 77.03 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.726 -0.609 . . . . 0.0 111.551 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -53.03 -55.42 23.86 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.688 -0.632 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.5 t -52.34 -50.38 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 67.6 p -58.74 -47.18 85.52 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.546 -0.721 . . . . 0.0 112.282 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 75.3 t -56.55 -51.45 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.528 -0.732 . . . . 0.0 111.775 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -53.78 -46.01 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.918 -0.489 . . . . 0.0 111.357 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.74 -56.42 20.68 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.686 -0.634 . . . . 0.0 110.931 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -55.53 -48.55 74.52 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.739 -0.601 . . . . 0.0 112.422 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.4 p -60.77 -44.01 97.32 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.644 -0.66 . . . . 0.0 112.11 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.81 -22.01 66.32 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.415 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 1.2 t80 -59.49 -54.92 51.22 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 120.97 -1.081 . . . . 0.0 111.431 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 56.1 Cg_endo -61.21 -34.73 88.04 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.58 2.187 . . . . 0.0 112.365 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.4 -51.78 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.12 0.873 . . . . 0.0 111.556 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.83 -50.21 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.686 -0.634 . . . . 0.0 111.304 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -60.7 -46.31 90.87 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.871 -0.518 . . . . 0.0 111.969 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 196' ' ' ALA . 26.6 tp -46.35 -50.28 16.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.131 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.5 mt -57.7 -59.82 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.981 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.89 53.12 4.7 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-O 121.403 0.446 . . . . 0.0 112.362 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 83.1 p -153.57 -55.49 0.11 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.102 -0.646 . . . . 0.0 109.406 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -150.33 -66.98 0.2 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 122.062 -0.399 . . . . 0.0 110.03 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 146.86 65.44 0.01 OUTLIER Glycine 0 N--CA 1.475 1.245 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.199 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 190' ' ' LEU . . . 52.77 67.99 0.9 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 169.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.74 -72.36 0.07 OUTLIER Glycine 0 N--CA 1.474 1.21 0 O-C-N 121.037 -1.039 . . . . 0.0 111.506 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.0 mt -67.04 -41.92 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.91 -0.759 . . . . 0.0 110.393 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.447 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 26.0 t -43.28 -56.76 6.19 Favored Pre-proline 0 N--CA 1.48 1.043 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.447 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 74.1 Cg_endo -66.28 -40.19 15.61 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.907 2.405 . . . . 0.0 112.684 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 45.8 tp -51.96 -45.91 64.57 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.86 -0.525 . . . . 0.0 111.801 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -51.58 -55.37 19.6 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.973 -0.455 . . . . 0.0 110.419 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 67.4 mt -49.41 -51.0 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 120.731 0.3 . . . . 0.0 111.158 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -57.81 -52.83 63.84 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 88.1 m -52.2 -51.07 60.39 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.641 -0.662 . . . . 0.0 111.859 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -47.96 83.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.005 -0.434 . . . . 0.0 112.164 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -54.87 24.23 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.545 -0.722 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -54.71 -49.93 69.54 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.454 0.302 . . . . 0.0 111.379 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 47.8 ttm -51.08 -49.5 60.53 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 72.6 t -54.14 -48.86 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.456 -0.777 . . . . 0.0 111.306 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.41 -51.32 65.25 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.948 -0.47 . . . . 0.0 111.284 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -51.11 -50.35 58.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.151 0.58 . . . . 0.0 111.617 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.97 -54.07 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 64.4 p -57.18 -45.34 83.79 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.351 -0.843 . . . . 0.0 111.539 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.27 76.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.707 0.403 . . . . 0.0 111.504 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -52.48 -50.78 62.02 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.949 -0.469 . . . . 0.0 111.952 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.41 -53.21 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 122.087 -0.383 . . . . 0.0 111.297 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.82 -50.55 49.59 Favored Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -54.31 -51.49 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.247 -0.561 . . . . 0.0 111.262 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.2 51.28 Favored Glycine 0 N--CA 1.475 1.281 0 O-C-N 121.923 -0.486 . . . . 0.0 112.216 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 87.1 mt -56.05 -51.22 68.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.966 -0.726 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.2 mt -55.8 -48.28 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.856 -0.527 . . . . 0.0 111.905 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.19 -50.64 72.21 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.874 -0.516 . . . . 0.0 111.562 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 39.2 tp -50.98 -55.49 17.09 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.609 -0.682 . . . . 0.0 110.313 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -53.36 -65.57 0.54 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 95.0 p -91.15 22.07 3.98 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.34 -57.8 0.18 Allowed 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.085 -1.009 . . . . 0.0 110.445 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -67.85 -54.37 19.48 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.629 0.728 . . . . 0.0 110.629 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.89 -56.63 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.69 73.0 5.25 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.403 1.097 . . . . 0.0 109.864 173.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.556 0 CA-C-N 115.476 -0.783 . . . . 0.0 113.076 174.529 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.199 0.523 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.453 ' HD3' ' HD2' ' A' ' 165' ' ' PRO . 24.3 tpp180 -69.88 132.04 88.94 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.652 -0.655 . . . . 0.0 109.613 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.453 ' HD2' ' HD3' ' A' ' 164' ' ' ARG . 66.9 Cg_endo -77.16 63.63 7.74 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.9 3.067 . . . . 0.0 112.772 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 169' ' ' SER . 2.3 mp0 62.83 -166.39 0.22 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.198 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.0 t 69.95 -76.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.644 1.178 . . . . 0.0 111.307 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.03 87.59 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 165.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.453 ' HB3' ' HA ' ' A' ' 166' ' ' GLU . 47.5 t -66.08 -49.75 66.49 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.596 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 84.5 m -53.52 -52.88 58.2 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 122.341 -0.225 . . . . 0.0 111.43 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -56.34 -49.31 74.72 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.622 -0.674 . . . . 0.0 111.708 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.52 -50.62 69.5 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.603 -0.686 . . . . 0.0 111.771 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.23 -58.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.967 -0.458 . . . . 0.0 111.668 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.18 -41.32 83.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.432 ' HA ' ' NE ' ' A' ' 175' ' ' ARG . 15.2 mmm-85 -60.96 -47.71 85.19 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.066 -1.021 . . . . 0.0 112.542 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -52.89 -51.48 61.03 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.816 -0.553 . . . . 0.0 110.645 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.06 -54.21 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 p -55.61 -46.46 77.35 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.49 -0.756 . . . . 0.0 112.666 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.55 -53.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.628 -0.67 . . . . 0.0 111.799 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.55 -45.91 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.777 -0.577 . . . . 0.0 111.837 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.79 -53.1 61.67 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.674 -0.641 . . . . 0.0 110.498 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -54.35 -51.63 64.16 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.032 -0.418 . . . . 0.0 112.03 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.5 p -61.68 -40.64 95.68 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -58.76 -47.66 83.89 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.444 -0.785 . . . . 0.0 112.571 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -41.3 -58.05 3.18 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -61.05 -38.16 70.21 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.157 2.571 . . . . 0.0 112.572 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.58 -53.17 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.574 -0.704 . . . . 0.0 110.768 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 72.4 t -53.59 -50.37 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.318 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -54.37 -54.77 36.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.871 0.367 . . . . 0.0 111.211 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.4 tp -49.11 -51.41 31.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.542 0.737 . . . . 0.0 111.479 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.02 -57.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.982 -0.448 . . . . 0.0 110.005 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.85 51.38 4.3 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 122.079 -0.388 . . . . 0.0 112.401 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.0 p -155.74 -34.05 0.09 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.672 -0.899 . . . . 0.0 111.862 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.36 68.95 0.79 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.967 0.889 . . . . 0.0 111.846 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -45.01 -45.32 9.31 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 123.785 0.707 . . . . 0.0 112.126 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.51 57.27 1.53 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 122.853 1.311 . . . . 0.0 111.508 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.65 -57.42 0.07 OUTLIER Glycine 0 CA--C 1.527 0.844 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.5 tt -64.62 -48.8 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.966 -0.726 . . . . 0.0 110.95 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' A' ' 200' ' ' PRO . 80.9 t -59.97 -55.69 43.04 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 121.577 -0.702 . . . . 0.0 111.619 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 199' ' ' VAL . 36.7 Cg_endo -57.04 -44.77 41.16 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.569 2.179 . . . . 0.0 112.956 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.58 -48.33 82.07 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.437 -0.789 . . . . 0.0 112.823 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -56.81 -44.49 82.02 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.044 -1.035 . . . . 0.0 112.789 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.6 mt -55.2 -51.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.497 -0.752 . . . . 0.0 111.169 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -53.57 -51.02 64.3 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.942 -0.473 . . . . 0.0 111.653 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 87.8 m -52.45 -51.3 59.97 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.133 0.573 . . . . 0.0 111.466 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.63 -50.2 72.72 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.927 -0.483 . . . . 0.0 112.064 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -53.43 -53.71 47.42 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.765 -0.584 . . . . 0.0 110.511 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.97 -48.41 73.27 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.104 -0.373 . . . . 0.0 110.852 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.6 ttt -52.62 -49.97 64.04 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.688 -0.633 . . . . 0.0 111.872 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.0 t -52.98 -50.61 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.54 -0.725 . . . . 0.0 111.28 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.3 mt -54.52 -50.23 68.33 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.888 -0.507 . . . . 0.0 112.194 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.22 -54.1 44.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.966 0.507 . . . . 0.0 111.426 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.04 -55.07 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.987 -0.445 . . . . 0.0 111.517 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -55.79 -47.63 76.75 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.596 -0.69 . . . . 0.0 112.284 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.96 -49.7 72.83 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.902 -0.499 . . . . 0.0 111.875 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 216' ' ' LYS . 0.1 OUTLIER -58.53 -43.1 89.07 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.804 0.442 . . . . 0.0 112.164 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 69.3 t -55.01 -54.01 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.495 -0.753 . . . . 0.0 110.645 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.87 -50.54 37.62 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -50.4 -50.63 51.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.159 0.583 . . . . 0.0 110.987 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.91 -51.65 33.59 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 122.004 -0.435 . . . . 0.0 112.549 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.33 -52.52 63.23 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 122.081 -0.658 . . . . 0.0 111.858 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 94.6 mt -54.7 -47.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.162 0.506 . . . . 0.0 111.894 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 29.2 tp -54.66 -54.91 35.45 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.784 -0.572 . . . . 0.0 109.743 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 228' ' ' ALA . 39.2 tp -80.67 59.43 3.61 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.615 1.197 . . . . 0.0 110.417 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -161.14 -60.7 0.05 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.378 1.471 . . . . 0.0 108.043 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 76.8 p -89.43 -47.37 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.368 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -83.61 -57.99 3.0 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.758 -0.589 . . . . 0.0 112.445 -175.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 224' ' ' LEU . . . -77.35 -53.65 7.42 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.03 -66.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.813 -0.554 . . . . 0.0 111.016 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -71.69 169.93 14.6 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.628 -0.67 . . . . 0.0 111.267 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 O-C-N 121.578 -0.701 . . . . 0.0 113.226 -178.641 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.456 ' SD ' ' HD2' ' A' ' 164' ' ' ARG . 4.7 ppp? . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.456 ' HD2' ' SD ' ' A' ' 163' ' ' MET . 0.9 OUTLIER -54.52 -50.12 87.16 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 178.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -80.52 62.79 8.65 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 124.057 3.172 . . . . 0.0 114.869 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 78.22 -45.07 0.41 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.739 1.615 . . . . 0.0 113.224 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 168' ' ' ALA . 1.4 p 55.65 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.426 1.49 . . . . 0.0 112.532 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.504 ' H ' HG22 ' A' ' 167' ' ' VAL . . . -49.56 -43.56 46.06 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.39 -0.819 . . . . 0.0 112.77 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 61.1 p -51.89 -63.31 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 m -74.89 -43.38 54.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 -174.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.03 -44.56 91.76 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.027 -0.42 . . . . 0.0 111.951 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.56 -50.26 72.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.232 -0.917 . . . . 0.0 110.997 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 83.7 t -54.6 -53.67 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.587 0.232 . . . . 0.0 110.497 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.42 -57.35 8.21 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.166 0.586 . . . . 0.0 111.237 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HE ' ' HA ' ' A' ' 176' ' ' ASN . 2.4 tmm_? -50.24 -57.95 6.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.336 0.654 . . . . 0.0 110.581 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.475 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 7.7 t30 -58.41 -49.7 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.169 -0.332 . . . . 0.0 111.181 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -54.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 23.9 p -55.47 -50.62 69.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.74 -0.6 . . . . 0.0 111.81 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.77 -50.87 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.701 -0.624 . . . . 0.0 111.606 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.1 t -55.86 -51.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.888 -0.508 . . . . 0.0 111.837 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -53.13 -48.13 68.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.252 -0.905 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -55.72 -52.83 62.56 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.4 p -60.7 -41.98 96.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.771 0.796 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -17.17 61.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.457 ' HB3' ' CD ' ' A' ' 186' ' ' PRO . 1.5 t80 -59.25 -59.9 12.32 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 119.972 1.26 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.457 ' CD ' ' HB3' ' A' ' 185' ' ' TYR . 52.5 Cg_endo -61.86 -30.99 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.88 2.387 . . . . 0.0 113.187 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.45 -56.56 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.408 -0.808 . . . . 0.0 110.675 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.92 -43.58 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.939 -0.476 . . . . 0.0 111.313 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -51.18 -59.46 4.17 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.038 -0.414 . . . . 0.0 111.086 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -50.99 45.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.388 0.675 . . . . 0.0 110.432 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.58 -61.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 122.127 -0.358 . . . . 0.0 110.612 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.12 51.31 3.74 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 122.025 -0.422 . . . . 0.0 112.129 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.2 p -159.25 -40.81 0.06 Allowed 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.623 -0.927 . . . . 0.0 112.495 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 64.5 77.91 0.3 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.199 1.0 . . . . 0.0 109.369 -167.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -37.44 -45.65 1.37 Allowed Glycine 0 N--CA 1.477 1.384 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.785 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -83.21 53.7 2.55 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.802 1.287 . . . . 0.0 110.666 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.3 -55.33 0.07 OUTLIER Glycine 0 N--CA 1.47 0.901 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 16.2 tt -61.1 -44.62 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 122.086 -0.655 . . . . 0.0 111.348 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.84 -59.74 11.56 Favored Pre-proline 0 N--CA 1.475 0.776 0 O-C-N 121.515 -0.741 . . . . 0.0 112.074 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -59.23 -43.46 41.23 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.44 2.093 . . . . 0.0 112.114 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.85 -56.3 18.89 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.113 -0.367 . . . . 0.0 111.927 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -55.28 -45.26 76.18 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 90.3 mt -50.44 -52.16 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.533 -0.729 . . . . 0.0 111.006 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -56.88 -49.32 75.88 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.224 0.535 . . . . 0.0 111.778 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 80.9 m -50.95 -49.98 58.88 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.573 0.749 . . . . 0.0 112.441 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.5 -50.74 70.91 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.676 -0.64 . . . . 0.0 112.3 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.9 tp -51.42 -51.05 58.2 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.443 0.64 . . . . 0.0 111.479 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.27 -52.9 61.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.118 0.485 . . . . 0.0 111.068 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 42.1 ttm -50.42 -49.64 54.22 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 112.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.34 -51.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.614 -0.678 . . . . 0.0 111.464 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.41 -48.95 71.01 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.2 0.524 . . . . 0.0 111.624 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 216' ' ' LYS . 70.7 m-20 -53.75 -54.37 39.06 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.006 -0.434 . . . . 0.0 111.908 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.35 -54.83 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.899 -0.501 . . . . 0.0 111.911 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -56.17 -45.22 79.8 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.42 -48.86 68.36 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.848 -0.532 . . . . 0.0 112.255 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 212' ' ' ASP . 9.5 mmtp -57.29 -46.48 83.1 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 122.003 -0.436 . . . . 0.0 111.598 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.42 -52.23 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.716 -0.615 . . . . 0.0 110.711 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.44 -51.17 33.03 Favored Glycine 0 N--CA 1.478 1.435 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -51.76 -48.51 63.68 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 122.364 -0.492 . . . . 0.0 111.584 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -49.65 -52.59 24.3 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 122.035 -0.415 . . . . 0.0 112.348 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.23 -50.79 72.31 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.05 -0.677 . . . . 0.0 112.331 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 38.6 mt -49.27 -49.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 121.299 0.571 . . . . 0.0 111.67 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 227' ' ' ARG . 40.2 tp -57.04 -56.8 17.09 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.847 -0.533 . . . . 0.0 111.125 174.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.55 56.81 2.7 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 123.018 1.389 . . . . 0.0 110.792 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -158.02 -56.53 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.508 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.477 ' HA ' ' H ' ' A' ' 230' ' ' PHE . 74.3 m -148.23 43.8 1.04 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 223' ' ' LEU . 0.1 OUTLIER -137.2 -47.22 0.58 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.083 -1.011 . . . . 0.0 110.156 166.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.65 -47.06 14.62 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 165.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.6 mt -77.11 -78.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.477 ' H ' ' HA ' ' A' ' 226' ' ' SER . 53.3 t80 -60.3 -51.56 69.0 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.016 1.28 . . . . 0.0 112.196 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.544 0 O-C-N 121.788 -0.57 . . . . 0.0 113.346 178.825 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 71.9 mtm . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 64.08 161.04 0.12 Allowed Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.533 1.133 . . . . 0.0 112.739 -173.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.25 -164.02 0.18 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.602 2.868 . . . . 0.0 113.5 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 58.3 59.93 2.83 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.224 1.012 . . . . 0.0 110.763 -171.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.0 p -53.28 -44.71 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.789 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.25 -51.99 67.12 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.75 -0.594 . . . . 0.0 111.557 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m -59.04 -52.95 63.55 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 0.0 111.696 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.2 p -56.59 -48.07 78.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.33 -46.63 83.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.735 -0.603 . . . . 0.0 111.303 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -51.92 -51.32 57.77 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.484 -0.76 . . . . 0.0 112.102 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.59 -53.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.43 -52.01 63.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.215 0.531 . . . . 0.0 111.97 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 -52.32 -52.63 52.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.409 0.683 . . . . 0.0 111.47 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -51.35 -57.93 7.6 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.925 -0.484 . . . . 0.0 111.614 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.0 t -54.41 -49.8 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.963 -0.46 . . . . 0.0 112.17 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.7 p -58.84 -49.34 78.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.62 -0.675 . . . . 0.0 112.718 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.9 t -57.21 -49.93 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.463 -0.773 . . . . 0.0 111.742 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.76 -51.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.742 -0.599 . . . . 0.0 110.929 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.9 tt -51.51 -50.07 60.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.57 -0.706 . . . . 0.0 111.395 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 42.7 t90 -51.81 -57.4 9.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.5 p -61.54 -37.48 83.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.52 0.676 . . . . 0.0 112.214 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.57 65.7 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.4 ' HB3' ' CD ' ' A' ' 186' ' ' PRO . 1.4 t80 -57.32 -56.1 37.41 Favored Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 121.137 -0.977 . . . . 0.0 111.97 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 185' ' ' TYR . 43.1 Cg_endo -59.9 -33.41 95.85 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.793 2.329 . . . . 0.0 113.145 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.1 t -59.3 -53.17 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.397 -0.814 . . . . 0.0 111.116 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.7 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.805 -0.559 . . . . 0.0 110.95 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -52.54 -56.4 15.52 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.139 -0.35 . . . . 0.0 111.428 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.469 HD22 ' HA2' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -42.09 -56.04 2.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.871 0.869 . . . . 0.0 110.128 178.205 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.1 mt -54.94 -59.67 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 122.04 -0.413 . . . . 0.0 110.655 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.54 30.79 3.05 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 90.6 p -167.84 24.97 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.11 1.455 . . . . 0.0 111.029 168.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.427 ' HG2' ' HA3' ' A' ' 197' ' ' GLY . 1.7 pm0 36.19 55.37 1.03 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.862 1.315 . . . . 0.0 112.698 -175.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.469 ' HA2' HD22 ' A' ' 190' ' ' LEU . . . 65.24 -140.75 41.97 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.993 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -80.81 51.33 1.5 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.666 -0.902 . . . . 0.0 110.245 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.427 ' HA3' ' HG2' ' A' ' 194' ' ' GLU . . . -89.86 -51.26 2.88 Favored Glycine 0 N--CA 1.473 1.105 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.7 mt -53.4 -41.13 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.154 -0.615 . . . . 0.0 111.519 173.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.434 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 71.7 t -49.93 -57.39 12.63 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 67.7 Cg_endo -67.68 -35.55 21.74 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.114 2.543 . . . . 0.0 113.053 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.85 -46.9 51.84 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.757 -0.59 . . . . 0.0 111.567 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -48.55 -54.15 15.53 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.678 -0.638 . . . . 0.0 111.406 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.7 mt -54.61 -49.07 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.041 0.536 . . . . 0.0 111.137 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -53.86 -56.07 20.94 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.877 0.37 . . . . 0.0 111.145 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 52.6 m -53.77 -51.7 62.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.116 0.566 . . . . 0.0 112.086 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -62.56 -42.71 99.72 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.614 -0.678 . . . . 0.0 112.417 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 206' ' ' LEU . 5.0 tt -56.26 -53.8 52.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.538 -0.726 . . . . 0.0 110.027 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -52.87 -50.57 63.54 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.659 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 54.5 ttm -51.29 -49.72 60.71 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -52.65 -52.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.694 -0.629 . . . . 0.0 111.289 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.54 -51.46 66.97 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.33 0.586 . . . . 0.0 111.827 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -48.78 -53.95 17.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.605 0.762 . . . . 0.0 111.327 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.84 -51.01 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 58.5 p -57.27 -39.13 75.04 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.281 -0.887 . . . . 0.0 111.486 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.89 73.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -52.76 -51.27 61.3 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 110.98 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.14 -52.42 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.067 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.12 -50.83 50.03 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.62 -50.87 67.07 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.093 -0.651 . . . . 0.0 111.235 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.39 -50.23 41.94 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.753 -0.592 . . . . 0.0 112.134 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.54 -53.56 54.86 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.153 -0.616 . . . . 0.0 112.15 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.427 HG12 HH21 ' A' ' 225' ' ' ARG . 79.0 mt -52.55 -51.95 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.108 0.48 . . . . 0.0 111.082 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 43.7 tp -55.17 -55.16 34.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.406 0.682 . . . . 0.0 112.128 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.11 -50.89 71.9 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.127 0.489 . . . . 0.0 111.38 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.427 HH21 HG12 ' A' ' 222' ' ' ILE . 35.7 ttp180 -49.55 -41.08 40.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.398 0.679 . . . . 0.0 112.75 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.406 ' HB2' ' NH1' ' A' ' 227' ' ' ARG . 75.3 m -64.19 -60.89 2.66 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.45 -0.781 . . . . 0.0 111.741 170.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.406 ' NH1' ' HB2' ' A' ' 226' ' ' SER . 51.3 mmt-85 -58.04 104.71 0.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 56.14 34.25 23.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.744 0.818 . . . . 0.0 112.743 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 69.1 mt -140.61 -40.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 121.866 -0.521 . . . . 0.0 110.316 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.403 ' HB2' ' HA ' ' A' ' 226' ' ' SER . 1.8 t80 -79.73 177.17 9.09 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.591 -0.693 . . . . 0.0 110.382 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.659 0 O-C-N 121.346 -0.847 . . . . 0.0 113.455 -177.384 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.511 ' HG2' ' H ' ' A' ' 164' ' ' ARG . 48.2 ttp . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.028 0.442 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.511 ' H ' ' HG2' ' A' ' 163' ' ' MET . 0.9 OUTLIER -58.43 -51.26 83.06 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 178.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -59.62 -63.46 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.983 2.455 . . . . 0.0 115.776 -162.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.57 162.41 27.11 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.198 -0.939 . . . . 0.0 111.953 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.01 -50.68 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 121.64 -0.663 . . . . 0.0 110.334 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.29 82.98 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.034 0.445 . . . . 0.0 110.645 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.3 m -49.3 -52.92 24.6 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.3 m -57.14 -49.72 75.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.805 -0.559 . . . . 0.0 111.586 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.18 -48.02 71.39 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.112 0.482 . . . . 0.0 111.709 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -55.65 -49.21 73.5 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.783 -0.573 . . . . 0.0 112.061 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.5 -49.16 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.94 -0.475 . . . . 0.0 111.667 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.4 tt -52.18 -55.0 23.9 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.184 0.516 . . . . 0.0 110.497 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -52.72 -50.5 63.29 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -52.82 -56.87 12.58 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.581 -0.699 . . . . 0.0 111.995 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.7 t -54.17 -49.74 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.971 -0.456 . . . . 0.0 111.935 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.2 p -56.16 -46.04 79.44 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.625 -0.672 . . . . 0.0 112.6 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.51 -48.4 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.373 -0.83 . . . . 0.0 111.879 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -54.16 -48.52 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.629 -0.669 . . . . 0.0 111.668 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.7 mt -55.61 -50.01 71.28 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.509 -0.744 . . . . 0.0 111.887 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -53.22 -53.3 52.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.868 -0.52 . . . . 0.0 112.353 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.5 p -61.5 -38.38 87.13 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.09 95.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.207 -0.933 . . . . 0.0 112.463 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -40.79 -51.83 6.84 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -58.47 -40.4 74.94 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.905 2.404 . . . . 0.0 112.516 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.5 t -60.63 -45.08 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.795 -0.565 . . . . 0.0 110.375 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.54 -50.05 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.823 -0.548 . . . . 0.0 110.723 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -53.1 -51.19 62.67 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.448 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 48.0 tp -47.04 -53.38 12.7 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.985 -0.447 . . . . 0.0 111.511 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -52.39 -55.71 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.04 52.55 4.55 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.89 -0.506 . . . . 0.0 112.192 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 58.6 p -164.16 -42.34 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.485 1.143 . . . . 0.0 112.522 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 53.21 30.6 10.17 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.824 0.821 . . . . 0.0 110.971 -171.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 143.08 -47.48 0.8 Allowed Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.37 58.7 2.67 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 122.471 1.129 . . . . 0.0 113.049 -172.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -172.84 -62.4 0.05 OUTLIER Glycine 0 N--CA 1.471 0.987 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 190' ' ' LEU . 6.0 mt -61.95 -47.81 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 O-C-N 121.959 -0.73 . . . . 0.0 112.161 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 71.1 t -46.28 -55.22 14.35 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -66.69 -43.16 7.81 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.729 2.286 . . . . 0.0 112.821 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 10.4 tt -51.48 -43.45 62.16 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.2 m120 -45.36 -46.11 12.89 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 61.2 mt -60.41 -48.9 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 121.457 0.646 . . . . 0.0 110.134 -175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -59.75 -47.92 83.73 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.413 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 83.5 m -53.69 -55.27 27.55 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.662 -0.649 . . . . 0.0 111.732 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -60.78 -39.86 90.42 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.626 -0.671 . . . . 0.0 112.279 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 206' ' ' LEU . 3.1 tm? -54.09 -56.19 20.43 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.544 -0.723 . . . . 0.0 110.603 174.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.43 -53.48 29.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.556 0.342 . . . . 0.0 111.385 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 92.6 mtp -49.1 -49.64 40.9 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 76.6 t -52.87 -51.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.601 -0.687 . . . . 0.0 111.372 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.83 -47.84 73.6 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -54.22 -52.59 60.82 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.703 -0.623 . . . . 0.0 111.889 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.8 t -56.38 -54.94 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.925 -0.484 . . . . 0.0 111.899 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.1 p -56.24 -47.68 77.99 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.781 -0.574 . . . . 0.0 112.3 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.03 -48.72 75.45 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.905 -0.497 . . . . 0.0 111.972 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -53.32 50.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.589 0.356 . . . . 0.0 111.273 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.26 -51.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.077 -0.39 . . . . 0.0 111.281 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.59 31.87 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -53.97 -47.56 71.23 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.239 -0.565 . . . . 0.0 111.583 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.21 -54.37 12.72 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.57 -53.35 58.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.134 -0.627 . . . . 0.0 112.226 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.8 mt -52.2 -54.05 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.6 tp -56.23 -51.81 66.76 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.279 0.632 . . . . 0.0 111.698 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -51.6 -53.57 36.93 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -58.76 -56.94 15.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 25.1 p -56.51 -46.18 80.68 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.825 -0.547 . . . . 0.0 112.052 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.44 -51.63 64.36 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.055 0.542 . . . . 0.0 111.575 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.49 76.86 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.02 -49.0 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 120.977 0.417 . . . . 0.0 111.464 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 231' ' ' GLY . 19.5 t80 -61.52 155.07 22.94 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.651 0.738 . . . . 0.0 112.229 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . 0.404 ' N ' ' CD1' ' A' ' 230' ' ' PHE . . . . . . . . 0 CA--C 1.54 1.645 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.68 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.514 ' HG2' ' H ' ' A' ' 164' ' ' ARG . 10.4 ttt . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.514 ' H ' ' HG2' ' A' ' 163' ' ' MET . 50.3 mmm-85 61.84 69.42 0.99 Allowed Pre-proline 0 N--CA 1.479 0.999 0 O-C-N 121.444 -0.785 . . . . 0.0 111.548 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.04 61.11 7.59 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.211 3.274 . . . . 0.0 111.034 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -157.86 -161.08 0.98 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.879 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m 52.16 -170.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.96 21.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.978 0.511 . . . . 0.0 112.365 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -51.07 -65.19 0.6 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.235 -0.291 . . . . 0.0 111.751 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.2 p -67.91 -39.52 83.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.424 -0.798 . . . . 0.0 111.83 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -53.69 -54.57 36.01 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.053 -0.404 . . . . 0.0 111.597 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.51 -47.21 84.93 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.747 -0.595 . . . . 0.0 112.128 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -50.17 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.873 -0.517 . . . . 0.0 111.569 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.8 tp -57.27 -48.57 78.54 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.775 -0.578 . . . . 0.0 111.541 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 20.8 mmm-85 -57.68 -44.79 86.02 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.453 -0.779 . . . . 0.0 112.919 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -51.31 -56.61 12.11 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.78 -0.575 . . . . 0.0 111.073 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.79 -51.08 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.2 p -56.84 -47.82 79.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.56 -47.04 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.463 -0.773 . . . . 0.0 111.979 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.94 -49.53 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.684 -0.635 . . . . 0.0 111.491 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.03 -48.34 76.14 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.628 -0.67 . . . . 0.0 111.994 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -52.37 -54.42 32.06 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.0 p -59.64 -47.49 85.39 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.477 -0.764 . . . . 0.0 111.554 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.6 -14.13 61.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.421 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 4.3 t80 -62.99 -56.29 29.9 Favored Pre-proline 0 N--CA 1.476 0.832 0 O-C-N 120.84 -1.162 . . . . 0.0 111.153 -173.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 58.2 Cg_endo -62.22 -35.96 71.39 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.994 2.463 . . . . 0.0 112.243 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.28 -57.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.812 -0.555 . . . . 0.0 111.057 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.88 -40.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.806 -0.559 . . . . 0.0 111.493 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.57 -50.22 68.48 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.62 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 54.9 tp -53.2 -43.42 67.17 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.958 -0.463 . . . . 0.0 111.181 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.49 -53.95 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.359 -0.838 . . . . 0.0 109.716 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -71.75 29.64 0.62 Allowed Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.62 -0.675 . . . . 0.0 113.738 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.0 p -151.07 -10.68 0.23 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.642 -0.916 . . . . 0.0 110.74 168.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -158.48 55.69 0.45 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.394 1.078 . . . . 0.0 108.562 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 176.94 -57.31 0.1 Allowed Glycine 0 N--CA 1.476 1.31 0 O-C-N 120.908 -1.12 . . . . 0.0 111.811 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 47.82 50.41 15.54 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.027 0.931 . . . . 0.0 112.485 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 157.46 -33.75 0.54 Allowed Glycine 0 N--CA 1.475 1.257 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 9.5 mt -73.92 25.95 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-O 121.258 0.551 . . . . 0.0 112.216 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.527 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 67.1 t -79.03 -59.43 0.63 Allowed Pre-proline 0 N--CA 1.478 0.933 0 O-C-N 119.893 -1.754 . . . . 0.0 108.79 175.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.527 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 37.8 Cg_endo -58.86 -41.07 66.2 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.623 2.215 . . . . 0.0 111.126 170.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 83.9 mt -56.46 -51.21 69.29 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 122.091 -0.381 . . . . 0.0 111.845 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -52.28 -57.19 10.49 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.58 -0.7 . . . . 0.0 111.868 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 80.0 mt -56.08 -51.66 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.217 0.532 . . . . 0.0 111.186 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.19 -56.45 14.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.378 0.671 . . . . 0.0 111.429 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 96.3 m -54.57 -47.53 73.16 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.128 -0.357 . . . . 0.0 111.683 -177.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.36 -57.1 13.22 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.718 -0.613 . . . . 0.0 111.89 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.22 -51.28 69.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.247 0.546 . . . . 0.0 111.773 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.79 -53.07 57.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.493 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 26.9 ttt -52.04 -45.57 64.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.638 0.375 . . . . 0.0 112.003 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.8 t -51.5 -53.24 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.513 -0.742 . . . . 0.0 111.202 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.97 -50.76 68.13 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.965 -0.459 . . . . 0.0 112.173 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -52.71 -54.91 27.09 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.051 -0.406 . . . . 0.0 111.752 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.3 t -57.16 -54.71 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 122.122 -0.361 . . . . 0.0 111.741 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.4 p -55.18 -49.96 70.54 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.519 -0.738 . . . . 0.0 112.306 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.65 76.86 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.908 -0.495 . . . . 0.0 112.037 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -57.2 -48.72 78.07 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.085 -0.385 . . . . 0.0 110.826 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.8 t -53.98 -53.27 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.481 -0.762 . . . . 0.0 111.235 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.83 -50.78 36.5 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 121.797 -0.564 . . . . 0.0 111.762 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.01 -49.51 68.72 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.267 -0.549 . . . . 0.0 111.186 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.62 -49.72 51.81 Favored Glycine 0 N--CA 1.475 1.274 0 O-C-N 121.962 -0.461 . . . . 0.0 112.754 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.92 -50.67 68.25 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.942 -0.74 . . . . 0.0 111.933 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.39 -50.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.293 0.568 . . . . 0.0 111.326 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 61.2 tp -53.13 -48.39 67.94 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.482 0.713 . . . . 0.0 111.94 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 tt -55.22 -56.22 22.43 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.798 -0.564 . . . . 0.0 109.848 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -59.51 -13.84 10.54 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.7 t -90.19 -60.05 2.03 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.36 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -59.96 103.84 0.25 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.913 0.885 . . . . 0.0 112.605 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 64.27 34.03 11.08 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 122.077 0.941 . . . . 0.0 111.968 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 51.3 mt -141.8 -48.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -84.6 -47.81 10.15 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.69 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.394 176.225 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.824 0.345 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -161.85 82.59 1.8 Allowed Pre-proline 0 N--CA 1.473 0.677 0 O-C-N 121.813 -0.554 . . . . 0.0 110.326 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.61 61.22 7.41 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.991 3.127 . . . . 0.0 111.572 172.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 61.69 85.69 0.12 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.271 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 53.2 t -44.79 -51.41 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.77 -49.49 75.12 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.914 -0.491 . . . . 0.0 111.773 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -59.37 -54.92 41.26 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.956 -0.465 . . . . 0.0 111.808 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.7 t -58.78 -41.37 86.52 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.957 -0.465 . . . . 0.0 111.643 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -56.19 -51.9 66.36 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.476 -0.765 . . . . 0.0 111.322 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -55.05 -46.74 75.36 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.847 -0.533 . . . . 0.0 112.224 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 70.9 t -55.4 -52.09 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 122.024 -0.423 . . . . 0.0 111.521 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.7 tp -52.81 -50.51 63.51 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.711 -0.618 . . . . 0.0 111.624 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.629 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.09 -50.39 66.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -53.67 -56.08 20.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.233 -0.292 . . . . 0.0 111.013 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.77 -52.78 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.659 0.383 . . . . 0.0 111.844 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.5 p -56.71 -52.24 65.73 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 80.4 t -58.33 -48.96 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.729 -0.607 . . . . 0.0 112.001 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 77.1 t -57.25 -54.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.703 -0.623 . . . . 0.0 111.215 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.3 mt -53.23 -46.83 69.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.492 -0.755 . . . . 0.0 111.857 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.8 t90 -53.5 -56.96 12.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.1 p -61.0 -42.91 99.35 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.695 0.759 . . . . 0.0 112.151 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.1 67.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.08 -56.19 36.21 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 121.345 -0.847 . . . . 0.0 112.652 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.15 -36.05 90.07 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.971 2.447 . . . . 0.0 112.802 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.99 -55.7 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.596 -0.69 . . . . 0.0 110.925 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.24 -45.65 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.98 -0.45 . . . . 0.0 111.234 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -50.32 -58.5 5.53 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.207 -0.308 . . . . 0.0 111.015 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -47.72 -49.63 27.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.799 0.84 . . . . 0.0 110.546 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.3 mt -52.32 -59.18 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.687 -0.633 . . . . 0.0 110.486 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.72 52.04 4.52 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 121.409 0.45 . . . . 0.0 112.985 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 14.3 p -163.21 -49.67 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.962 -0.728 . . . . 0.0 110.529 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.15 42.91 0.11 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.748 0.785 . . . . 0.0 111.521 176.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -159.57 38.62 0.48 Allowed Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.982 -1.074 . . . . 0.0 111.858 173.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -80.9 -42.37 21.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.777 -0.837 . . . . 0.0 110.926 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -58.44 -44.88 95.06 Favored Glycine 0 N--CA 1.475 1.274 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.952 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 28.1 pt 8.72 73.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 200' ' ' PRO . 99.1 t -41.66 -58.03 3.45 Favored Pre-proline 0 N--CA 1.475 0.808 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -172.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 199' ' ' VAL . 40.4 Cg_endo -56.36 -38.38 95.29 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.038 2.492 . . . . 0.0 113.785 -175.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.25 -51.74 22.88 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -51.99 -47.79 64.72 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.012 0.434 . . . . 0.0 111.941 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 81.0 mt -55.06 -53.47 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.982 -0.448 . . . . 0.0 111.517 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -56.42 -44.65 80.57 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.728 -0.607 . . . . 0.0 112.052 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 m -51.97 -52.6 49.26 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.448 -0.783 . . . . 0.0 110.889 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.73 -52.12 65.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.914 0.387 . . . . 0.0 111.792 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.5 tt -51.11 -56.59 11.93 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.469 0.708 . . . . 0.0 110.772 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.76 -48.43 72.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.242 0.617 . . . . 0.0 111.366 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 56.5 ttp -53.73 -50.72 65.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.597 -0.689 . . . . 0.0 111.913 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.4 t -54.3 -48.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.786 -0.571 . . . . 0.0 111.401 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.0 mt -53.31 -53.79 45.88 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.864 -0.522 . . . . 0.0 111.67 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -47.67 -54.24 12.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.888 -0.508 . . . . 0.0 111.659 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.66 -57.23 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 122.002 -0.436 . . . . 0.0 111.706 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 86.5 p -58.71 -48.7 80.22 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.695 -0.628 . . . . 0.0 112.621 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.19 94.6 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.88 -0.513 . . . . 0.0 111.319 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -55.06 -49.91 70.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.77 0.428 . . . . 0.0 111.547 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.22 -52.57 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 122.041 -0.412 . . . . 0.0 111.005 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.54 -50.4 36.24 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 121.885 -0.509 . . . . 0.0 112.391 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -53.12 -49.96 65.45 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.056 -0.673 . . . . 0.0 111.102 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.43 -48.53 64.31 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 121.888 -0.508 . . . . 0.0 112.714 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.429 ' HB3' HH21 ' A' ' 225' ' ' ARG . 83.0 mt -56.82 -45.27 82.41 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.783 -0.834 . . . . 0.0 112.463 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.13 -47.5 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.653 -0.654 . . . . 0.0 111.902 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 227' ' ' ARG . 65.5 tp -50.39 -55.53 15.32 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.794 -0.566 . . . . 0.0 110.601 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 32.6 tp -80.94 62.06 4.79 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.761 1.267 . . . . 0.0 110.16 174.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.429 HH21 ' HB3' ' A' ' 221' ' ' LEU . 9.7 ttm180 -164.02 -54.54 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.6 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 55.2 p -147.03 54.16 1.09 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.155 0.979 . . . . 0.0 111.858 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.407 ' HB3' HD12 ' A' ' 223' ' ' LEU . 0.2 OUTLIER -163.89 -66.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.521 -0.737 . . . . 0.0 109.396 176.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -70.81 -46.14 63.36 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.704 0.764 . . . . 0.0 109.68 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.9 mt -57.16 -29.35 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.144 173.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -83.94 64.65 8.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.486 1.136 . . . . 0.0 110.412 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.653 0 CA-C-N 115.672 -0.694 . . . . 0.0 113.184 177.535 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 20.5 ptt? . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -153.82 62.76 4.07 Favored Pre-proline 0 N--CA 1.475 0.813 0 O-C-N 121.589 -0.695 . . . . 0.0 111.225 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.3 -62.99 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.141 2.561 . . . . 0.0 111.883 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.94 -114.92 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 170.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.667 HG12 ' H ' ' A' ' 168' ' ' ALA . 2.7 t 63.19 -169.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.005 -1.059 . . . . 0.0 110.004 168.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.667 ' H ' HG12 ' A' ' 167' ' ' VAL . . . -45.7 -31.1 1.81 Allowed 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.716 -1.24 . . . . 0.0 113.562 174.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.5 m -60.32 -64.94 0.77 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.522 -0.737 . . . . 0.0 111.433 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.2 m -63.5 -36.76 84.85 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.635 -0.665 . . . . 0.0 111.758 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -52.49 -52.38 54.71 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.558 -0.714 . . . . 0.0 111.306 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -58.98 -47.27 85.74 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.939 -0.476 . . . . 0.0 111.464 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 68.8 t -51.59 -53.26 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 122.06 -0.4 . . . . 0.0 111.48 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.8 tt -54.15 -52.37 61.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.112 0.565 . . . . 0.0 110.869 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -52.35 45.57 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.948 0.404 . . . . 0.0 110.632 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -53.52 -55.11 28.3 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.701 -0.625 . . . . 0.0 111.776 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.1 t -52.95 -48.66 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 71.8 p -61.46 -45.58 93.67 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.518 -0.738 . . . . 0.0 112.252 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.51 -49.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.346 -0.846 . . . . 0.0 111.638 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.7 t -52.99 -51.03 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 122.047 -0.408 . . . . 0.0 110.722 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.67 -54.46 22.86 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.742 -0.599 . . . . 0.0 111.106 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -57.52 -47.39 82.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.4 p -61.15 -42.87 99.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.242 -0.912 . . . . 0.0 111.08 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.24 -13.0 61.56 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -62.48 -56.42 30.32 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.464 -1.398 . . . . 0.0 111.197 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -61.41 -39.17 58.47 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.801 2.334 . . . . 0.0 111.862 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 202' ' ' ASN . 35.8 t -46.87 -52.6 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 122.004 -0.435 . . . . 0.0 111.753 173.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.49 -57.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 122.059 -0.401 . . . . 0.0 111.086 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -47.94 -45.07 30.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.7 tp -50.7 -35.22 30.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.572 ' HB ' HD11 ' A' ' 198' ' ' ILE . 9.8 tt -68.95 -44.39 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.095 -1.003 . . . . 0.0 109.658 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.26 52.13 4.26 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 18.8 p -169.47 -67.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.308 0.643 . . . . 0.0 110.557 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -95.17 47.79 1.15 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.281 1.038 . . . . 0.0 111.18 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 57.25 -166.15 5.47 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 121.6 -0.687 . . . . 0.0 112.231 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.466 ' HA ' HG13 ' A' ' 191' ' ' ILE . . . -81.59 37.83 0.48 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.471 -1.017 . . . . 0.0 112.443 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -85.73 45.22 3.45 Favored Glycine 0 N--CA 1.476 1.322 0 O-C-N 121.459 -0.776 . . . . 0.0 112.19 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 191' ' ' ILE . 7.3 pt -151.83 -175.03 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 122.063 -0.669 . . . . 0.0 111.308 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . 0.275 94.6 t 113.63 -64.68 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 126.89 2.076 . . . . 0.0 112.777 171.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.01 -54.4 1.15 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.934 1.756 . . . . 0.0 111.369 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.98 -45.37 74.99 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.944 0.402 . . . . 0.0 110.809 173.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.487 ' HB3' HG13 ' A' ' 187' ' ' VAL . 4.4 m120 -57.28 -53.08 62.22 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 95.9 mt -57.67 -46.86 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.109 -0.369 . . . . 0.0 110.704 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -50.95 -55.08 18.98 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.196 -0.315 . . . . 0.0 111.313 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.3 m -53.31 -50.7 64.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.916 0.487 . . . . 0.0 111.899 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.05 -50.8 71.62 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.805 -0.56 . . . . 0.0 111.604 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.35 -54.03 42.42 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.441 0.639 . . . . 0.0 110.349 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -52.0 -51.65 55.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.093 0.557 . . . . 0.0 111.477 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.2 ttt -49.4 -48.07 47.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 90.7 t -52.3 -52.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.76 -0.588 . . . . 0.0 111.29 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.8 mp -54.05 -50.65 66.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -50.09 -57.45 7.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.772 -0.58 . . . . 0.0 111.306 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.07 -53.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 122.21 -0.306 . . . . 0.0 111.504 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.6 p -57.03 -44.84 83.29 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.944 -0.472 . . . . 0.0 111.604 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.42 65.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.958 -0.464 . . . . 0.0 112.202 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -46.11 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.04 -50.7 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.659 -0.65 . . . . 0.0 111.524 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.16 -51.39 54.35 Favored Glycine 0 N--CA 1.475 1.238 0 O-C-N 121.806 -0.559 . . . . 0.0 112.018 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.82 -51.59 63.05 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 122.109 -0.642 . . . . 0.0 110.989 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.0 -48.16 63.83 Favored Glycine 0 N--CA 1.473 1.163 0 O-C-N 122.07 -0.394 . . . . 0.0 112.218 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.28 -51.17 65.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.912 -0.758 . . . . 0.0 112.399 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.72 -50.74 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.717 -0.614 . . . . 0.0 111.083 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.5 tp -53.68 -58.28 7.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.136 0.574 . . . . 0.0 111.263 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.32 60.89 4.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.357 1.075 . . . . 0.0 110.59 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.419 ' HD2' ' OG ' ' A' ' 226' ' ' SER . 7.0 tmm_? -172.73 -53.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.346 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.419 ' OG ' ' HD2' ' A' ' 225' ' ' ARG . 75.1 m -139.2 65.52 1.44 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.501 1.143 . . . . 0.0 111.041 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -174.55 -60.23 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -85.35 -51.57 6.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.6 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 18.4 mt -70.03 -75.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.98 -0.45 . . . . 0.0 110.567 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.94 -174.25 2.82 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.516 0 O-C-N 121.053 -1.03 . . . . 0.0 112.336 172.685 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.509 ' CG ' ' HD2' ' A' ' 165' ' ' PRO . 48.0 ttt85 69.58 158.19 0.15 Allowed Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -149.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 164' ' ' ARG . 80.4 Cg_endo -74.22 42.42 0.75 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.134 1.889 . . . . 0.0 114.121 173.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 36.01 41.15 0.12 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 176.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.35 -55.77 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.73 91.75 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.173 0.511 . . . . 0.0 110.442 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 m -53.97 -59.07 5.12 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.801 0.44 . . . . 0.0 111.475 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 41.5 p -59.83 -44.59 93.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.724 -0.61 . . . . 0.0 112.131 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.95 -55.35 14.87 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.851 -0.531 . . . . 0.0 111.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -55.09 -52.1 64.31 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.038 -0.414 . . . . 0.0 111.953 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 79.3 t -53.93 -51.93 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 122.141 -0.35 . . . . 0.0 111.876 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 174' ' ' LEU . 6.2 tt -56.81 -57.2 13.5 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.786 0.434 . . . . 0.0 110.902 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -53.17 -49.54 66.45 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.054 0.454 . . . . 0.0 110.515 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -52.05 -62.07 1.86 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.991 -0.443 . . . . 0.0 111.946 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.9 t -55.65 -46.82 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.8 p -58.86 -50.43 74.04 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.708 -0.62 . . . . 0.0 112.426 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.88 -45.4 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.596 -0.69 . . . . 0.0 111.854 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.53 -55.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.748 -0.595 . . . . 0.0 110.918 175.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.07 -49.71 60.1 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.813 -0.555 . . . . 0.0 111.114 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -49.75 -58.04 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 82.4 p -61.12 -41.09 96.06 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.765 0.793 . . . . 0.0 111.833 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.17 -29.49 68.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' TYR . . . . . 0.416 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 51.6 t80 -54.81 -53.94 55.17 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 39.3 Cg_endo -59.17 -36.93 94.57 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.994 2.462 . . . . 0.0 112.762 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.49 -52.68 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.613 -0.68 . . . . 0.0 110.459 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.52 -46.12 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.04 0.536 . . . . 0.0 111.365 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -52.04 -58.85 5.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.012 -0.43 . . . . 0.0 111.24 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 53.7 tp -50.44 -42.92 54.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.604 0.362 . . . . 0.0 111.93 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 91.0 mt -56.08 -61.16 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 122.072 -0.393 . . . . 0.0 110.192 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.35 53.14 4.63 Favored Glycine 0 N--CA 1.477 1.418 0 CA-C-O 121.781 0.656 . . . . 0.0 112.506 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 88.1 p -171.34 -26.39 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.144 0.978 . . . . 0.0 110.333 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 38.48 40.16 0.36 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.433 1.093 . . . . 0.0 113.44 -166.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -79.12 51.15 3.83 Favored Glycine 0 N--CA 1.478 1.481 0 O-C-N 122.054 -0.404 . . . . 0.0 113.281 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.64 82.84 0.43 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.909 0.861 . . . . 0.0 111.532 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 63.91 26.72 70.36 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 16.6 mt -72.17 -34.79 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.684 -0.892 . . . . 0.0 110.925 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.424 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 90.7 t -52.26 -60.88 5.32 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.517 -0.739 . . . . 0.0 111.836 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.424 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 57.8 Cg_endo -61.72 -38.95 56.79 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.763 2.309 . . . . 0.0 112.749 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 201' ' ' LEU . 6.0 tt -50.11 -59.06 4.28 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.038 -0.414 . . . . 0.0 110.872 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -59.02 -40.75 85.92 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 88.5 mt -50.96 -55.7 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.547 -0.721 . . . . 0.0 110.706 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -55.23 -51.07 67.79 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.919 -0.488 . . . . 0.0 111.619 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.0 m -49.33 -46.98 47.48 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.695 0.398 . . . . 0.0 111.946 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -53.93 -58.24 8.0 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.934 -0.479 . . . . 0.0 111.821 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -54.77 -48.24 72.93 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.771 -0.581 . . . . 0.0 111.987 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.59 -55.49 21.92 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.106 0.479 . . . . 0.0 110.958 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 28.0 ttt -54.28 -47.11 72.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 69.8 t -51.17 -52.05 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.499 -0.751 . . . . 0.0 111.255 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.9 mt -56.64 -48.51 77.4 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.097 0.475 . . . . 0.0 111.9 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -53.91 -53.61 50.31 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.381 0.61 . . . . 0.0 112.253 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -58.02 -53.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.947 -0.471 . . . . 0.0 111.632 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 63.6 p -55.7 -45.8 77.77 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.739 -0.601 . . . . 0.0 111.923 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.68 -49.44 72.93 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.882 -0.511 . . . . 0.0 112.057 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 216' ' ' LYS . 5.5 mmpt? -57.11 -45.8 83.15 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 95.8 t -54.57 -51.99 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.618 -0.676 . . . . 0.0 110.549 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.24 -51.66 30.28 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -49.79 -49.25 49.33 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.241 -0.564 . . . . 0.0 112.123 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.19 -52.58 31.19 Favored Glycine 0 N--CA 1.476 1.365 0 O-C-N 122.094 -0.379 . . . . 0.0 112.396 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.93 -51.88 67.39 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.966 -0.726 . . . . 0.0 112.147 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.7 mt -49.75 -49.37 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.041 0.536 . . . . 0.0 111.294 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 60.5 tp -54.45 -58.54 7.05 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.038 -0.414 . . . . 0.0 110.755 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.29 52.91 2.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.19 0.995 . . . . 0.0 111.116 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.25 -47.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.281 -0.887 . . . . 0.0 111.04 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 58.8 m -144.92 58.81 1.3 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.008 0.909 . . . . 0.0 111.324 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -166.98 -62.63 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.49 -0.756 . . . . 0.0 109.839 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -95.45 -48.49 5.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 4.1 mt 56.15 61.69 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.39 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -77.21 173.59 11.69 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.851 -1.155 . . . . 0.0 110.631 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.648 0 O-C-N 121.409 -0.807 . . . . 0.0 112.715 177.841 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 120.634 0.254 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.9 t -47.03 -60.46 2.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.7 t -59.3 -40.44 86.19 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.473 -0.767 . . . . 0.0 112.462 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -56.56 -53.91 52.11 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.628 -0.67 . . . . 0.0 111.523 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -59.46 -44.0 93.09 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.809 -0.557 . . . . 0.0 112.287 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -54.19 -48.59 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.763 -0.586 . . . . 0.0 111.559 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.4 tt -52.4 -56.1 17.25 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.831 -0.543 . . . . 0.0 110.816 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.28 -47.82 71.91 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -50.76 -58.19 6.53 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.735 -0.603 . . . . 0.0 111.492 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.59 -50.75 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 122.047 -0.408 . . . . 0.0 111.945 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 47.0 p -58.64 -49.04 78.98 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.8 -48.25 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.512 -0.743 . . . . 0.0 111.846 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.26 -53.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.723 -0.611 . . . . 0.0 110.96 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.2 tt -51.78 -51.74 54.09 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.817 -0.552 . . . . 0.0 110.499 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -50.4 -56.22 12.37 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -61.02 -42.77 99.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.717 0.77 . . . . 0.0 111.728 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.97 68.12 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.408 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 60.2 t80 -57.4 -54.85 50.62 Favored Pre-proline 0 N--CA 1.475 0.819 0 O-C-N 121.289 -0.882 . . . . 0.0 112.889 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 48.0 Cg_endo -60.51 -36.86 84.45 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.943 2.429 . . . . 0.0 112.606 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.58 -55.27 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.813 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 82.1 t -56.03 -45.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.972 0.509 . . . . 0.0 111.283 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -51.51 -58.98 4.8 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.935 -0.478 . . . . 0.0 111.252 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.63 -47.17 49.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.226 0.611 . . . . 0.0 111.63 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.91 -55.64 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.834 -0.541 . . . . 0.0 110.239 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 O-C-N 121.671 -0.643 . . . . 0.0 113.546 177.14 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.476 0.83 0 CA-C-O 120.956 0.408 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.65 -54.82 39.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.031 -0.418 . . . . 0.0 110.85 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.29 -53.53 27.87 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.223 0.535 . . . . 0.0 111.252 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.74 -52.82 54.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.127 0.571 . . . . 0.0 111.254 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.34 -48.14 68.76 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.772 -0.58 . . . . 0.0 112.351 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -53.42 -49.7 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.544 -0.723 . . . . 0.0 111.239 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.94 -51.09 64.92 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.986 -0.446 . . . . 0.0 111.237 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -50.38 -53.09 31.72 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.907 -0.496 . . . . 0.0 111.612 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.24 -54.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 122.04 -0.412 . . . . 0.0 111.895 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 70.4 p -57.37 -45.37 84.5 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.666 -0.646 . . . . 0.0 111.752 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.93 73.98 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.002 -0.436 . . . . 0.0 111.975 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -54.52 -48.62 71.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.16 -51.92 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.855 -0.528 . . . . 0.0 111.165 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.51 -50.95 46.05 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 121.964 -0.46 . . . . 0.0 112.039 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -52.52 -49.73 64.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.165 -0.609 . . . . 0.0 111.385 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.78 -52.86 32.26 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 121.93 -0.481 . . . . 0.0 111.964 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.9 mt -53.67 -50.56 65.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 122.084 -0.656 . . . . 0.0 111.93 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.24 -51.46 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 122.064 -0.397 . . . . 0.0 111.384 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.3 tp . . . . . 0 N--CA 1.476 0.827 0 O-C-N 121.936 -0.478 . . . . 0.0 112.281 179.344 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.647 0 CA-C-O 120.698 0.285 . . . . 0.0 111.709 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -66.74 -46.98 73.7 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.844 -0.535 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 89.4 m -51.99 -50.17 61.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.674 0.39 . . . . 0.0 111.356 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.6 -53.24 59.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.896 -0.503 . . . . 0.0 111.129 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.82 -48.39 59.81 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.16 -50.68 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.984 -0.448 . . . . 0.0 111.549 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 174' ' ' LEU . 6.6 tt -52.57 -54.26 35.29 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.099 0.476 . . . . 0.0 111.092 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -52.67 -48.61 66.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.176 0.59 . . . . 0.0 111.761 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -53.32 -57.9 8.95 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.97 -0.456 . . . . 0.0 111.472 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 69.5 t -52.25 -49.61 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.959 -0.463 . . . . 0.0 112.192 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 45.6 p -58.46 -53.79 54.3 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.775 -0.578 . . . . 0.0 111.921 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.44 -46.18 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.421 -0.8 . . . . 0.0 111.991 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.53 -53.31 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.65 -0.656 . . . . 0.0 110.913 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 tt -51.74 -50.08 61.3 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.699 -0.626 . . . . 0.0 110.547 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.83 -54.62 31.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 111.851 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -61.89 -41.91 98.45 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.582 0.706 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.54 66.81 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -58.58 -56.92 30.68 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.197 -0.939 . . . . 0.0 111.859 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -60.38 -35.84 89.46 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.898 2.399 . . . . 0.0 112.65 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.83 -56.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.563 -0.711 . . . . 0.0 111.041 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 77.1 t -56.99 -45.62 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.831 -0.543 . . . . 0.0 111.229 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -53.12 -52.03 60.02 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 0.0 111.287 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.33 -49.29 64.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.14 0.576 . . . . 0.0 111.185 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 86.4 mt -51.92 -49.79 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.302 -0.874 . . . . 0.0 110.842 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.625 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 177.541 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -61.79 -44.25 97.25 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.451 -0.781 . . . . 0.0 112.024 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 206' ' ' LEU . 91.6 mt -57.62 -50.97 71.39 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.511 -0.743 . . . . 0.0 111.398 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.62 -53.3 48.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 59.8 ttp -52.36 -50.67 61.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.209 0.604 . . . . 0.0 112.385 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -52.27 -49.62 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.466 -0.771 . . . . 0.0 111.592 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.63 -49.02 73.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.136 0.493 . . . . 0.0 111.811 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -54.11 -51.96 62.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.14 0.495 . . . . 0.0 111.853 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.1 -54.66 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.117 -0.364 . . . . 0.0 111.688 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.4 p -56.0 -46.42 78.72 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.713 -0.617 . . . . 0.0 112.014 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.13 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.917 -0.489 . . . . 0.0 111.975 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.59 -48.49 74.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.956 -0.465 . . . . 0.0 112.087 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.8 t -55.04 -52.14 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.948 -0.47 . . . . 0.0 111.137 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.93 -51.65 33.69 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.83 -48.72 66.8 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 122.23 -0.57 . . . . 0.0 111.224 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.99 -56.41 16.63 Favored Glycine 0 N--CA 1.475 1.252 0 O-C-N 121.874 -0.516 . . . . 0.0 112.205 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.4 -45.66 69.41 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.734 -0.862 . . . . 0.0 112.265 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.7 mt -55.73 -49.95 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.741 -0.6 . . . . 0.0 111.661 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.3 tp . . . . . 0 N--CA 1.475 0.818 0 C-N-CA 122.944 0.498 . . . . 0.0 111.766 177.427 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 80.3 p -59.79 -48.47 81.54 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.62 -0.675 . . . . 0.0 112.085 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 25.5 p -56.42 -43.21 79.16 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.931 -0.481 . . . . 0.0 112.204 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -55.08 -48.04 74.08 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.715 -0.616 . . . . 0.0 111.501 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -52.89 -53.24 51.99 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.974 -0.454 . . . . 0.0 111.287 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.14 -46.48 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 122.426 0.29 . . . . 0.0 111.589 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 tt -51.32 -59.83 3.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.915 0.486 . . . . 0.0 110.889 177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -58.26 -44.06 88.17 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -51.23 -59.79 3.82 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.797 -0.564 . . . . 0.0 111.571 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.3 t -55.57 -49.29 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 122.073 -0.392 . . . . 0.0 111.774 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.4 p -56.84 -49.59 74.99 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.5 t -56.89 -48.83 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.503 -0.748 . . . . 0.0 111.667 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.2 t -56.67 -57.79 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.664 -0.648 . . . . 0.0 111.494 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 97.4 mt -56.07 -42.83 77.28 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.466 -0.771 . . . . 0.0 112.002 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -52.11 -59.54 4.25 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.999 -0.438 . . . . 0.0 111.924 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.6 p -60.85 -37.52 82.36 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.457 0.646 . . . . 0.0 111.928 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.33 63.81 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -54.89 -58.61 13.72 Favored Pre-proline 0 N--CA 1.478 0.945 0 CA-C-N 119.223 0.919 . . . . 0.0 113.213 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -57.9 -37.55 95.77 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.897 2.398 . . . . 0.0 112.678 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.05 -54.89 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.765 -0.584 . . . . 0.0 111.03 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 78.3 t -56.0 -46.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.891 -0.506 . . . . 0.0 111.386 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.8 t90 -50.71 -55.32 17.13 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.966 -0.459 . . . . 0.0 111.391 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tt -52.56 -50.8 62.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.781 0.433 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 97.9 mt -52.15 -52.74 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.683 -0.635 . . . . 0.0 111.296 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.542 0 O-C-N 121.833 -0.542 . . . . 0.0 114.258 179.145 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 120.812 0.339 . . . . 0.0 111.54 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.411 ' C ' HD13 ' A' ' 206' ' ' LEU . 3.0 tm? -52.95 -54.31 36.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.027 -0.421 . . . . 0.0 111.235 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.1 tp -51.23 -51.59 52.59 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.947 -0.47 . . . . 0.0 111.979 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -53.65 -50.54 65.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.871 0.367 . . . . 0.0 111.356 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 57.3 ttp -54.01 -51.09 65.06 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 122.07 -0.393 . . . . 0.0 111.977 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.09 -50.26 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.787 -0.571 . . . . 0.0 111.507 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 95.4 mt -53.78 -52.39 60.39 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.062 -0.399 . . . . 0.0 111.73 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.45 -56.13 14.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.82 -0.55 . . . . 0.0 111.227 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.3 t -50.6 -52.88 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.3 p -58.13 -44.08 87.59 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.696 -0.627 . . . . 0.0 111.586 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.07 -48.49 75.99 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.897 -0.502 . . . . 0.0 111.961 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -58.18 -45.09 88.13 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.872 -0.518 . . . . 0.0 112.227 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.8 t -55.41 -50.42 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.44 -0.787 . . . . 0.0 111.405 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.99 -51.18 47.63 Favored Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.77 -52.44 31.85 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.087 0.555 . . . . 0.0 111.268 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.11 -52.42 35.81 Favored Glycine 0 N--CA 1.477 1.398 0 O-C-N 121.803 -0.56 . . . . 0.0 112.585 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 66.7 tp -54.58 -52.65 61.47 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.04 -0.682 . . . . 0.0 111.64 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.73 -49.96 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.67 0.388 . . . . 0.0 111.421 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.0 tp . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 122.938 0.495 . . . . 0.0 111.85 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 120.356 0.122 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.3 m -52.32 -57.54 9.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 23.9 p -58.38 -46.81 85.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.74 -48.73 72.21 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.699 -0.626 . . . . 0.0 111.662 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.25 -49.95 74.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.614 -0.679 . . . . 0.0 112.284 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.6 t -54.29 -47.3 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 121.819 -0.551 . . . . 0.0 111.738 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 174' ' ' LEU . 6.8 tt -52.85 -56.65 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.001 -0.437 . . . . 0.0 110.788 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -52.05 -49.24 63.85 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -49.73 -59.41 3.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.981 -0.449 . . . . 0.0 111.7 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.76 -52.28 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 122.057 -0.402 . . . . 0.0 111.94 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -58.03 -49.7 75.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.5 t -59.53 -50.46 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.598 -0.688 . . . . 0.0 111.59 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.83 -48.82 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.826 -0.546 . . . . 0.0 111.319 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 181' ' ' LEU . 5.9 tt -54.29 -56.13 21.53 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.795 -0.565 . . . . 0.0 110.876 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -54.09 -51.43 64.19 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -59.32 -44.8 92.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.602 -0.686 . . . . 0.0 112.0 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.84 -20.2 64.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -58.91 -55.71 43.55 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 120.99 -1.069 . . . . 0.0 112.134 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -60.43 -31.84 93.09 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.0 2.466 . . . . 0.0 112.769 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.11 -52.31 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.463 -0.773 . . . . 0.0 110.672 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.07 -46.38 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.848 -0.533 . . . . 0.0 111.024 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -51.83 -55.95 16.89 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.995 -0.441 . . . . 0.0 111.157 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.915 0.886 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 73.4 mt -51.59 -60.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 173.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.449 0 CA-C-O 121.283 0.38 . . . . 0.0 113.067 179.669 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.7 mt -54.31 -54.76 35.88 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -48.34 75.07 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.666 -0.647 . . . . 0.0 111.778 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -53.5 -53.36 52.58 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.029 -0.419 . . . . 0.0 111.463 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 58.1 ttp -49.38 -48.79 46.68 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.324 0.65 . . . . 0.0 112.45 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.1 t -51.29 -51.0 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.725 -0.609 . . . . 0.0 111.201 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.8 mt -54.92 -51.46 65.99 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 122.203 -0.311 . . . . 0.0 111.605 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -51.08 -50.83 57.96 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.875 -0.516 . . . . 0.0 111.969 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.5 -51.2 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.5 p -58.55 -46.05 87.66 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.433 -0.792 . . . . 0.0 111.681 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.1 77.03 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.925 -0.484 . . . . 0.0 111.845 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -50.01 -54.25 21.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.899 0.48 . . . . 0.0 111.648 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.3 t -55.26 -50.56 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 122.212 -0.305 . . . . 0.0 111.555 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.95 -51.49 34.42 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 121.897 -0.502 . . . . 0.0 112.134 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.34 -52.58 63.03 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.972 -0.722 . . . . 0.0 111.289 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.82 -48.45 44.47 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 94.8 mt -56.02 -56.31 22.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.205 -0.585 . . . . 0.0 111.921 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.1 mt -49.66 -43.81 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.542 0.687 . . . . 0.0 111.736 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 36.9 tp . . . . . 0 N--CA 1.47 0.527 0 O-C-N 121.818 -0.551 . . . . 0.0 110.513 175.168 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.5 p -73.66 -44.02 57.85 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.387 -0.821 . . . . 0.0 111.116 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.0 t -57.38 -43.25 83.45 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.418 -0.802 . . . . 0.0 110.735 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.76 -50.45 73.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.689 -0.632 . . . . 0.0 110.926 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -50.32 -50.56 50.47 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.42 -53.04 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.629 0.372 . . . . 0.0 111.712 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tt -51.16 -53.54 33.68 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.382 0.611 . . . . 0.0 110.59 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.9 ttm105 -52.33 -51.78 56.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.609 0.764 . . . . 0.0 112.401 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -53.03 -54.08 40.61 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.566 -0.708 . . . . 0.0 111.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.76 -52.79 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.02 -0.425 . . . . 0.0 111.648 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 56.5 p -55.05 -44.8 75.05 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.647 -0.658 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 68.9 t -56.11 -48.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.561 -0.712 . . . . 0.0 111.83 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.82 -55.12 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.526 -0.734 . . . . 0.0 111.473 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.4 -45.06 72.85 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.438 -0.789 . . . . 0.0 112.116 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -55.44 23.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.011 -0.431 . . . . 0.0 111.367 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.7 p -61.47 -38.85 88.74 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.562 -0.711 . . . . 0.0 112.533 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.89 -56.66 17.99 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.738 -0.601 . . . . 0.0 112.309 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -37.62 -56.99 1.63 Allowed Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -59.61 -44.58 30.91 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.001 2.467 . . . . 0.0 112.379 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.4 -46.87 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.751 -0.593 . . . . 0.0 110.682 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.1 t -51.25 -53.14 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -57.05 -52.47 65.13 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.932 -0.48 . . . . 0.0 111.768 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 59.7 tp -46.18 -50.81 15.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 1.9 mp -66.59 -43.72 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.799 -0.563 . . . . 0.0 111.448 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 CA-C-O 121.753 0.64 . . . . 0.0 112.836 173.874 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -61.74 -38.93 89.78 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.579 -0.701 . . . . 0.0 112.28 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 206' ' ' LEU . 64.6 tp -54.84 -54.39 43.0 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.51 -0.744 . . . . 0.0 110.937 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.11 -50.35 61.84 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.258 0.623 . . . . 0.0 111.187 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 63.5 mtt -52.23 -52.3 53.21 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.654 -0.654 . . . . 0.0 112.395 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.68 -47.76 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.639 -0.663 . . . . 0.0 111.674 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -54.72 -47.98 73.08 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -54.23 -56.11 21.5 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.873 -0.517 . . . . 0.0 110.713 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.8 t -51.68 -54.97 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.97 -0.456 . . . . 0.0 111.918 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 61.8 p -58.08 -50.48 73.32 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.665 -0.647 . . . . 0.0 112.451 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.7 85.56 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.857 -0.527 . . . . 0.0 111.907 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -55.71 -50.48 70.21 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.572 0.749 . . . . 0.0 111.343 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.95 -51.39 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.998 -0.439 . . . . 0.0 111.11 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -49.52 -51.29 27.94 Favored Glycine 0 N--CA 1.476 1.307 0 O-C-N 121.935 -0.478 . . . . 0.0 111.926 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -53.96 -47.64 71.14 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.142 -0.622 . . . . 0.0 111.182 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.46 -51.16 22.55 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.975 -0.453 . . . . 0.0 112.446 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 9.2 mp -58.37 -52.27 66.31 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.933 -0.745 . . . . 0.0 112.07 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.2 mt -49.87 -46.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.818 -0.551 . . . . 0.0 111.376 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 N--CA 1.47 0.565 0 O-C-N 121.823 -0.548 . . . . 0.0 110.443 173.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 121.37 0.605 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.1 m -54.19 -63.38 1.17 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.067 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 86.8 m -61.96 -48.68 79.3 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.893 -0.505 . . . . 0.0 111.302 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.9 -52.71 47.97 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 110.795 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.24 -51.68 68.92 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 63.9 t -55.71 -53.41 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.846 -0.533 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.15 -47.23 86.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.699 -0.625 . . . . 0.0 112.242 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -56.25 -48.19 77.03 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.726 -0.609 . . . . 0.0 111.551 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -53.03 -55.42 23.86 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.688 -0.632 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.5 t -52.34 -50.38 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 67.6 p -58.74 -47.18 85.52 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.546 -0.721 . . . . 0.0 112.282 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 75.3 t -56.55 -51.45 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.528 -0.732 . . . . 0.0 111.775 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -53.78 -46.01 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.918 -0.489 . . . . 0.0 111.357 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.74 -56.42 20.68 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.686 -0.634 . . . . 0.0 110.931 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -55.53 -48.55 74.52 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.739 -0.601 . . . . 0.0 112.422 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.4 p -60.77 -44.01 97.32 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.644 -0.66 . . . . 0.0 112.11 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.81 -22.01 66.32 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.415 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 1.2 t80 -59.49 -54.92 51.22 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 120.97 -1.081 . . . . 0.0 111.431 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 56.1 Cg_endo -61.21 -34.73 88.04 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.58 2.187 . . . . 0.0 112.365 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.4 -51.78 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.12 0.873 . . . . 0.0 111.556 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.83 -50.21 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.686 -0.634 . . . . 0.0 111.304 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -60.7 -46.31 90.87 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.871 -0.518 . . . . 0.0 111.969 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 26.6 tp -46.35 -50.28 16.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.131 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.5 mt -57.7 -59.82 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.981 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 CA-C-O 121.403 0.446 . . . . 0.0 112.362 179.141 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.907 0.384 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -47.96 83.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.005 -0.434 . . . . 0.0 112.164 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -54.87 24.23 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.545 -0.722 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -54.71 -49.93 69.54 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.454 0.302 . . . . 0.0 111.379 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 47.8 ttm -51.08 -49.5 60.53 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 72.6 t -54.14 -48.86 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.456 -0.777 . . . . 0.0 111.306 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.41 -51.32 65.25 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.948 -0.47 . . . . 0.0 111.284 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -51.11 -50.35 58.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.151 0.58 . . . . 0.0 111.617 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.97 -54.07 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 64.4 p -57.18 -45.34 83.79 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.351 -0.843 . . . . 0.0 111.539 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.27 76.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.707 0.403 . . . . 0.0 111.504 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -52.48 -50.78 62.02 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.949 -0.469 . . . . 0.0 111.952 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.41 -53.21 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 122.087 -0.383 . . . . 0.0 111.297 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.82 -50.55 49.59 Favored Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -54.31 -51.49 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.247 -0.561 . . . . 0.0 111.262 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.2 51.28 Favored Glycine 0 N--CA 1.475 1.281 0 O-C-N 121.923 -0.486 . . . . 0.0 112.216 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 87.1 mt -56.05 -51.22 68.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.966 -0.726 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.2 mt -55.8 -48.28 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.856 -0.527 . . . . 0.0 111.905 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.2 tp . . . . . 0 N--CA 1.474 0.75 0 O-C-N 121.874 -0.516 . . . . 0.0 111.562 177.563 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.5 t -66.08 -49.75 66.49 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.596 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 84.5 m -53.52 -52.88 58.2 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 122.341 -0.225 . . . . 0.0 111.43 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -56.34 -49.31 74.72 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.622 -0.674 . . . . 0.0 111.708 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.52 -50.62 69.5 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.603 -0.686 . . . . 0.0 111.771 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.23 -58.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.967 -0.458 . . . . 0.0 111.668 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.18 -41.32 83.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 175' ' ' ARG . 15.2 mmm-85 -60.96 -47.71 85.19 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.066 -1.021 . . . . 0.0 112.542 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -52.89 -51.48 61.03 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.816 -0.553 . . . . 0.0 110.645 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.06 -54.21 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 p -55.61 -46.46 77.35 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.49 -0.756 . . . . 0.0 112.666 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.55 -53.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.628 -0.67 . . . . 0.0 111.799 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.55 -45.91 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.777 -0.577 . . . . 0.0 111.837 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.79 -53.1 61.67 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.674 -0.641 . . . . 0.0 110.498 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -54.35 -51.63 64.16 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.032 -0.418 . . . . 0.0 112.03 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.5 p -61.68 -40.64 95.68 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -58.76 -47.66 83.89 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.444 -0.785 . . . . 0.0 112.571 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -41.3 -58.05 3.18 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -61.05 -38.16 70.21 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.157 2.571 . . . . 0.0 112.572 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.58 -53.17 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.574 -0.704 . . . . 0.0 110.768 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 72.4 t -53.59 -50.37 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.318 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -54.37 -54.77 36.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.871 0.367 . . . . 0.0 111.211 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.4 tp -49.11 -51.41 31.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.542 0.737 . . . . 0.0 111.479 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.02 -57.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.982 -0.448 . . . . 0.0 110.005 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.334 0 O-C-N 122.079 -0.388 . . . . 0.0 112.401 177.251 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.583 0.23 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.63 -50.2 72.72 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.927 -0.483 . . . . 0.0 112.064 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -53.43 -53.71 47.42 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.765 -0.584 . . . . 0.0 110.511 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.97 -48.41 73.27 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.104 -0.373 . . . . 0.0 110.852 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.6 ttt -52.62 -49.97 64.04 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.688 -0.633 . . . . 0.0 111.872 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.0 t -52.98 -50.61 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.54 -0.725 . . . . 0.0 111.28 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.3 mt -54.52 -50.23 68.33 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.888 -0.507 . . . . 0.0 112.194 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.22 -54.1 44.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.966 0.507 . . . . 0.0 111.426 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.04 -55.07 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.987 -0.445 . . . . 0.0 111.517 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -55.79 -47.63 76.75 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.596 -0.69 . . . . 0.0 112.284 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.96 -49.7 72.83 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.902 -0.499 . . . . 0.0 111.875 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.536 ' HA ' ' HE3' ' A' ' 216' ' ' LYS . 0.1 OUTLIER -58.53 -43.1 89.07 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.804 0.442 . . . . 0.0 112.164 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 69.3 t -55.01 -54.01 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.495 -0.753 . . . . 0.0 110.645 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.87 -50.54 37.62 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -50.4 -50.63 51.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.159 0.583 . . . . 0.0 110.987 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.91 -51.65 33.59 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 122.004 -0.435 . . . . 0.0 112.549 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.33 -52.52 63.23 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 122.081 -0.658 . . . . 0.0 111.858 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 94.6 mt -54.7 -47.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.162 0.506 . . . . 0.0 111.894 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 29.2 tp . . . . . 0 N--CA 1.472 0.66 0 O-C-N 121.784 -0.572 . . . . 0.0 109.743 175.769 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 61.1 p -51.89 -63.31 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 m -74.89 -43.38 54.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 -174.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.03 -44.56 91.76 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.027 -0.42 . . . . 0.0 111.951 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.56 -50.26 72.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.232 -0.917 . . . . 0.0 110.997 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 83.7 t -54.6 -53.67 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.587 0.232 . . . . 0.0 110.497 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.42 -57.35 8.21 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.166 0.586 . . . . 0.0 111.237 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HE ' ' HA ' ' A' ' 176' ' ' ASN . 2.4 tmm_? -50.24 -57.95 6.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.336 0.654 . . . . 0.0 110.581 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.475 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 7.7 t30 -58.41 -49.7 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.169 -0.332 . . . . 0.0 111.181 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -54.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 23.9 p -55.47 -50.62 69.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.74 -0.6 . . . . 0.0 111.81 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.77 -50.87 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.701 -0.624 . . . . 0.0 111.606 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.1 t -55.86 -51.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.888 -0.508 . . . . 0.0 111.837 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -53.13 -48.13 68.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.252 -0.905 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -55.72 -52.83 62.56 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.4 p -60.7 -41.98 96.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.771 0.796 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -17.17 61.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.457 ' HB3' ' CD ' ' A' ' 186' ' ' PRO . 1.5 t80 -59.25 -59.9 12.32 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 119.972 1.26 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.457 ' CD ' ' HB3' ' A' ' 185' ' ' TYR . 52.5 Cg_endo -61.86 -30.99 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.88 2.387 . . . . 0.0 113.187 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.45 -56.56 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.408 -0.808 . . . . 0.0 110.675 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.92 -43.58 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.939 -0.476 . . . . 0.0 111.313 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -51.18 -59.46 4.17 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.038 -0.414 . . . . 0.0 111.086 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -50.99 45.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.388 0.675 . . . . 0.0 110.432 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.58 -61.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 122.127 -0.358 . . . . 0.0 110.612 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.18 0 O-C-N 122.025 -0.422 . . . . 0.0 112.129 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 80.9 m . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.5 -50.74 70.91 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.676 -0.64 . . . . 0.0 112.3 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.9 tp -51.42 -51.05 58.2 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.443 0.64 . . . . 0.0 111.479 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.27 -52.9 61.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.118 0.485 . . . . 0.0 111.068 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 42.1 ttm -50.42 -49.64 54.22 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 112.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.34 -51.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.614 -0.678 . . . . 0.0 111.464 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.41 -48.95 71.01 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.2 0.524 . . . . 0.0 111.624 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 216' ' ' LYS . 70.7 m-20 -53.75 -54.37 39.06 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.006 -0.434 . . . . 0.0 111.908 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.35 -54.83 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.899 -0.501 . . . . 0.0 111.911 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -56.17 -45.22 79.8 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.42 -48.86 68.36 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.848 -0.532 . . . . 0.0 112.255 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 212' ' ' ASP . 9.5 mmtp -57.29 -46.48 83.1 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 122.003 -0.436 . . . . 0.0 111.598 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.42 -52.23 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.716 -0.615 . . . . 0.0 110.711 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.44 -51.17 33.03 Favored Glycine 0 N--CA 1.478 1.435 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -51.76 -48.51 63.68 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 122.364 -0.492 . . . . 0.0 111.584 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -49.65 -52.59 24.3 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 122.035 -0.415 . . . . 0.0 112.348 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.23 -50.79 72.31 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.05 -0.677 . . . . 0.0 112.331 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 38.6 mt -49.27 -49.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 121.299 0.571 . . . . 0.0 111.67 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 40.2 tp . . . . . 0 N--CA 1.475 0.788 0 O-C-N 121.847 -0.533 . . . . 0.0 111.125 174.622 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.787 0.327 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m -59.04 -52.95 63.55 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 0.0 111.696 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.2 p -56.59 -48.07 78.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.33 -46.63 83.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.735 -0.603 . . . . 0.0 111.303 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -51.92 -51.32 57.77 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.484 -0.76 . . . . 0.0 112.102 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.59 -53.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.43 -52.01 63.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.215 0.531 . . . . 0.0 111.97 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 -52.32 -52.63 52.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.409 0.683 . . . . 0.0 111.47 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -51.35 -57.93 7.6 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.925 -0.484 . . . . 0.0 111.614 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.0 t -54.41 -49.8 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.963 -0.46 . . . . 0.0 112.17 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.7 p -58.84 -49.34 78.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.62 -0.675 . . . . 0.0 112.718 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.9 t -57.21 -49.93 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.463 -0.773 . . . . 0.0 111.742 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.76 -51.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.742 -0.599 . . . . 0.0 110.929 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.9 tt -51.51 -50.07 60.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.57 -0.706 . . . . 0.0 111.395 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 42.7 t90 -51.81 -57.4 9.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.5 p -61.54 -37.48 83.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.52 0.676 . . . . 0.0 112.214 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.57 65.7 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.4 ' HB3' ' CD ' ' A' ' 186' ' ' PRO . 1.4 t80 -57.32 -56.1 37.41 Favored Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 121.137 -0.977 . . . . 0.0 111.97 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 185' ' ' TYR . 43.1 Cg_endo -59.9 -33.41 95.85 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.793 2.329 . . . . 0.0 113.145 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.1 t -59.3 -53.17 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.397 -0.814 . . . . 0.0 111.116 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.7 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.805 -0.559 . . . . 0.0 110.95 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -52.54 -56.4 15.52 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.139 -0.35 . . . . 0.0 111.428 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.09 -56.04 2.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.871 0.869 . . . . 0.0 110.128 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.1 mt -54.94 -59.67 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 122.04 -0.413 . . . . 0.0 110.655 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.391 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -175.767 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -62.56 -42.71 99.72 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.614 -0.678 . . . . 0.0 112.417 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 206' ' ' LEU . 5.0 tt -56.26 -53.8 52.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.538 -0.726 . . . . 0.0 110.027 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -52.87 -50.57 63.54 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.659 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 54.5 ttm -51.29 -49.72 60.71 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -52.65 -52.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.694 -0.629 . . . . 0.0 111.289 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.54 -51.46 66.97 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.33 0.586 . . . . 0.0 111.827 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -48.78 -53.95 17.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.605 0.762 . . . . 0.0 111.327 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.84 -51.01 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 58.5 p -57.27 -39.13 75.04 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.281 -0.887 . . . . 0.0 111.486 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.89 73.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -52.76 -51.27 61.3 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 110.98 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.14 -52.42 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.067 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.12 -50.83 50.03 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.62 -50.87 67.07 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.093 -0.651 . . . . 0.0 111.235 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.39 -50.23 41.94 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.753 -0.592 . . . . 0.0 112.134 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.54 -53.56 54.86 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.153 -0.616 . . . . 0.0 112.15 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 79.0 mt -52.55 -51.95 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.108 0.48 . . . . 0.0 111.082 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 43.7 tp . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 123.406 0.682 . . . . 0.0 112.128 -178.02 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.034 0.445 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.3 m -49.3 -52.92 24.6 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.3 m -57.14 -49.72 75.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.805 -0.559 . . . . 0.0 111.586 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.18 -48.02 71.39 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.112 0.482 . . . . 0.0 111.709 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -55.65 -49.21 73.5 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.783 -0.573 . . . . 0.0 112.061 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.5 -49.16 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.94 -0.475 . . . . 0.0 111.667 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.4 tt -52.18 -55.0 23.9 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.184 0.516 . . . . 0.0 110.497 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -52.72 -50.5 63.29 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -52.82 -56.87 12.58 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.581 -0.699 . . . . 0.0 111.995 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.7 t -54.17 -49.74 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.971 -0.456 . . . . 0.0 111.935 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.2 p -56.16 -46.04 79.44 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.625 -0.672 . . . . 0.0 112.6 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.51 -48.4 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.373 -0.83 . . . . 0.0 111.879 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -54.16 -48.52 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.629 -0.669 . . . . 0.0 111.668 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.7 mt -55.61 -50.01 71.28 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.509 -0.744 . . . . 0.0 111.887 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -53.22 -53.3 52.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.868 -0.52 . . . . 0.0 112.353 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.5 p -61.5 -38.38 87.13 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.09 95.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.207 -0.933 . . . . 0.0 112.463 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -40.79 -51.83 6.84 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -58.47 -40.4 74.94 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.905 2.404 . . . . 0.0 112.516 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.5 t -60.63 -45.08 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.795 -0.565 . . . . 0.0 110.375 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.54 -50.05 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.823 -0.548 . . . . 0.0 110.723 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -53.1 -51.19 62.67 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 48.0 tp -47.04 -53.38 12.7 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.985 -0.447 . . . . 0.0 111.511 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -52.39 -55.71 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.188 0 O-C-N 121.89 -0.506 . . . . 0.0 112.192 177.043 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -60.78 -39.86 90.42 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.626 -0.671 . . . . 0.0 112.279 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 206' ' ' LEU . 3.1 tm? -54.09 -56.19 20.43 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.544 -0.723 . . . . 0.0 110.603 174.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.43 -53.48 29.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.556 0.342 . . . . 0.0 111.385 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 92.6 mtp -49.1 -49.64 40.9 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 76.6 t -52.87 -51.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.601 -0.687 . . . . 0.0 111.372 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.83 -47.84 73.6 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -54.22 -52.59 60.82 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.703 -0.623 . . . . 0.0 111.889 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.8 t -56.38 -54.94 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.925 -0.484 . . . . 0.0 111.899 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.1 p -56.24 -47.68 77.99 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.781 -0.574 . . . . 0.0 112.3 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.03 -48.72 75.45 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.905 -0.497 . . . . 0.0 111.972 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -53.32 50.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.589 0.356 . . . . 0.0 111.273 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.26 -51.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.077 -0.39 . . . . 0.0 111.281 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.59 31.87 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -53.97 -47.56 71.23 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.239 -0.565 . . . . 0.0 111.583 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.21 -54.37 12.72 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.57 -53.35 58.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.134 -0.627 . . . . 0.0 112.226 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.8 mt -52.2 -54.05 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.6 tp . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 123.279 0.632 . . . . 0.0 111.698 -179.882 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -51.07 -65.19 0.6 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.235 -0.291 . . . . 0.0 111.751 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.2 p -67.91 -39.52 83.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.424 -0.798 . . . . 0.0 111.83 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -53.69 -54.57 36.01 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.053 -0.404 . . . . 0.0 111.597 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.51 -47.21 84.93 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.747 -0.595 . . . . 0.0 112.128 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -50.17 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.873 -0.517 . . . . 0.0 111.569 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.8 tp -57.27 -48.57 78.54 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.775 -0.578 . . . . 0.0 111.541 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 20.8 mmm-85 -57.68 -44.79 86.02 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.453 -0.779 . . . . 0.0 112.919 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -51.31 -56.61 12.11 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.78 -0.575 . . . . 0.0 111.073 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.79 -51.08 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.2 p -56.84 -47.82 79.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.56 -47.04 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.463 -0.773 . . . . 0.0 111.979 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.94 -49.53 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.684 -0.635 . . . . 0.0 111.491 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.03 -48.34 76.14 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.628 -0.67 . . . . 0.0 111.994 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -52.37 -54.42 32.06 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.0 p -59.64 -47.49 85.39 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.477 -0.764 . . . . 0.0 111.554 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.6 -14.13 61.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.421 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 4.3 t80 -62.99 -56.29 29.9 Favored Pre-proline 0 N--CA 1.476 0.832 0 O-C-N 120.84 -1.162 . . . . 0.0 111.153 -173.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 58.2 Cg_endo -62.22 -35.96 71.39 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.994 2.463 . . . . 0.0 112.243 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.28 -57.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.812 -0.555 . . . . 0.0 111.057 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.88 -40.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.806 -0.559 . . . . 0.0 111.493 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.57 -50.22 68.48 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.62 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 54.9 tp -53.2 -43.42 67.17 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.958 -0.463 . . . . 0.0 111.181 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.49 -53.95 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.359 -0.838 . . . . 0.0 109.716 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.58 0 O-C-N 121.62 -0.675 . . . . 0.0 113.738 177.788 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 96.3 m . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.36 -57.1 13.22 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.718 -0.613 . . . . 0.0 111.89 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.22 -51.28 69.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.247 0.546 . . . . 0.0 111.773 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.79 -53.07 57.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.493 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 26.9 ttt -52.04 -45.57 64.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.638 0.375 . . . . 0.0 112.003 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.8 t -51.5 -53.24 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.513 -0.742 . . . . 0.0 111.202 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.97 -50.76 68.13 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.965 -0.459 . . . . 0.0 112.173 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -52.71 -54.91 27.09 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.051 -0.406 . . . . 0.0 111.752 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.3 t -57.16 -54.71 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 122.122 -0.361 . . . . 0.0 111.741 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.4 p -55.18 -49.96 70.54 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.519 -0.738 . . . . 0.0 112.306 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.65 76.86 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.908 -0.495 . . . . 0.0 112.037 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -57.2 -48.72 78.07 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.085 -0.385 . . . . 0.0 110.826 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.8 t -53.98 -53.27 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.481 -0.762 . . . . 0.0 111.235 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.83 -50.78 36.5 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 121.797 -0.564 . . . . 0.0 111.762 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.01 -49.51 68.72 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.267 -0.549 . . . . 0.0 111.186 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.62 -49.72 51.81 Favored Glycine 0 N--CA 1.475 1.274 0 O-C-N 121.962 -0.461 . . . . 0.0 112.754 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.92 -50.67 68.25 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.942 -0.74 . . . . 0.0 111.933 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.39 -50.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.293 0.568 . . . . 0.0 111.326 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 61.2 tp . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 123.482 0.713 . . . . 0.0 111.94 178.304 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 121.012 0.434 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -59.37 -54.92 41.26 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.956 -0.465 . . . . 0.0 111.808 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.7 t -58.78 -41.37 86.52 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.957 -0.465 . . . . 0.0 111.643 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -56.19 -51.9 66.36 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.476 -0.765 . . . . 0.0 111.322 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -55.05 -46.74 75.36 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.847 -0.533 . . . . 0.0 112.224 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 70.9 t -55.4 -52.09 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 122.024 -0.423 . . . . 0.0 111.521 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.7 tp -52.81 -50.51 63.51 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.711 -0.618 . . . . 0.0 111.624 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.629 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.09 -50.39 66.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -53.67 -56.08 20.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.233 -0.292 . . . . 0.0 111.013 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.77 -52.78 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.659 0.383 . . . . 0.0 111.844 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.5 p -56.71 -52.24 65.73 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 80.4 t -58.33 -48.96 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.729 -0.607 . . . . 0.0 112.001 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 77.1 t -57.25 -54.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.703 -0.623 . . . . 0.0 111.215 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.3 mt -53.23 -46.83 69.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.492 -0.755 . . . . 0.0 111.857 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.8 t90 -53.5 -56.96 12.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.1 p -61.0 -42.91 99.35 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.695 0.759 . . . . 0.0 112.151 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.1 67.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.08 -56.19 36.21 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 121.345 -0.847 . . . . 0.0 112.652 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.15 -36.05 90.07 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.971 2.447 . . . . 0.0 112.802 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.99 -55.7 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.596 -0.69 . . . . 0.0 110.925 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.24 -45.65 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.98 -0.45 . . . . 0.0 111.234 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -50.32 -58.5 5.53 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.207 -0.308 . . . . 0.0 111.015 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -47.72 -49.63 27.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.799 0.84 . . . . 0.0 110.546 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.3 mt -52.32 -59.18 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.687 -0.633 . . . . 0.0 110.486 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.435 0 CA-C-O 121.409 0.45 . . . . 0.0 112.985 179.268 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 121.147 0.498 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.73 -52.12 65.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.914 0.387 . . . . 0.0 111.792 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.5 tt -51.11 -56.59 11.93 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.469 0.708 . . . . 0.0 110.772 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.76 -48.43 72.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.242 0.617 . . . . 0.0 111.366 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 56.5 ttp -53.73 -50.72 65.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.597 -0.689 . . . . 0.0 111.913 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.4 t -54.3 -48.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.786 -0.571 . . . . 0.0 111.401 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.0 mt -53.31 -53.79 45.88 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.864 -0.522 . . . . 0.0 111.67 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -47.67 -54.24 12.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.888 -0.508 . . . . 0.0 111.659 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.66 -57.23 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 122.002 -0.436 . . . . 0.0 111.706 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 86.5 p -58.71 -48.7 80.22 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.695 -0.628 . . . . 0.0 112.621 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.19 94.6 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.88 -0.513 . . . . 0.0 111.319 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -55.06 -49.91 70.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.77 0.428 . . . . 0.0 111.547 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.22 -52.57 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 122.041 -0.412 . . . . 0.0 111.005 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.54 -50.4 36.24 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 121.885 -0.509 . . . . 0.0 112.391 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -53.12 -49.96 65.45 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.056 -0.673 . . . . 0.0 111.102 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.43 -48.53 64.31 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 121.888 -0.508 . . . . 0.0 112.714 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.82 -45.27 82.41 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.783 -0.834 . . . . 0.0 112.463 177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.13 -47.5 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.653 -0.654 . . . . 0.0 111.902 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 65.5 tp . . . . . 0 N--CA 1.476 0.827 0 O-C-N 121.794 -0.566 . . . . 0.0 110.601 175.634 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.5 m -60.32 -64.94 0.77 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.522 -0.737 . . . . 0.0 111.433 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.2 m -63.5 -36.76 84.85 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.635 -0.665 . . . . 0.0 111.758 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -52.49 -52.38 54.71 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.558 -0.714 . . . . 0.0 111.306 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -58.98 -47.27 85.74 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.939 -0.476 . . . . 0.0 111.464 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 68.8 t -51.59 -53.26 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 122.06 -0.4 . . . . 0.0 111.48 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.8 tt -54.15 -52.37 61.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.112 0.565 . . . . 0.0 110.869 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -52.35 45.57 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.948 0.404 . . . . 0.0 110.632 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -53.52 -55.11 28.3 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.701 -0.625 . . . . 0.0 111.776 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.1 t -52.95 -48.66 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 71.8 p -61.46 -45.58 93.67 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.518 -0.738 . . . . 0.0 112.252 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.51 -49.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.346 -0.846 . . . . 0.0 111.638 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.7 t -52.99 -51.03 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 122.047 -0.408 . . . . 0.0 110.722 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.67 -54.46 22.86 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.742 -0.599 . . . . 0.0 111.106 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -57.52 -47.39 82.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.4 p -61.15 -42.87 99.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.242 -0.912 . . . . 0.0 111.08 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.24 -13.0 61.56 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -62.48 -56.42 30.32 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.464 -1.398 . . . . 0.0 111.197 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -61.41 -39.17 58.47 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.801 2.334 . . . . 0.0 111.862 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.8 t -46.87 -52.6 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 122.004 -0.435 . . . . 0.0 111.753 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.49 -57.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 122.059 -0.401 . . . . 0.0 111.086 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -47.94 -45.07 30.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.7 tp -50.7 -35.22 30.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.8 tt -68.95 -44.39 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.095 -1.003 . . . . 0.0 109.658 178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.249 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.55 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.05 -50.8 71.62 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.805 -0.56 . . . . 0.0 111.604 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.35 -54.03 42.42 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.441 0.639 . . . . 0.0 110.349 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -52.0 -51.65 55.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.093 0.557 . . . . 0.0 111.477 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.2 ttt -49.4 -48.07 47.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 90.7 t -52.3 -52.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.76 -0.588 . . . . 0.0 111.29 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.8 mp -54.05 -50.65 66.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -50.09 -57.45 7.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.772 -0.58 . . . . 0.0 111.306 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.07 -53.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 122.21 -0.306 . . . . 0.0 111.504 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.6 p -57.03 -44.84 83.29 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.944 -0.472 . . . . 0.0 111.604 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.42 65.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.958 -0.464 . . . . 0.0 112.202 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -46.11 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.04 -50.7 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.659 -0.65 . . . . 0.0 111.524 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.16 -51.39 54.35 Favored Glycine 0 N--CA 1.475 1.238 0 O-C-N 121.806 -0.559 . . . . 0.0 112.018 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.82 -51.59 63.05 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 122.109 -0.642 . . . . 0.0 110.989 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.0 -48.16 63.83 Favored Glycine 0 N--CA 1.473 1.163 0 O-C-N 122.07 -0.394 . . . . 0.0 112.218 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.28 -51.17 65.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.912 -0.758 . . . . 0.0 112.399 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.72 -50.74 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.717 -0.614 . . . . 0.0 111.083 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.5 tp . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 123.136 0.574 . . . . 0.0 111.263 179.341 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 121.173 0.511 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 m -53.97 -59.07 5.12 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.801 0.44 . . . . 0.0 111.475 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 41.5 p -59.83 -44.59 93.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.724 -0.61 . . . . 0.0 112.131 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.95 -55.35 14.87 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.851 -0.531 . . . . 0.0 111.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -55.09 -52.1 64.31 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.038 -0.414 . . . . 0.0 111.953 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 79.3 t -53.93 -51.93 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 122.141 -0.35 . . . . 0.0 111.876 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 174' ' ' LEU . 6.2 tt -56.81 -57.2 13.5 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.786 0.434 . . . . 0.0 110.902 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -53.17 -49.54 66.45 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.054 0.454 . . . . 0.0 110.515 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -52.05 -62.07 1.86 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.991 -0.443 . . . . 0.0 111.946 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.9 t -55.65 -46.82 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.8 p -58.86 -50.43 74.04 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.708 -0.62 . . . . 0.0 112.426 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.88 -45.4 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.596 -0.69 . . . . 0.0 111.854 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.53 -55.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.748 -0.595 . . . . 0.0 110.918 175.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.07 -49.71 60.1 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.813 -0.555 . . . . 0.0 111.114 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -49.75 -58.04 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 82.4 p -61.12 -41.09 96.06 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.765 0.793 . . . . 0.0 111.833 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.17 -29.49 68.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' TYR . . . . . 0.416 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 51.6 t80 -54.81 -53.94 55.17 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 39.3 Cg_endo -59.17 -36.93 94.57 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.994 2.462 . . . . 0.0 112.762 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.49 -52.68 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.613 -0.68 . . . . 0.0 110.459 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.52 -46.12 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.04 0.536 . . . . 0.0 111.365 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -52.04 -58.85 5.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.012 -0.43 . . . . 0.0 111.24 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 53.7 tp -50.44 -42.92 54.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.604 0.362 . . . . 0.0 111.93 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 91.0 mt -56.08 -61.16 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 122.072 -0.393 . . . . 0.0 110.192 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.418 0 CA-C-O 121.781 0.656 . . . . 0.0 112.506 179.588 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -53.93 -58.24 8.0 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.934 -0.479 . . . . 0.0 111.821 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -54.77 -48.24 72.93 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.771 -0.581 . . . . 0.0 111.987 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.59 -55.49 21.92 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.106 0.479 . . . . 0.0 110.958 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 28.0 ttt -54.28 -47.11 72.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 69.8 t -51.17 -52.05 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.499 -0.751 . . . . 0.0 111.255 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.9 mt -56.64 -48.51 77.4 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.097 0.475 . . . . 0.0 111.9 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -53.91 -53.61 50.31 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.381 0.61 . . . . 0.0 112.253 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -58.02 -53.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.947 -0.471 . . . . 0.0 111.632 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 63.6 p -55.7 -45.8 77.77 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.739 -0.601 . . . . 0.0 111.923 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.68 -49.44 72.93 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.882 -0.511 . . . . 0.0 112.057 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 216' ' ' LYS . 5.5 mmpt? -57.11 -45.8 83.15 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 95.8 t -54.57 -51.99 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.618 -0.676 . . . . 0.0 110.549 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.24 -51.66 30.28 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -49.79 -49.25 49.33 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.241 -0.564 . . . . 0.0 112.123 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.19 -52.58 31.19 Favored Glycine 0 N--CA 1.476 1.365 0 O-C-N 122.094 -0.379 . . . . 0.0 112.396 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.93 -51.88 67.39 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.966 -0.726 . . . . 0.0 112.147 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.7 mt -49.75 -49.37 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.041 0.536 . . . . 0.0 111.294 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 60.5 tp . . . . . 0 N--CA 1.473 0.683 0 O-C-N 122.038 -0.414 . . . . 0.0 110.755 174.186 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 120.836 0.351 . . . . 0.0 111.53 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.29 118.86 4.28 Favored Pre-proline 0 N--CA 1.475 0.823 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 175.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.39 57.89 6.7 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.871 3.048 . . . . 0.0 111.626 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -68.96 165.83 19.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.229 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.55 -50.1 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 171.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.71 -53.28 58.5 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.691 174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.9 t -47.03 -60.46 2.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.7 t -59.3 -40.44 86.19 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.473 -0.767 . . . . 0.0 112.462 -177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -56.56 -53.91 52.11 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.628 -0.67 . . . . 0.0 111.523 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -59.46 -44.0 93.09 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.809 -0.557 . . . . 0.0 112.287 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -54.19 -48.59 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.763 -0.586 . . . . 0.0 111.559 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.4 tt -52.4 -56.1 17.25 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.831 -0.543 . . . . 0.0 110.816 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.28 -47.82 71.91 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -50.76 -58.19 6.53 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.735 -0.603 . . . . 0.0 111.492 175.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.7 t -54.59 -50.75 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 O-C-N 122.047 -0.408 . . . . 0.0 111.945 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 47.0 p -58.64 -49.04 78.98 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.8 -48.25 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.512 -0.743 . . . . 0.0 111.846 178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.6 t -55.26 -53.4 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.723 -0.611 . . . . 0.0 110.96 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.2 tt -51.78 -51.74 54.09 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.817 -0.552 . . . . 0.0 110.499 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -50.4 -56.22 12.37 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 79.9 p -61.02 -42.77 99.09 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.717 0.77 . . . . 0.0 111.728 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.25 -25.97 68.12 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.408 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 60.2 t80 -57.4 -54.85 50.62 Favored Pre-proline 0 N--CA 1.475 0.819 0 O-C-N 121.289 -0.882 . . . . 0.0 112.889 -171.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 48.0 Cg_endo -60.51 -36.86 84.45 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.943 2.429 . . . . 0.0 112.606 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.58 -55.27 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 121.681 -0.637 . . . . 0.0 110.813 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 82.1 t -56.03 -45.57 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 122.972 0.509 . . . . 0.0 111.283 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -51.51 -58.98 4.8 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.935 -0.478 . . . . 0.0 111.252 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.63 -47.17 49.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.226 0.611 . . . . 0.0 111.63 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -52.91 -55.64 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 O-C-N 121.834 -0.541 . . . . 0.0 110.239 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.07 29.68 2.44 Favored Glycine 0 CA--C 1.537 1.434 0 O-C-N 121.671 -0.643 . . . . 0.0 113.546 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 90.2 p -163.09 40.14 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.464 1.132 . . . . 0.0 110.114 169.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER -48.24 -65.39 0.57 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 171.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.554 ' H ' ' CD ' ' A' ' 194' ' ' GLU . . . -77.37 -39.88 25.15 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 175.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -55.89 -63.47 1.17 Allowed 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.789 -0.83 . . . . 0.0 111.913 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -90.37 34.49 4.14 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 9.3 tt -67.57 -36.38 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.581 -0.953 . . . . 0.0 109.94 175.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 98.5 t -44.85 -57.8 6.41 Favored Pre-proline 0 N--CA 1.479 1.007 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -175.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -60.94 -41.39 45.07 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.0 2.467 . . . . 0.0 112.696 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -53.67 -52.55 59.65 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 122.012 -0.43 . . . . 0.0 110.416 176.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -52.56 -50.61 62.59 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.86 0.464 . . . . 0.0 111.699 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 99.8 mt -51.65 -52.59 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 122.159 -0.338 . . . . 0.0 111.701 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -58.98 -49.69 76.93 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.938 -0.476 . . . . 0.0 111.935 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 91.1 m -52.63 -47.83 66.79 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.604 -0.685 . . . . 0.0 111.499 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.65 -54.82 39.44 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 122.031 -0.418 . . . . 0.0 110.85 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -50.29 -53.53 27.87 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.223 0.535 . . . . 0.0 111.252 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.74 -52.82 54.76 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.127 0.571 . . . . 0.0 111.254 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.7 ttt -53.34 -48.14 68.76 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 121.772 -0.58 . . . . 0.0 112.351 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.3 t -53.42 -49.7 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 O-C-N 121.544 -0.723 . . . . 0.0 111.239 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 92.6 mt -53.94 -51.09 64.92 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.986 -0.446 . . . . 0.0 111.237 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -50.38 -53.09 31.72 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.907 -0.496 . . . . 0.0 111.612 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.24 -54.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 122.04 -0.412 . . . . 0.0 111.895 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 70.4 p -57.37 -45.37 84.5 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.666 -0.646 . . . . 0.0 111.752 -177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.85 -49.93 73.98 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 122.002 -0.436 . . . . 0.0 111.975 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -54.52 -48.62 71.72 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.16 -51.92 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 O-C-N 121.855 -0.528 . . . . 0.0 111.165 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.51 -50.95 46.05 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 121.964 -0.46 . . . . 0.0 112.039 177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -52.52 -49.73 64.24 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.165 -0.609 . . . . 0.0 111.385 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.78 -52.86 32.26 Favored Glycine 0 N--CA 1.475 1.297 0 O-C-N 121.93 -0.481 . . . . 0.0 111.964 176.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 90.9 mt -53.67 -50.56 65.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 122.084 -0.656 . . . . 0.0 111.93 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.24 -51.46 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 122.064 -0.397 . . . . 0.0 111.384 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.2 -50.04 68.0 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.936 -0.478 . . . . 0.0 112.281 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 90.2 mt -53.31 -51.3 62.82 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.303 0.573 . . . . 0.0 111.772 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -55.13 -51.52 66.2 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.068 0.461 . . . . 0.0 111.89 177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 53.2 m -53.67 -53.95 44.74 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.499 ' HD2' ' N ' ' A' ' 228' ' ' ALA . 0.1 OUTLIER -61.67 -37.25 83.39 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.698 -0.626 . . . . 0.0 112.458 -178.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.499 ' N ' ' HD2' ' A' ' 227' ' ' ARG . . . -59.98 -50.59 73.13 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.668 -0.645 . . . . 0.0 111.817 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 98.3 mt -57.16 -46.59 84.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 120.9 0.381 . . . . 0.0 111.621 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -56.3 -53.78 53.19 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.627 0 N-CA-C 114.199 0.44 . . . . 0.0 114.199 179.062 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.2 ptm . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 8.1 ttp-105 -163.19 86.32 1.33 Allowed Pre-proline 0 N--CA 1.476 0.853 0 O-C-N 121.452 -0.78 . . . . 0.0 111.437 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -65.02 105.47 0.68 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.004 2.469 . . . . 0.0 110.459 169.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -54.18 135.47 43.85 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -169.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.85 -42.48 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.39 -174.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.74 -46.37 81.42 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 122.089 -0.382 . . . . 0.0 111.709 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.6 p -66.74 -46.98 73.7 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.844 -0.535 . . . . 0.0 110.616 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 89.4 m -51.99 -50.17 61.83 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.674 0.39 . . . . 0.0 111.356 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -56.6 -53.24 59.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.896 -0.503 . . . . 0.0 111.129 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -50.82 -48.39 59.81 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.5 t -56.16 -50.68 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.984 -0.448 . . . . 0.0 111.549 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 174' ' ' LEU . 6.6 tt -52.57 -54.26 35.29 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.099 0.476 . . . . 0.0 111.092 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -52.67 -48.61 66.4 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.176 0.59 . . . . 0.0 111.761 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -53.32 -57.9 8.95 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.97 -0.456 . . . . 0.0 111.472 175.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 69.5 t -52.25 -49.61 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.959 -0.463 . . . . 0.0 112.192 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 45.6 p -58.46 -53.79 54.3 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.775 -0.578 . . . . 0.0 111.921 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 69.0 t -55.44 -46.18 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.421 -0.8 . . . . 0.0 111.991 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.53 -53.31 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.65 -0.656 . . . . 0.0 110.913 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 tt -51.74 -50.08 61.3 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.699 -0.626 . . . . 0.0 110.547 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.83 -54.62 31.66 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.995 0.518 . . . . 0.0 111.851 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.3 p -61.89 -41.91 98.45 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.582 0.706 . . . . 0.0 111.831 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.9 -25.54 66.81 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 176.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -58.58 -56.92 30.68 Favored Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 121.197 -0.939 . . . . 0.0 111.859 -173.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -60.38 -35.84 89.46 Favored 'Trans proline' 0 N--CA 1.475 0.419 0 C-N-CA 122.898 2.399 . . . . 0.0 112.65 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.8 t -57.83 -56.5 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.563 -0.711 . . . . 0.0 111.041 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 77.1 t -56.99 -45.62 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 O-C-N 121.831 -0.543 . . . . 0.0 111.229 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 48.7 t90 -53.12 -52.03 60.02 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.888 -0.507 . . . . 0.0 111.287 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.4 tt -52.33 -49.29 64.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.14 0.576 . . . . 0.0 111.185 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 86.4 mt -51.92 -49.79 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.302 -0.874 . . . . 0.0 110.842 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.21 -19.48 75.82 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 114.739 0.656 . . . . 0.0 114.739 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 64.4 p -174.47 69.72 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 122.987 1.375 . . . . 0.0 110.276 -167.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 194' ' ' GLU . 0.0 OUTLIER -66.45 -48.74 68.97 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.905 -176.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 69.89 -158.89 53.39 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.29 56.41 2.08 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 122.27 1.033 . . . . 0.0 110.701 174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 61.75 54.19 37.42 Favored Glycine 0 N--CA 1.474 1.181 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 79.7 mt -64.32 -52.5 54.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.796 -0.826 . . . . 0.0 111.013 -174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 96.7 t -51.71 -58.71 10.05 Favored Pre-proline 0 N--CA 1.478 0.933 0 O-C-N 121.727 -0.608 . . . . 0.0 112.4 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -60.38 -39.89 62.82 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.605 2.203 . . . . 0.0 113.028 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 58.6 tp -54.74 -52.53 62.24 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.563 -0.71 . . . . 0.0 111.546 175.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -55.83 -46.23 78.16 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.669 -0.644 . . . . 0.0 112.732 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 96.4 mt -52.65 -51.69 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 O-C-N 121.73 -0.606 . . . . 0.0 111.258 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.33 -56.2 18.56 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.777 -0.577 . . . . 0.0 111.252 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 60.3 m -54.7 -49.87 69.68 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -175.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -61.79 -44.25 97.25 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.451 -0.781 . . . . 0.0 112.024 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 206' ' ' LEU . 91.6 mt -57.62 -50.97 71.39 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.511 -0.743 . . . . 0.0 111.398 176.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -52.62 -53.3 48.72 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.22 0.608 . . . . 0.0 110.76 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 59.8 ttp -52.36 -50.67 61.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.209 0.604 . . . . 0.0 112.385 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -52.27 -49.62 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.466 -0.771 . . . . 0.0 111.592 177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.63 -49.02 73.97 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.136 0.493 . . . . 0.0 111.811 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -54.11 -51.96 62.54 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.14 0.495 . . . . 0.0 111.853 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 82.5 t -57.1 -54.66 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 122.117 -0.364 . . . . 0.0 111.688 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.4 p -56.0 -46.42 78.72 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.713 -0.617 . . . . 0.0 112.014 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.13 73.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.917 -0.489 . . . . 0.0 111.975 176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -55.59 -48.49 74.76 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.956 -0.465 . . . . 0.0 112.087 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.8 t -55.04 -52.14 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.948 -0.47 . . . . 0.0 111.137 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.93 -51.65 33.69 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -52.83 -48.72 66.8 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 122.23 -0.57 . . . . 0.0 111.224 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.99 -56.41 16.63 Favored Glycine 0 N--CA 1.475 1.252 0 O-C-N 121.874 -0.516 . . . . 0.0 112.205 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.9 mp -53.4 -45.66 69.41 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.734 -0.862 . . . . 0.0 112.265 178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.495 HG23 HH12 ' A' ' 225' ' ' ARG . 96.7 mt -55.73 -49.95 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 O-C-N 121.741 -0.6 . . . . 0.0 111.661 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 56.3 tp -54.16 -48.12 71.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.944 0.498 . . . . 0.0 111.766 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 11.1 mp -56.51 -51.15 69.59 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.759 -0.588 . . . . 0.0 112.135 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.495 HH12 HG23 ' A' ' 222' ' ' ILE . 21.7 ttp-105 -47.5 -53.74 13.48 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 121.405 -0.809 . . . . 0.0 111.001 178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 61.6 m -62.97 -58.55 6.95 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.444 HH22 ' C ' ' A' ' 231' ' ' GLY . 5.1 tpm_? -91.22 -59.85 2.05 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.48 -0.762 . . . . 0.0 112.431 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.2 -48.66 73.52 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 121.471 -0.768 . . . . 0.0 112.378 -172.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 53.7 mt -85.18 -66.71 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 122.095 -0.378 . . . . 0.0 111.355 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.442 ' CG ' ' N ' ' A' ' 231' ' ' GLY . 53.9 t80 -82.4 176.13 9.68 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -174.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.444 ' C ' HH22 ' A' ' 227' ' ' ARG . . . . . . . . 0 CA--C 1.54 1.61 0 N-CA-C 114.723 0.649 . . . . 0.0 114.723 173.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 121.194 0.521 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 85.7 mtm-85 -130.5 73.23 81.42 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.9 -0.5 . . . . 0.0 110.14 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.15 82.24 1.34 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 124.193 3.262 . . . . 0.0 112.895 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 166' ' ' GLU . 0.0 OUTLIER -69.87 -174.66 0.78 Allowed 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.892 0.853 . . . . 0.0 112.487 -178.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.9 t -46.51 -42.6 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.429 0.692 . . . . 0.0 112.7 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.52 -57.78 11.43 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 121.459 -0.775 . . . . 0.0 111.795 -178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 80.3 p -59.79 -48.47 81.54 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.62 -0.675 . . . . 0.0 112.085 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 25.5 p -56.42 -43.21 79.16 Favored 'General case' 0 N--CA 1.475 0.776 0 O-C-N 121.931 -0.481 . . . . 0.0 112.204 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -55.08 -48.04 74.08 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.715 -0.616 . . . . 0.0 111.501 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -52.89 -53.24 51.99 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 121.974 -0.454 . . . . 0.0 111.287 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.6 t -54.14 -46.48 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 122.426 0.29 . . . . 0.0 111.589 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 tt -51.32 -59.83 3.79 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.915 0.486 . . . . 0.0 110.889 177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -58.26 -44.06 88.17 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -51.23 -59.79 3.82 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.797 -0.564 . . . . 0.0 111.571 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.3 t -55.57 -49.29 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 O-C-N 122.073 -0.392 . . . . 0.0 111.774 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.4 p -56.84 -49.59 74.99 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.5 t -56.89 -48.83 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 121.503 -0.748 . . . . 0.0 111.667 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 85.2 t -56.67 -57.79 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 121.664 -0.648 . . . . 0.0 111.494 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 97.4 mt -56.07 -42.83 77.28 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.466 -0.771 . . . . 0.0 112.002 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 32.7 t90 -52.11 -59.54 4.25 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.999 -0.438 . . . . 0.0 111.924 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.6 p -60.85 -37.52 82.36 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.457 0.646 . . . . 0.0 111.928 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -56.42 -31.33 63.81 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -54.89 -58.61 13.72 Favored Pre-proline 0 N--CA 1.478 0.945 0 CA-C-N 119.223 0.919 . . . . 0.0 113.213 -174.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -57.9 -37.55 95.77 Favored 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 122.897 2.398 . . . . 0.0 112.678 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.05 -54.89 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 O-C-N 121.765 -0.584 . . . . 0.0 111.03 175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 78.3 t -56.0 -46.9 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.891 -0.506 . . . . 0.0 111.386 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.8 t90 -50.71 -55.32 17.13 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 121.966 -0.459 . . . . 0.0 111.391 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 7.8 tt -52.56 -50.8 62.22 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.781 0.433 . . . . 0.0 111.211 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 97.9 mt -52.15 -52.74 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 O-C-N 121.683 -0.635 . . . . 0.0 111.296 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -69.15 -20.21 74.71 Favored Glycine 0 CA--C 1.539 1.542 0 O-C-N 121.833 -0.542 . . . . 0.0 114.258 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 57.1 p -174.1 76.72 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.39 -1.065 . . . . 0.0 109.698 -167.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -64.94 -71.04 0.2 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -171.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 170.06 104.97 0.18 Allowed Glycine 0 N--CA 1.475 1.283 0 O-C-N 121.134 -0.979 . . . . 0.0 112.59 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -51.44 -44.26 62.3 Favored 'General case' 0 N--CA 1.48 1.036 0 O-C-N 121.67 -0.9 . . . . 0.0 112.72 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -53.35 -21.99 14.16 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 123.316 0.484 . . . . 0.0 114.283 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.02 -38.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 121.342 -1.093 . . . . 0.0 111.195 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.428 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 88.4 t -58.42 -60.19 11.07 Favored Pre-proline 0 N--CA 1.476 0.828 0 O-C-N 121.601 -0.687 . . . . 0.0 111.301 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.428 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 50.5 Cg_endo -60.97 -37.44 76.77 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.519 2.146 . . . . 0.0 112.767 178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 52.1 tp -54.63 -53.6 52.56 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.6 -0.688 . . . . 0.0 111.846 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -59.54 -43.04 93.62 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.547 -0.721 . . . . 0.0 112.722 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.6 mt -54.09 -48.81 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 121.382 -0.824 . . . . 0.0 111.574 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -55.65 -48.88 74.26 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.671 -0.643 . . . . 0.0 111.603 175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 37.4 m -51.68 -50.33 60.64 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.923 -0.485 . . . . 0.0 111.54 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.411 ' C ' HD13 ' A' ' 206' ' ' LEU . 3.0 tm? -52.95 -54.31 36.85 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.027 -0.421 . . . . 0.0 111.235 176.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.1 tp -51.23 -51.59 52.59 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.947 -0.47 . . . . 0.0 111.979 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -53.65 -50.54 65.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.871 0.367 . . . . 0.0 111.356 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 57.3 ttp -54.01 -51.09 65.06 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 122.07 -0.393 . . . . 0.0 111.977 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.4 t -53.09 -50.26 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.787 -0.571 . . . . 0.0 111.507 177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 95.4 mt -53.78 -52.39 60.39 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.062 -0.399 . . . . 0.0 111.73 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.45 -56.13 14.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.82 -0.55 . . . . 0.0 111.227 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.3 t -50.6 -52.88 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.3 p -58.13 -44.08 87.59 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.696 -0.627 . . . . 0.0 111.586 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.07 -48.49 75.99 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 121.897 -0.502 . . . . 0.0 111.961 175.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -58.18 -45.09 88.13 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 121.872 -0.518 . . . . 0.0 112.227 177.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 76.8 t -55.41 -50.42 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.44 -0.787 . . . . 0.0 111.405 175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.99 -51.18 47.63 Favored Glycine 0 N--CA 1.474 1.198 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.77 -52.44 31.85 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.087 0.555 . . . . 0.0 111.268 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.11 -52.42 35.81 Favored Glycine 0 N--CA 1.477 1.398 0 O-C-N 121.803 -0.56 . . . . 0.0 112.585 178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 66.7 tp -54.58 -52.65 61.47 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 122.04 -0.682 . . . . 0.0 111.64 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.73 -49.96 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 122.67 0.388 . . . . 0.0 111.421 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.0 tp -52.84 -50.6 63.41 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.938 0.495 . . . . 0.0 111.85 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -57.82 -49.54 76.31 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.889 -0.507 . . . . 0.0 110.992 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.539 HH21 ' C ' ' A' ' 231' ' ' GLY . 51.8 ttt85 -55.54 -44.06 76.39 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 121.713 -0.617 . . . . 0.0 112.409 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.502 ' HA ' ' HB2' ' A' ' 230' ' ' PHE . 77.9 p -62.93 -57.03 12.16 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.713 -1.242 . . . . 0.0 113.769 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.22 100.11 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 53.95 33.32 17.12 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.73 0.812 . . . . 0.0 112.772 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.422 ' HB ' ' O ' ' A' ' 225' ' ' ARG . 77.2 mt -145.98 -19.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.964 -0.46 . . . . 0.0 110.892 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 226' ' ' SER . 46.9 t80 -50.17 155.06 1.03 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 -174.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.539 ' C ' HH21 ' A' ' 225' ' ' ARG . . . . . . . . 0 CA--C 1.537 1.458 0 CA-C-N 114.379 -1.282 . . . . 0.0 111.227 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.296 0.57 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.459 ' CZ ' ' HG3' ' A' ' 166' ' ' GLU . 23.4 mtp-105 -60.44 160.62 17.25 Favored Pre-proline 0 N--CA 1.477 0.915 0 O-C-N 121.824 -0.548 . . . . 0.0 111.55 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.37 52.45 3.89 Favored 'Trans proline' 0 N--CA 1.482 0.804 0 C-N-CA 124.972 3.781 . . . . 0.0 111.81 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.459 ' HG3' ' CZ ' ' A' ' 164' ' ' ARG . 5.1 mm-40 -144.92 -26.32 0.49 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 113.932 -1.486 . . . . 0.0 110.315 -167.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.9 p -55.38 -45.69 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.597 0.713 . . . . 0.0 109.176 170.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -59.75 -46.48 89.0 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.057 -0.402 . . . . 0.0 111.302 173.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.3 m -52.32 -57.54 9.44 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.539 0.685 . . . . 0.0 111.097 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 23.9 p -58.38 -46.81 85.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.551 0.575 . . . . 0.0 112.551 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.74 -48.73 72.21 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.699 -0.626 . . . . 0.0 111.662 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -57.25 -49.95 74.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.614 -0.679 . . . . 0.0 112.284 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 87.6 t -54.29 -47.3 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 O-C-N 121.819 -0.551 . . . . 0.0 111.738 176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 174' ' ' LEU . 6.8 tt -52.85 -56.65 14.25 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.001 -0.437 . . . . 0.0 110.788 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -52.05 -49.24 63.85 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -49.73 -59.41 3.83 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.981 -0.449 . . . . 0.0 111.7 175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 92.1 t -55.76 -52.28 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 122.057 -0.402 . . . . 0.0 111.94 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 44.2 p -58.03 -49.7 75.98 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.5 t -59.53 -50.46 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.598 -0.688 . . . . 0.0 111.59 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.7 t -54.83 -48.82 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.826 -0.546 . . . . 0.0 111.319 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 181' ' ' LEU . 5.9 tt -54.29 -56.13 21.53 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.795 -0.565 . . . . 0.0 110.876 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -54.09 -51.43 64.19 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.133 0.419 . . . . 0.0 112.133 -176.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.2 p -59.32 -44.8 92.54 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.602 -0.686 . . . . 0.0 112.0 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.84 -20.2 64.84 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -58.91 -55.71 43.55 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 120.99 -1.069 . . . . 0.0 112.134 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -60.43 -31.84 93.09 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 123.0 2.466 . . . . 0.0 112.769 175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.4 t -60.11 -52.31 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 121.463 -0.773 . . . . 0.0 110.672 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.07 -46.38 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 121.848 -0.533 . . . . 0.0 111.024 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 57.7 t90 -51.83 -55.95 16.89 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.995 -0.441 . . . . 0.0 111.157 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.915 0.886 . . . . 0.0 110.779 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.457 HG12 HG21 ' A' ' 199' ' ' VAL . 73.4 mt -51.59 -60.11 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 O-C-N 121.726 -0.609 . . . . 0.0 109.97 173.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.84 51.21 4.27 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 121.283 0.38 . . . . 0.0 113.067 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 44.5 p -162.07 -57.48 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.477 0.711 . . . . 0.0 109.82 173.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -150.43 46.01 0.88 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.11 0.481 . . . . 0.0 110.807 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -166.74 29.12 0.18 Allowed Glycine 0 N--CA 1.475 1.275 0 O-C-N 120.289 -1.507 . . . . 0.0 113.376 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -81.36 55.29 2.54 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 123.352 1.549 . . . . 0.0 109.672 170.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.95 -46.71 0.09 OUTLIER Glycine 0 N--CA 1.469 0.864 0 N-CA-C 108.146 -1.982 . . . . 0.0 108.146 -173.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 67.1 mt -57.93 -57.27 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 122.44 -0.447 . . . . 0.0 110.001 175.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.457 HG21 HG12 ' A' ' 191' ' ' ILE . 86.6 t -57.58 -54.6 53.43 Favored Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 121.754 -0.591 . . . . 0.0 112.484 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 199' ' ' VAL . 41.1 Cg_endo -58.97 -40.43 71.5 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 122.49 2.127 . . . . 0.0 113.127 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.413 HD13 ' C ' ' A' ' 201' ' ' LEU . 3.3 tm? -56.03 -53.51 56.13 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.507 -0.746 . . . . 0.0 110.96 174.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -53.02 -47.77 68.07 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.684 -0.635 . . . . 0.0 112.427 176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.2 mt -52.09 -54.59 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.734 -0.604 . . . . 0.0 111.179 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -50.32 -51.92 41.24 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.341 0.591 . . . . 0.0 111.494 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 46.0 m -53.15 -48.89 67.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.899 0.48 . . . . 0.0 111.826 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.7 mt -54.31 -54.76 35.88 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.62 -48.34 75.07 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.666 -0.647 . . . . 0.0 111.778 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -53.5 -53.36 52.58 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.029 -0.419 . . . . 0.0 111.463 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 58.1 ttp -49.38 -48.79 46.68 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.324 0.65 . . . . 0.0 112.45 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.1 t -51.29 -51.0 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.725 -0.609 . . . . 0.0 111.201 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 76.8 mt -54.92 -51.46 65.99 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 122.203 -0.311 . . . . 0.0 111.605 177.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -51.08 -50.83 57.96 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.875 -0.516 . . . . 0.0 111.969 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.5 -51.2 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.5 p -58.55 -46.05 87.66 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 121.433 -0.792 . . . . 0.0 111.681 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.1 77.03 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.925 -0.484 . . . . 0.0 111.845 177.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -50.01 -54.25 21.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.899 0.48 . . . . 0.0 111.648 176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.3 t -55.26 -50.56 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 O-C-N 122.212 -0.305 . . . . 0.0 111.555 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.95 -51.49 34.42 Favored Glycine 0 N--CA 1.476 1.319 0 O-C-N 121.897 -0.502 . . . . 0.0 112.134 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -55.34 -52.58 63.03 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.972 -0.722 . . . . 0.0 111.289 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.82 -48.45 44.47 Favored Glycine 0 N--CA 1.475 1.238 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 94.8 mt -56.02 -56.31 22.35 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 122.205 -0.585 . . . . 0.0 111.921 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.1 mt -49.66 -43.81 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-O 121.542 0.687 . . . . 0.0 111.736 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.524 ' N ' HH21 ' A' ' 227' ' ' ARG . 36.9 tp -58.59 -59.17 5.81 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.818 -0.551 . . . . 0.0 110.513 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.04 56.56 3.53 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 122.712 1.244 . . . . 0.0 109.841 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.6 -57.51 0.07 Allowed 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.544 -0.722 . . . . 0.0 109.918 -177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 74.0 p -157.83 53.3 0.46 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.153 0.978 . . . . 0.0 111.64 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.524 HH21 ' N ' ' A' ' 223' ' ' LEU . 17.0 ttp180 -154.4 -57.93 0.11 Allowed 'General case' 0 N--CA 1.473 0.693 0 O-C-N 121.43 -0.794 . . . . 0.0 109.937 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -73.19 -46.1 52.58 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 167.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 33.1 mt -58.13 -39.03 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.678 171.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -61.31 -53.94 50.27 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.022 -0.424 . . . . 0.0 110.678 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.705 0 N-CA-C 114.081 0.392 . . . . 0.0 114.081 176.47 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 20.3 ptp . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 120.665 0.269 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.445 ' HB2' ' CD ' ' A' ' 165' ' ' PRO . 51.3 mtp85 -163.2 -64.45 0.01 OUTLIER Pre-proline 0 N--CA 1.48 1.034 0 O-C-N 122.113 -0.367 . . . . 0.0 110.847 -172.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.445 ' CD ' ' HB2' ' A' ' 164' ' ' ARG . 40.9 Cg_endo -79.44 -179.62 5.54 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.075 2.517 . . . . 0.0 111.155 172.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -81.45 -75.49 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.025 -1.047 . . . . 0.0 110.194 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 58.1 t -55.16 -52.56 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -170.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.406 ' HB3' ' CG ' ' A' ' 165' ' ' PRO . . . -58.18 -43.06 87.32 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.626 -0.671 . . . . 0.0 112.368 -176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.5 p -73.66 -44.02 57.85 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.387 -0.821 . . . . 0.0 111.116 -175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.0 t -57.38 -43.25 83.45 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 121.418 -0.802 . . . . 0.0 110.735 177.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.76 -50.45 73.19 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.689 -0.632 . . . . 0.0 110.926 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -50.32 -50.56 50.47 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.741 -0.599 . . . . 0.0 112.58 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.42 -53.04 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 122.629 0.372 . . . . 0.0 111.712 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tt -51.16 -53.54 33.68 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.382 0.611 . . . . 0.0 110.59 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.9 ttm105 -52.33 -51.78 56.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.609 0.764 . . . . 0.0 112.401 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -53.03 -54.08 40.61 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.566 -0.708 . . . . 0.0 111.646 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -54.76 -52.79 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 O-C-N 122.02 -0.425 . . . . 0.0 111.648 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 56.5 p -55.05 -44.8 75.05 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.647 -0.658 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 68.9 t -56.11 -48.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.561 -0.712 . . . . 0.0 111.83 174.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 95.0 t -54.82 -55.12 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.526 -0.734 . . . . 0.0 111.473 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.7 mp -54.4 -45.06 72.85 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.438 -0.789 . . . . 0.0 112.116 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.91 -55.44 23.31 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 122.011 -0.431 . . . . 0.0 111.367 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.7 p -61.47 -38.85 88.74 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 121.562 -0.711 . . . . 0.0 112.533 -179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -55.89 -56.66 17.99 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.738 -0.601 . . . . 0.0 112.309 175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -37.62 -56.99 1.63 Allowed Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -59.61 -44.58 30.91 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 123.001 2.467 . . . . 0.0 112.379 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.0 t -59.4 -46.87 92.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.751 -0.593 . . . . 0.0 110.682 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.559 ' HA ' HD11 ' A' ' 198' ' ' ILE . 96.1 t -51.25 -53.14 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 CA-C-O 120.936 0.398 . . . . 0.0 110.969 177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 71.8 t90 -57.05 -52.47 65.13 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.932 -0.48 . . . . 0.0 111.768 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 59.7 tp -46.18 -50.81 15.22 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.459 HG21 ' H ' ' A' ' 198' ' ' ILE . 1.9 mp -66.59 -43.72 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.799 -0.563 . . . . 0.0 111.448 174.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.62 53.57 2.84 Favored Glycine 0 CA--C 1.539 1.551 0 CA-C-O 121.753 0.64 . . . . 0.0 112.836 173.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 33.4 p -172.23 -49.64 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.864 1.266 . . . . 0.0 109.318 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -132.73 -45.48 0.88 Allowed 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.55 -168.27 11.52 Favored Glycine 0 CA--C 1.537 1.459 0 O-C-N 121.457 -0.777 . . . . 0.0 113.956 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -153.56 -7.29 0.17 Allowed 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.569 -0.959 . . . . 0.0 113.267 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -51.42 -37.34 39.85 Favored Glycine 0 N--CA 1.481 1.681 0 O-C-N 121.308 -0.87 . . . . 0.0 114.14 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.559 HD11 ' HA ' ' A' ' 188' ' ' VAL . 86.0 mt -52.82 -38.18 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 78.5 t -41.83 -59.7 2.39 Favored Pre-proline 0 N--CA 1.483 1.19 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -166.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -59.19 -47.92 15.73 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.037 2.491 . . . . 0.0 112.951 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -56.46 -49.7 73.86 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 121.957 -0.464 . . . . 0.0 112.145 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -57.47 -47.51 81.65 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.436 0.694 . . . . 0.0 111.812 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.1 mt -52.55 -51.0 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 O-C-N 121.868 -0.52 . . . . 0.0 111.134 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -59.0 -45.77 89.83 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.62 -0.675 . . . . 0.0 111.802 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 62.4 m -52.59 -54.59 30.91 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.363 -0.836 . . . . 0.0 111.805 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -61.74 -38.93 89.78 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.579 -0.701 . . . . 0.0 112.28 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 206' ' ' LEU . 64.6 tp -54.84 -54.39 43.0 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.51 -0.744 . . . . 0.0 110.937 174.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.11 -50.35 61.84 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.258 0.623 . . . . 0.0 111.187 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 63.5 mtt -52.23 -52.3 53.21 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.654 -0.654 . . . . 0.0 112.395 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.5 t -55.68 -47.76 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 121.639 -0.663 . . . . 0.0 111.674 177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 93.8 mt -54.72 -47.98 73.08 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -54.23 -56.11 21.5 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.873 -0.517 . . . . 0.0 110.713 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 73.8 t -51.68 -54.97 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.97 -0.456 . . . . 0.0 111.918 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 61.8 p -58.08 -50.48 73.32 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.665 -0.647 . . . . 0.0 112.451 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.28 -46.7 85.56 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.857 -0.527 . . . . 0.0 111.907 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -55.71 -50.48 70.21 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.572 0.749 . . . . 0.0 111.343 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.9 t -55.95 -51.39 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 121.998 -0.439 . . . . 0.0 111.11 175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -49.52 -51.29 27.94 Favored Glycine 0 N--CA 1.476 1.307 0 O-C-N 121.935 -0.478 . . . . 0.0 111.926 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -53.96 -47.64 71.14 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.142 -0.622 . . . . 0.0 111.182 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.46 -51.16 22.55 Favored Glycine 0 N--CA 1.477 1.4 0 O-C-N 121.975 -0.453 . . . . 0.0 112.446 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 9.2 mp -58.37 -52.27 66.31 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.933 -0.745 . . . . 0.0 112.07 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.2 mt -49.87 -46.84 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 O-C-N 121.818 -0.551 . . . . 0.0 111.376 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 63.4 tp -57.64 -62.32 1.88 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.823 -0.548 . . . . 0.0 110.443 173.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 26.0 tp -85.43 54.42 3.11 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 122.692 1.234 . . . . 0.0 111.366 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.64 -66.66 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 33.2 t -71.78 -58.66 3.28 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.486 HH22 ' C ' ' A' ' 231' ' ' GLY . 0.0 OUTLIER -85.18 58.75 5.21 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 123.704 1.716 . . . . 0.0 109.057 175.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -159.38 -64.36 0.08 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.361 -1.29 . . . . 0.0 108.632 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 85.2 mt -66.69 -42.29 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 122.96 0.504 . . . . 0.0 110.631 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.66 -36.48 67.13 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.486 ' C ' HH22 ' A' ' 227' ' ' ARG . . . . . . . . 0 CA--C 1.543 1.807 0 O-C-N 121.451 -0.78 . . . . 0.0 113.045 -164.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 167' ' ' VAL . 25.1 ptt? . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 120.669 0.271 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 47.1 tpt85 -174.64 -58.54 0.0 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -67.4 -81.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.38 2.053 . . . . 0.0 112.138 178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -78.27 44.3 0.49 Allowed 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.329 -0.857 . . . . 0.0 112.144 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.594 HG13 ' H ' ' A' ' 168' ' ' ALA . 7.3 p -65.99 -65.43 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 O-C-N 120.974 -1.079 . . . . 0.0 110.46 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.594 ' H ' HG13 ' A' ' 167' ' ' VAL . . . -69.05 -35.64 76.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.37 0.605 . . . . 0.0 110.198 175.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.1 m -54.19 -63.38 1.17 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.067 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 86.8 m -61.96 -48.68 79.3 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.893 -0.505 . . . . 0.0 111.302 -177.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -51.9 -52.71 47.97 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.235 0.541 . . . . 0.0 110.795 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -59.24 -51.68 68.92 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 63.9 t -55.71 -53.41 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.846 -0.533 . . . . 0.0 112.078 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.15 -47.23 86.07 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.699 -0.625 . . . . 0.0 112.242 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -56.25 -48.19 77.03 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 121.726 -0.609 . . . . 0.0 111.551 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -53.03 -55.42 23.86 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.688 -0.632 . . . . 0.0 111.194 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.5 t -52.34 -50.38 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 67.6 p -58.74 -47.18 85.52 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.546 -0.721 . . . . 0.0 112.282 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 75.3 t -56.55 -51.45 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.528 -0.732 . . . . 0.0 111.775 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -53.78 -46.01 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.918 -0.489 . . . . 0.0 111.357 177.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.7 tt -55.74 -56.42 20.68 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.686 -0.634 . . . . 0.0 110.931 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -55.53 -48.55 74.52 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.739 -0.601 . . . . 0.0 112.422 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 25.4 p -60.77 -44.01 97.32 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.644 -0.66 . . . . 0.0 112.11 176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.81 -22.01 66.32 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.415 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 1.2 t80 -59.49 -54.92 51.22 Favored Pre-proline 0 N--CA 1.476 0.852 0 O-C-N 120.97 -1.081 . . . . 0.0 111.431 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 56.1 Cg_endo -61.21 -34.73 88.04 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 122.58 2.187 . . . . 0.0 112.365 174.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.5 t -57.4 -51.78 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 119.12 0.873 . . . . 0.0 111.556 175.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 73.4 t -53.83 -50.21 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.686 -0.634 . . . . 0.0 111.304 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -60.7 -46.31 90.87 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.871 -0.518 . . . . 0.0 111.969 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 196' ' ' ALA . 26.6 tp -46.35 -50.28 16.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.908 0.883 . . . . 0.0 111.131 177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.5 mt -57.7 -59.82 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.981 172.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.89 53.12 4.7 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-O 121.403 0.446 . . . . 0.0 112.362 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 83.1 p -153.57 -55.49 0.11 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.102 -0.646 . . . . 0.0 109.406 174.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -150.33 -66.98 0.2 Allowed 'General case' 0 N--CA 1.475 0.811 0 O-C-N 122.062 -0.399 . . . . 0.0 110.03 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 146.86 65.44 0.01 OUTLIER Glycine 0 N--CA 1.475 1.245 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.199 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 190' ' ' LEU . . . 52.77 67.99 0.9 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.779 1.399 . . . . 0.0 114.779 169.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 178.74 -72.36 0.07 OUTLIER Glycine 0 N--CA 1.474 1.21 0 O-C-N 121.037 -1.039 . . . . 0.0 111.506 173.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 66.0 mt -67.04 -41.92 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.91 -0.759 . . . . 0.0 110.393 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.447 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 26.0 t -43.28 -56.76 6.19 Favored Pre-proline 0 N--CA 1.48 1.043 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.447 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 74.1 Cg_endo -66.28 -40.19 15.61 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.907 2.405 . . . . 0.0 112.684 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 45.8 tp -51.96 -45.91 64.57 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.86 -0.525 . . . . 0.0 111.801 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -51.58 -55.37 19.6 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 121.973 -0.455 . . . . 0.0 110.419 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 67.4 mt -49.41 -51.0 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-O 120.731 0.3 . . . . 0.0 111.158 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -57.81 -52.83 63.84 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 88.1 m -52.2 -51.07 60.39 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.641 -0.662 . . . . 0.0 111.859 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.4 -47.96 83.84 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.005 -0.434 . . . . 0.0 112.164 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -51.86 -54.87 24.23 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.545 -0.722 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -54.71 -49.93 69.54 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.454 0.302 . . . . 0.0 111.379 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 47.8 ttm -51.08 -49.5 60.53 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 72.6 t -54.14 -48.86 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.456 -0.777 . . . . 0.0 111.306 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -54.41 -51.32 65.25 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.948 -0.47 . . . . 0.0 111.284 175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -51.11 -50.35 58.98 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.151 0.58 . . . . 0.0 111.617 178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 77.2 t -57.97 -54.07 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 64.4 p -57.18 -45.34 83.79 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.351 -0.843 . . . . 0.0 111.539 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.63 -49.27 76.99 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.707 0.403 . . . . 0.0 111.504 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -52.48 -50.78 62.02 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.949 -0.469 . . . . 0.0 111.952 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 87.2 t -55.41 -53.21 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 O-C-N 122.087 -0.383 . . . . 0.0 111.297 177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -52.82 -50.55 49.59 Favored Glycine 0 N--CA 1.475 1.298 0 N-CA-C 111.924 -0.47 . . . . 0.0 111.924 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -54.31 -51.49 64.5 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 122.247 -0.561 . . . . 0.0 111.262 178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.85 -50.2 51.28 Favored Glycine 0 N--CA 1.475 1.281 0 O-C-N 121.923 -0.486 . . . . 0.0 112.216 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 87.1 mt -56.05 -51.22 68.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.966 -0.726 . . . . 0.0 112.034 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 97.2 mt -55.8 -48.28 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.856 -0.527 . . . . 0.0 111.905 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.19 -50.64 72.21 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.874 -0.516 . . . . 0.0 111.562 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 39.2 tp -50.98 -55.49 17.09 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.609 -0.682 . . . . 0.0 110.313 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 -53.36 -65.57 0.54 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 95.0 p -91.15 22.07 3.98 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.34 -57.8 0.18 Allowed 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.085 -1.009 . . . . 0.0 110.445 -176.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -67.85 -54.37 19.48 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.629 0.728 . . . . 0.0 110.629 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.89 -56.63 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -78.69 73.0 5.25 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 122.403 1.097 . . . . 0.0 109.864 173.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.556 0 CA-C-N 115.476 -0.783 . . . . 0.0 113.076 174.529 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 21.2 ptm . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.199 0.523 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.453 ' HD3' ' HD2' ' A' ' 165' ' ' PRO . 24.3 tpp180 -69.88 132.04 88.94 Favored Pre-proline 0 N--CA 1.474 0.755 0 O-C-N 121.652 -0.655 . . . . 0.0 109.613 174.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.453 ' HD2' ' HD3' ' A' ' 164' ' ' ARG . 66.9 Cg_endo -77.16 63.63 7.74 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.9 3.067 . . . . 0.0 112.772 174.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 169' ' ' SER . 2.3 mp0 62.83 -166.39 0.22 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.582 -0.735 . . . . 0.0 112.198 172.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.0 t 69.95 -76.13 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.644 1.178 . . . . 0.0 111.307 170.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.03 87.59 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 165.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.453 ' HB3' ' HA ' ' A' ' 166' ' ' GLU . 47.5 t -66.08 -49.75 66.49 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.596 177.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 84.5 m -53.52 -52.88 58.2 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 122.341 -0.225 . . . . 0.0 111.43 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -56.34 -49.31 74.72 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.622 -0.674 . . . . 0.0 111.708 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.52 -50.62 69.5 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.603 -0.686 . . . . 0.0 111.771 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 82.2 t -59.23 -58.96 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.967 -0.458 . . . . 0.0 111.668 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.2 mp -58.18 -41.32 83.62 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 175' ' ' ARG . 15.2 mmm-85 -60.96 -47.71 85.19 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.066 -1.021 . . . . 0.0 112.542 175.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -52.89 -51.48 61.03 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.816 -0.553 . . . . 0.0 110.645 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 72.5 t -54.06 -54.21 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 24.8 p -55.61 -46.46 77.35 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 121.49 -0.756 . . . . 0.0 112.666 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.55 -53.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.628 -0.67 . . . . 0.0 111.799 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.0 t -57.55 -45.91 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 121.777 -0.577 . . . . 0.0 111.837 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.79 -53.1 61.67 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.674 -0.641 . . . . 0.0 110.498 176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 t-105 -54.35 -51.63 64.16 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 122.032 -0.418 . . . . 0.0 112.03 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 68.5 p -61.68 -40.64 95.68 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -58.76 -47.66 83.89 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.444 -0.785 . . . . 0.0 112.571 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -41.3 -58.05 3.18 Favored Pre-proline 0 N--CA 1.479 0.982 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -61.05 -38.16 70.21 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.157 2.571 . . . . 0.0 112.572 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.2 t -58.58 -53.17 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 O-C-N 121.574 -0.704 . . . . 0.0 110.768 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 72.4 t -53.59 -50.37 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.093 0.473 . . . . 0.0 111.318 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 65.9 t90 -54.37 -54.77 36.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.871 0.367 . . . . 0.0 111.211 177.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.4 tp -49.11 -51.41 31.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.542 0.737 . . . . 0.0 111.479 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.02 -57.47 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.982 -0.448 . . . . 0.0 110.005 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.85 51.38 4.3 Favored Glycine 0 CA--C 1.535 1.334 0 O-C-N 122.079 -0.388 . . . . 0.0 112.401 177.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.0 p -155.74 -34.05 0.09 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 121.672 -0.899 . . . . 0.0 111.862 176.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -72.36 68.95 0.79 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.967 0.889 . . . . 0.0 111.846 172.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -45.01 -45.32 9.31 Favored Glycine 0 N--CA 1.476 1.336 0 C-N-CA 123.785 0.707 . . . . 0.0 112.126 175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -77.51 57.27 1.53 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 122.853 1.311 . . . . 0.0 111.508 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.65 -57.42 0.07 OUTLIER Glycine 0 CA--C 1.527 0.844 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.5 tt -64.62 -48.8 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 121.966 -0.726 . . . . 0.0 110.95 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' A' ' 200' ' ' PRO . 80.9 t -59.97 -55.69 43.04 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 121.577 -0.702 . . . . 0.0 111.619 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 199' ' ' VAL . 36.7 Cg_endo -57.04 -44.77 41.16 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.569 2.179 . . . . 0.0 112.956 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.58 -48.33 82.07 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.437 -0.789 . . . . 0.0 112.823 175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -56.81 -44.49 82.02 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.044 -1.035 . . . . 0.0 112.789 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 97.6 mt -55.2 -51.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.497 -0.752 . . . . 0.0 111.169 174.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -53.57 -51.02 64.3 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.942 -0.473 . . . . 0.0 111.653 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 87.8 m -52.45 -51.3 59.97 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.133 0.573 . . . . 0.0 111.466 177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.63 -50.2 72.72 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.927 -0.483 . . . . 0.0 112.064 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -53.43 -53.71 47.42 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 121.765 -0.584 . . . . 0.0 110.511 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.97 -48.41 73.27 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.104 -0.373 . . . . 0.0 110.852 177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.6 ttt -52.62 -49.97 64.04 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.688 -0.633 . . . . 0.0 111.872 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.0 t -52.98 -50.61 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.54 -0.725 . . . . 0.0 111.28 176.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.3 mt -54.52 -50.23 68.33 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.888 -0.507 . . . . 0.0 112.194 177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -54.22 -54.1 44.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.966 0.507 . . . . 0.0 111.426 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 76.2 t -55.04 -55.07 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.987 -0.445 . . . . 0.0 111.517 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -55.79 -47.63 76.75 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.596 -0.69 . . . . 0.0 112.284 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.96 -49.7 72.83 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.902 -0.499 . . . . 0.0 111.875 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.536 ' HA ' ' HE3' ' A' ' 216' ' ' LYS . 0.1 OUTLIER -58.53 -43.1 89.07 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 122.804 0.442 . . . . 0.0 112.164 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 69.3 t -55.01 -54.01 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 O-C-N 121.495 -0.753 . . . . 0.0 110.645 173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.87 -50.54 37.62 Favored Glycine 0 N--CA 1.477 1.426 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -50.4 -50.63 51.15 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.159 0.583 . . . . 0.0 110.987 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -50.91 -51.65 33.59 Favored Glycine 0 N--CA 1.477 1.37 0 O-C-N 122.004 -0.435 . . . . 0.0 112.549 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.33 -52.52 63.23 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 122.081 -0.658 . . . . 0.0 111.858 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 94.6 mt -54.7 -47.33 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.162 0.506 . . . . 0.0 111.894 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 29.2 tp -54.66 -54.91 35.45 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.784 -0.572 . . . . 0.0 109.743 175.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 228' ' ' ALA . 39.2 tp -80.67 59.43 3.61 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 122.615 1.197 . . . . 0.0 110.417 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -161.14 -60.7 0.05 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.378 1.471 . . . . 0.0 108.043 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 76.8 p -89.43 -47.37 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.368 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -83.61 -57.99 3.0 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.758 -0.589 . . . . 0.0 112.445 -175.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.454 ' HB3' ' HA ' ' A' ' 224' ' ' LEU . . . -77.35 -53.65 7.42 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -175.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.03 -66.93 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.813 -0.554 . . . . 0.0 111.016 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -71.69 169.93 14.6 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.628 -0.67 . . . . 0.0 111.267 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.567 0 O-C-N 121.578 -0.701 . . . . 0.0 113.226 -178.641 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.456 ' SD ' ' HD2' ' A' ' 164' ' ' ARG . 4.7 ppp? . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.456 ' HD2' ' SD ' ' A' ' 163' ' ' MET . 0.9 OUTLIER -54.52 -50.12 87.16 Favored Pre-proline 0 N--CA 1.476 0.874 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 178.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -80.52 62.79 8.65 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 124.057 3.172 . . . . 0.0 114.869 -172.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 78.22 -45.07 0.41 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.739 1.615 . . . . 0.0 113.224 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 168' ' ' ALA . 1.4 p 55.65 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.426 1.49 . . . . 0.0 112.532 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.504 ' H ' HG22 ' A' ' 167' ' ' VAL . . . -49.56 -43.56 46.06 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.39 -0.819 . . . . 0.0 112.77 -177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 61.1 p -51.89 -63.31 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 m -74.89 -43.38 54.67 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.658 -0.651 . . . . 0.0 110.663 -174.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.03 -44.56 91.76 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.027 -0.42 . . . . 0.0 111.951 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.56 -50.26 72.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.232 -0.917 . . . . 0.0 110.997 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 83.7 t -54.6 -53.67 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 120.587 0.232 . . . . 0.0 110.497 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.42 -57.35 8.21 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.166 0.586 . . . . 0.0 111.237 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.475 ' HE ' ' HA ' ' A' ' 176' ' ' ASN . 2.4 tmm_? -50.24 -57.95 6.68 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.336 0.654 . . . . 0.0 110.581 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.475 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 7.7 t30 -58.41 -49.7 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.169 -0.332 . . . . 0.0 111.181 -174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.39 -54.51 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 23.9 p -55.47 -50.62 69.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.74 -0.6 . . . . 0.0 111.81 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.5 t -52.77 -50.87 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.701 -0.624 . . . . 0.0 111.606 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.1 t -55.86 -51.31 61.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 121.888 -0.508 . . . . 0.0 111.837 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -53.13 -48.13 68.12 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.252 -0.905 . . . . 0.0 112.243 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -55.72 -52.83 62.56 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 78.4 p -60.7 -41.98 96.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.771 0.796 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.02 -17.17 61.92 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.457 ' HB3' ' CD ' ' A' ' 186' ' ' PRO . 1.5 t80 -59.25 -59.9 12.32 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 119.972 1.26 . . . . 0.0 111.203 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.457 ' CD ' ' HB3' ' A' ' 185' ' ' TYR . 52.5 Cg_endo -61.86 -30.99 84.91 Favored 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.88 2.387 . . . . 0.0 113.187 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.9 t -57.45 -56.56 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 121.408 -0.808 . . . . 0.0 110.675 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.92 -43.58 84.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 121.939 -0.476 . . . . 0.0 111.313 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 58.0 t90 -51.18 -59.46 4.17 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.038 -0.414 . . . . 0.0 111.086 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.02 -50.99 45.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.388 0.675 . . . . 0.0 110.432 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.58 -61.21 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 O-C-N 122.127 -0.358 . . . . 0.0 110.612 175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -89.12 51.31 3.74 Favored Glycine 0 N--CA 1.474 1.18 0 O-C-N 122.025 -0.422 . . . . 0.0 112.129 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 60.2 p -159.25 -40.81 0.06 Allowed 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.623 -0.927 . . . . 0.0 112.495 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 64.5 77.91 0.3 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 122.199 1.0 . . . . 0.0 109.369 -167.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -37.44 -45.65 1.37 Allowed Glycine 0 N--CA 1.477 1.384 0 CA-C-N 114.735 -1.12 . . . . 0.0 113.785 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -83.21 53.7 2.55 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.802 1.287 . . . . 0.0 110.666 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -178.3 -55.33 0.07 OUTLIER Glycine 0 N--CA 1.47 0.901 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 16.2 tt -61.1 -44.62 98.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 122.086 -0.655 . . . . 0.0 111.348 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 95.5 t -56.84 -59.74 11.56 Favored Pre-proline 0 N--CA 1.475 0.776 0 O-C-N 121.515 -0.741 . . . . 0.0 112.074 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -59.23 -43.46 41.23 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.44 2.093 . . . . 0.0 112.114 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.85 -56.3 18.89 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.113 -0.367 . . . . 0.0 111.927 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -55.28 -45.26 76.18 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 90.3 mt -50.44 -52.16 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.533 -0.729 . . . . 0.0 111.006 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -56.88 -49.32 75.88 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.224 0.535 . . . . 0.0 111.778 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 80.9 m -50.95 -49.98 58.88 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.573 0.749 . . . . 0.0 112.441 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.5 -50.74 70.91 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.676 -0.64 . . . . 0.0 112.3 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 62.9 tp -51.42 -51.05 58.2 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.443 0.64 . . . . 0.0 111.479 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.27 -52.9 61.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.118 0.485 . . . . 0.0 111.068 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 42.1 ttm -50.42 -49.64 54.22 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.464 0.706 . . . . 0.0 112.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 74.4 t -52.34 -51.3 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 121.614 -0.678 . . . . 0.0 111.464 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.6 mt -54.41 -48.95 71.01 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.2 0.524 . . . . 0.0 111.624 176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 216' ' ' LYS . 70.7 m-20 -53.75 -54.37 39.06 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.006 -0.434 . . . . 0.0 111.908 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 95.0 t -55.35 -54.83 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 O-C-N 121.899 -0.501 . . . . 0.0 111.911 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 22.0 p -56.17 -45.22 79.8 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -53.42 -48.86 68.36 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 121.848 -0.532 . . . . 0.0 112.255 175.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 212' ' ' ASP . 9.5 mmtp -57.29 -46.48 83.1 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 122.003 -0.436 . . . . 0.0 111.598 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.6 t -53.42 -52.23 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.716 -0.615 . . . . 0.0 110.711 175.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.44 -51.17 33.03 Favored Glycine 0 N--CA 1.478 1.435 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -51.76 -48.51 63.68 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 122.364 -0.492 . . . . 0.0 111.584 175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -49.65 -52.59 24.3 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 122.035 -0.415 . . . . 0.0 112.348 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -58.23 -50.79 72.31 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.05 -0.677 . . . . 0.0 112.331 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 38.6 mt -49.27 -49.21 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 CA-C-O 121.299 0.571 . . . . 0.0 111.67 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 227' ' ' ARG . 40.2 tp -57.04 -56.8 17.09 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.847 -0.533 . . . . 0.0 111.125 174.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 64.4 mt -80.55 56.81 2.7 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 123.018 1.389 . . . . 0.0 110.792 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -158.02 -56.53 0.07 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.559 -1.2 . . . . 0.0 108.508 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.477 ' HA ' ' H ' ' A' ' 230' ' ' PHE . 74.3 m -148.23 43.8 1.04 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 223' ' ' LEU . 0.1 OUTLIER -137.2 -47.22 0.58 Allowed 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.083 -1.011 . . . . 0.0 110.156 166.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.65 -47.06 14.62 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 165.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.6 mt -77.11 -78.63 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.477 ' H ' ' HA ' ' A' ' 226' ' ' SER . 53.3 t80 -60.3 -51.56 69.0 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 120.016 1.28 . . . . 0.0 112.196 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.544 0 O-C-N 121.788 -0.57 . . . . 0.0 113.346 178.825 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 71.9 mtm . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 64.08 161.04 0.12 Allowed Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.533 1.133 . . . . 0.0 112.739 -173.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.25 -164.02 0.18 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.602 2.868 . . . . 0.0 113.5 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 58.3 59.93 2.83 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.224 1.012 . . . . 0.0 110.763 -171.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.0 p -53.28 -44.71 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.789 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.25 -51.99 67.12 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.75 -0.594 . . . . 0.0 111.557 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.6 m -59.04 -52.95 63.55 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 0.0 111.696 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.2 p -56.59 -48.07 78.2 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.33 -46.63 83.08 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.735 -0.603 . . . . 0.0 111.303 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -51.92 -51.32 57.77 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.484 -0.76 . . . . 0.0 112.102 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.59 -53.08 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.1 mt -54.43 -52.01 63.12 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.215 0.531 . . . . 0.0 111.97 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ttm105 -52.32 -52.63 52.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.409 0.683 . . . . 0.0 111.47 177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -51.35 -57.93 7.6 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.925 -0.484 . . . . 0.0 111.614 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 70.0 t -54.41 -49.8 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 121.963 -0.46 . . . . 0.0 112.17 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 27.7 p -58.84 -49.34 78.11 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.62 -0.675 . . . . 0.0 112.718 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 77.9 t -57.21 -49.93 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 O-C-N 121.463 -0.773 . . . . 0.0 111.742 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.0 t -56.76 -51.99 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.742 -0.599 . . . . 0.0 110.929 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.9 tt -51.51 -50.07 60.66 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.57 -0.706 . . . . 0.0 111.395 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 42.7 t90 -51.81 -57.4 9.42 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.5 p -61.54 -37.48 83.92 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.52 0.676 . . . . 0.0 112.214 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.1 -27.57 65.7 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.4 ' HB3' ' CD ' ' A' ' 186' ' ' PRO . 1.4 t80 -57.32 -56.1 37.41 Favored Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 121.137 -0.977 . . . . 0.0 111.97 -174.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 185' ' ' TYR . 43.1 Cg_endo -59.9 -33.41 95.85 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.793 2.329 . . . . 0.0 113.145 176.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.1 t -59.3 -53.17 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 121.397 -0.814 . . . . 0.0 111.116 174.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.7 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 121.805 -0.559 . . . . 0.0 110.95 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 38.4 t90 -52.54 -56.4 15.52 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 122.139 -0.35 . . . . 0.0 111.428 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.469 HD22 ' HA2' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -42.09 -56.04 2.99 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.871 0.869 . . . . 0.0 110.128 178.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 82.1 mt -54.94 -59.67 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 O-C-N 122.04 -0.413 . . . . 0.0 110.655 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.54 30.79 3.05 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 -175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 90.6 p -167.84 24.97 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.11 1.455 . . . . 0.0 111.029 168.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.427 ' HG2' ' HA3' ' A' ' 197' ' ' GLY . 1.7 pm0 36.19 55.37 1.03 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 122.862 1.315 . . . . 0.0 112.698 -175.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.469 ' HA2' HD22 ' A' ' 190' ' ' LEU . . . 65.24 -140.75 41.97 Favored Glycine 0 N--CA 1.474 1.175 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.993 -174.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -80.81 51.33 1.5 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.666 -0.902 . . . . 0.0 110.245 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.427 ' HA3' ' HG2' ' A' ' 194' ' ' GLU . . . -89.86 -51.26 2.88 Favored Glycine 0 N--CA 1.473 1.105 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 177.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.7 mt -53.4 -41.13 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 122.154 -0.615 . . . . 0.0 111.519 173.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.434 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 71.7 t -49.93 -57.39 12.63 Favored Pre-proline 0 N--CA 1.48 1.057 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -175.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 67.7 Cg_endo -67.68 -35.55 21.74 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.114 2.543 . . . . 0.0 113.053 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -49.85 -46.9 51.84 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.757 -0.59 . . . . 0.0 111.567 175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -48.55 -54.15 15.53 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 121.678 -0.638 . . . . 0.0 111.406 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 57.7 mt -54.61 -49.07 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.041 0.536 . . . . 0.0 111.137 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -53.86 -56.07 20.94 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.877 0.37 . . . . 0.0 111.145 175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 52.6 m -53.77 -51.7 62.57 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.116 0.566 . . . . 0.0 112.086 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.3 pp -62.56 -42.71 99.72 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.614 -0.678 . . . . 0.0 112.417 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.444 ' N ' HD12 ' A' ' 206' ' ' LEU . 5.0 tt -56.26 -53.8 52.92 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.538 -0.726 . . . . 0.0 110.027 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -52.87 -50.57 63.54 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.659 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 54.5 ttm -51.29 -49.72 60.71 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.2 t -52.65 -52.54 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 121.694 -0.629 . . . . 0.0 111.289 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.1 mt -55.54 -51.46 66.97 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.33 0.586 . . . . 0.0 111.827 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -48.78 -53.95 17.04 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.605 0.762 . . . . 0.0 111.327 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 87.1 t -59.84 -51.01 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 58.5 p -57.27 -39.13 75.04 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 121.281 -0.887 . . . . 0.0 111.486 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.67 -44.89 73.73 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -52.76 -51.27 61.3 Favored 'General case' 0 N--CA 1.482 1.155 0 CA-C-O 121.513 0.673 . . . . 0.0 110.98 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.14 -52.42 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.067 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.12 -50.83 50.03 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -54.62 -50.87 67.07 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 122.093 -0.651 . . . . 0.0 111.235 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.39 -50.23 41.94 Favored Glycine 0 N--CA 1.476 1.331 0 O-C-N 121.753 -0.592 . . . . 0.0 112.134 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 79.6 mt -55.54 -53.56 54.86 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.153 -0.616 . . . . 0.0 112.15 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.427 HG12 HH21 ' A' ' 225' ' ' ARG . 79.0 mt -52.55 -51.95 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.108 0.48 . . . . 0.0 111.082 178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 43.7 tp -55.17 -55.16 34.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.406 0.682 . . . . 0.0 112.128 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.0 tp -58.11 -50.89 71.9 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.127 0.489 . . . . 0.0 111.38 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.427 HH21 HG12 ' A' ' 222' ' ' ILE . 35.7 ttp180 -49.55 -41.08 40.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.398 0.679 . . . . 0.0 112.75 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.406 ' HB2' ' NH1' ' A' ' 227' ' ' ARG . 75.3 m -64.19 -60.89 2.66 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.45 -0.781 . . . . 0.0 111.741 170.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.406 ' NH1' ' HB2' ' A' ' 226' ' ' SER . 51.3 mmt-85 -58.04 104.71 0.21 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -172.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 56.14 34.25 23.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.744 0.818 . . . . 0.0 112.743 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 69.1 mt -140.61 -40.77 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 121.866 -0.521 . . . . 0.0 110.316 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.403 ' HB2' ' HA ' ' A' ' 226' ' ' SER . 1.8 t80 -79.73 177.17 9.09 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.591 -0.693 . . . . 0.0 110.382 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.659 0 O-C-N 121.346 -0.847 . . . . 0.0 113.455 -177.384 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.511 ' HG2' ' H ' ' A' ' 164' ' ' ARG . 48.2 ttp . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 121.028 0.442 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.511 ' H ' ' HG2' ' A' ' 163' ' ' MET . 0.9 OUTLIER -58.43 -51.26 83.06 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 178.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -59.62 -63.46 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.983 2.455 . . . . 0.0 115.776 -162.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -77.57 162.41 27.11 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.198 -0.939 . . . . 0.0 111.953 -172.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.01 -50.68 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 O-C-N 121.64 -0.663 . . . . 0.0 110.334 174.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.29 82.98 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.034 0.445 . . . . 0.0 110.645 175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.3 m -49.3 -52.92 24.6 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.3 m -57.14 -49.72 75.03 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.805 -0.559 . . . . 0.0 111.586 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -54.18 -48.02 71.39 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.112 0.482 . . . . 0.0 111.709 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -55.65 -49.21 73.5 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.783 -0.573 . . . . 0.0 112.061 176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 78.7 t -54.5 -49.16 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 121.94 -0.475 . . . . 0.0 111.667 176.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.4 tt -52.18 -55.0 23.9 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.184 0.516 . . . . 0.0 110.497 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 85.5 mtt-85 -52.72 -50.5 63.29 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 15.7 t30 -52.82 -56.87 12.58 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.581 -0.699 . . . . 0.0 111.995 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 79.7 t -54.17 -49.74 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 121.971 -0.456 . . . . 0.0 111.935 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 21.2 p -56.16 -46.04 79.44 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 121.625 -0.672 . . . . 0.0 112.6 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.1 t -56.51 -48.4 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.373 -0.83 . . . . 0.0 111.879 174.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 82.2 t -54.16 -48.52 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 121.629 -0.669 . . . . 0.0 111.668 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.7 mt -55.61 -50.01 71.28 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.509 -0.744 . . . . 0.0 111.887 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 36.0 t90 -53.22 -53.3 52.64 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.868 -0.52 . . . . 0.0 112.353 178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 18.5 p -61.5 -38.38 87.13 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.52 -45.09 95.12 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.207 -0.933 . . . . 0.0 112.463 174.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -40.79 -51.83 6.84 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 115.825 1.787 . . . . 0.0 115.825 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -58.47 -40.4 74.94 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.905 2.404 . . . . 0.0 112.516 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.5 t -60.63 -45.08 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 121.795 -0.565 . . . . 0.0 110.375 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 67.4 t -53.54 -50.05 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.823 -0.548 . . . . 0.0 110.723 175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 12.4 m95 -53.1 -51.19 62.67 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.448 ' HB2' ' CD1' ' A' ' 198' ' ' ILE . 48.0 tp -47.04 -53.38 12.7 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.985 -0.447 . . . . 0.0 111.511 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -52.39 -55.71 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.995 0.426 . . . . 0.0 110.117 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -86.04 52.55 4.55 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.89 -0.506 . . . . 0.0 112.192 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 58.6 p -164.16 -42.34 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 118.485 1.143 . . . . 0.0 112.522 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 53.21 30.6 10.17 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.824 0.821 . . . . 0.0 110.971 -171.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 143.08 -47.48 0.8 Allowed Glycine 0 N--CA 1.472 1.048 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -79.37 58.7 2.67 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 122.471 1.129 . . . . 0.0 113.049 -172.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -172.84 -62.4 0.05 OUTLIER Glycine 0 N--CA 1.471 0.987 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 190' ' ' LEU . 6.0 mt -61.95 -47.81 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 O-C-N 121.959 -0.73 . . . . 0.0 112.161 176.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 71.1 t -46.28 -55.22 14.35 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -66.69 -43.16 7.81 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.729 2.286 . . . . 0.0 112.821 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 10.4 tt -51.48 -43.45 62.16 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.433 HD21 HG22 ' A' ' 198' ' ' ILE . 72.7 m-80 -45.36 -46.11 12.89 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 61.2 mt -60.41 -48.9 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-O 121.457 0.646 . . . . 0.0 110.134 -175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -59.75 -47.92 83.73 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.413 176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 83.5 m -53.69 -55.27 27.55 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.662 -0.649 . . . . 0.0 111.732 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 207' ' ' LEU . 4.5 pp -60.78 -39.86 90.42 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.626 -0.671 . . . . 0.0 112.279 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.434 ' N ' HD12 ' A' ' 206' ' ' LEU . 3.1 tm? -54.09 -56.19 20.43 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.544 -0.723 . . . . 0.0 110.603 174.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.43 -53.48 29.24 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.556 0.342 . . . . 0.0 111.385 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 92.6 mtp -49.1 -49.64 40.9 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 76.6 t -52.87 -51.26 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 O-C-N 121.601 -0.687 . . . . 0.0 111.372 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.83 -47.84 73.6 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -54.22 -52.59 60.82 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.703 -0.623 . . . . 0.0 111.889 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.8 t -56.38 -54.94 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 121.925 -0.484 . . . . 0.0 111.899 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.1 p -56.24 -47.68 77.99 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.781 -0.574 . . . . 0.0 112.3 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.03 -48.72 75.45 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.905 -0.497 . . . . 0.0 111.972 177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -53.32 50.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.589 0.356 . . . . 0.0 111.273 177.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.26 -51.69 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 122.077 -0.39 . . . . 0.0 111.281 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -51.37 -52.59 31.87 Favored Glycine 0 N--CA 1.475 1.279 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -53.97 -47.56 71.23 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 122.239 -0.565 . . . . 0.0 111.583 177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -48.21 -54.37 12.72 Favored Glycine 0 N--CA 1.477 1.387 0 N-CA-C 112.199 -0.36 . . . . 0.0 112.199 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.57 -53.35 58.63 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.134 -0.627 . . . . 0.0 112.226 177.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 98.8 mt -52.2 -54.05 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 55.6 tp -56.23 -51.81 66.76 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.279 0.632 . . . . 0.0 111.698 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -51.6 -53.57 36.93 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 120.916 0.389 . . . . 0.0 110.937 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 77.8 mtt-85 -58.76 -56.94 15.77 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 25.1 p -56.51 -46.18 80.68 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.825 -0.547 . . . . 0.0 112.052 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.44 -51.63 64.36 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.055 0.542 . . . . 0.0 111.575 175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.49 76.86 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 96.8 mt -58.02 -49.0 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-O 120.977 0.417 . . . . 0.0 111.464 178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 231' ' ' GLY . 19.5 t80 -61.52 155.07 22.94 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.651 0.738 . . . . 0.0 112.229 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . 0.404 ' N ' ' CD1' ' A' ' 230' ' ' PHE . . . . . . . . 0 CA--C 1.54 1.645 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.68 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.514 ' HG2' ' H ' ' A' ' 164' ' ' ARG . 10.4 ttt . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.514 ' H ' ' HG2' ' A' ' 163' ' ' MET . 50.3 mmm-85 61.84 69.42 0.99 Allowed Pre-proline 0 N--CA 1.479 0.999 0 O-C-N 121.444 -0.785 . . . . 0.0 111.548 -176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.04 61.11 7.59 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.211 3.274 . . . . 0.0 111.034 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -157.86 -161.08 0.98 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.879 -172.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.9 m 52.16 -170.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.96 21.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.978 0.511 . . . . 0.0 112.365 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -51.07 -65.19 0.6 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.235 -0.291 . . . . 0.0 111.751 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 76.2 p -67.91 -39.52 83.54 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.424 -0.798 . . . . 0.0 111.83 -177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -53.69 -54.57 36.01 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 122.053 -0.404 . . . . 0.0 111.597 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -62.51 -47.21 84.93 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 121.747 -0.595 . . . . 0.0 112.128 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -50.17 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.873 -0.517 . . . . 0.0 111.569 178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 57.8 tp -57.27 -48.57 78.54 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.775 -0.578 . . . . 0.0 111.541 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 20.8 mmm-85 -57.68 -44.79 86.02 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.453 -0.779 . . . . 0.0 112.919 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -51.31 -56.61 12.11 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 121.78 -0.575 . . . . 0.0 111.073 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.2 t -53.79 -51.08 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.2 p -56.84 -47.82 79.47 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 74.8 t -59.56 -47.04 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.463 -0.773 . . . . 0.0 111.979 177.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.94 -49.53 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 O-C-N 121.684 -0.635 . . . . 0.0 111.491 176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.5 mt -56.03 -48.34 76.14 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.628 -0.67 . . . . 0.0 111.994 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -52.37 -54.42 32.06 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 58.0 p -59.64 -47.49 85.39 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.477 -0.764 . . . . 0.0 111.554 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.6 -14.13 61.99 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.421 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 4.3 t80 -62.99 -56.29 29.9 Favored Pre-proline 0 N--CA 1.476 0.832 0 O-C-N 120.84 -1.162 . . . . 0.0 111.153 -173.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 58.2 Cg_endo -62.22 -35.96 71.39 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.994 2.463 . . . . 0.0 112.243 175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.28 -57.23 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.812 -0.555 . . . . 0.0 111.057 176.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 97.3 t -60.88 -40.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 O-C-N 121.806 -0.559 . . . . 0.0 111.493 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -54.57 -50.22 68.48 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.276 -0.89 . . . . 0.0 111.62 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 54.9 tp -53.2 -43.42 67.17 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.958 -0.463 . . . . 0.0 111.181 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 mm -54.49 -53.95 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 121.359 -0.838 . . . . 0.0 109.716 171.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -71.75 29.64 0.62 Allowed Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.62 -0.675 . . . . 0.0 113.738 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 22.0 p -151.07 -10.68 0.23 Allowed 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.642 -0.916 . . . . 0.0 110.74 168.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -158.48 55.69 0.45 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.394 1.078 . . . . 0.0 108.562 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 176.94 -57.31 0.1 Allowed Glycine 0 N--CA 1.476 1.31 0 O-C-N 120.908 -1.12 . . . . 0.0 111.811 -177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . 47.82 50.41 15.54 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.027 0.931 . . . . 0.0 112.485 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 157.46 -33.75 0.54 Allowed Glycine 0 N--CA 1.475 1.257 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 9.5 mt -73.92 25.95 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 CA-C-O 121.258 0.551 . . . . 0.0 112.216 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.527 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 67.1 t -79.03 -59.43 0.63 Allowed Pre-proline 0 N--CA 1.478 0.933 0 O-C-N 119.893 -1.754 . . . . 0.0 108.79 175.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.527 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 37.8 Cg_endo -58.86 -41.07 66.2 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.623 2.215 . . . . 0.0 111.126 170.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 83.9 mt -56.46 -51.21 69.29 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 122.091 -0.381 . . . . 0.0 111.845 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -52.28 -57.19 10.49 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.58 -0.7 . . . . 0.0 111.868 177.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 80.0 mt -56.08 -51.66 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 121.217 0.532 . . . . 0.0 111.186 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.19 -56.45 14.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.378 0.671 . . . . 0.0 111.429 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 96.3 m -54.57 -47.53 73.16 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.128 -0.357 . . . . 0.0 111.683 -177.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.4 mt -55.36 -57.1 13.22 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.718 -0.613 . . . . 0.0 111.89 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -57.22 -51.28 69.98 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.247 0.546 . . . . 0.0 111.773 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -53.79 -53.07 57.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.033 0.533 . . . . 0.0 110.493 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 26.9 ttt -52.04 -45.57 64.72 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.638 0.375 . . . . 0.0 112.003 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 94.8 t -51.5 -53.24 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 O-C-N 121.513 -0.742 . . . . 0.0 111.202 174.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 10.5 mp -54.97 -50.76 68.13 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 121.965 -0.459 . . . . 0.0 112.173 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -52.71 -54.91 27.09 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.051 -0.406 . . . . 0.0 111.752 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 71.3 t -57.16 -54.71 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 122.122 -0.361 . . . . 0.0 111.741 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.4 p -55.18 -49.96 70.54 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.519 -0.738 . . . . 0.0 112.306 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.75 -49.65 76.86 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.908 -0.495 . . . . 0.0 112.037 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -57.2 -48.72 78.07 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 122.085 -0.385 . . . . 0.0 110.826 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 63.8 t -53.98 -53.27 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 121.481 -0.762 . . . . 0.0 111.235 176.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.83 -50.78 36.5 Favored Glycine 0 N--CA 1.477 1.424 0 O-C-N 121.797 -0.564 . . . . 0.0 111.762 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -54.01 -49.51 68.72 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.267 -0.549 . . . . 0.0 111.186 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -52.62 -49.72 51.81 Favored Glycine 0 N--CA 1.475 1.274 0 O-C-N 121.962 -0.461 . . . . 0.0 112.754 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp -54.92 -50.67 68.25 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 121.942 -0.74 . . . . 0.0 111.933 176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.39 -50.41 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-O 121.293 0.568 . . . . 0.0 111.326 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 61.2 tp -53.13 -48.39 67.94 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.482 0.713 . . . . 0.0 111.94 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 tt -55.22 -56.22 22.43 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 121.798 -0.564 . . . . 0.0 109.848 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -59.51 -13.84 10.54 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 32.7 t -90.19 -60.05 2.03 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.287 -0.883 . . . . 0.0 109.36 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -59.96 103.84 0.25 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.913 0.885 . . . . 0.0 112.605 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . 64.27 34.03 11.08 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 122.077 0.941 . . . . 0.0 111.968 177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 51.3 mt -141.8 -48.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -84.6 -47.81 10.15 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 169.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.69 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.394 176.225 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 120.824 0.345 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -161.85 82.59 1.8 Allowed Pre-proline 0 N--CA 1.473 0.677 0 O-C-N 121.813 -0.554 . . . . 0.0 110.326 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -77.61 61.22 7.41 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.991 3.127 . . . . 0.0 111.572 172.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 61.69 85.69 0.12 Allowed 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.271 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 53.2 t -44.79 -51.41 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -176.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.77 -49.49 75.12 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.914 -0.491 . . . . 0.0 111.773 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 51.0 m -59.37 -54.92 41.26 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.956 -0.465 . . . . 0.0 111.808 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.7 t -58.78 -41.37 86.52 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.957 -0.465 . . . . 0.0 111.643 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -56.19 -51.9 66.36 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.476 -0.765 . . . . 0.0 111.322 174.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -55.05 -46.74 75.36 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.847 -0.533 . . . . 0.0 112.224 177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 70.9 t -55.4 -52.09 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 O-C-N 122.024 -0.423 . . . . 0.0 111.521 176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.7 tp -52.81 -50.51 63.51 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 121.711 -0.618 . . . . 0.0 111.624 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.629 ' HA ' ' HE ' ' A' ' 175' ' ' ARG . 0.0 OUTLIER -54.09 -50.39 66.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 176.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -53.67 -56.08 20.44 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.233 -0.292 . . . . 0.0 111.013 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.0 t -51.77 -52.78 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 122.659 0.383 . . . . 0.0 111.844 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.5 p -56.71 -52.24 65.73 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 80.4 t -58.33 -48.96 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.729 -0.607 . . . . 0.0 112.001 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 77.1 t -57.25 -54.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 O-C-N 121.703 -0.623 . . . . 0.0 111.215 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.3 mt -53.23 -46.83 69.28 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 121.492 -0.755 . . . . 0.0 111.857 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 39.8 t90 -53.5 -56.96 12.56 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.1 p -61.0 -42.91 99.35 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.695 0.759 . . . . 0.0 112.151 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.61 -25.1 67.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -57.08 -56.19 36.21 Favored Pre-proline 0 N--CA 1.474 0.727 0 O-C-N 121.345 -0.847 . . . . 0.0 112.652 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -60.15 -36.05 90.07 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.971 2.447 . . . . 0.0 112.802 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.99 -55.7 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.596 -0.69 . . . . 0.0 110.925 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.24 -45.65 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 O-C-N 121.98 -0.45 . . . . 0.0 111.234 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -50.32 -58.5 5.53 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.207 -0.308 . . . . 0.0 111.015 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.2 tt -47.72 -49.63 27.58 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.799 0.84 . . . . 0.0 110.546 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 85.3 mt -52.32 -59.18 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 O-C-N 121.687 -0.633 . . . . 0.0 110.486 174.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.72 52.04 4.52 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-O 121.409 0.45 . . . . 0.0 112.985 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 14.3 p -163.21 -49.67 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.962 -0.728 . . . . 0.0 110.529 175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.15 42.91 0.11 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.748 0.785 . . . . 0.0 111.521 176.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -159.57 38.62 0.48 Allowed Glycine 0 CA--C 1.533 1.189 0 O-C-N 120.982 -1.074 . . . . 0.0 111.858 173.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -80.9 -42.37 21.53 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.777 -0.837 . . . . 0.0 110.926 172.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -58.44 -44.88 95.06 Favored Glycine 0 N--CA 1.475 1.274 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.952 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 28.1 pt 8.72 73.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 176.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.415 ' N ' ' HD2' ' A' ' 200' ' ' PRO . 99.1 t -41.66 -58.03 3.45 Favored Pre-proline 0 N--CA 1.475 0.808 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -172.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 199' ' ' VAL . 40.4 Cg_endo -56.36 -38.38 95.29 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 123.038 2.492 . . . . 0.0 113.785 -175.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 2.8 tt -71.25 -51.74 22.88 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -51.99 -47.79 64.72 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.012 0.434 . . . . 0.0 111.941 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 81.0 mt -55.06 -53.47 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.982 -0.448 . . . . 0.0 111.517 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -56.42 -44.65 80.57 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 121.728 -0.607 . . . . 0.0 112.052 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 40.2 m -51.97 -52.6 49.26 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 121.448 -0.783 . . . . 0.0 110.889 177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 55.7 tp -55.73 -52.12 65.0 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.914 0.387 . . . . 0.0 111.792 176.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.5 tt -51.11 -56.59 11.93 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.469 0.708 . . . . 0.0 110.772 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -54.76 -48.43 72.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.242 0.617 . . . . 0.0 111.366 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 56.5 ttp -53.73 -50.72 65.34 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.597 -0.689 . . . . 0.0 111.913 177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.4 t -54.3 -48.98 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 121.786 -0.571 . . . . 0.0 111.401 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 98.0 mt -53.31 -53.79 45.88 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.864 -0.522 . . . . 0.0 111.67 176.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -47.67 -54.24 12.6 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.888 -0.508 . . . . 0.0 111.659 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.0 t -55.66 -57.23 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 O-C-N 122.002 -0.436 . . . . 0.0 111.706 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 86.5 p -58.71 -48.7 80.22 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.695 -0.628 . . . . 0.0 112.621 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.47 -45.19 94.6 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.88 -0.513 . . . . 0.0 111.319 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -55.06 -49.91 70.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.77 0.428 . . . . 0.0 111.547 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 84.4 t -55.22 -52.57 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 O-C-N 122.041 -0.412 . . . . 0.0 111.005 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.54 -50.4 36.24 Favored Glycine 0 N--CA 1.477 1.374 0 O-C-N 121.885 -0.509 . . . . 0.0 112.391 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -53.12 -49.96 65.45 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.056 -0.673 . . . . 0.0 111.102 177.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.43 -48.53 64.31 Favored Glycine 0 N--CA 1.477 1.406 0 O-C-N 121.888 -0.508 . . . . 0.0 112.714 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.429 ' HB3' HH21 ' A' ' 225' ' ' ARG . 83.0 mt -56.82 -45.27 82.41 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 121.783 -0.834 . . . . 0.0 112.463 177.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.13 -47.5 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 121.653 -0.654 . . . . 0.0 111.902 175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.407 HD12 ' HB3' ' A' ' 227' ' ' ARG . 65.5 tp -50.39 -55.53 15.32 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 121.794 -0.566 . . . . 0.0 110.601 175.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 32.6 tp -80.94 62.06 4.79 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 122.761 1.267 . . . . 0.0 110.16 174.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.429 HH21 ' HB3' ' A' ' 221' ' ' LEU . 9.7 ttm180 -164.02 -54.54 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.6 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 55.2 p -147.03 54.16 1.09 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.155 0.979 . . . . 0.0 111.858 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.407 ' HB3' HD12 ' A' ' 223' ' ' LEU . 0.2 OUTLIER -163.89 -66.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 O-C-N 121.521 -0.737 . . . . 0.0 109.396 176.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -70.81 -46.14 63.36 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.704 0.764 . . . . 0.0 109.68 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.9 mt -57.16 -29.35 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.144 173.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -83.94 64.65 8.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.486 1.136 . . . . 0.0 110.412 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.653 0 CA-C-N 115.672 -0.694 . . . . 0.0 113.184 177.535 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 20.5 ptt? . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -153.82 62.76 4.07 Favored Pre-proline 0 N--CA 1.475 0.813 0 O-C-N 121.589 -0.695 . . . . 0.0 111.225 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -62.3 -62.99 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 123.141 2.561 . . . . 0.0 111.883 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.94 -114.92 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 170.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.667 HG12 ' H ' ' A' ' 168' ' ' ALA . 2.7 t 63.19 -169.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.005 -1.059 . . . . 0.0 110.004 168.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.667 ' H ' HG12 ' A' ' 167' ' ' VAL . . . -45.7 -31.1 1.81 Allowed 'General case' 0 N--CA 1.475 0.824 0 O-C-N 120.716 -1.24 . . . . 0.0 113.562 174.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 55.5 m -60.32 -64.94 0.77 Allowed 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.522 -0.737 . . . . 0.0 111.433 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.2 m -63.5 -36.76 84.85 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.635 -0.665 . . . . 0.0 111.758 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -52.49 -52.38 54.71 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.558 -0.714 . . . . 0.0 111.306 175.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -58.98 -47.27 85.74 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.939 -0.476 . . . . 0.0 111.464 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 68.8 t -51.59 -53.26 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 122.06 -0.4 . . . . 0.0 111.48 175.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.8 tt -54.15 -52.37 61.34 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.112 0.565 . . . . 0.0 110.869 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -52.35 45.57 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.948 0.404 . . . . 0.0 110.632 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -53.52 -55.11 28.3 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.701 -0.625 . . . . 0.0 111.776 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 75.1 t -52.95 -48.66 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 71.8 p -61.46 -45.58 93.67 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.518 -0.738 . . . . 0.0 112.252 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 72.4 t -55.51 -49.73 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 O-C-N 121.346 -0.846 . . . . 0.0 111.638 174.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.7 t -52.99 -51.03 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 O-C-N 122.047 -0.408 . . . . 0.0 110.722 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.3 tt -50.67 -54.46 22.86 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.742 -0.599 . . . . 0.0 111.106 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -57.52 -47.39 82.1 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 60.4 p -61.15 -42.87 99.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 121.242 -0.912 . . . . 0.0 111.08 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.24 -13.0 61.56 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -62.48 -56.42 30.32 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.464 -1.398 . . . . 0.0 111.197 -177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -61.41 -39.17 58.47 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.801 2.334 . . . . 0.0 111.862 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 202' ' ' ASN . 35.8 t -46.87 -52.6 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 122.004 -0.435 . . . . 0.0 111.753 173.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.49 -57.33 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 O-C-N 122.059 -0.401 . . . . 0.0 111.086 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.8 t90 -47.94 -45.07 30.64 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.7 tp -50.7 -35.22 30.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.572 ' HB ' HD11 ' A' ' 198' ' ' ILE . 9.8 tt -68.95 -44.39 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.095 -1.003 . . . . 0.0 109.658 178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.26 52.13 4.26 Favored Glycine 0 N--CA 1.475 1.249 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 176.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 18.8 p -169.47 -67.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.308 0.643 . . . . 0.0 110.557 177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -95.17 47.79 1.15 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 122.281 1.038 . . . . 0.0 111.18 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 57.25 -166.15 5.47 Favored Glycine 0 CA--C 1.537 1.43 0 O-C-N 121.6 -0.687 . . . . 0.0 112.231 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.466 ' HA ' HG13 ' A' ' 191' ' ' ILE . . . -81.59 37.83 0.48 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.471 -1.017 . . . . 0.0 112.443 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -85.73 45.22 3.45 Favored Glycine 0 N--CA 1.476 1.322 0 O-C-N 121.459 -0.776 . . . . 0.0 112.19 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 191' ' ' ILE . 7.3 pt -151.83 -175.03 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 O-C-N 122.063 -0.669 . . . . 0.0 111.308 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . 0.275 94.6 t 113.63 -64.68 0.0 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 126.89 2.076 . . . . 0.0 112.777 171.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -63.01 -54.4 1.15 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 121.934 1.756 . . . . 0.0 111.369 -177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.98 -45.37 74.99 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.944 0.402 . . . . 0.0 110.809 173.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.487 ' HB3' HG13 ' A' ' 187' ' ' VAL . 4.4 m120 -57.28 -53.08 62.22 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -176.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 95.9 mt -57.67 -46.86 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 O-C-N 122.109 -0.369 . . . . 0.0 110.704 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -50.95 -55.08 18.98 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.196 -0.315 . . . . 0.0 111.313 175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 51.3 m -53.31 -50.7 64.41 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.916 0.487 . . . . 0.0 111.899 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 57.5 tp -57.05 -50.8 71.62 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 121.805 -0.56 . . . . 0.0 111.604 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.35 -54.03 42.42 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.441 0.639 . . . . 0.0 110.349 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -52.0 -51.65 55.88 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.093 0.557 . . . . 0.0 111.477 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 27.2 ttt -49.4 -48.07 47.36 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 90.7 t -52.3 -52.89 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 O-C-N 121.76 -0.588 . . . . 0.0 111.29 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 8.8 mp -54.05 -50.65 66.24 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -50.09 -57.45 7.62 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.772 -0.58 . . . . 0.0 111.306 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.2 t -53.07 -53.62 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 122.21 -0.306 . . . . 0.0 111.504 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 60.6 p -57.03 -44.84 83.29 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.944 -0.472 . . . . 0.0 111.604 -177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.1 -52.42 65.37 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 121.958 -0.464 . . . . 0.0 112.202 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -46.11 83.16 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 177.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.04 -50.7 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.659 -0.65 . . . . 0.0 111.524 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.16 -51.39 54.35 Favored Glycine 0 N--CA 1.475 1.238 0 O-C-N 121.806 -0.559 . . . . 0.0 112.018 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -53.82 -51.59 63.05 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 122.109 -0.642 . . . . 0.0 110.989 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -54.0 -48.16 63.83 Favored Glycine 0 N--CA 1.473 1.163 0 O-C-N 122.07 -0.394 . . . . 0.0 112.218 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.28 -51.17 65.43 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.912 -0.758 . . . . 0.0 112.399 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.72 -50.74 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 O-C-N 121.717 -0.614 . . . . 0.0 111.083 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 48.5 tp -53.68 -58.28 7.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.136 0.574 . . . . 0.0 111.263 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.32 60.89 4.59 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 122.357 1.075 . . . . 0.0 110.59 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.419 ' HD2' ' OG ' ' A' ' 226' ' ' SER . 7.0 tmm_? -172.73 -53.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.346 -178.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.419 ' OG ' ' HD2' ' A' ' 225' ' ' ARG . 75.1 m -139.2 65.52 1.44 Allowed 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.501 1.143 . . . . 0.0 111.041 177.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -174.55 -60.23 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -85.35 -51.57 6.47 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.6 175.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 18.4 mt -70.03 -75.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 O-C-N 121.98 -0.45 . . . . 0.0 110.567 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -97.94 -174.25 2.82 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 169.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.516 0 O-C-N 121.053 -1.03 . . . . 0.0 112.336 172.685 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.509 ' CG ' ' HD2' ' A' ' 165' ' ' PRO . 48.0 ttt85 69.58 158.19 0.15 Allowed Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -149.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 164' ' ' ARG . 80.4 Cg_endo -74.22 42.42 0.75 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.134 1.889 . . . . 0.0 114.121 173.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 36.01 41.15 0.12 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 176.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.35 -55.77 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 O-C-N 121.258 -0.901 . . . . 0.0 110.123 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -61.38 -39.73 91.75 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.173 0.511 . . . . 0.0 110.442 173.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.8 m -53.97 -59.07 5.12 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 122.801 0.44 . . . . 0.0 111.475 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 41.5 p -59.83 -44.59 93.98 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.724 -0.61 . . . . 0.0 112.131 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -49.95 -55.35 14.87 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.851 -0.531 . . . . 0.0 111.471 177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -55.09 -52.1 64.31 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 122.038 -0.414 . . . . 0.0 111.953 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 79.3 t -53.93 -51.93 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 122.141 -0.35 . . . . 0.0 111.876 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.408 ' C ' HD23 ' A' ' 174' ' ' LEU . 6.2 tt -56.81 -57.2 13.5 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.786 0.434 . . . . 0.0 110.902 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -53.17 -49.54 66.45 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.054 0.454 . . . . 0.0 110.515 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -52.05 -62.07 1.86 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.991 -0.443 . . . . 0.0 111.946 175.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 68.9 t -55.65 -46.82 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 33.8 p -58.86 -50.43 74.04 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.708 -0.62 . . . . 0.0 112.426 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.88 -45.4 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.596 -0.69 . . . . 0.0 111.854 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.4 t -54.53 -55.01 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.748 -0.595 . . . . 0.0 110.918 175.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.4 tt -51.07 -49.71 60.1 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 121.813 -0.555 . . . . 0.0 111.114 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 47.9 t90 -49.75 -58.04 6.12 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 82.4 p -61.12 -41.09 96.06 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.765 0.793 . . . . 0.0 111.833 -178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -60.17 -29.49 68.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . 0.416 ' N ' ' HD2' ' A' ' 186' ' ' PRO . 51.6 t80 -54.81 -53.94 55.17 Favored Pre-proline 0 N--CA 1.478 0.932 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -171.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 185' ' ' TYR . 39.3 Cg_endo -59.17 -36.93 94.57 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.994 2.462 . . . . 0.0 112.762 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 27.5 t -59.49 -52.68 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 O-C-N 121.613 -0.68 . . . . 0.0 110.459 175.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.8 t -53.52 -46.12 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.04 0.536 . . . . 0.0 111.365 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -52.04 -58.85 5.31 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 122.012 -0.43 . . . . 0.0 111.24 173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 53.7 tp -50.44 -42.92 54.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.604 0.362 . . . . 0.0 111.93 -177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 91.0 mt -56.08 -61.16 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 O-C-N 122.072 -0.393 . . . . 0.0 110.192 172.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.35 53.14 4.63 Favored Glycine 0 N--CA 1.477 1.418 0 CA-C-O 121.781 0.656 . . . . 0.0 112.506 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 88.1 p -171.34 -26.39 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.144 0.978 . . . . 0.0 110.333 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 38.48 40.16 0.36 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.433 1.093 . . . . 0.0 113.44 -166.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -79.12 51.15 3.83 Favored Glycine 0 N--CA 1.478 1.481 0 O-C-N 122.054 -0.404 . . . . 0.0 113.281 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -69.64 82.84 0.43 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.909 0.861 . . . . 0.0 111.532 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 63.91 26.72 70.36 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 16.6 mt -72.17 -34.79 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 121.684 -0.892 . . . . 0.0 110.925 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.424 ' HB ' ' CD ' ' A' ' 200' ' ' PRO . 90.7 t -52.26 -60.88 5.32 Favored Pre-proline 0 N--CA 1.476 0.834 0 O-C-N 121.517 -0.739 . . . . 0.0 111.836 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.424 ' CD ' ' HB ' ' A' ' 199' ' ' VAL . 57.8 Cg_endo -61.72 -38.95 56.79 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.763 2.309 . . . . 0.0 112.749 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.402 HD23 ' C ' ' A' ' 201' ' ' LEU . 6.0 tt -50.11 -59.06 4.28 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 122.038 -0.414 . . . . 0.0 110.872 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -59.02 -40.75 85.92 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 88.5 mt -50.96 -55.7 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.547 -0.721 . . . . 0.0 110.706 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -55.23 -51.07 67.79 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.919 -0.488 . . . . 0.0 111.619 177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 53.0 m -49.33 -46.98 47.48 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.695 0.398 . . . . 0.0 111.946 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 58.2 tp -53.93 -58.24 8.0 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.934 -0.479 . . . . 0.0 111.821 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -54.77 -48.24 72.93 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.771 -0.581 . . . . 0.0 111.987 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -52.59 -55.49 21.92 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.106 0.479 . . . . 0.0 110.958 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 28.0 ttt -54.28 -47.11 72.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 69.8 t -51.17 -52.05 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 O-C-N 121.499 -0.751 . . . . 0.0 111.255 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 86.9 mt -56.64 -48.51 77.4 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.097 0.475 . . . . 0.0 111.9 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -53.91 -53.61 50.31 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.381 0.61 . . . . 0.0 112.253 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -58.02 -53.34 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 121.947 -0.471 . . . . 0.0 111.632 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 63.6 p -55.7 -45.8 77.77 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.739 -0.601 . . . . 0.0 111.923 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.68 -49.44 72.93 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.882 -0.511 . . . . 0.0 112.057 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 216' ' ' LYS . 5.5 mmpt? -57.11 -45.8 83.15 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 177.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 95.8 t -54.57 -51.99 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 O-C-N 121.618 -0.676 . . . . 0.0 110.549 174.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.24 -51.66 30.28 Favored Glycine 0 N--CA 1.476 1.31 0 N-CA-C 111.924 -0.471 . . . . 0.0 111.924 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -49.79 -49.25 49.33 Favored 'General case' 0 N--CA 1.477 0.878 0 O-C-N 122.241 -0.564 . . . . 0.0 112.123 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -51.19 -52.58 31.19 Favored Glycine 0 N--CA 1.476 1.365 0 O-C-N 122.094 -0.379 . . . . 0.0 112.396 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 10.0 mp -56.93 -51.88 67.39 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 121.966 -0.726 . . . . 0.0 112.147 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 96.7 mt -49.75 -49.37 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.041 0.536 . . . . 0.0 111.294 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 60.5 tp -54.45 -58.54 7.05 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 122.038 -0.414 . . . . 0.0 110.755 174.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.29 52.91 2.46 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.19 0.995 . . . . 0.0 111.116 -178.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.25 -47.99 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.281 -0.887 . . . . 0.0 111.04 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 58.8 m -144.92 58.81 1.3 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.008 0.909 . . . . 0.0 111.324 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -166.98 -62.63 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.49 -0.756 . . . . 0.0 109.839 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -95.45 -48.49 5.83 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 4.1 mt 56.15 61.69 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.39 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -77.21 173.59 11.69 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.851 -1.155 . . . . 0.0 110.631 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.648 0 O-C-N 121.409 -0.807 . . . . 0.0 112.715 177.841 . . . . . . . . 0 0 . 1 stop_ save_